Citation
The Role of cytokines in Sendai virus-induced bronchiolar fibrosis

Material Information

Title:
The Role of cytokines in Sendai virus-induced bronchiolar fibrosis
Creator:
Uhl, Elizabeth Whitford, 1957-
Publication Date:
Language:
English
Physical Description:
vi, 152 leaves : ill. ; 29 cm.

Subjects

Subjects / Keywords:
Fibroblasts ( jstor )
Fibrosis ( jstor )
Infections ( jstor )
Inoculation ( jstor )
Lungs ( jstor )
Macrophages ( jstor )
Messenger RNA ( jstor )
Rats ( jstor )
RNA ( jstor )
Sendai virus ( jstor )
Cell Line ( mesh )
Gene Expression Regulation ( mesh )
Macrophages, Alveolar ( mesh )
Pulmonary Fibrosis -- etiology ( mesh )
Pulmonary Fibrosis -- physiopathology ( mesh )
Rats, Inbred BN ( mesh )
Rats, Inbred F344 ( mesh )
Respirovirus -- immunology ( mesh )
Respirovirus -- pathogenicity ( mesh )
Transforming Growth Factor beta -- metabolism ( mesh )
Transforming Growth Factor beta -- physiology ( mesh )
Tumor Necrosis Factor -- metabolism ( mesh )
Tumor Necrosis Factor -- physiology ( mesh )
Genre:
bibliography ( marcgt )
theses ( marcgt )
non-fiction ( marcgt )

Notes

Thesis:
Thesis (Ph. D.)--University of Florida, 1996.
Bibliography:
Includes bibliographical references (leaves 135-151).
General Note:
Typescript.
General Note:
Vita.
Statement of Responsibility:
by Elizabeth Whitford Uhl.

Record Information

Source Institution:
University of Florida
Holding Location:
University of Florida
Rights Management:
Copyright [name of dissertation author]. Permission granted to the University of Florida to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder.
Resource Identifier:
49818329 ( OCLC )
ocm49818329
002298730 ( ALEPH )

Downloads

This item has the following downloads:

AA00011214_00001.pdf

AA00011214_00001_0008.txt

AA00011214_00001_0100.txt

AA00011214_00001_0003.txt

roleofcytokinesi00uhle_0159.txt

AA00011214_00001_0147.txt

AA00011214_00001_0137.txt

roleofcytokinesi00uhle_0148.txt

AA00011214_00001_0097.txt

roleofcytokinesi00uhle_0077.txt

AA00011214_00001_0089.txt

roleofcytokinesi00uhle_0081.txt

roleofcytokinesi00uhle_0121.txt

roleofcytokinesi00uhle_0017.txt

AA00011214_00001_0114.txt

AA00011214_00001_0012.txt

AA00011214_00001_0151.txt

AA00011214_00001_0103.txt

roleofcytokinesi00uhle_0045.txt

AA00011214_00001_0016.txt

roleofcytokinesi00uhle_0036.txt

roleofcytokinesi00uhle_0014.txt

AA00011214_00001_0040.txt

roleofcytokinesi00uhle_0003.txt

roleofcytokinesi00uhle_0089.txt

AA00011214_00001_0056.txt

AA00011214_00001_0148.txt

AA00011214_00001_0063.txt

roleofcytokinesi00uhle_0024.txt

roleofcytokinesi00uhle_0008.txt

AA00011214_00001_0123.txt

roleofcytokinesi00uhle_0070.txt

AA00011214_00001_0140.txt

roleofcytokinesi00uhle_0001.txt

roleofcytokinesi00uhle_0135.txt

roleofcytokinesi00uhle_0010.txt

AA00011214_00001_0125.txt

roleofcytokinesi00uhle_0154.txt

AA00011214_00001_0142.txt

roleofcytokinesi00uhle_0026.txt

AA00011214_00001_0112.txt

roleofcytokinesi00uhle_0032.txt

roleofcytokinesi00uhle_0023.txt

roleofcytokinesi00uhle_0113.txt

AA00011214_00001_0156.txt

roleofcytokinesi00uhle_0056.txt

AA00011214_00001_0073.txt

AA00011214_00001_0124.txt

roleofcytokinesi00uhle_0131.txt

AA00011214_00001_0032.txt

roleofcytokinesi00uhle_0027.txt

roleofcytokinesi00uhle_0060.txt

roleofcytokinesi00uhle_0138.txt

AA00011214_00001_0152.txt

AA00011214_00001_0099.txt

roleofcytokinesi00uhle_0019.txt

AA00011214_00001_0116.txt

roleofcytokinesi00uhle_0074.txt

AA00011214_00001_0155.txt

AA00011214_00001_0005.txt

roleofcytokinesi00uhle_0115.txt

roleofcytokinesi00uhle_0049.txt

roleofcytokinesi00uhle_0099.txt

roleofcytokinesi00uhle_0021.txt

roleofcytokinesi00uhle_0000.txt

roleofcytokinesi00uhle_0055.txt

AA00011214_00001_0046.txt

roleofcytokinesi00uhle_0097.txt

AA00011214_00001_0157.txt

roleofcytokinesi00uhle_0152.txt

roleofcytokinesi00uhle_0022.txt

roleofcytokinesi00uhle_0139.txt

AA00011214_00001_0093.txt

roleofcytokinesi00uhle_0047.txt

roleofcytokinesi00uhle_0119.txt

roleofcytokinesi00uhle_0102.txt

AA00011214_00001_0039.txt

AA00011214_00001_0122.txt

AA00011214_00001_0052.txt

AA00011214_00001_0035.txt

AA00011214_00001_0059.txt

AA00011214_00001_0150.txt

roleofcytokinesi00uhle_0039.txt

roleofcytokinesi00uhle_0143.txt

AA00011214_00001_0091.txt

AA00011214_00001_0085.txt

roleofcytokinesi00uhle_0117.txt

AA00011214_00001_0149.txt

roleofcytokinesi00uhle_0043.txt

AA00011214_00001_0042.txt

AA00011214_00001_0077.txt

roleofcytokinesi00uhle_0082.txt

roleofcytokinesi00uhle_0031.txt

AA00011214_00001_0050.txt

AA00011214_00001_0138.txt

AA00011214_00001_0045.txt

AA00011214_00001_0153.txt

roleofcytokinesi00uhle_0065.txt

roleofcytokinesi00uhle_0069.txt

AA00011214_00001_0021.txt

roleofcytokinesi00uhle_0007.txt

AA00011214_00001_0096.txt

roleofcytokinesi00uhle_0156.txt

AA00011214_00001_0007.txt

AA00011214_00001_0025.txt

roleofcytokinesi00uhle_0094.txt

roleofcytokinesi00uhle_0052.txt

roleofcytokinesi00uhle_0133.txt

roleofcytokinesi00uhle_0061.txt

roleofcytokinesi00uhle_0028.txt

AA00011214_00001_0105.txt

roleofcytokinesi00uhle_0068.txt

roleofcytokinesi00uhle_0087.txt

AA00011214_00001_0018.txt

AA00011214_00001_0015.txt

AA00011214_00001_0043.txt

AA00011214_00001_0022.txt

AA00011214_00001_0047.txt

AA00011214_00001_0131.txt

AA00011214_00001_0086.txt

roleofcytokinesi00uhle_0090.txt

AA00011214_00001_0027.txt

AA00011214_00001_0006.txt

roleofcytokinesi00uhle_0015.txt

AA00011214_00001_0061.txt

AA00011214_00001_0160.txt

roleofcytokinesi00uhle_0011.txt

roleofcytokinesi00uhle_0084.txt

roleofcytokinesi00uhle_0112.txt

AA00011214_00001_0051.txt

roleofcytokinesi00uhle_0035.txt

AA00011214_00001_0126.txt

roleofcytokinesi00uhle_0020.txt

AA00011214_00001_0064.txt

AA00011214_00001_0092.txt

AA00011214_00001_0104.txt

roleofcytokinesi00uhle_0093.txt

AA00011214_00001_0080.txt

roleofcytokinesi00uhle_0105.txt

AA00011214_00001_0132.txt

roleofcytokinesi00uhle_0111.txt

roleofcytokinesi00uhle_0004.txt

roleofcytokinesi00uhle_0132.txt

roleofcytokinesi00uhle_0155.txt

roleofcytokinesi00uhle_0140.txt

roleofcytokinesi00uhle_0037.txt

AA00011214_00001_0121.txt

roleofcytokinesi00uhle_0057.txt

AA00011214_00001_0004.txt

roleofcytokinesi00uhle_0078.txt

AA00011214_00001_0161.txt

roleofcytokinesi00uhle_0002.txt

AA00011214_00001_0010.txt

roleofcytokinesi00uhle_0040.txt

roleofcytokinesi00uhle_0073.txt

AA00011214_00001_0094.txt

AA00011214_00001_0106.txt

AA00011214_00001_0079.txt

AA00011214_00001_0066.txt

AA00011214_00001_0011.txt

AA00011214_00001_0065.txt

AA00011214_00001_0145.txt

AA00011214_00001_0069.txt

AA00011214_00001_0120.txt

roleofcytokinesi00uhle_0147.txt

roleofcytokinesi00uhle_0145.txt

roleofcytokinesi00uhle_0129.txt

AA00011214_00001_0072.txt

AA00011214_00001_0088.txt

roleofcytokinesi00uhle_0059.txt

AA00011214_00001_0117.txt

roleofcytokinesi00uhle_0092.txt

AA00011214_00001_0014.txt

roleofcytokinesi00uhle_0013.txt

AA00011214_00001_0133.txt

roleofcytokinesi00uhle_0079.txt

AA00011214_00001_0049.txt

AA00011214_00001_0139.txt

roleofcytokinesi00uhle_0042.txt

roleofcytokinesi00uhle_0066.txt

roleofcytokinesi00uhle_0096.txt

AA00011214_00001_0030.txt

AA00011214_00001_0113.txt

roleofcytokinesi00uhle_0005.txt

roleofcytokinesi00uhle_0063.txt

roleofcytokinesi00uhle_0157.txt

AA00011214_00001_0036.txt

roleofcytokinesi00uhle_0095.txt

AA00011214_00001_0026.txt

roleofcytokinesi00uhle_0085.txt

AA00011214_00001_0013.txt

AA00011214_00001_0111.txt

roleofcytokinesi00uhle_0151.txt

roleofcytokinesi00uhle_0030.txt

AA00011214_00001_0019.txt

roleofcytokinesi00uhle_0130.txt

roleofcytokinesi00uhle_0038.txt

AA00011214_00001_0048.txt

roleofcytokinesi00uhle_0110.txt

AA00011214_00001_0024.txt

AA00011214_00001_0146.txt

roleofcytokinesi00uhle_0149.txt

roleofcytokinesi00uhle_0034.txt

AA00011214_00001_0078.txt

AA00011214_00001_0101.txt

AA00011214_00001_0028.txt

AA00011214_00001_0037.txt

AA00011214_00001_0159.txt

roleofcytokinesi00uhle_0101.txt

roleofcytokinesi00uhle_0016.txt

roleofcytokinesi00uhle_0137.txt

roleofcytokinesi00uhle_0122.txt

AA00011214_00001_0087.txt

AA00011214_00001_0128.txt

roleofcytokinesi00uhle_0158.txt

roleofcytokinesi00uhle_0076.txt

roleofcytokinesi00uhle_0054.txt

roleofcytokinesi00uhle_0018.txt

roleofcytokinesi00uhle_0012.txt

AA00011214_00001_0070.txt

AA00011214_00001_0067.txt

roleofcytokinesi00uhle_0114.txt

AA00011214_00001_0020.txt

roleofcytokinesi00uhle_0071.txt

roleofcytokinesi00uhle_0051.txt

AA00011214_00001_0158.txt

roleofcytokinesi00uhle_0108.txt

roleofcytokinesi00uhle_0100.txt

roleofcytokinesi00uhle_0153.txt

AA00011214_00001_0075.txt

AA00011214_00001_0154.txt

roleofcytokinesi00uhle_0118.txt

roleofcytokinesi00uhle_0107.txt

AA00011214_00001_0107.txt

AA00011214_00001_0082.txt

roleofcytokinesi00uhle_0072.txt

roleofcytokinesi00uhle_0058.txt

roleofcytokinesi00uhle_0048.txt

roleofcytokinesi00uhle_0103.txt

roleofcytokinesi00uhle_0123.txt

AA00011214_00001_0023.txt

AA00011214_00001_0058.txt

roleofcytokinesi00uhle_0067.txt

roleofcytokinesi00uhle_0160.txt

AA00011214_00001_0068.txt

AA00011214_00001_0118.txt

AA00011214_00001_0060.txt

roleofcytokinesi00uhle_0080.txt

roleofcytokinesi00uhle_0075.txt

AA00011214_00001_0031.txt

AA00011214_00001_0115.txt

roleofcytokinesi00uhle_0128.txt

AA00011214_00001_0102.txt

AA00011214_00001_0041.txt

roleofcytokinesi00uhle_0009.txt

AA00011214_00001_0076.txt

AA00011214_00001_0134.txt

roleofcytokinesi00uhle_0126.txt

AA00011214_00001_0001.txt

roleofcytokinesi00uhle_0062.txt

roleofcytokinesi00uhle_0041.txt

roleofcytokinesi00uhle_0109.txt

roleofcytokinesi00uhle_0064.txt

roleofcytokinesi00uhle_0029.txt

AA00011214_00001_0029.txt

roleofcytokinesi00uhle_0136.txt

AA00011214_00001_0090.txt

AA00011214_00001_0081.txt

roleofcytokinesi00uhle_0150.txt

roleofcytokinesi00uhle_0053.txt

AA00011214_00001_0083.txt

roleofcytokinesi00uhle_0106.txt

AA00011214_00001_0109.txt

roleofcytokinesi00uhle_0083.txt

AA00011214_00001_0071.txt

roleofcytokinesi00uhle_0142.txt

roleofcytokinesi00uhle_0044.txt

roleofcytokinesi00uhle_0120.txt

AA00011214_00001_0009.txt

AA00011214_00001_0098.txt

AA00011214_00001_0136.txt

roleofcytokinesi00uhle_0124.txt

AA00011214_00001_0054.txt

roleofcytokinesi00uhle_0146.txt

roleofcytokinesi00uhle_0098.txt

roleofcytokinesi00uhle_0088.txt

AA00011214_00001_0062.txt

roleofcytokinesi00uhle_0006.txt

roleofcytokinesi00uhle_0033.txt

AA00011214_00001_0055.txt

AA00011214_00001_0074.txt

AA00011214_00001_0053.txt

AA00011214_00001_0095.txt

roleofcytokinesi00uhle_0104.txt

AA00011214_00001_0084.txt

roleofcytokinesi00uhle_0046.txt

roleofcytokinesi00uhle_0086.txt

AA00011214_00001_0129.txt

roleofcytokinesi00uhle_0127.txt

roleofcytokinesi00uhle_0050.txt

AA00011214_00001_0127.txt

AA00011214_00001_0143.txt

AA00011214_00001_0057.txt

AA00011214_00001_0038.txt

AA00011214_00001_0108.txt

roleofcytokinesi00uhle_0141.txt

AA00011214_00001_0141.txt

roleofcytokinesi00uhle_0116.txt

AA00011214_00001_0144.txt

AA00011214_00001_0002.txt

roleofcytokinesi00uhle_0144.txt

AA00011214_00001_0033.txt

AA00011214_00001_0034.txt

roleofcytokinesi00uhle_0134.txt

AA00011214_00001_0110.txt

AA00011214_00001_0130.txt

roleofcytokinesi00uhle_0091.txt

AA00011214_00001_0017.txt

AA00011214_00001_pdf.txt

AA00011214_00001_0119.txt

AA00011214_00001_0044.txt

roleofcytokinesi00uhle_0025.txt

AA00011214_00001_0135.txt

roleofcytokinesi00uhle_0125.txt


Full Text










THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS













By

ELIZABETH WHITFORD UHL


A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL
OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY

UNIVERSITY OF FLORIDA













ACKNOWLEDGMENTS


I cannot begin to thank my family for their support: my parents for their

example and their encouragement, my sisters, Jean and Mary, and brother

Charlie, for never letting me feel too sorry for myself when going got tough, and

especially my husband Frank for his unfailing support and for covering for the

many times I was not there. Special thanks go to William Castleman for giving

me the opportunity to do the work, and for setting and maintaining high

standards. I thank my the members of my committee Claus Buergelt, Mary

Brown, Anthony Barbet and especially Rosalia Simmen for their interest and

assistance. I would also like to acknowledge Lyle Moldawer for providing the

TNF receptor fusion protein and for his enthusiasm. Roberta O'Connor, Karen

Dukes, Allison Mays, Christine Klein and especially Tracy Jack provided both

help with the laboratory work and friendship, without which this project would

have been much more difficult.









TABLE OF CONTENTS



ACKNOWLEDGMENTS................................................ ii

ABSTRACT............................ ......... ...... ........................ v

CHAPTER 1 LITERATURE REVIEW

Viral Respiratory Infections and Asthma ........................................ 1
Sendai Virus Infection in Rats ....................... ..................... 4
The Role of Cytokines in Pulmonary Disease .................................. 6
T G F ........................................................... ............... .... 7
TN F-a ...................................................... .................... 12
P D G F ..................................................... ........................... 16

CHAPTER 2: RESEARCH PROTOCOL

Hypothesis and Specific Aims ....................... ........................ 19
Background/Significance .................................................................... 20
Experim ental Design .......................................................................... 21

CHAPTER 3: INCREASED TRANSFORMING GROWTH FACTOR Pi
(TGF-0P) GENE EXPRESSION PRECEDES SENDAI
VIRUS-INDUCED BRONCHIOLAR FIBROSIS

S um m ary ....................................................................... ............... 34
Introduction ......................................................... ................... 35
Materials and Methods ................... .. ................. 38
R e su lts ............................................................................................... 4 3
D discussion .......................................................................................... 4 5

CHAPTER 4: INCREASED TUMOR NECROSIS FACTOR-a (TNF-a)
GENE EXPRESSION IN MACROPHAGES PRECEDES
BRONCHIOLAR FIBROSIS IN VIRUS-SUSCEPTIBLE BN RATS

S um m ary .............................................. ........................ 55
Introduction .......................................................... .................. 56
M materials and M ethods ........................................ ....................... 59
Results ................... .. ........................... 65
D discussion ....................................... ............................................. 67









CHAPTER 5: FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF
SENDAI VIRUS-INDUCED BRONCHIOLAR FIBROSIS IN BN
RATS IS INHIBITED BY A SOLUBLE TNF RECEPTOR

Summary ....................................... ....... .................. 77
Introduction ................................... ......... ....................... 78
Materials and Methods ................................... ......................... 80
Results ............................................... ........................ 85
D discussion ........................................................ .......................... 89

CHAPTER 6: SENDAI VIRUS DIRECTLY UPREGULATES TUMOR NECROSIS
FACTOR-a (TNF-a), BUT NOT TRANSFORMING GROWTH
FACTOR-3, (TGF-p ) GENE EXPRESSION IN RAT ALVEOLAR
MACROPHAGES

Sum m ary ............................................................. .................. 102
Introduction ..................................... ..... ................. ................ 103
Materials and Methods ........................................... ..................... 105
R results ............................................................ .................... ....... 109
D discussion ......................................................... .................... 111

CHAPTER 7: GENERAL SUMMARY....................................................... 123

APPENDIX ............................................ 129

REFERENCES .............................................. 135

BIOGRAPHICAL SKETCH .................................................... 152









Abstract of Dissertation Presented to the Graduate School of the University of
Florida in Partial Fulfillment of the Requirements for the Degree of Doctor of
Philosophy

THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS

By

Elizabeth Whitford Uhl

May 1996

Chairperson: Dr. William L. Castleman
Major Department: Veterinary Medicine

Viral bronchiolitis in children may induce persistent alterations in lung

function including increased airway resistance and airway hyperresponsiveness.

Similar pulmonary functional abnormalities induced in rats following infection

with parainfluenza type I (Sendai) virus are associated with bronchiolar mural

fibrosis. This observation led to the hypothesis that virus-induced bronchiolar

mural fibrosis is mediated through virus-induced increases in gene expression of

transforming growth factor-B, (TGF-13), platelet-derived growth factor-B (PDGF),

andlor tumor necrosis factor-a (TNF-a) in the bronchiolar microenvironment.

Pulmonary TGF-B, and TNF-a mRNA and protein expression were assessed

in rat strains that are susceptible (BN) and resistant (F344) to virus-induced

bronchiolar fibrosis. Northern analysis, in situ hybridization and protein

immunocytochemistry demonstrated that virus-inoculated BN rats had

significantly higher increases in TGF-B, and TNF-a pulmonary mRNA and

increased numbers of bronchiolar macrophages and fibroblasts expressing









TGF-B, and TNF-a protein than virus-inoculated F344 rats. Pulmonary PDGF

mRNA levels were not altered by viral infection in either rat strain.

The significance of TNF-a in the development of virus-induced bronchiolar

fibrosis was determined by using a 55 kD soluble TNF receptor-immunoglobulin

G fusion protein (sTNFR-IgG) to inhibit TNF-a bioactivity in virus-inoculated BN

rats. Treated rats had fewer proliferating bronchiolar fibroblasts, as detected by

bromodeoxyuridine incorporation, compared to virus-inoculated control rats.

There was also significantly increased mortality in p55sTNFR-lgG-treated virus-

inoculated rats associated with increased viral replication and decreased

numbers of macrophages and lymphocytes in bronchioalveolar lavage fluid.

To assess the mechanism of the virus-induced increase in cytokine

expression in macrophages, a rat alveolar macrophage cell line (NR8383) was

inoculated with Sendai virus, and the levels of TNF-a and TGF-p, mRNA and

protein were determined. TNF-a mRNA and protein levels were significantly

elevated at 24, 48, and 72 hours after virus-inoculation. Cells incubated with

UV-inactivated virus did not have any detectable TNF-a mRNA 24 hours after

inoculation. TGF-p, mRNA and protein levels in virus-inoculated cells were not

consistently elevated over those from control cells. The results of these

experiments indicate that TGF-31 and TNF-a are important mediators of virus-

induced bronchiolar fibrosis. They also demonstrate that Sendai virus can

directly upregulate TNF-a expression, and that TNF-a is critical to the immune

and inflammatory response to the virus.














CHAPTER 1
LITERATURE REVIEW



Viral Respiratory Infections and Asthma



The majority of individuals who develop viral respiratory infections recover

with normal airway function. However, following clinical resolution of acute viral

infections, a subgroup of patients develop airway functional abnormalities

ranging from persistent increases in airway resistance and airway

hyperresponsiveness to asthma.17 The potentiating impact of viral respiratory

infections on asthma appears to be dependent on the presence of underlying

risk factors, with young children, especially boys, being the most likely to

develop wheezing with a viral respiratory infection. Other risk factors include: a

family history of allergic disease, the development of an IgE-dominated immune

response, the severity of both the infection and the underlying asthma, and the

type of virus.17

Epidemiological studies have associated infection with respiratory syncytial

virus, parainfluenza viruses, adenoviruses, or rhinoviruses with the development

of asthma, and several pathogenic mechanisms have been proposed to explain

the development of virus-induced pulmonary functional abnormalities.1'78 In










children with acute respiratory syncytial virus (RSV) bronchiolitis, for example,

prospective studies have shown that titers of RSV-specific IgE are independent

predictors of airway hyperresponsiveness,O and rising titers correlate with

increased leukotriene C4 (LTC4) levels in nasopharyngeal washes during

subsequent RSV infections.10 These results suggest that RSV itself may act as

an allergen in susceptible patients. Viral respiratory infections also may

facilitate sensitization to non-viral antigens in genetically predisposed individuals

since virus-induced epithelial damage permits exposure of allergens to the host

immune system."

A further consequence of epithelial damage is exposure of nerves in the

airway wall. There is an extensive network of afferent nerves situated

immediately below the epithelial tight junctions.12 Exposure of these nerves to

the environment can result in the release of neuropeptides such as substance P

and neurokinin A, both of which can stimulate smooth muscle contraction.12.13

Viral infections also can have effects on neuropeptide release and metabolism

as well as nerve conduction and receptor function.14'15

Inflammation of the airways is a characteristic feature of asthma, and

increased recruitment and persistence of inflammatory cells in airways may be

potential mechanisms by which viral infections contribute to the development of

airway functional abnormalities.8'6 Studies using animal models of virus-

induced hyperresponsiveness have correlated the appearance of airway

hyperresponsiveness induced by viruses with the influx of inflammatory cells.'718









3

Most of these inflammatory cells were macrophages, which have the capacity to

release a vast array of inflammatory mediators and cytokines including

leukotrienes, thromboxanes, platelet activating factor, tumor necrosis factor-a

(TNF-a), interleukin-2 (IL-2), and prostaglandin F 2 that can modulate airway

smooth muscle contraction, affect mucus secretion and alter vascular

permeability.1920,21

Viral infections may also induce abnormalities in pulmonary structure. Airway

wall thickening with fibrosis is a common lesion in asthmatics that can contribute

to the development of increased airway resistance by altering the mechanical

properties of airways.2224 Viral infections may enhance the development of

airway fibrosis by causing epithelial necrosis, which leads to the build up of

necrotic debris, inflammatory cells, mucus, and plasma exudate in airways.

Subsequent organization of this material leads to the deposition of fibrous

connective tissue and can result in irreversible peripheral airway loss and airway

obstruction. The stimulation of aberrant or exuberant repair processes following

viral infection may also result in mural fibrosis, which can be significant even if

airways are not completely occluded, since the deposition of connective tissue in

airway walls dramatically affects the degree of luminal narrowing during smooth

muscle contraction."

The development of persistent pulmonary functional abnormalities associated

with viral respiratory infections is dependent upon a complex interplay of

mechanisms that include IgE-dependent reactions, enhanced inflammation,










epithelial damage, autonomic nervous system dysfunction, modulation of the

immune response, and the induction of structural abnormalities. The purpose of

the studies presented here was to investigate the potential role of fibrogenic

cytokines in the pathogenesis of virus-induced bronchiolar fibrosis using

parainfluenza type I (Sendai) virus infection in rats as the experimental model.



Sendai Virus Infection in Rats: Summary of Previous Studies



Sendai virus is a common pathogen of rodents that can induce either clinical

disease or inapparent infection in laboratory rats, mice, guinea pigs, and

hamsters.227 Spontaneous disease associated with Sendai virus infection is

well documented,28 and the pathological features have been defined

experimentally.213 Following aerosol infection, CD (Sprague-Dawley) rats

develop multifocal necrotizing bronchiolitis associated with viral replication in

bronchiolar epithelial cells. Infection of neonatal (5 day old) rats produces the

most severe pneumonia at seven days post infection (dpi), with epithelial repair

and resolution of the bronchiolitis being largely complete at 17 dpi.29 3 Neonatal

CD rats infected with Sendai virus develop long term pathological sequelae

consisting of bronchiolar hypoplasia and fibrosis, alveolar dysplasia, and

bronchiolar mastocytosis.30 These morphological changes are associated

with pulmonary functional abnormalities including increased pulmonary

resistance, decreased arterial PO2, and airway hyperresponsiveness to

aerosolized methacholine.35.











Inbred rat strains that are susceptible ( Brown Norway: BN) and resistant

(Fischer 344: F344) to Sendai virus induced bronchiolar hypoplasia, fibrosis,

mastocytosis and the associated pulmonary function abnormalities have been

identified.37 At 7 days after Sendai virus infection, BN rats had higher pulmonary

viral titers, and increased numbers of neutrophils in the bronchoalveolar lavage

fluid compared to F344 rats.37 Significantly increased numbers of bronchioles

with aggregates of lymphocytes and macrophages were observed in BN rats at

14 days post infection.37 Neonatally infected BN rats also had an over 3-fold

increase in the area of bronchiolar wall per unit length of bronchiolar basement

membrane by 65 days dpi." This peribronchiolar increase in tissue was largely

accounted for by a 1.5-fold increase in the number of fibroblasts per mm2 of

bronchiolar basement membrane (b.m.) as well as by a 4-fold increase in

collagen fiber density, and a 4.7 fold increase in extracellular matrix (um3 lum2

b.m.).3 Active proliferation of fibroblasts, assessed by bromodeoxyuridine

labeling, demonstrated significant increases (p<0.05) in the percentages of

labeled bronchiolar fibroblasts in BN rats at 7, 10, & 14 dpi (unpublished data).

In contrast, neonatally infected F344 rats did not have evidence of diffuse

bronchiolar fibrosis.3

The results of these studies indicate that bronchiolar fibrosis is an important

component of Sendai virus-induced increases in bronchiolar wall thickness and

therefore could explain the persistently increased airway resistance noted in

neonatally infected BN rats. Comparison of BN and F344 rats allows an unique










opportunity to determine which of several potentially important mediators are

responsible for the dysplastic, fibrotic, and hyperresponsive changes induced by

neonatal viral bronchiolitis. The studies outlined in this proposal are designed to

investigate the role of three potent mediators of pulmonary fibrosis, transforming

growth factor-B (TGF-B), tumor necrosis factor-a (TNF-a), and platelet-derived

growth factor (PDGF), in the pathogenesis of Sendai virus-induced bronchiolar

fibrosis, and to assess the ability of Sendai virus to directly induce expression of

these cytokines.



The Role of Cvtokines in Pulmonary Disease



In recent years the role of cytokines in the regulation of both physiologic and

pathologic processes occurring in the lung has been extensively investigated."

5 Studies on naturally occurring and chemically induced pulmonary fibrosis

indicate that TGF-B,TNF-a, and PDGF are important mediators of pulmonary

fibrosis.'4" In addition, the ability of infectious agents to directly effect the

expression of inflammatory and fibrogenic mediators, including TGF-B and TNF-

a, has been demonstrated and is believed to be an important aspect in the

pathogenesis of several viral diseases."0










Transforming Growth Factor-B (TGF-B )



TGF-B is a multifunctional growth factor, having growth regulatory activities

on essentially all cell types. The cellular response to TGF-B is complex, being

dependent on cell type, the presence of other growth factors, level of

differentiation, and the state of cell activation.61 It is a potent inhibitor of

epithelial cell growth,6 probably through inhibition of the c-myc proto-

oncogene,6 while in combination with PDGF it is mitogenic for cells of

mesenchymal origin." TGF-B is also an important regulator of differentiation for

mesenchymal cells."

In the normal lung, TGF-B is postulated to have a role in the stabilization of

the structural cell populations;5 however, if regulation of its biosynthesis is

disrupted, high protein levels could suppress repair processes by inhibiting

epithelial cell proliferation. All three isoforms of TGF-B (-B,,-r2,-B3) are

constitutively expressed in the lung. mRNA transcripts are found in

macrophages, smooth muscle cells and fibroblasts, while protein expression

also may be associated with the bronchiolar epithelium.65 There are cell type-

specific differences in the number and type of TGF-B receptors as well as

subtypes of receptors with different affinities for the different TGF-13 isoforms.

Rat lung fibroblasts, for example, have receptors with a higher affinity for TGF-B,

than for TGF-112." This finding correlates well with the fact that TGF-R, is the

isoform most implicated in fibrosis.67








8

TGF-B is a potent inducer of tissue fibrosis," with a variety of both paracrine

and autocrine effects. It can increase the tissue levels of collagen and other

matrix proteins" by increasing the transcription of fibronectin and procollagen

genes,68'7 through postranscriptional regulation of steady-state levels of

fibroblast collagen and fibronectin mRNA,7 and by inhibiting the degradation of

existing extracellular matrix by both decreasing the biosynthesis of proteases"

and increasing the synthesis of protease inhibitors.46 TGF-B, along with TNF-a,

can also enhance the development of pulmonary fibrosis by impairing the ability

of lung fibroblasts to degrade fibrin,n thus stabilizing a transitional matrix on

which fibroblasts can proliferate and secrete collagen. In addition, TGF-1 has

effects on the expression of other fibrogenic growth factors including; PDGF,

TNF-a, and basic fibroblast growth factor (bFGF).74-7

Evidence that TGF-B is one of the most potent fibrogenic agents known has

come from studies of several different models of tissue fibrosis (see reference 67

for review). Investigations of fetal wounds, which heal without the formation of a

scar, revealed that unlike in neonates or adults, TGF-B was not associated with

the wound, while the injection of TGF-B into fetal wounds led to scarring.47 The

significance of this finding was followed up by the observation that the injection

of antibodies to TGF-B into wounds in adults resulted in healing without the

formation of a scar.7 In models of pathological fibrosis increased TGF-B

expression has been observed in humans with liver cirrhosis, idiopathic

pulmonary fibrosis,7 or systemic sclerosis,78 in mice with hepatic fibrosis,79 and










in rats with experimental glomerulonephritis.a' The importance of TGF-B in the

pathogenesis of glomerulonephritis in rats was confirmed by the ability of

injected neutralizing antibodies against TGF-I to suppress the disease.

Studies of chemically induced and naturally occurring pulmonary

fibrosis',12 have confirmed the importance of TGF-B in the pathogenesis of the

lung lesions. Bleomycin treatment of rat lung fibroblast cultures resulted in an

increase of TGF-B mRNA and an increased secretion of TGF-B protein. The

response could be blocked by treatment with an inhibitor of protein synthesis,

and by an inhibitor of RNA synthesis." In an in vivo study, Hoyt and Lazo4

demonstrated that the amount of TGF-B mRNA extracted from the lungs of mice

chronically exposed to bleomycin was five-times the amount extracted from the

lungs of control animals. This increase preceded changes in gene expression

for collagens and fibronectin and coincided with areas of active fibrosis. Of

particular interest is the observation that a mouse strain that does not develop

pulmonary fibrosis after bleomycin exposure had a decrease in total mRNA that

included a drop in TGF-I mRNA.' Bleomycin also induced increases in lung

collagen accumulation which could be inhibited by the administration of

antibodies to TGF-B, confirming TGF-B has an important role in the etiology of

bleomycin induced pulmonary fibrosis." Immunocytochemical analysis has

identified macrophages as the most common pulmonary cell type expressing

TGF-B protein in bleomycin-treated rats.81 Patients with idiopathic pulmonary

fibrosis also have increased pulmonary expression of TGF-B protein; however, it










is predominantly in bronchiolar and alveolar epithelial cells and deposited

extracellularly in subepithelial areas adjacent to the fibrotic lesions." Finally,

neutralization of TGF-3, in a mouse model of immune-induced lung fibrosis

caused by repeated intranasal exposure to heat-killed bacillus Calmette-Guerin

(BCG) resulted in substantial decreases in lung fibrosis and granulomatous

inflammation, which implies a role for TGF-B, in inducing inflammation and lung

fibrosis in response to an immune stimulus."

In addition to its role in tissue fibrosis, TGF-B is an important modulator of the

immune response, with both immunosuppressive and proinflammatory effects

depending upon the context in which it is presented. In experimental acute and

chronic arthritis, for example, systemic administration of TGF-1 nearly

obliterates the disease process"7 whereas local administration exacerbates it."

Systemically delivered TGF-B initially encounters the endothelium and its

primary action may be to decrease endothelial cell adhesion molecule

expressionO"' thus impairing leukocyte recruitment. TGF-B also can inhibit

activated T-cell proliferation and deactivate macrophages." These

immunosuppressive effects may not be predominant in all situations, however,

since TGF-B is strongly chemotactic for monocytes and macrophages and can

induce undifferentiated monocytes to express a variety of inflammatory

mediators including: IL-1, TNF-a, IL-6, and PDGF.9'

The complex modulation of the immune response by TGF-B has been

partially characterized by studies of transgenic and gene knockout mice.










Targeted disruption of the TGF-1, gene in mice results in a multifocal

inflammatory disease in many tissues, especially the heart and lungs.'"10' The

nature of the inflammatory response varied depending upon the tissue, for

example: the lungs had interstitial inflammatory infiltrates consisting of T and B

lymphocytes associated with increased vascular expression of major

histocompatibility complex class I and II antigens, while macrophages were the

major type of inflammatory cell in the heart. Surprisingly, inflammatory lesions

were also prominent in transgenic mice overexpressing TGF-13.7 TGF-B can

activate immature monocytes and T lymphocytes while inhibiting macrophages

and activated lymphocytes.76 In the normal inflammatory response this means

immature cells are turned on to participate in inflammation, while mature,

activated cells are switched off, promoting resolution of the inflammatory process

and tissue repair. The unexpected similarities in the phenotypes of the

transgenic and gene knockout mice is probably the result of TGF-I3's ability to

both accelerate and inhibit the inflammatory response.

In several infectious diseases, the immunosuppressive effects of TGF-1

predominate, resulting in prolonged survival of the pathogen and increased

tissue damage.55, In Leishmania infection the down-regulation of macrophages

by TGF-I1 is a virulence factor that determines in vivo susceptibility.9-102 During

acute Trypanosoma cruzi infection in mice, TGF-B1 inhibited the protective,

macrophage activating effects of interferon-y and exacerbated infection.10 In

Mycobacterium tuberculosis infection in human monocytes, neutralizing antibody









12
to TGF-B, reduced the intracellular bacterial growth, while treatment with TGF-B,

abrogated the bacteriostatic effects of TNF-a and interferon-y.14 TGF-1 also

has been implicated as having a role in the pathogenesis of viral infections. In

acquired immunodeficiency syndrome (AIDS), a viral protein (tat) appears to

directly upregulate the production of TGF-1B,'1 setting up a potential feedback

loop since TGF-B enhances HIV-1 replication in some cell lines.108 TGF-B has

also been demonstrated to increase human cytomegalovirus replication in

human lung fibroblasts; in contrast, basic fibroblast growth factor repressed viral

replication. 107

Considering the wide-ranging effects of TGF-B on both the inflammatory

response and the pathogenesis of fibrosis, excessive production of TGF-B in the

susceptible BN rats could be contributing both to the increased viral titers

observed in these rats at 7 dpi, and to the peribronchiolar fibrosis and the

epithelial hypoplasia.



Tumor Necrosis Factor-a



TNF-a is a pro-inflammatory cytokine produced by monocytes and

macrophages.'" Its effects are complex, as it appears to play an important role

in both acute injury and in the fibroproliferative response.. '44S. 110 In the

inflammatory response, TNF-a stimulates the adhesion of leukocytes to the

endothelial surface by inducing the expression of adhesion molecules for










neutrophils, monocytes and lymphocytes.1' Other pro-inflammatory effects on

endothelial cells include alterations in the transcription and cell surface

expression of class I MHC antigens and induction of IL-1 secretion."' TNF-a

also has direct stimulatory effects on neutrophils, acting to enhance the

phagocytic capacity, antibody-dependent cytotoxicity, degranulation, and

production of reactive oxygen species."' In the repair process, a role for TNF-a

is suggested by its growth stimulatory effect on fibroblasts, which is thought to

be mediated by the increased cell surface expression of epithelial growth factor

receptors, and by its ability to induce angiogenesis.11

Several of the pro-inflammatory effects of TNF-a, for example: its ability to

increase the adhesion of both neutrophils and eosinophils to vascular

endothelium,11'112 the potentiation of interleukin-3 and granulocyte/macrophage-

colony stimulating factor induced proliferation of hemopoietic progenitor cells,"3

the enhancement of eosinophil cytotoxicity,"4 and its mechanistic role in the

activation of dermal endothelium triggered by mast cell degranulation,"'5 suggest

TNF-a may be important in the pathogenesis of allergic inflammation. In the

lung, this importance has been implicated by studies of airway

hyperresponsiveness.

Bronchial hyperresponsiveness and inflammation, induced by the

administration of aerosolized endotoxin to rats, has been demonstrated to be

mediated by TNF-a.11 Pretreatment of rats with antibodies against TNF-a

decreased the hyperresponsiveness, while administration of recombinant TNF-a










induced it. The same study also demonstrated that the increase in neutrophil

numbers observed after the administration of endotoxin was partially inhibited by

antibodies to TNF-a."1 Treatment with antibodies to TNF-a was also used in a

mouse model of hypersensitivity pneumonitis induced by intranasal inoculation

with the actinomycete Faenia rectiviroula (farmer's lung).116 Such treatment

blocked inflammatory cell recruitment to the lungs, completely abolished TNF-a

secretion by bronchiolar associated lymphoid tissue, and prevented the

development of fibrosis."1 At the cellular level, in vitro studies have

demonstrated the production of TNF-a in pulmonary mast cells, alveolar

macrophages, and bronchiolar epithelial cells in lung fragments following IgE

receptor triggering.117

Several studies have indicated the importance of TNF-a in fibrotic pulmonary

disorders. For example, significant increases in TNF-a mRNA have been

observed in the lungs of treated mice susceptible to bleomycin induced

pulmonary fibrosis, but not in the lungs of treated non-responder mice.10 In rats,

the importance of bleomycin-induced increases in the pulmonary expression of

TNF-a was further emphasized by the finding that the development of fibrosis

could be blocked by the administration of antibodies to TNF-a.11" In bleomycin-

induced pulmonary fibrosis there is a strong correlation between collagen

deposition and platelet trapping, which is probably due to the fact that platelets

are rich sources of fibrogenic mediators such as TGF-P and PDGF. TNF-a may

contribute to bleomycin-induced pulmonary fibrosis through platelet trapping by










upregulating endothelial expression of CD54, an adhesion molecule for

platelets.1" An association between increased levels of TNF-a mRNA and the

development of silicosis has been demonstrated in mice. In this model the

fibrotic changes were not only inhibited by antibodies to TNF-a, but also

enhanced by the infusion of recombinant TNF-a.120

Several viruses,121,1".0 including Sendai virus,57 directly induce the

expression and production of TNF-a; however, its role in the pathogenesis of

viral diseases is complex. TNF-a can inhibit the replication of several DNA and

RNA viruses including herpes simplex type II, vesicular stomatitis virus,

encephalomyocarditis virus and adenovirus type-2," and can kill virus-infected

cells originally resistant to its cytolytic actions." The importance of TNF-a as an

antiviral cytokine has also been emphasized by the discovery that several

viruses produce virulence factors that specifically inhibit TNF-a activity.'22124

TNF-a is not protective in all viral infections, however, as it can reactivate latent

herpes simplex infection in monocytes,125 and HIV infection in cell lines of T-cell

and monocyte origin.126 111 Viral infections also may act to prime cells for the

production of TNF-a. For example, influenza A virus infection of murine

macrophages resulted in a massive accumulation of TNF-a mRNA, including a

unique high molecular weight transcript, that was not translated to the bioactive

protein until the cells were exposed to small amounts of endotoxin."

Based upon the studies demonstrating the importance of TNF-a in the

pathogenesis of airway fibrosis, its probable role in the development of airway









16
hyperresponsiveness, its importance in viral pathogenesis, and the observation

that Sendai virus induces the production of TNF-a in monocytes, TNF-a can be

predicted to play a role in the pathogenesis of the Sendai virus-induced

bronchiolar fibrosis and airway hyperresponsiveness observed in the susceptible

BN rats. The studies presented here were designed to test that prediction.



Platelet-Derived Growth Factor



PDGF is a highly cationic protein dimer composed of two chains, A&B, that

can exist as AA, AB, or BB depending upon the species, cellular source," and

transcriptional regulator. PDGF is secreted by platelets, endothelial cells,

activated monocytes, macrophages, and mesenchymal cells.8,127 It is a

competence or priming type growth factor for cells of mesenchymal origin,'28 and

a chemoattractant for fibroblasts and smooth muscle cells.'1 PDGF stimulates

collagen synthesis, and may act to carry out the fibro-proliferative actions of

TGF-R since cells that cannot both synthesize and respond to PDGF remain

inhibited by TGF-B.4~50 Stimulation of fibroblast proliferation by both IL-1 and

TNF-a may also be mediated by the induction of PDGF.'30,131

Expression of PDGF in normal cells is tightly regulated; it acts locally in low

concentration and is rapidly cleared. In the lung, PDGF accounts for most of the

mitogenic activity of alveolar macrophages,51 and there is evidence that it is

important in fetal lung development.'32 At sites of tissue injury, PDGF-BB










enhances the inflammatory phase by: increasing the directed migration of

macrophages, inhibiting natural killer cell activity,13 and stimulating T

lymphocytes to secrete IL-1, while decreasing their secretion of IL-4, IL-5, and

interferon.'" In the repair phase of tissue injury, PDGF triggers an earlier, more

sustained influx of procollagen type I fibroblasts than that produced by TGF-B.52

PDGF-BB has also been found to activate eosinophils, and has been speculated

to play a role in the pathogenesis of asthma.13

Clinical and experimental evidence of the importance of PDGF in the

pathogenesis of pulmonary fibrosis consists of investigations of its role in

idiopathic and chemically-induced pulmonary fibrosis.'" 137', Patients with

idiopathic pulmonary fibrosis (IPF) were demonstrated to have a 3-fold increase

in the percentages of interstitial macrophages expressing PDGF compared to

normal individuals.1l PDGF was also aberrantly expressed in the alveolar

epithelial cells of IPF patients.1'3 Pulmonary PDGF levels have also been

measured in patients with asbestosis and silicosis and those positive for PDGF

experienced progression of their disease." There is also evidence that

chrysotile asbestos may stimulate a PDGF-AA-mediated autocrine loop leading

to hyperplasia in rat lung fibroblasts.1'4

In the rat, measurement of pulmonary PDGF mRNA levels indicate that it is

constitutively expressed at a low level. However, during continuous exposure to

85% oxygen, the steady state levels of PDGF-BB mRNA rose 2.5 fold above

control levels. This increase preceded an increase in DNA synthesis and









18

implies a causal role for PDGF in the fibroblast proliferation induced by

hyperoxic injury to the lung."

The role of PDGF in the pathogenesis of viral-induced tissue damage has not

been investigated. However, the prolonged induction of PDGF production either

by direct transcriptional upregulation by the virus, or some other factor (ie TGF-

B), may be contributing to the airway fibrosis observed in BN rats following

Sendai virus infection.














CHAPTER 2
RESEARCH PROTOCOL


Hypothesis and Specific Aims



The goal of this research was to identify cytokines critical to the development

of bronchiolar fibrosis following bronchiolitis induced by parainfluenza (Sendai)

virus infection during early life. The hypothesis tested was that bronchiolar

mural fibrosis following viral bronchiolitis is mediated by virus-induced increases

in transcription and/or translation of transforming growth factor-3, (TGF-P,),

platelet-derived growth factor-B (PDGF), andlor tumor necrosis factor-a (TNF-a)

in infiltrating bronchiolar and peribronchiolar macrophages. There were 4

specific objectives:



1) Determine whether Sendai virus-induced bronchiolar fibrosis in virus-

susceptible BN rats is preceded by increased gene expression of

fibrogenic cytokines TGF-P,, PDGF, and/or TNF-a in macrophages and

in other bronchiolar cells.

2) Determine whether rats susceptible to virus-induced bronchiolar fibrosis

(BN) have higher cellular expression of fibrogenic cytokines in

bronchioles after virus infection relative to virus-resistant (F344) rats.










3) Determine if the development of virus-induced bronchiolar fibrosis in BN

rats can be blocked by neutralizing cytokine activity.

4) Determine whether parainfluenza virus directly or indirectly induces gene

transcription and/or translation for TGF-P,, PDGF, and/or TNF-a in

pulmonary macrophages.



Background/Significance



Epidemiological studies have associated childhood viral bronchiolitis,

especially as the result of infection with respiratory syncytial virus, parainfluenza

viruses, adenoviruses, or rhinovirus, with the subsequent development of

persistent increases in airway resistance and recurrent wheezing or airway

hyperresponsiveness.'8 A rat model of parainfluenza virus-induced bronchiolar

hyperresponsiveness and increased airway resistance has been characterized,

and both susceptible and resistant inbred rat strains have been identified.33'335,

3637 In this model, the increased airway resistance observed in the susceptible

rats is associated with collagen deposition in the bronchiolar walls, and

increases in the number of peribronchiolar fibroblasts."

Airway wall thickening and fibrosis has also been identified as a common

lesion occurring in human asthma and may contribute to exaggerated airway

luminal obstruction following smooth muscle contraction.8.22.23 In asthmatics,

collagen deposition is most likely the result of fibroblast activation, because it










consists of interstitial structural proteins (collagens III & V), rather than of

basement membrane components (type IV collagen, and laminin).23 This study

investigated the role of fibrogenic cytokines in the development of viral-induced

bronchiolar fibrosis, and assessed the direct effects of virus infection on the

expression of these cytokines.



Experimental Design and Methods



Experiment 1: Pulmonary expression of TGF-1,. PDGF. and TNF-a in Sendai
virus-infected BN and F344 rats


Objectives



1) To determine the magnitude and duration of pulmonary expression of TGF-

a,, PDGF, and TNF-a in control and Sendai virus-infected BN and F344

rats.

2) To determine the number and type of bronchiolar cells expressing

cytokine mRNA and protein in Sendai virus-infected BN and F344 rats.



Rationale



Increases in pulmonary mRNA for TGF-B, PDGF and TNF-a have been

demonstrated in several models of chemically-induced pulmonary fibrosis." ''-70
48, 77,81, 8218,12,9 52 Northern analyses were used to assess the overall magnitude










and duration of pulmonary cytokine expression in infected rats. In situ

hybridization and immunohistochemistry were used to identify the pulmonary cell

types expressing cytokine mRNA and protein after viral infection, and to

determine their association with areas of inflammation and fibrosis.



Design and Methods



Twenty-two day old weanling male BN and F344 rats were inoculated with

Sendai virus or sterile chorioallantoic fluid, and studied according to the

schedule outlined in Table 2-1.

Necropsy and tissue Drocessing. The rats were deeply anesthetized with

sodium pentobarbital and killed by exsanguination via intracardiac puncture. For

Northern analyses, the lungs were frozen in liquid nitrogen after removal and

stored at -80"C until processed. Lungs were harvested and fixed by 2 hour

perfusion via the trachea with 4% paraformaldehyde-PBS (pH 7.4) and

embedded in paraffin, for in situ hybridization and immunohistochemistry.

cDNA probes. 1) A 985 bp cDNA fragment including the major coding

region of rat TGF-1, precursor (supplied by Dr. Su Wen Quian, Laboratory of

Chemoprevention, NIH). 2) PDGF-B: cDNA (human) 2.6 kb ATCC; and 3) TNF-

a: cDNA (rat supplied by Dr. T. Shirai, Laboratory for Chemical Research,

Asahi Chemical Industry Co. Ltd, Tagata-gun, Shizuoka).










Northern analysis. Lung tissue was lysed in guanidium thiocyanate, and

total RNA extracted and precipitated.13 Preliminary Northerns for TGF-p,, TNF-

a, and PDGF were performed on poly (A) RNA pooled from 3-5 animals per

group. Virus-induced increases in pulmonary TGF-J, and TNF-a RNA were

present (data not shown), but pulmonary PDGF RNA levels were not increased

in the virus-inoculated rats of either strain (see Figure 2-1). Northern analysis for

TGF-0, and TNF-a RNA was performed on total RNA extracted from the lungs of

individual animals.

In situ hybridization. The TGF-P, and TNF-a cDNA probes used above

were subcloned and used as templates for the production of the RNA probes.

Digoxigenin- (TNF-a) and 3S-(TGF-P,) labeled antisense riboprobes were made

and used to qualitatively determine which bronchiolar cell types were expressing

cytokine mRNA in lung sections taken from virus- or sham-inoculated rats.

Control sections were incubated with labeled sense riboprobes.

Immunohistochemistry. Antibodies against TGF-B, and TNF-a were used

to detect bronchiolar cell expression of cytokine protein using

immunocytochemical techniques. The labeled bronchiolar macrophages and

fibroblasts were quantitated and the numbers of cells positive for cytokine

protein were compared between treatment groups.

Data analysis. Comparisons of pulmonary cytokine mRNA levels between

BN and F344 rat strains pre- and postinfection, were made by comparing the

relative optical densities (ROD) of the bands on the Northern autoradiographs.









24
The RODs of the total RNA from individual lungs were compared, both between

and within groups, to assess the amount of individual animal variation.

Statistical analysis was performed using a microcomputer-based statistical

program (Systat version 4, Evanston IL). Density of mRNA and protein labeling

were assessed by counting and classifying the number of labeled cells per mm

bronchiolar basement membrane in 25 high power (400X) fields per slide. Three

slides per animal were counted. Differences in the density of stained cells

between the infected and control, BN and F344 rats were compared using

ANOVA and Tukey tests.



Experiment 2: The effects of cytokine inhibition on the development of viral-

induced bronchiolar fibrosis.



Objective



1) To determine if the development of Sendai virus-induced bronchiolar

fibrosis in BN rats can be inhibited by blocking the activity of a

single highly expressed cytokine identified in the above experiments.



Rationale



TNF-a was chosen to block because: 1) Its transcription is directly induced

by the virus, 2) TNF-a pulmonary mRNA is elevated earlier in both rat strains









25
(3 dpi) than is TGF-13 mRNA, 3) Inhibition of TNF-a has been more effective in

blocking the development of chemically-induced pulmonary fibrosis. The basic

plan was to treat infected BN rats with a 55 kD soluble TNF-a receptor

immunoglobulin G fusion protein (p55 sTNFR-IgG), a treatment which has been

used to successfully block TNF-a activity in animal models of gram-negative

sepsis, and to assess the amount of fibroblast proliferation present at 10 dpi by

counting BrdU labeled fibroblasts.



Design and Methods



Experimental Design. One group of eighteen 25-day-old, male BN rats

were infected with Sendai virus, while a second group of 12 were sham-

inoculated with CAF (see Figure 2 -2). Six rats from the control and 9 from the

virus-inoculated rats were injected intraperitoneally (ip) with 10 mg/kg of p55

sTNFR-lgG1 fusion protein on days 0, 2, 4, 6, & 8 days post inoculation (dpi).

The remaining rats were injected ip with an equivalent volume of human IgG

according to the same schedule. At 7dpi, bronchoalveolar lavage fluid (BAL)

was taken from 3 of the virus-inoculated, p55 sTNFR-IgG1 fusion protein-treated

rats, and 3 of the virus-inoculated, human IgG treated animals. The TNF-a

protein content of this fluid was determined using a mouse TNF-a ELISA kit and

by bioassay. On day 9 post inoculation, 6 rats from each of the four groups were

given 200 pg/g 5-bromo-2' -deoxyuridine (BrdU, 2 mg/ml in PBS) ip 12 hours

before they were sacrificed at 10 dpi.










Tissue processing. All rats were anesthetized with sodium pentobarbital

(approximately 200 pg/g body weight) and were killed by exsanguination via

intracardiac puncture. BAL's were performed on the rats at the time they were

sacrificed, total and differential cell counts and the TNF-a protein content of the

BAL fluid was determined. Lungs were fixed by tracheal perfusion at 30 cm H20

pressure with 4% paraformaldehyde for 2 hours.

BrdU Labeling. Four transverse sections were taken from the fixed left

lungs of rats treated with BrdU: at the hilus, between the hilar section and the

cranial lung margin, and at points equidistant caudal from the hilar section and

cranial from the caudal lung margin. Tissue blocks were embedded in paraffin,

sectioned and immunocytochemical staining to detect BrdU was performed.

Data Analysis. Fibroblast proliferation was assessed by counting the

number of BrdU-labeled fibroblasts (identified by their spindloid shape) in 25

high power (400X) fields per slide. Three slides per animal were counted.

Differences in the density of labeled cells between sham- and virus-inoculated

and p55 sTNFR-lgGI and human IgG treated animals were compared using

ANOVA and Tukey tests.









27

Experiment 3: Assessing the ability of Sendai virus to induce increased cvtokine

gene expression.



Objectives



The original objectives for experiment 3 were as follows:

1) To determine whether Sendai virus induces TGF-iB, TNF-a, andlor PDGF

gene transcription and translation in pulmonary macrophages isolated from

BN rats and whether the induction of cytokine gene transcription is

dependent on protein synthesis, and/or is associated with an increase in

the stability of cytokine mRNA.

2) To determine if pulmonary macrophages isolated from F344 rats have the

same Sendai virus-induced pattern of cytokine expression as BN rats.

Because of the high number of animals required to obtain adequate cell

numbers for these experiments, and the fact that PDGF mRNA levels were not

elevated in the virus-inoculated rats, the objectives were revised:

1) Determine whether Sendai virus directly or indirectly induces gene

expression for TGF-p, and TNF-a in a rat alveolar macrophage cell line

NR8383 by: comparing cytokine mRNA and protein levels in virus infected

NR8383 cells with those incubated with chorioallantoic fluid (CAF).

2) Determine whether live virus is required for any increase in TGF-B, and

TNF-a gene expression observed in virus-inoculated cells.









28

3) Determine whether there is an increase in the stability of cytokine mRNA in

NR8383 cells associated with Sendai virus infection.



Rationale:



Several viruses, including Sendai virus, have been shown to directly

upregulate the production of cytokines.127'131'"'74 Macrophages are major

sources for TGF-11, and TNF-a, and can be infected with Sendai virus. Nuclear

run on assays were attempted (see Appendix), but produced inconsistent

results. The objectives were addressed by using Northern analysis and enzyme-

linked immunoabsorbant assays.



Design and Methods



Baseline Studies. NR8383 cells were infected with Sendai virus at

multiplicity of infection (MOI) of 1:1 and 1:10. The viral titer of culture

supernatants was determined at 4, 12, 24, 48, 72, 96, and 120 hours after

infection by performing plaque assays. These assays were done to verify that

the cells could support a productive viral infection, and to determine the time of

peak viral replication. Immunoperoxidase staining for viral antigens was also

performed on the infected cells to confirm infection.

Northern analysis. Northern analysis for TGF-P, and TNF-a was

performed on cytoplasmic RNA isolated from chorioallantoic fluid (CAF) and











virus-inoculated cells (MOI = 1) at 4, 8, 24, 48, and 72 hours post inoculation.

Blots were re-probed with a "P-labeled probe for human 3-actin to assess the

equality of loading.

Studies with UV-inactivated Sendai virus. UV-inactivated virus was

produced by exposing virus to a 30 watt UV lamp overnight. Plaque assays

were used to confirm viral inactivation. Cells were inoculated with inactivated

virus at an MOI of 1:1, and cytoplasmic RNA extracted 24 hours after virus-

inoculation.

Actinomvcin-D Experiments. Cells were incubated with virus (MOI = 1:1) or

CAF for 1 hour, media containing a final concentration of 5 mg/ml of

actinomycin-D (Sigma, St. Louis, MO) was added, and the cells were incubated

at 37* C, 5% CO2) for 24 hours. Cytoplasmic RNA was extracted and the

relative abundance of TNF-a and TGF-P RNA was determined using Northern

analysis.

Protein Assays. The secretion of TNF-a and TGF-p protein from CAF and

virus-inoculated macrophages was monitored by ELISA.

Data Analysis. Cytoplasmic TNF-a, TGF-p,, and p-actin RNA levels were

evaluated by comparing the relative optical densities (ROD) of bands on

Northern autoradiographs. Comparisons of band densities were only made

between bands in RNA run on the same gel. ROD values, TNF-a and TGF-p,

protein levels were normalized to cell counts. Statistical analysis of group

means was performed by one-way analysis of variance (one-way ANOVA) using








30

a computer-based statistical program (SigmaStat, Jandel Corporation, San

Rafael, CA). Differences between individual means were assessed by

Bonferroni's method of all pairwise multiple comparison."'













Northern Analysis


31



Immunocvtochemistr


Days BN Rats F344 Rats BN Rats/ F344 Rats

After Control Virus Control Virus Control Virus

Inoculation

3 6 6 4

7 6 6 6 6 4 4

10 6 6 4

14 6 6 6 6 4 4

30 6 6 4 4



The blots were re-probed wherever possible



Table 2-1. Experimental design for Northern analysis and immunocytochemical

studies


















m


BN F344 BN F344


S-PDGF



BN


7V 10V 10V 14S 14V 14S 14V


Figure 2-1: Northern analysis of PDGF pulmonary RNA levels in sham- and
virus-inoculated BN and F344 rats. Each lane was loaded with 5 pg of pooled
mRNA from sham- and virus-inoculated rats. No significant differences in band
densities were noted in either rat strain at 7, 10, or 14 days after inoculation
(F344 expression at 7 days is not shown). Based upon these results, PDGF
gene expression was not studied further.






33




BN
Virus-Inoculated Sham-Inoculated
Days 0, 2, 4, 6, 8 Days 0, 2, 4, 6, 8

Con IgG p55 sTNFR- IgG p55 sTNFR- IgG Cn
10 mg/kg 10 mg/kg 10 mg/kg 10 m/kg

TNF assay

10 days
TNF Assay
"6= n=6 BRDU Fibroblast Labelling [n l



Figure 2-2: Experimental design for Experiment 3.














CHAPTER 3
INCREASED TRANSFORMING GROWTH FACTOR B, (TGF-B1) GENE
EXPRESSION PRECEDES SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS



Summary



Rats infected early in life with parainfluenza type 1 (Sendai) virus develop

bronchiolitis that is followed by long-term increases in airway resistance and

hyperresponsiveness. These virus-induced functional abnormalities are closely

associated with bronchiolar mural fibrosis and persistent increases in

bronchiolar inflammatory cells including macrophages and mast cells. Brown

Norway (BN) rats are highly susceptible to virus-induced bronchiolar fibrosis and

airway function abnormalities, whereas Fischer-344 (F344) rats are resistant.

We hypothesized that bronchiolar fibrosis was regulated by the production of

TGF-p, by bronchiolar mural macrophages during the acute and chronic

inflammatory response induced by virus. Pulmonary and bronchiolar TGF-B,

gene expression was studied in BN and F344 rats following Sendai virus

infection by combined methods of Northern analysis and in situ hybridization for

TGF-B, mRNA and by immunocytochemistry for protein. Steady-state pulmonary

TGF-P, mRNA was increased in both BN and F344 rats at 7 days after

34










inoculation (p<0.001). BN rats had over two-fold greater increases than F344

rats (p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-B, mRNA

remained elevated in BN rats, but not in F344 rats (p<0.001). TGF-B, mRNA

was identified by in situ hybridization in bronchiolar mural macrophages and

fibroblasts. Seven days after inoculation, BN rats had over two-fold greater

numbers of bronchiolar mural macrophages positive for TGF-B, mRNA than did

control BN rats (p<0.05). Pulmonary TGF-R, protein expression was assessed

by immunocytochemistry at 3, 7, 10, 14, and 30 days after inoculation. BN rats

had over a two-fold increase in numbers of bronchiolar macrophages expressing

TGF-B, protein at 7 days after inoculation as compared to both sham-inoculated

BN and virus-inoculated F344 rats (p<0.0001). At 10 days after inoculation,

virus-inoculated BN rats had three-fold increases in numbers of bronchiolar

macrophages and fibroblasts expressing TGF-B, protein as compared to the

control animals (p<0.0001). We conclude that virus-induced bronchiolar TGF-11

gene expression precedes bronchiolar mural fibrosis and may play an important

pathogenetic role in virus-induced bronchiolar fibrosis and airway function

abnormalities.



Introduction



Clinical and epidemiological studies have linked severe viral bronchiolitis

during infancy with subsequent long-term pulmonary function abnormalities








36
including increased airway resistance and hyperresponsiveness.25 Viral lower

respiratory tract disease is also identified as a risk factor in the development of

asthma.3,6 However, it remains to be determined what direct role viral infection

plays in the pathogenesis of pulmonary function abnormalities and what genetic

factors may be contributing to adverse sequelae from viral and/or immunologic

lung injury during early life.e

Parainfluenza type 1 (Sendai) virus infection in young rats has been

developed as an animal model of bronchiolitis in children. Sendai virus induces

acute necrotizing bronchiolitis and pneumonia that is followed by persistent

alterations in pulmonary function. Functional alterations include elevated

respiratory resistance, decreased dynamic compliance, and

hyperresponsiveness to methacholine. "361 37 38. Susceptibility to virus-induced

functional abnormalities has been demonstrated to be influenced both by the

age and by the strain of the rat. In rats inoculated with virus as 25 day old

weanlings, persistent airway lesions associated with long-term pulmonary

function abnormalities include bronchiolar mural fibrosis and inflammation

characterized by mural aggregates of macrophages, mast cells, and

eosinophils.3 Both BN and LEW rats appear to be more susceptible to virus-

induced alterations in pulmonary structure and function than are F344 rats.36.'8

37, 835 Comparative viral pathogenesis studies with virus-susceptible BN rats

and resistant F344 rats indicate that genetic differences between the strains

influence important factors in host-virus interaction including duration of viral









37

replication, magnitude of immune response, and severity of acute and persistent

inflammatory cell response." 37. W

Bronchiolar mural fibrosis and associated airway wall thickening is a

prominent feature of virus-induced lung injury that is associated with lung

dysfunction in susceptible weanling BN rats.3 Fibrosis develops as early as 15

to 30 days after viral inoculation. Airway wall thickening and fibrosis has also

been identified as a common lesion occurring in human asthma and may

contribute to exaggerated airway luminal obstruction following modest smooth

muscle contraction."224

A growing body of research has demonstrated that several cytokines,

including transforming growth factor-p (TGF-1), tumor necrosis factor-a (TNF-a),

and platelet-derived growth factor ( PDGF), play critical roles in regulating

pulmonary fibrosis following alveolar injury by toxins such as bleomycin or in

less well-defined spontaneous fibrosis.4'1, 'o', 1. 84 Furthermore, there is

evidence that genetic susceptibility to develop pulmonary fibrosis in response to

chemically-induced damage may be controlled at the level of TGF-P

expression.4 TGF-p upregulates both fibroblast proliferation and the synthesis

of collagens and glycosaminoglycans in the lung." '"1

Based on the preceding information, we hypothesized that virus-induced

airway fibrosis and thickening in virus-susceptible BN rats was due to greater

expression of TGF-3 in airway walls following viral infection than in virus-

resistant F344 rats. The objectives of this study were to determine if Sendai









38
virus infection induces increased expression of TGF-B, in bronchiolar walls prior

to fibrosis and to determine whether TGF-P, gene expression induced by viral

bronchiolitis is greater in BN rats that are susceptible to virus-induced fibrosis

than in F344 rats that are resistant to this virus-induced effect.



Materials and Methods

Animals



Twenty-two day old weanling male BN and F344 rats were purchased from

Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum

antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat

virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic

bacteria. The control and experimental groups were separated and housed in

adjacent isolation cubicles.



Experimental Protocol



Three days after arrival, the rats in the experimental group were inoculated

with parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming

units per ml of gas in an aerosol exposure apparatus (Tri-R Instruments,

Rockville Center, NY) for 15 minutes. Viral assays to calibrate exposure were

performed as previously described.332 Sendai virus strain P3193 produced in










embryonated chicken eggs was used. Control rats were exposed to sterile

chorioallantoic fluid also harvested from embryonated chicken eggs. Virus-

inoculated BN and F344 rats were processed at 3, 7, 10, 14 and 30 days after

inoculation. Sham-inoculated animals were sacrificed at 7, 14, and 30 days after

inoculation. The rats were deeply anesthetized with sodium pentobarbital and

killed by exsanguination via intracardiac puncture. For Northern analysis, the

lungs from six rats from each group were frozen in liquid nitrogen and stored at

-80*C until processed. Lungs from four animals in each group were processed

for in situ hybridization and immunohistochemistry. These lungs were fixed for 2

hours via airway perfusion at 30 cm fixative pressure with 4%

paraformaldehyde-phosphate buffered saline (pH 7.4) and embedded in paraffin.



Northern Analysis



Lung tissue was lysed in guanidine thiocyanate, and total RNA was extracted,

precipitated and further processed to recover polyadenylated mRNA as

described.1' Twenty pg of total RNA from each lung or 5 pg of mRNA extracted

from pooled lung tissue was electrophorectically separated on 1.2% (wt:vol)

agarose gels containing 6% (vol:vol) formaldehyde, transferred to a positively

charged nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN),

and fixed by UV-crosslinking. Equality of RNA loading between lanes was

evaluated by visually comparing the intensity of ethidium bromide staining of the










18s and 28s ribosomal RNA bands on gels and membranes. A 985 bp cDNA

fragment containing the major coding region of the rat TGF-B, gene (supplied by

Dr. Su Wen Quian, Laboratory of Chemoprevention, NIH, Bethesda, MD) and a

2.6 kb human cDNA fragment of platelet derived growth factor (PDGF)

(American Type Culture Collection, Rockville, MD) were labeled with 32P-dCTP

using the random primer method as described.4' Prehybridization (15 min,

60-65"C) and hybridization (overnight, 65C) was in 0.5 M Na2HPO4, 7% SDS,

1% BSA, and 10mM EDTA as described.'41 The membranes were washed at the

hybridization temperature in 20mM phosphate, 1% SDS, and used to expose

Kodak XAR-5 film with Dupont Cronex intensifying screens. Film band densities

were quantified using a computerized video image analysis unit (MicroComputer

Imaging Device, Imaging Research Inc., St. Catharines, Ontario).



In Situ Hybridization and Immunocytochemistry



For in situ hybridization, the rat TGF-B, cDNA probe in pBluescript II KS+

(Stratagene, La Jolla, CA) was linearized and used as a template for the

production of "S-labeled RNA sense and antisense probes by a modified

version of the Riboprobe Gemini System II kit (Promega Biotech, Madison,

WI).142 To synthesize the antisense probe, plasmids were linearized with Xba I

and incubated with T3 polymerase. The sense probe was made by linearizing

with Hind III and incubating with T7 polymerase. Lung sections were









41
prehybridized, hybridized, and washed as described.142 Briefly, the slides were

initially de-paraffinized in xylene, re-hydrated through a graded series of ethanol

washes, and denatured in 0.2 N HCI and in 2X SSC at 70C. Prehybridization

consisted of incubation in 0.001% proteinase K (30 min, 37C), acetylation in

acetic anhydride, and dehydration in ascending concentrations of ethanol.

Hybridization was performed at 57C overnight in a humidified chamber. The

slides were washed in 4X SSC, incubated in RNase A (30 min, 37"C) and

washed in descending concentrations of SSC. A final high stringency wash was

performed using 0.1X SSC at 65C for 30 min. The slides were then dehydrated

and dried. Signal was detected by coating the slides with Ilford K.5D nuclear

emulsion (Polysciences, Inc., Warrington, PA), and development in Kodak D-19

developer (Kodak, Rochester, NY) after 7-14 days. 42 Autoradiograms were

stained with hematoxylin and eosin. Specificity of the probes was determined by

comparison with slides hybridized with labeled sense transcripts. Only lungs

from BN rats were processed for in situ hybridization.

For immunocytochemistry, lung sections from BN and F344 rats were de-

paraffinized and re-hydrated as described above for in situ hybridization, washed

in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with

either chicken IgG against recombinant human TGF-B, (R&D Systems,

Minneapolis, MN), or normal chicken IgG (Sigma, St. Louis, MO), both at 0.01

mg/ml. Antibody binding was detected using an avidin-biotin alkaline

phosphatase system (Vectastain ABC-AP and substrate kits, Vector Lab,

Burlingame, CA) as described.81










Quantitation Methods and Data Analysis



Evaluation of pulmonary cytokine mRNA levels in control and virus-

inoculated BN and F344 rat strains was made by comparing the relative optical

densities (ROD) of bands on Northern autoradiograms. The density of cells

expressing mRNA and protein was assessed by counting and classifying the

number of labeled cells per millimeter of bronchiolar basement membrane in 25

consecutive fields at 400X per slide." Macrophages and fibroblasts were the

cells most consistently labeled by the TGF-P, immunocytochemistry and in situ

hybridization procedures. Vascular and airway smooth muscle cells also

contained TGF-P, mRNA and protein, while epithelial cells were occasionally

positive for TGF-p, protein. Macrophages and fibroblasts were counted in the

bronchiolar wall. In addition, macrophages in immediately adjacent alveolar

spaces were counted in the same microscopic fields. Three lung sections from

each rat were evaluated in the immunocytochemistry procedures. In more

limited quantitative procedures for the in situ hybridization of BN rats, one slide

per rat was counted. Cells that had round profiles, central round to ovoid nuclei,

and abundant eosinophilic cytoplasm were counted as macrophages. Cells

were counted as fibroblasts when they had elongated ovoid nuclei and

elongated, spindle-shaped cytoplasm. Statistical analysis among group means

was performed using ANOVA and Tukey's HSD multiple comparison

procedure'" in a computer-based statistical program (Systat version 4,

Evanston, IL).














Effect of Sendai virus infection on total lung levels of TGF-B, mRNA



At 7 days after inoculation, viral infection resulted in significant increases in

pulmonary TGF-1, mRNA in both rat strains (Figures 3-1 and 3-2). Virus-

susceptible BN rats had a greater than two-fold increase in TGF-B, mRNA as

compared to the peak elevation observed in the virus-resistant F344 rats

(p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-B, mRNA levels

remained elevated in the virus-inoculated BN rats, whereas in virus-inoculated

F344 rats the levels were not significantly increased over those of control rats.

The level of pulmonary TGF-B, mRNA in lungs of virus-inoculated BN rats was

equivalent to that of the control animals by 30 days after inoculation. Pulmonary

PDGF mRNA was not increased in either rat strain at 7, 10, & 14 days after

inoculation (see Figure 2-1).



Identification of pulmonary cell types expressing TGF-B, mRNA



Macrophages and fibroblasts were the main cell types expressing TGF-1,

mRNA as detected by in situ hybridization in both control and virus-inoculated

rats (Figure 3-3). Macrophages in bronchiolar walls and alveolar macrophages

hybridized antisense probe. Bronchiolar smooth muscle cells as well as arterial










and venous smooth muscle cells were also positive for TGF-P, mRNA. In

control BN rats, the density of bronchiolar mural macrophages positive for TGF-

B, mRNA was 6.3 1.1 (mean sem) per mm bronchiolar basement membrane.

The density of alveolar macrophages positive for mRNA was 70.7 7.2 per mm

(data not shown). At 7 days after inoculation, there were approximately two-fold

increases in the density of bronchiolar mural macrophages positive for TGF-B,

mRNA as compared to control rats (11.7 1.8 per mm, p<0.05), and over 30-fold

increases in labeled alveolar macrophages (197.3 13.6 per mm, p<0.005)

(data not shown). Mean numbers of labeled macrophages at 10 days after

inoculation and labeled fibroblasts at 7 or 10 days after inoculation did not differ

significantly from controls (data not shown). Non-specific labeling was assessed

in tissue sections hybridized with the sense riboprobe.



Pulmonary TGF-B1 protein expression



Seven days after viral inoculation there were significantly increased

numbers of macrophages expressing TGF-1, protein in the lungs of both BN and

F344 rats (Figures 3-4 & 3-5). In infected BN rats at 7 days after inoculation, the

increase was ten-fold (p<0.0001) over control BN rats and greater than two-fold

(p<0.0001) over the number observed in infected F344 rats at 7 days after

inoculation. At 10 days after inoculation, BN rats had three-fold increases in

macrophages and fibroblasts expressing TGF-B, protein as compared to










controls (p<0.0001). At 10 days after inoculation in F344 rats, the numbers of

macrophages and fibroblasts positive for TGF-131 were not significantly different

than sham-inoculated animals (Figures 3-5 & 3-6). TGF-P, protein was also

detected in bronchiolar, venous, and arterial smooth muscle in both BN and

F344 rats.





Discussion



The goal of this study was to determine whether TGF-P, expression induced

by viral bronchiolitis might be an important stimulus for bronchiolar mural fibrosis

and thickening. The bronchiolar fibrosis that follows acute virus-induced injury

and inflammation is associated with long-term airway dysfunction 36 and,

therefore, is an important pathologic endpoint to investigate. Two main

observations from this study are consistent with the interpretation that increased

TGF-P, gene expression may be an important stimulus for virus-induced

bronchiolar fibrosis. First, increases in pulmonary steady-state mRNA levels

and in density of bronchiolar cells expressing mRNA and protein precede the

bronchiolar fibrosis that develops by 15 or 30 days following inoculation.3 38

Second, BN rats (high responders to Sendai virus-induced bronchiolar fibrosis)

have higher and more prolonged levels of increased TGF-P, protein and mRNA

expression in lung and airways than do F344 rats (low responders).3









46
Although the results are consistent with TGF-P, being an important regulator

of virus-induced bronchiolar fibrosis, they do not delineate the specific

mechanism for increased gene expression. Increased quantities of TGF-P,

mRNA in whole lung homogenates were associated with increased numbers of

macrophages and fibroblasts in airway walls and surrounding alveoli expressing

cytoplasmic mRNA and protein. Increased mRNA levels in lung could be due to

increased infiltration of cells containing TGF-P, mRNA, virus-induced gene

transcription and protein expression in macrophages and fibroblasts, or a

combination of the two mechanisms. Although the data do not clearly

distinguish the relative importance of these mechanisms, several findings

suggest that the increased TGF-P, mRNA and protein expression in cells around

virus-infected bronchioles may be due at least in part to virus-induced increases

in gene transcription and/or protein synthesis.

First, increased numbers of peribronchiolar fibroblasts expressing TGF-0P

protein were observed at 7 days after inoculation and prior to appreciable

increases in numbers of bronchiolar mural fibroblasts. Increases in fibroblast

numbers are observed at 15 to 30 days after viral inoculation. Second, if all the

increases in TGF-0, mRNA were due to infiltration of macrophages, we would

expect to see similar increases in mRNA for PDGF, another cytokine associated

with macrophages.4 Pulmonary steady-state levels of PDGF mRNA did not

increase following infection in either BN or F344 rats at 7, 10, and 14 days after

inoculation (Figure 2-1).










Transcriptional upregulation of TGF-11, gene expression could be a direct

result of viral infection. The ability of viruses to directly increase expression of

inflammatory cytokines is considered to be an important mechanism in the

pathogenesis of several viral diseases. 105.57 In acquired immunodeficiency

syndrome (AIDS), a viral protein (tat) appears to directly upregulate the

production of TGF-B.1"0 More complex viral effects on host cell gene regulation

are also recognized. Influenza A virus infection of murine macrophages not only

increases transcription of tumor necrosis factor-a (TNF-a), but also induces the

production of a unique TNF-a transcript.1' Sendai virus infection of cultured

macrophages has been shown to directly stimulate the production of TNF-a.57 In

Sendai virus infected rats, pulmonary viral titers peak around 5 days after

inoculation,3 before the peak expression of TGF-B at 7 days after inoculation.

Direct upregulation of TGF-P, gene transcription and protein synthesis by

Sendai virus infection could explain some of the differences in the pathologic

response of BN and F344 rats to viral infection. Pulmonary Sendai viral

replication persists for several days longer in weanling BN rats than in F344

rats.37 Persisting viral replication could be an important stimulus of persisting

cytokine expression and more severe fibrosis in BN rats.

TGF-1, is a major regulator of fibrosis and other tissue repair mechanisms. It

contributes to increasing tissue levels of collagen and other matrix proteins by

several mechanisms. TGF-1, increases transcription of fibronectin and

procollagen genes", post-transcriptionally regulates fibroblast, collagen and










fibronectin mRNA," and inhibits the degradation of existing extracellular

matrix.71 Studies of naturally occurring and chemically-induced fibrotic lung

lesions indicate that TGF-B, is an important mediator of pulmonary fibrosis.4 ,'"
48, -oo.08. In this study, the prolonged upregulation of TGF-B, in the susceptible

rats implies that such increases may also be important in the regulation of virus-

induced bronchiolar fibrosis and airway function abnormalities.

In addition to its regulatory effects on repair and fibrosis, TGF-B, can

suppress both T- and B-lymphocytes, decrease cytotoxic and lymphokine-

activated killer cell production, and down-regulate macrophage activity.925 In

several models of infectious disease, these immunosuppressive effects have

resulted in direct correlations between the level of TGF-B, expression, the

prolonged survival of infectious agents and the extent of tissue damage. 9'2-102.

103 It is reasonable to speculate that prolonged and excessive TGF-P,

expression in infected BN rats may be contributing to less effective immunity and

to virus-induced tissue damage and abnormal repair marked by fibrosis.

In conclusion, the results of this study demonstrate that virus-induced

bronchiolar TGF-B, gene expression precedes bronchiolar mural fibrosis and

suggest that it may play an important pathogenetic role in virus-induced

bronchiolar fibrosis and airway function abnormalities.
















3- E



8 l. We
* I00a)

'o-






S4)














E E
I~_ .a

o o
-a-









-: E-C
<-


c2 .E -z

.:, A oo -,E











e O F344
S* p< 0.001
E A BNp



S 4
O
0




Z

0' o' '-------
0 2 4 6 8 10 12 14 30
Days After Inoculation



Figure 3-2: Graphic presentation of the results of Northern analysis for
TGF -P1. Data points and bars represent the mean relative optical band
density (ROD) and standard error of the mean (SEM) for 4-6 rats.
Statistical comparisons of ROD's were only made between sham- and
virus-inoculated groups represented on the same blot.









































I-












Figure 3-3. TGF-1B mRNA in lung sections was detected by in situ hybridization.
Top panel: brightfield and darkfield micrographs from a sham-inoculated BN rat.
The bottom panel shows a bronchiole from an infected BN rat at 10 days after
inoculation. (x200).






















Irbi- AW I S
Vd. -- ^




















Figure 3-4. TGF-a, protein in bronchiolar macrophages. Both micrographs are
of sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
top was incubated with 0.01 mg/ml normal chicken IgG and the bottom with 0.01
mg/ml chicken anti-human TGF-I, IgG (x600).














Sp< 0.0001
og 0 F344 Control
2 g V F344 Infected
0 f BN Control
S40 \ BN Infected

*E n- p< o.ooo1



z

0 5 10 18 20 25 0
Days After Inoculation



Figure 3-5: Density of bronchiolar mural macrophages expressing
TGF-01 protein. Data points represent mean + SEM (n=4).















L* p< 0.0001
a 0 F344 Control
2 / \ V F344 Infected
S\ BN Control
0 y BN Infected
m


0 -
2-


zM

0 5 10 15 20 25 30
Days After Inoculation




Figure 3-6: Density of bronchiolar mural fibroblasts expressing TGF-P1
protein. Data points represent mean + SEM (n=4).














CHAPTER 4
INCREASED TUMOR NECROSIS FACTOR-a (TNF-a) GENE EXPRESSION IN
MACROPHAGES PRECEDES BRONCHIOLAR FIBROSIS IN VIRUS-
SUSCEPTIBLE BN RATS


Summary


Parainfluenza type I (Sendai) virus infection in genetically susceptible young

rats induces persistent increases in airway resistance and airway

hyperresponsiveness. In virus-susceptible BN rats, the pulmonary function

abnormalities are associated with bronchiolar mural fibrosis and recruitment and

persistence of inflammatory cells including mast cells and macrophages. We

hypothesized that TNF-a gene expression is an important regulatory event in

virus-induced bronchiolar fibrosis. Pulmonary TNF-a mRNA and protein

expression were assessed at 3, 7, 10, 14, and 30 days after virus-inoculation in

rat strains that are susceptible (BN) and resistant ( F344) to virus-induced

bronchiolar fibrosis. Northern analysis revealed elevated pulmonary TNF-a

mRNA levels in both rat strains at 3, 7, and 10 days after inoculation (p<0.01).

At 14 days after inoculation only the virus-susceptible BN rats had increased

levels of TNF-a mRNA in their lungs (p<0.01). Macrophages and fibroblasts

were identified as being the main bronchiolar cell types containing TNF-a mRNA










and protein by in situ hybridization and immunocytochemistry. Macrophage

expression of TNF-a protein peaked at 7 days after inoculation in both rat

strains (p<0.0001). Virus-inoculated BN rats had almost twice the density of

TNF-a-positive macrophages in their bronchiolar walls as infected F344 rats

(p<0.0001). The number of macrophages positive for TNF-a protein remained

significantly elevated in infected BN rats at 10 dpi (p<0.05). Over two-fold

increases in the number of labeled bronchiolar fibroblasts were observed in

infected rats of both strains at 7 dpi (p<0.001) compared to the control rats. At

10 dpi the mean number of fibroblasts positive for TNF-a protein had increased

to over 5-fold that of the control in the infected BN rats (p<0.0001), but was not

significantly elevated in the infected F344 rats. The data suggest that increased

TNF-a gene expression may be important in the pathogenesis of virus-induced

bronchiolar fibrosis.





Introduction



Viral bronchiolitis in early childhood has been linked with persisting

pulmonary functional abnormalities including increased airway resistance and

airway hyperresponsiveness and has been identified as a risk factor for the

development of asthma.2" The development of asthma-like symptoms following

viral infection appears to be associated with an aberrant, IgE-dominated








57

immunological response that is probably determined by a combination of genetic

and viral factors.2" Young rats develop similar pulmonary functional

abnormalities after infection with parainfluenza virus type I (Sendai) and are

being studied as an animal model to identify genetic and viral factors important

in the pathogenesis of virus-induced lung injury. 1, .35

The development of virus-induced pulmonary function abnormalities in rats is

associated with infection as neonates or weanlings and genetic susceptibility.

Brown Norway (BN) rats develop virus-induced alterations in pulmonary

structure and function, while Fischer 344 (F344) rats are relatively resistant."'"

' Comparative viral pathogenesis studies indicate there are differences in

duration of viral replication, magnitude of immune response, and severity of both

the acute and persistent inflammatory response between the virus-susceptible

BN and virus-resistant F344 rats.3" The virus-induced abnormalities in

pulmonary function consist of increased respiratory resistance, decreased

dynamic compliance and hyperresponsiveness to methacholine. These

functional abnormalities are associated with bronchiolar aggregates of

macrophages, mast cells, and eosinophils, and bronchiolar mural fibrosis.3

Bronchiolar mural fibrosis and the resulting airway wall thickening is

prominent in BN rats 15 to 30 days after being infected with Sendai virus.

Bronchial fibrosis is a common finding in human asthmatics.22-24 4 The

importance of mural fibrosis in the development of increased airway resistance is

indicated by airway modeling studies that demonstrate that moderate amounts of










airway wall thickening markedly alter mechanical properties of airways and

accentuate airway luminal narrowing during smooth muscle contraction.24

Several cytokines including tumor necrosis factor-a (TNF-a), transforming

growth factor-3 (TGF-P), and platelet-derived growth factor (PDGF) stimulate

pulmonary fibroblast proliferation and collagen synthesis and are upregulated in

both naturally occurring and chemically-induced pulmonary fibrosis.40'6 "-'0, 85,
84.11820 Pulmonary expression of TGF-P, and PDGF during Sendai virus

infection has been assessed in both virus-susceptible BN and virus-resistant

F344 rats (see Chapter 3 and Figure 2-1). Virus-induced increases in

pulmonary PDGF mRNA were not observed. However, prolonged increases in

pulmonary TGF-P, mRNA, as well as increased numbers of bronchiolar

macrophages and fibroblasts expressing TGF-P, protein were present in infected

BN rats before the development of virus-induced fibrosis.

Increased pulmonary expression of TGF-P appears to be important in the

pathogenesis of some, but not all forms of pulmonary fibrosis. The

administration of antibodies to TGF-1 significantly reduced bleomycin-induced

increases in lung collagen." In contrast, pulmonary TGF-1 mRNA was not

increased in lungs during the development of silica-induced pulmonary

fibrosis.'20 TNF-a has been shown to be increased in both silica-induced

pulmonary fibrosis and bleomycin-induced fibrosis."' 120 The importance of

TNF-a in these two forms of fibrosis further emphasized by studies showing that

TNF-a inhibition with antibody reduces severity of fibrosis.11 "2 Furthermore,










the infusion of recombinant TNF-a accentuated the severity of pulmonary

fibrosis in silica-treated mice.12

Based upon these observations, we hypothesized that the development of

Sendai virus-induced bronchiolar fibrosis in susceptible BN rats also may be

regulated by bronchiolar expression of TNF-a. The objectives of this study were

to determine if Sendai virus infection induces increases in pulmonary TNF-a

mRNA levels prior to the development of fibrosis and to determine whether rats

susceptible to virus-induced bronchiolar fibrosis (BN) have increased numbers

of bronchiolar cells expressing TNF-a protein compared to the virus-resistant

(F344) rats.



Materials and Methods


Animals



Twenty-two day old weanling male BN and F344 rats were purchased from

Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum

antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat

virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic

bacteria. The control and experimental groups were separated and housed in

adjacent individually ventilated isolation units.
















Three days after arrival, the rats in the experimental group were exposed to

parainfluenza type I (Sendai) virus at a concentration of 1-3 plaque forming

units (PFU) per ml of gas for 15 minutes in a Tri-R aerosol exposure apparatus

(Tri-R Instruments, Rockville Center, NY). Viral assays to calibrate exposure

were performed as previously described."37 Sendai virus strain P3193

produced in embryonated chicken eggs was used. Control rats were exposed to

sterile chorioallantoic fluid. Virus-inoculated BN and F344 rats were processed

at 3, 7, 10, 14 and 30 dpi. Sham inoculated animals were sacrificed at 7, 14,

and 30 dpi. The rats were deeply anesthetized with sodium pentobarbital and

killed by exsanguination via intracardiac puncture. For Northern analysis, the

lungs of six rats from each group were frozen in liquid nitrogen and stored at

-80*C until processed. Lungs from four animals in each group were processed

for in situ hybridization and immunohistochemistry. These lungs were fixed for 2

hours via airway perfusion with 4% paraformaldehyde-PBS (pH 7.4), at 30 cm

perfusion pressure, and embedded in paraffin for in situ hybridization and

immunocytochemistry.










Northern Analysis



Lung tissue was lysed in guanidine thiocyanate, and total RNA extracted and

precipitated as described.1' Twenty micrograms (pg) of total RNA from each

lung was electrophorectially fractionated on a series of 1.2% (wt:vol) agarose

gels containing 6% (vol:vol) formaldehyde, transferred to a positively charged

nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN), and

fixed by UV-crosslinking. Equality of RNA loading between lanes was assessed

by visually comparing the intensity of ethidium bromide staining of ribosomal

RNA bands in the gels and membranes. A cDNA probe for rat TNF-a (supplied

by Dr. T. Shirai, Laboratory for Chemical Research, Asahi Chemical Industry Co.

Ltd, Tagata-gun, Shizuoka, Japan) was labeled with "P-dCTP using the random

primer method as described.14 Prehybridization (15 min, 58C) and

hybridization (overnight, 58C) was in 0.5 M Na2HPO4, 7% SDS, 1% BSA, and

10mM EDTA as described.141 The membranes were washed at the hybridization

temperature in 40mM phosphate, 1% SDS, and exposed to Kodak (Rochester,

NY) XLS-5 film with Dupont Cronex intensifying screens. Film band densities

were quantified using a computerized video image analysis unit (MicroComputer

Imaging Device, Imaging Research Inc., St Catharines, Ontario).










In Situ Hybridization/Immunocytochemistry



In situ hybridization was performed by subcloning the rat TNF-a cDNA probe

into pBluescript II KS+ (Stratagene, La Jolla, CA) as a template for the

production of digoxigenin-labeled RNA probes. Sense and antisense riboprobes

were made according to manufacturer's instructions (The Genius System,

Boehringer Mannheim, Indianapolis, IN). Lung sections were initially de-

paraffinized in xylene, re-hydrated through a graded series of ethanol washes,

and denatured in 0.2 N HCI. Prehybridization treatment consisted of: incubation

in 0.001% proteinase K (30 min, 37C), acetylation in acetic anhydride, and

dehydration in ascending concentrations of ethanol. The probe was added to

the hybridization solution (62.5% formamide, 12.5% dextran sulfate, 0.3 M NaCI,

0.025X Denhart's solution [Sigma, St. Louis, MO] 12.5 mM Tris-HCI pH 8.0, 1.25

mM EDTA pH 8.0) and denatured at 65* C for 10 minutes. Approximately 50 ng

of probe was added to each slide, coverslips were applied and the slides were

placed in a 65 C oven for 10 minutes. Hybridization was then performed at

37C overnight in a humidified chamber. The slides were washed in 2 X SSC

(10 min, 37"C), 1 X SSC (10 min, 37C), and 0.1 X SSC (10 min, 37"C). The

sections were blocked in 2% normal sheep sera (30 min, room temperature) and

incubated (2 hours, room temperature) with an alkaline phosphatase-conjugated

antibody to digoxigenin (Boehringer Mannheim, Indianapolis, IN). Signal was

detected using nitroblue tetrazolium (4-8 hours, room temperature) (Boehringer










Mannheim, Indianapolis, IN). Specificity of the probes was determined by

comparison with slides hybridized with equivalent quantities of labeled sense

transcripts.

For immunocytochemistry, lung sections from BN and F344 rats were de-

paraffinized and re-hydrated as described above for in situ hybridization, washed

in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with

either rabbit sera (Sigma, St. Louis, MO) or polyclonal rabbit anti-mouse TNF-a

(Genzyme, Cambridge, MA) both at 0.001 mg/ml. Antibody binding was

detected using an avidin-biotin alkaline phosphatase system (Vectastain ABC-

AP and substrate kits, Vector Lab, Burlingame, CA).



Protein Analysis on BAL Fluid



Bronchioalveolar lavage fluid (BAL) was collected from sham- and virus-

inoculated BN and F344 rats at 7 and 10 dpi using two phosphate-buffered

saline lavages as described.5 The amount of rat TNF-a protein in each sample

was determined by enzyme-linked immuno-absorbance assays (ELISA) using an

immunoassay kit according to the manufacture's instructions (BioSource

International, Inc. Camarillo, CA).










Quantitation Methods and Data Analysis



Pulmonary TNF-a mRNA levels were evaluated by comparing the relative

optical densities (ROD) of the bands on Northern autoradiographs.

Comparisons of TNF-a bands detected in pulmonary RNA were only made

between bands in RNA run on the same gel. ROD's of the bands were

expressed as percentages of the band density of a positive standard (30 pg of

pooled pulmonary poly-A mRNA from Sendai virus-inoculated BN rats harvested

at 7 dpi) run on each gel. The density of cells expressing TNF-a protein was

assessed by counting and classifying the number of labeled cells per millimeter

of bronchiolar basement membrane in 25 high power (400X) fields per slide.

Round cells with central round to ovoid nuclei and abundant cytoplasm were

counted as macrophages, cells with elongated ovoid nuclei and spindle-shaped

cytoplasm were counted as fibroblasts, and culsters of round cells with central

round nuclei and sparse cytoplasm were identified as lymphocytes. Labeled

macrophages in the bronchiolar wall and immediately adjacent alveolar spaces

and labeled fibroblasts in the bronchiolar wall were counted in the same

microscopic field. Three slides from each of 4 animals per group were counted.

Statistical analysis of group means was performed using ANOVA and Tukey's

HSD multiple comparison procedurel" in a computer-based statistical program

(Systat version 4).










Results



Sendai virus infection causes an increase in total lung levels of TNF-a mRNA



TNF-a transcripts were not detected in pulmonary mRNA extracted from

sham-inoculated animals. Viral infection resulted in increased total lung levels

of TNF-a mRNA in both rat strains at 3, 7, and 10 days after inoculation

(p<0.01). Pulmonary TNF-a mRNA levels peaked at 3 dpi in the F344 rats and

at 7 dpi in the BN rats. Virus-susceptible BN rats still had increased levels of

TNF-a mRNA in their lungs 14 days after inoculation (p<0.01), while in the virus-

resistant F344 rats levels were not significantly above those of the sham-

inoculated rats. Pulmonary TNF-a mRNA levels in the BN rats did not return to

baseline levels until 30 days after inoculation (Figures 4-1 & 4-2).



Identification of pulmonarv cell types expressing TNF-a mRNA and protein



In situ hybridization identified macrophages and fibroblasts as the main

bronchiolar cells expressing TNF-a mRNA in infected BN rats (Figure 4-3).

Epithelial cells and occasional scattered aggregates of lynmphocytes around

bronchi (BALT) were also labeled in sections hybridized with the anti-sense

TNF-a riboprobe.









66
The number of bronchiolar macrophages positive for TNF-a protein peaked

at 7 days after inoculation in both rat strains (p<0.0001, Figures 4-4 & 4-5).

Infected virus-sensitive BN rats had almost twice as many labeled macrophages

in their bronchiolar walls as infected F344 rats (p<0.0001). The number of

labeled macrophages was still elevated in infected BN rats at 10 days after

inoculation (p<0.05). The number of bronchiolar fibroblasts positive for TNF-a

protein increased over two-fold in both rat strains at 7 days after inoculation

(p<0.001, Figure 4-6). The largest number of labeled fibroblasts observed in the

virus-resistant F344 rats was at 7 dpi, while in the virus-susceptible BN rats, the

numbers increased until 10 days after inoculation (p<0.0001, Figure 4-6). TNF-

a protein was also observed in epithelial cells and in BALT lymphocytes.



Effects of Sendai virus infection on TNF-a protein levels in BAL fluid



TNF-a protein levels in the BAL fluid harvested from infected BN rats at 7 dpi

were elevated at 346.7 47.5 pg/ml (mean sem) compared to 55.83 36.38

pg/ml for infected F344 rats (p<0.05). At 10 dpi, the levels of TNF-a protein

were not significantly different between the two rat strains (BN = 104.7 24.3

pg/ml, F344 = 74.5 41.5 pg/ml).














The deposition of collagen in bronchiolar walls increases wall thickness and

may be a major factor accounting for persistent increases in airway resistance

observed in BN rats following viral infection.""1 Two main observations of this

study support a potential role for TNF-a in the pathogenesis of this virus-

induced airway fibrosis. First, pulmonary TNF-a mRNA and protein expression

are elevated before the development of bronchiolar fibrosis at 14-30 days after

virus inoculation." Second, although increases in TNF-a mRNA and protein

were induced by viral infection in both rat strains, higher and more prolonged

TNF-a gene expression was observed in the rats that develop bronchiolar

fibrosis (BN) compared with that in the rats that do not (F344).

These observations are similar to those made in studies of chemically-

induced airway fibrosis in which susceptibility and resistance to the development

of bleomycin-induced pulmonary fibrosis in mice was associated with the level of

TNF-a expression. As was observed in the virus-susceptible and -resistant rats

in this study, mice with a high level of TNF-a expression after exposure

developed fibrosis, while those exhibiting a low level did not.109 The significance

of elevated TNF-a mRNA and protein in the pathogenesis of pulmonary fibrosis

has been demonstrated in rodent studies in which both the development of

bleomycin-induced pulmonary fibrosis and the lesions of silicosis were

prevented by the administration of antibodies to TNF-a."'1 2










The results of this study imply that TNF-a is also important in the

pathogenesis of virus-induced airway fibrosis. However, the mechanism of the

increased gene expression is unclear. The initial increase in the amount of

TNF-a mRNA present in whole lung homogenates was observed at 3 days after

inoculation, while increases in the numbers of cells (mostly macrophages and

fibroblasts) expressing cytoplasmic protein were not noted until 7-10 days post

inoculation. This finding indicates that not all of the increased expression was

the result of the inflammatory cell infilitrate, especially since macrophages do not

inflitrate until 4-5 days after virus-inoculation.37 Epithelial cells and and

lymphocytes in the airway associated lymphoid tissue (BALT) were also positive

for TNF-a mRNA and protein and are the most likely sources of the initial

increase in TNF-a mRNA levels observed in the whole lung homogenates.

Epithelial cells are also the first cells infected by Sendai virus, and the induction

of TNF-a expression may be a direct effect of infection.

Several viruses can directly increase TNF-a mRNA and protein expression.".
111.112, 145. 1 Influenza A virus infection of murine macrophages results in a

massive accumulation of TNF-a mRNA, including a unique high molecular

weight transcript that is not translated into protein until the cells are exposed to a

secondary trigger, such as small amounts of endotoxin.14 Although unique

species of TNF-a mRNA were not observed in this study, Sendai virus has been

found to stimulate TNF-a protein production in monocytes57 and direct

upregulation of TNF-a transcription may contribute to the increased expression









69
observed in infected rats. Direct upregulation of TNF-a gene transcription and

translation by Sendai virus infection could also account for some of the

differences in the pathologic responses of BN and F344 rats. Viral replication

persists for several days longer in the lungs of weanling BN rats than in those of

F344 rats.37 Persisting viral replication could be an important stimulus for

prolonged cytokine expression and result in airway fibrosis in BN rats.

The mechanism by which TNF-a contributes to the development of

pulmonary fibrosis is not completely understood. TNF-a can upregulate the

inflammatory response through its ability to activate macrophages, stimulate

lymphocyte proliferation, and increase the adhesion of both neutrophils and

eosinophils.147' 1' It has also been shown to induce necrosis of alveolar

epithelial and endothelial cells when given intravenously."1'.4 Both of these

effects contribute to the development of fibrosis by increasing the extent of

tissue damage. In addition, TNF-a can directly stimulate fibroblast proliferation

and collagen deposition, and induce the expression of other fibrogenic cytokines

such as PDGF.13

Recently, it has been found that pulmonary platelet trapping strongly

correlates with collagen deposition in bleomycin-induced pulmonary fibrosis.11

The same study also found that antibodies to TNF-a, as well as other treatments









70
mediate the development of fibrosis."1 The importance of platelet trapping in

the pathogenesis of Sendai virus-induced bronchiolar fibrosis is uncertain.

Elevations in pulmonary TGF-P mRNA and protein expression were found in the

infected susceptible BN rats, but the increases were associated with the peak

macrophage infiltration at 7 days after inoculation, and pulmonary PDGF mRNA

levels were not increased by viral infection.

The results of this study demonstrate that virus-induced bronchiolar TNF-a

gene expression precedes bronchiolar mural fibrosis and suggest that it may

play an important pathogenetic role in bronchiolar fibrosis and the associated

airway function abnormalities.
























18s -. ... : TNF-a


SHAM ][ 3 DPI ][ 7 DPI ]



Figure 4-1: Northern blot of rat pulmonary total RNA hybridized with a "P-
labeled cDNA probe for rat TNF-a. This blot contains pulmonary RNA extracted
from sham-inoculated F344 rats at 7 days after inoculation (Sham), and from
virus-inoculated F344 rats at 3 & 7 days after inoculation. Each lane was loaded
with 20 pg of RNA from an individual animal. The upper panel shows the
ethidium bromide-stained gel.















CO
0: 60
S E

Z2
W 20
E ao


0 2 4 6 8 10 12 14 30
Days After Inoculation


Figure 4-2: Graphic presentation of the results of Northern analysis for
TNF-a. Data points and bars represent the mean % maximum relative
optical band density (ROD) and standard error of the mean (SEM) for
4-6 rats. The maximum ROD for each blot was determined from
positive control RNA. Statisical comparisons of ROD's were only made
between bands from sham- and virus-inoculated rats present on the
same autoradiograph.














































riboprobe (x600).
M %








Figure 4-3: TNF-a mRNA in bronchiolar macrophages. These serial sections
were taken from a virus-inoculated BN rat at 7 days after inoculation. The top
section was incubated with 50 ng of a digoxigenin-labeled antisense riboprobe
for rat TNF-a and the bottom with 50 ng of the digoxigenin-labeled sense
riboprobe (x600).












,-AW' %


-Ac


Figure 4-4: TNF-a protein in bronchiolar macrophages. Both micrographs are of
sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
upper section was incubated with 0.001 mg/ml normal rabbit sera and the lower
with 0.001 mg/ml polyclonal rabbit anti-mouse TNF-a (x600).


























s- T 15 20 25
Days After Inoculation


Figure 4-5: Density of bronchiolar mural macrophages expressing
TNF-a protein. Data points represent group mean + SEM (n=4).














P, U.UUUI
0 F344 Control
V F344 Infected
S 4 0 BN Control
g 1 BN Infected


o < / I
0 -V




0 5 15 20 25 30
Days After Inoculation



Figure 4-6: Density of bronchiolar fibroblasts expressing TNF-a
protein. Data points represent group mean + SEM (n=4).
















CHAPTER 5
FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF SENDAI VIRUS-
INDUCED BRONCHIOLAR FIBROSIS IN BN RATS IS INHIBITED BYA
SOLUBLE TNF RECEPTOR


Summary



Sendai virus infection in virus-susceptible BN rats induces bronchiolar

fibrosis associated with airway hyperresponsiveness and persistent increases in

airway resistance. This study investigated the significance of TNF-a in the

pathogenesis of Sendai virus-induced bronchiolar fibrosis by determining

whether the numbers of proliferating bronchiolar fibroblasts induced by virus

infection could be reduced by inhibition of TNF-a bioactivity. Virus-susceptible

BN rats were treated with a 55 kD soluble TNF receptor-immunoglobulin G

fusion protein (p55sTNFR-IgG) following either sham- or virus-inoculation.

Control sham- and virus-inoculated animals were treated with human IgG.

Proliferating bronchiolar fibroblasts were labeled with bromodeoxyuridine

(BrdU), detected by immunocytochemical staining and quantitated. At 8 to 9

days after virus-inoculation, rats treated with p55sTNFR-lgG had decreased

numbers of bronchiolar fibroblasts incorporating BrdU compared to virus-









78
inoculated IgG-treated rats (p<0.05). There was significantly increased mortality

in p55sTNFR-IgG-treated virus-inoculated rats associated with increased viral

replication and decreased numbers of macrophages and lymphocytes (p<0.05),

in bronchioalveolar lavage fluid. In conclusion, TNF-a is an important mediator

of bronchiolar fibrosis and has a critical role in the termination of Sendai viral

replication in the lung.



Introduction



Viral bronchiolitis in early childhood is associated with the development of

chronic respiratory disease and has been identified as a risk factor for the

development of asthma.26 After inoculation with parainfluenza virus type I

(Sendai), weanling rats develop persistent increases in airway resistance,

decreased dynamic compliance and airway hyperresponsiveness; and are a

useful model to determine which genetic, inflammatory and immunological

factors are important in the pathogenesis of virus-induced airway

abnormalities.'8 33.35

The development of virus-induced pulmonary function abnormalities in

rats is determined by age at infection and genetic susceptibility.18'3S" Neonatal

and weanling Brown Norway (BN) rats are susceptible to persistent virus-

induced alterations in pulmonary structure and function. Fischer 344 (F344) rats

are resistant.18' 3 Bronchiolar inflammation composed of aggregates of










macrophages, mast cells and eosinophils, and bronchiolar mural fibrosis" is

associated with the virus-induced abnormalities in pulmonary function.

Bronchiolar mural fibrosis and the resulting airway thickening is prominent in

BN rats 15 to 30 days after being infected with Sendai virus." Airway modeling

studies have shown that the dynamics of increased airway resistance can be

profoundly affected by mural fibrosis since even moderate amounts of airway

wall thickening can greatly accentuate airway luminal narrowing during smooth

muscle contraction." Bronchiolar fibrosis is a common finding in asthmatics,"22

and has been linked to airway obstruction.

The pathogenesis of airway fibrosis is poorly understood, however, tumor

necrosis factor-a (TNF-a) has been implicated as an important mediator of

chemically-induced pulmonary fibrosis.' 1", 1' 2' In models of both silica- and

bleomycin-induced pulmonary fibrosis, the administration of antibodies to TNF-a

prevented the development of fibrotic lung lesions.11""12 In the silicosis model,

lung lesions were also enhanced by the infusion of recombinant TNF-a.'12

The results of previous studies indicate that the development of Sendai virus-

induced bronchiolar fibrosis in BN rats is preceded by prolonged increases in

pulmonary TNF-a mRNA, and increases in the numbers of bronchiolar

macrophages and fibroblasts expressing TNF-a protein (see Chapter 4). The

objective of this study was to determine whether the inhibition of TNF-a

bioactivity during Sendai virus infection would prevent the development of

bronchiolar fibrosis in BN rats. Since preliminary studies indicated that










increases in the number of proliferating bronchiolar fibroblasts precede the

development of Sendai virus-induced airway fibrosis, bronchiolar fibroblast

proliferation was used as an indicator of fibrosis. The bioactivity of TNF-a was

inhibited using a fusion protein composed of the soluble part of the p55 TNF

receptor linked to the human IgG heavy chain constant region, a construct that

has been successfully used to block TNF activity in animal models of

endotoxemia.'5-152



Materials and Methods


Animals. Infection Protocol



Twenty-two day old weanling male BN rats were purchased from Harlan

Sprague Dawley Inc., Indianapolis, IN. They were negative for serum antibodies

to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat virus, and

sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic bacteria.

The sham- and virus-inoculated groups were separated and housed in

individually ventilated isolation units located in separate rooms. Three days

after arrival, the rats in the virus-inoculated groups were exposed to

parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming

units (PFU) per ml of gas for 15 minutes as previously described."32 Sham-

inoculated rats were exposed to sterile chorioallantoic fluid (CAF).













Experimental Design



One group of eighteen 25-day-old, male BN rats were inoculated with Sendai

virus, while a second group of 12 were sham-inoculated with CAF. Six rats from

the sham and 9 from the virus-inoculated rats were injected intraperitoneally (ip)

with 10 mg/kg of p55 sTNFR-IgG fusion protein (generously supplied by

Hoffman- La Roche, Basel, Switzerland) on 0, 2, 4, 6, & 8 days post inoculation

(dpi). The remaining animals: 6 sham-inoculated and 9 virus-inoculated rats,

were injected ip with10 mg/kg of human IgG according to the same schedule.

Three rats from each of the virus-inoculated groups were sacrificed at 7 dpi.

The rest of the rats were given 200 .g/g 5-bromo-2' -deoxyuridine (BrdU, Sigma,

St Louis, MO, 2 mg/ml in PBS) ip 12 hours before they were processed at 9 dpi

(Figure 2-2).

In a separate infection run, an additional group of 12 virus-inoculated rats

received 1 mg/kg of p55 sTNFR-IgG on the same schedule as above. These

animals were injected with BrdU 12 hours before being sacrificed at 7 dpi (n=6)

and 8 dpi (n=6). All rats were anesthetized with sodium pentobarbital

(approximately 200 pg/g body weight) and were killed by exsanguination via

intra cardiac puncture. Bronchoalveolar lavages (BAL) were performed, and the

lungs were fixed by tracheal perfusion with 4% paraformaldehyde at 30 cm H20

pressure for 2 hours.










Bronchoalveolar Lavage



Phosphate-buffered saline (PBS) was used to perform bronchoalveolar

lavage (BAL) as previously described.53 Total cell counts were made using a

hemacytometer. Cytocentrifuge cell samples of lavage fluid were made with a

Cytospin 2 (Shandon Southern Instruments, Inc, Swickley, PA), fixed in

methanol, and stained with Giemsa solution. A cell differential was calculated

after evaluating 200 cells. Total cell numbers recovered per lung were

calculated (macrophages, neutrophils, and lymphocytes) and normalized per

100 g body weight. The levels of TNF-a protein and bioactivity in the BAL fluid

were determined as described below.



TNF-a Protein and Bioassays



The amount of TNF-a protein present in the BAL fluid samples was

determined using an enzyme-linked immunoabsorbance assay (ELISA) kit

(Biosource International Inc. Camarillo, CA) performed according to the

manufacter's instructions. The level of TNF-a bioactivity in BAL fluid samples

was determined by cytotoxicity assays.'"'" Briefly, 50,000 cells from the

mouse cell line Wehi 164, a BALB/c fibrosarcoma'5 were plated per microtiter

well in 200 pl RPMI media with Glutamine, penicillin (50 IU/ml) streptomycin (50

mcg/ml) and incubated over-night at 37*, 5% CO2. Eighty pI of a 1.2 pg/ml










actinomycin D/RPMI solution, followed by 20 jl of the appropriate standard or

sample was then added to each well and the plates were incubated over-night at

37", 5% CO2. Ten pl of a freshly prepared 6 mg/ml MTT solution in RPMI was

then added to each well and the plates were incubated for 4 hours at 37', 5%

CO,. At the end of this incubation, 100 pl of 2-propanol was added to each

well, the plates were shaken at room temperature for 30 min, and 100 / of

water/well was added. The optical densities of the standard and sample wells

was read at 570/690 nm, and the amount of TNF-a bioactivity present in the

samples was determined from the standard curve.



BrdU Labeling



Four transverse sections were taken from the fixed left lungs of rats treated

with BrdU. Sections were taken at the hilus, between the hilar section and the

cranial lung margin, and at points equidistant caudal to the hilar section and

cranial to the caudal lung margin. Tissue blocks were embedded in paraffin the

same day. Five pm-thick sections were cut, mounted on slides, deparaffinized in

xylene, rehydrated, and washed in distilled water. Immunocytochemical staining

for BrdU was performed using a method modified from that previously

described.'17 Slides were placed in 3.0% H202 for 10 minutes to quench

endogenous peroxidase, washed twice in PBS, and pretreated in both 2N HCI

(30 min, 37* C) and 0.1% w/v trypsin in PBS (20 min, 37" C). Sections were









84
rinsed in PBS, covered with antibody diluent (1.0% BSA and 0.5% Tween 20 in

PBS) for 30 min to block nonspecific binding, blotted and incubated for 1 hour in

mouse anti-BrdU monoclonal antibody (Becton-Dickinson, Mountain View, CA)

diluted 1:100 in antibody diluent. Sections were washed and covered with

peroxidase-conjugated goat anti-mouse IgG (Fc specific, Sigma, St Louis, MO)

diluted 1:100 in antibody diluent for 1 hour. Bound peroxidase-conjugated

antibody was detected by development in the chromogen diaminobenzidine

(Sigma, St. Louis, MO) in 0.25 mg/ml in 0.025 M Tris, pH 7.6 and 0.01% H202 for

20 min. The slides were counter-stained with hematoxylin and eosin.



Virology



Following bronchoalveolar lavage, the right lungs of virus-inoculated rats

treated with 1 mg/kg of p55 sTNFR-IgG were collected aseptically, frozen in

liquid nitrogen, and stored at -80 C until viral assays were run. Plaque assays

for infectious virus were performed on lung homogenates using Madin-Darby

bovine kidney cells as previously described.32 The presence of viral antigens in

paraffin-embedded lung sections from infected p55sTNFR-lgG-treated rats was

detected by immunocytochemistry. Tissue sections were pretreated as

described above for the detection of BrdU, and incubated with a mouse

monoclonal antibody to parainfluenza type 1 virus (Chemicon, Temecula, CA).

Application of peroxidase-conjugated Cappel goat anti-mouse antibody and the









85
detection of bound peroxidase-conjugated antibody was performed as described

above.





Data Analysis



Fibroblast proliferation was assessed by counting the number of BrdU-

labeled bronchiolar fibroblasts in 100 high power (400X) fields per lung. Cells

counted as fibroblasts had elongated spindloid profiles, oval nuclei, and

eosinophilic cytoplasm. Only cells with nuclei within the plane of section were

counted. Mean values between groups were compared by one-way analysis of

variance (one-way ANOVA) using a microcomputer-based statistical program

(SigmaStat, Jandel Corporation, San Rafael, CA). Differences between

individual means were assessed by Bonferroni's method of all pairwise multiple

comparison.14 BAL fluid data were subjected to logarithmic transformation prior

to analysis.



Results



p55sTNFR-lgG Inhibits Virus-induced Proliferation of Bronchiolar Fibroblasts



Nine days after virus-inoculation, the mean number of BrdU-labeled

fibroblasts in the bronchiolar walls of virus-inoculated, p55sTNFR-lgG-treated










rats was significantly lower than that of virus-inoculated IgG-treated controls

(p55sTNFR-lgG: 12.3 2.3, IgG: 48.7 5.2, p<0.05) (Figure 5-1). Virus-

inoculated IgG-treated rats also had higher numbers of BrdU-labeled bronchiolar

fibroblasts than the sham-inoculated rats (p<0.05). The number of labeled

fibroblasts in the virus-inoculated p55sTNF-lgG treated rats was not significantly

different from that of the sham-inoculated rats. The numbers of BrdU-labeled

bronchiolar fibroblasts in the p55sTNF-lgG and IgG treated sham-inoculated rats

were not significantly different.



Bronchoalveolar Lavaae Fluid: TNF-a Protein and Bioassays



The mean pg/ml of TNF-a protein in the BAL fluid of virus-inoculated

p55sTNFR-lgG-treated rats was over four-fold higher than that of the virus-

inoculated IgG-treated rats at 7 days after inoculation (p< 0.003, Figure 5-2).

However, the level of TNF-a bioactivity in the BAL fluid of virus-inoculated rats

treated with 10 mg/kg of p55sTNF-IgG was significantly lower at 7 dpi than that

present in the virus-inoculated IgG-treated controls (p55sTNF-IgG: 2.5 1.41

pg/ml, IgG: 95.5 54.58 pg/ml, mean sem, p<0.05) (Figure 5-3). TNF-a

bioactivity was also decreased in the virus-inoculated rats treated with 10 mg/kg

p55sTNF-lgG at 9 dpi, but the means between the two virus-inoculated groups

were not significantly different. The virus-inoculated rats given 1 mg/kg

p55sTNF-IgG also had decreased, but not significantly lower, TNF-a bioactivity









87
in their BAL fluid at 7 dpi compared to the IgG-treated virus-inoculated rats (data

not shown). At 9 dpi, the surviving virus-inoculated rats in the 1 mg/kg

p55sTNF-lgG treated group had slightly but not significantly increased levels of

TNF-a bioactivity in their BAL fluid (data not shown). TNF-a bioactivity was not

detected in the lavage fluid of any of the rats in the sham-inoculated groups

(Figure 5-3).



Bronchoalveolar Lavage Fluid: Cell Counts



The data from total and differential cell counts performed on BAL fluid

samples are presented in Figures 5-4, 5-5, 5-6, 5-7. The counts from the virus-

inoculated low and high dose p55sTNFR-lgG-treated groups were pooled.

Virus-inoculated rats treated with p55sTNF-lgG had 3.5 fold fewer total cells/g

present in their BAL fluid at 7 days after inoculation compared to virus-

inoculated rats receiving IgG (p55sTNF-lgG: 12714 2004 IgG: 44886 5415,

mean sem, p<0.05). Sixfold decreases in total cell numbers were present at 9

days after inoculation (p55sTNF-lgG: 8217 1542, IgG: 52782 13632, p<0.05)

(Figure 5-4). Differential counts at seven days after inoculation, revealed virus-

inoculated p55sTNF-lgG treated rats had fivefold fewer numbers of

macrophages/g (p55sTNF-IgG: 4036 720, IgG: 20981 2433, p<0.05) and

almost sixfold fewer lymphocytes/g (p55sTNF-lgG: 586 + 145, IgG: 3948 1371,

p<0.05) in their BAL fluid compared to virus-inoculated IgG-treated rats (Figures









88
5-5 & 5-6). Ninefold fewer numbers of macrophages (p55sTNF-IgG: 2674 384,

IgG: 26153 6042, p<0.05) and fourteen-fold fewer lymphocytes (p55sTNF-IgG:

233 66, IgG: 3381 1068, p<0.05) were observed at 9 days after virus-

inoculation (Figures 5-5 & 5-6). Neutrophil counts were also two- and sixfold

lower in the p55sTNF-lgG treated virus-inoculated rats at 7 and 9 dpi

respectively, however the difference was not statistically significant (Figure 5-7).

The virus-inoculated, IgG-treated rats had more total cells, with increased

numbers of macrophages, lymphocytes, and neutrophils in their BAL fluid than

did the rats in either of the sham-inoculated groups (p<0.05). In contrast, virus-

inoculated, p55sTNF-lgG treated rats did not have increased numbers of

macrophages or lymphocytes in their BAL fluid compared to the sham-inoculated

rats. However, they did have increased numbers of neutrophils compared to

both groups of sham-inoculated rats, and higher total cell numbers than the

p55sTNF-lgG treated sham-inoculated rats (p<0.05). There were no significant

differences in the BAL fluid total or differential cell counts between the p55sTNF-

IgG and the IgG-treated sham inoculated rats.



Increased Mortality and Pulmonary Lesions in the Sendai Virus-Inoculated

p55sTNF-lIG Treated Rats



All of the virus-inoculated rats treated with 10 mg/kg p55sTNF-lgG died or

were found moribund and were sacrificed 8-9 days after virus-inoculation. Four










of the six virus-inoculated rats given 1 mg/kg p55sTNF-IgG also died 8-9 days

after virus-inoculation. Three rats from these two groups (one received 10

mg/kg, two were treated with 1 mg/kg) were labeled with BrdU. Unexpected

mortality did not occur in the other experimental groups. Compared to virus-

inoculated control animals, many of the airways in the virus-inoculated

p55sTNFR-lgG-treated rats were characterized by hyperplastic bronchiolar and

alveolar epithelial cells, which were heavily labeled in the BrdU-stained sections.

Virus-inoculated p55sTNFR-lgG rats also had subjectively fewer inflammatory

cells with proportionally fewer lymphocytes than the virus-inoculated controls.

Viral antigens were detected in the hyperplastic epithelial cells using

immunocytochemistry.



Pulmonary Viral Titers



The virus-inoculated rats treated with 1 mg/kg of p55sTNFR-lgG had mean

pulmonary viral titers that were 5-fold higher at both 7 and 9 dpi than those of

comparable groups of untreated virus-inoculated rats (Figure 5-8), however the

increase did not reach statistical significance.



Discussion



TNF-a has been implicated as an important mediator in the pathogenesis of

the pulmonary fibrosis induced by pneumotoxins such as silica and











bleomycin.108'1"'120 This study investigated the significance of TNF-a in a rat

model of virus-induced bronchiolar fibrosis. We wanted to determine whether

inhibition of TNF-a bioactivity in virus-inoculated BN rats abrogated virus-

induced increases in bronchiolar fibroblast proliferation. Fibroblast proliferation

precedes virus-induced bronchiolar fibrosis, and is a well-characterized effect of

TNF-a.'1

Although the results of this study are complicated by the profound effects the

inhibition of TNF-a bioactivity had on the immune/inflammatory response to the

virus, treatment with p55sTNFR-IgG blocked TNF-a activity and partially blocked

the virus-induced BrdU incorporation. Significantly fewer bronchiolar fibroblasts

were labeled with BrdU in the virus-inoculated p55sTNFR-lgG-treated rats

compared to the number labeled in the IgG-treated virus-inoculated animals.

This is consistent with the interpretation that TNF-a is stimulating fibroblast

proliferation.

The results of the TNF-a bioassays on BAL fluid from the virus-inoculated,

p55sTNFR-lgG-treated animals confirm that p55sTNFR-IgG did effectively

inhibit TNF-a's biological activity, even though TNF-a protein levels as detected

by ELISA were elevated. The increased protein levels in the p55TNFR-lgG-

treated rats was probably due to decreased rate of breakdown of the bound

inactivated protein. The low level of TNF-a bioactivity observed at 9 days after

virus-inoculation in the rats given the low dose of p55sTNFR-lgG (1 mg/kg)

indicates that TNF-a was not completely inhibited in these animals at this dose.










The mechanism by which TNF-a may be inducing fibroblast proliferation in

this model is unclear. TNF-a is a mitogen for certain fibroblasts,1' and could

therefore be directly stimulating bronchiolar fibroblast proliferation. TNF-a could

also be affecting fibroblast proliferation indirectly through several different

mechanisms. It is a potent activator and chemoattractant for macrophages,"'111

and induces expression of adhesion molecules for platelets,119 both of which are

important sources of other fibroblast mitogens such as transforming growth

factor-p (TGF-p), and platelet-derived growth factor (PDGF). The results of

previous studies have identified an influx of macrophages expressing TGF-p,

mRNA and protein into bronchioles as a prominent feature of rats developing

virus-induced bronchiolar fibrosis (see Chapter 3), and the depression in

macrophage numbers observed in the BAL fluid of the infected p55sTNFR-IgG-

treated rats confirms that TNF-a is critical to the virus-induced macrophage

recruitment. Other indirect effects of TNF-a on fibroblast proliferation and the

development of bronchiolar fibrosis include its ability to increase the expression

of adhesion molecules for both neutrophils and eosinophils,'11"2 and to depress

fibrinolysis.7 These effects enhance the inflammatory response, increase the

extent of tissue damage, and therefore contribute to fibroblast proliferation and

fibrosis.

TNF-a is a potent antiviral cytokine.1~'" The results of in vitro studies using

several different cell and virus systems indicate TNF-a has both the ability to

enhance the killing of virus-infected cells and protect uninfected cells from










infection.l", le1,6 In addition, several viruses produce virulence factors that

specifically inhibit TNF-a.16385 For example, adenoviruses inhibit the action of

TNF by blocking signal transduction from its receptor'" while several pox

viruses contain genes that encode a soluble TNF receptor similar to the one

used in this study.'" TNF-a is also able to activate macrophages independent

of T and B cells in murine cytomegalovirus and herpes simplex virus

infections.'"

The importance of TNF-a in the inflammatory response to Sendai virus

infection is indicated by the high mortality in the virus-inoculated, p55sTNFR-

IgG-treated rats. The increased mortality was associated with significant

reductions in the numbers of macrophages and lymphocytes in the BAL fluid, the

tendency towards higher pulmonary viral titers and the presence of numerous

hyperplastic epithelial cells that were positive for viral antigens. These findings

suggest that inhibition of TNF-a activity decreased the inflammatory cell

response to the virus, prevented the destruction of infected epithelial cells and

allowed prolonged viral replication. Paradoxically, however, BN rats have

prolonged elevations of pulmonary TNF-a expression but also higher pulmonary

viral titers compared to Fischer 344 rats, which are resistant to virus-induced

airway abnormalities.37 These observations suggest that TNF-a may be

protective early in the course of Sendai virus infection, while prolonged

expression may be harmful.

There is evidence that the role of TNF-a in T-cell-mediated inflammation is








93
dependent upon the Thl/Th2 cytokine profile. In studies using Mycobacterium

tuberculosis in dosing protocols designed to elicit a predominantly Thi

response, TNF-a was found to act as an additional macrophage-activating

factor.167 However, when the dosing regime was altered to elicit a predominantly

Th2 response, TNF-a contributed to tissue damage.1' Studies using T cells

stimulated by individual proteins of respiratory syncytial virus to secrete either a

Thi or Th2 cytokine profile indicate that different forms of viral bronchiolitis can

be caused by functionally distinct types of antiviral T cells.'" These findings

imply that the underlying cytokine profile may determine the role of TNF-a in

viral pathogenesis and may explain the higher viral titers observed in BN rats in

the face of high pulmonary expression of TNF- a.

In conclusion, the results from this study indicate that TNF-a is a potentially

important mediator of virus-induced bronchiolar fibrosis, and is critical to the

immune/inflammatory response to parainfluenza type-1 infection.
















Sso5- I r *p < 0.05

SS4 Mean + SE
E0


20
S30-


0

10-



Sham Virus: 9 dpi


Figure 5-1: Density of BrdU-labeled bronchiolar mural fibroblasts in
sham- and virus-inoculated BN rats (n=5 or 6 for sham and infected
IgG-treated groups; n=3 for the infected p55sTNFR-lgG-treated group).




Full Text
2
children with acute respiratory syncytial virus (RSV) bronchiolitis, for example,
prospective studies have shown that titers of RSV-specific IgE are independent
predictors of airway hyperresponsiveness,9 and rising titers correlate with
increased leukotriene C4 (LTC4) levels in nasopharyngeal washes during
subsequent RSV infections.10 These results suggest that RSV itself may act as
an allergen in susceptible patients. Viral respiratory infections also may
facilitate sensitization to non-viral antigens in genetically predisposed individuals
since virus-induced epithelial damage permits exposure of allergens to the host
immune system.11
A further consequence of epithelial damage Is exposure of nerves In the
airway wall. There is an extensive network of afferent nerves situated
immediately below the epithelial tight junctions.12 Exposure of these nerves to
the environment can result in the release of neuropeptides such as substance P
and neurokinin A, both of which can stimulate smooth muscle contraction.12,13
Viral infections also can have effects on neuropeptide release and metabolism
as well as nerve conduction and receptor function.14,15
Inflammation of the airways is a characteristic feature of asthma, and
increased recruitment and persistence of inflammatory cells in airways may be
potential mechanisms by which viral infections contribute to the development of
airway functional abnormalities.8,16 Studies using animal models of virus-
induced hyperresponsiveness have correlated the appearance of airway
hyperresponsiveness induced by viruses with the influx of inflammatory cells.17,18


Figure 5-1: Density of BrdU-labeled bronchiolar mural fibroblasts in
sham- and virus-inoculated BN rats (n=5 or 6 for sham and infected
IgG-treated groups; n=3 for the infected p55sTNFR-lgG-treated group).


TABLE OF CONTENTS
ACKNOWLEDGMENTS ii
ABSTRACT v
CHAPTER 1 LITERATURE REVIEW
Viral Respiratory Infections and Asthma 1
Sendai Virus Infection in Rats 4
The Role of Cytokines in Pulmonary Disease 6
TGF-p 7
TNF-cc 12
PDGF 16
CHAPTER 2: RESEARCH PROTOCOL
Hypothesis and Specific Aims 19
Background/Significance 20
Experimental Design 21
CHAPTER 3: INCREASED TRANSFORMING GROWTH FACTOR P,
(TGF-P,) GENE EXPRESSION PRECEDES SENDAI
VIRUS-INDUCED BRONCHIOLAR FIBROSIS
Summary 34
Introduction 35
Materials and Methods 38
Results 43
Discussion 45
CHAPTER 4: INCREASED TUMOR NECROSIS FACTOR-a (TNF-a)
GENE EXPRESSION IN MACROPHAGES PRECEDES
BRONCHIOLAR FIBROSIS IN VIRUS-SUSCEPTIBLE BN RATS
Summary 55
Introduction 56
Materials and Methods 59
Results 65
Discussion 67


141
66. Kalter VG, Brody AR. Receptors for transforming growth factor-p (TGF-p)
on rat lung fibroblasts have higher affinity for TGF-p, than for TGF-p2. Am
J Respir Cell Mol Biol. 4:397-407.
67. Border WA, Noble NA.1994. Transforming growth factor-p in tissue
fibrosis. New Eng J Med. 331:1286-1292.
68. Fine A, Goldstein RH. 1987. The effect of transforming growth factor-13 on
cell proliferation and collagen formation by lung fibroblasts. J Biol Chem.
262:3897-3902.
69. Ignotz RA, Endo R, Massague J. 1987. Regulation of fibronectin and type
I collagen mRNA levels by tranforming growth factor-6. J Biol Chem. 262-
6443-6446.
70. Roberts CJ, Birkenmeier TM, McQuillan JJ. 1988. Transforming growth
factor beta stimulates the expression of fibronectin and of both subunits of
the human fibronectin receptor by cultured human lung fibroblasts. J Biol
Chem. 263:4586-4592.
71. Raghow, R Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. 1987.
Transforming growth factor beta increases steady state levels of type I
procollogen and fibronectin messenger RNAs posttranscriptionally in
cultured human dermal fibroblasts. J Clin Invest. 79:1285-1288.
72. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel
P, Heath JK. 1987. Transforming growth factor beta modulates the
expression of collagenase and metalloproteinase inhibitor. Embo J.
6:1899-1904.
73. Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. 1992.
Mechanisms of fibrin formation and lysis by human lung fibroblasts:
influence of TGF-6 and TNF-a. Am J Physiol. 263:L487-L494.
74. Goldsmith KT, Gammon RB, Garver Rl. 1991. Modulation of bFGF in lung
fibroblasts by TGF-6 and PDGF. Am J Physiol. 261 :L378-L385.
75. Khalil N, Greenberg AH. 1991. The role of TGF-6 in pulmonary fibrosis.
In: Clinical applications of TGF-6. Wiley, Chichester (Ciba Foundation
Symposium 157) p 194-211.
76. McCartney-Francis NL, Wahl SM. 1994. Transforming growth factor-6: a
matter of life and death. J Leukocyte Biol. 55:401-409.


131
2) Add 1 ml of TRIzol reagent and mix well, and incubate at RT for 5 min.
3) Add 0.2 ml of chloroform, mix for 15 sec and incubate at RT for 2-3 min.
Centrifuge the samples at no more than 12,000 x g for 15 min at 4 C.
4) Remove colorless upper phase to a fresh microfuge tube. Add 0.5 ml
isopropyl alcohol, mix well, and percipitate 15 min at RT.
5) Pellet RNA at no more than 12,000 x g, 10 min, 4 C. Wash in 70% EtOH.
6) Remove EtOH, and allow pellet to dry briefly (do not let the pellet
completely dry out, or it will be hard to get it back into solution). Dissolve
RNA in 100-200 pi autoclaved, millique H20. Use 1:200 (5 pl:995 pi) to
determine RNA yield. Dot 3-5 pi on a strip of membrane and uv-link it to
the membrane. This will be developed along with the NRO as a positive
control.
7) Hybridize RNA to DNA immobilized on strips of nylon membrane (see
below) in 5 ml of Church-Gilbert solution. Incubate hybridization mixture by
shaking in small 5-ml plastic scintillation vials for 24 hr at 37-65C.
8) Wash each filter 2X in 5 ml of 20 or 40 mM phosphate, 0.1 % SDS for 15
min at 37-65C.
9) Wet the membrane with a small amount of maleate buffer.
10) Incubate the membrane in 1X blocking solution for 15 min at RT (make 20
ml: 4 ml 5X blocking soln + 16 ml maleate buffer. Use 10 ml here and 10 ml
in step 13).
11) Dilute anti-DIG-alkaline phosphatase (Vial 3, Genius Kit #3) 1:5,000 in 1X


91
The mechanism by which TNF-a may be inducing fibroblast proliferation in
this model is unclear. TNF-a is a mitogen for certain fibroblasts,158 and could
therefore be directly stimulating bronchiolar fibroblast proliferation. TNF-a could
also be affecting fibroblast proliferation indirectly through several different
mechanisms. It is a potent activator and chemoattractant for macrophages,111'159
and induces expression of adhesion molecules for platelets,119 both of which are
important sources of other fibroblast mitogens such as transforming growth
factor-p (TGF-P), and platelet-derived growth factor (PDGF). The results of
previous studies have identified an influx of macrophages expressing TGF-p,
mRNA and protein into bronchioles as a prominent feature of rats developing
virus-induced bronchiolar fibrosis (see Chapter 3), and the depression in
macrophage numbers observed in the BAL fluid of the infected p55sTNFR-lgG-
treated rats confirms that TNF-a is critical to the virus-induced macrophage
recruitment. Other indirect effects of TNF-a on fibroblast proliferation and the
development of bronchiolar fibrosis include its ability to increase the expression
of adhesion molecules for both neutrophils and eosinophils,111,112 and to depress
fibrinolysis.73 These effects enhance the inflammatory response, increase the
extent of tissue damage, and therefore contribute to fibroblast proliferation and
fibrosis.
TNF-a is a potent antiviral cytokine.159-166 The results of in vitro studies using
several different cell and virus systems indicate TNF-a has both the ability to
enhance the killing of virus-infected cells and protect uninfected cells from


83
actinomycin D/RPMI solution, followed by 20 ¡A of the appropriate standard or
sample was then added to each well and the plates were incubated over-night at
37, 5% C02. Ten //I of a freshly prepared 6 mg/ml MTT solution in RPMI was
then added to each well and the plates were incubated for 4 hours at 37, 5%
C02. At the end of this incubation, 100 t of 2-propanol was added to each
well, the plates were shaken at room temperature for 30 min, and 100 pi of
water/well was added. The optical densities of the standard and sample wells
was read at 570/690 nm, and the amount of TNF-a bioactivity present in the
samples was determined from the standard curve.
BrdU Labeling
Four transverse sections were taken from the fixed left lungs of rats treated
with BrdU. Sections were taken at the hilus, between the hilar section and the
cranial lung margin, and at points equidistant caudal to the hilar section and
cranial to the caudal lung margin. Tissue blocks were embedded in paraffin the
same day. Five pm-thick sections were cut, mounted on slides, deparaffinized in
xylene, rehydrated, and washed in distilled water. Immunocytochemical staining
for BrdU was performed using a method modified from that previously
described.157 Slides were placed in 3.0% H202 for 10 minutes to quench
endogenous peroxidase, washed twice in PBS, and pretreated in both 2N HCI
(30 min, 37 C) and 0.1 % w/v trypsin in PBS (20 min, 37 C). Sections were


108
a computerized video image analysis unit (Image Store 7500, Ultra Violet
Product Ltd San Gabriel, CA).
Protein Assays
The amount of TNF-a and TGF-p, protein present in cell culture supernatants
was determined using enzyme-linked immunoabsorbance assay (ELISA) kits
(TNF-a: Biosource International Inc. Camarillo, CA; TGF-p,: R&D Systems
Minneapolis, MN) performed according to the manufacters instructions.
Quantitation Methods and Data Analysis
Cytoplasmic TNF-a, TGF-p,, and p-actin RNA levels were evaluated by
comparing the relative optical densities (ROD) of bands on Northern
autoradiographs. Comparisons of band densities were only made between
bands in RNA run on the same gel. ROD values, TNF-a and TGF-p, protein
levels were normalized to cell counts. Statistical analysis of group means was
performed by one-way analysis of variance (one-way ANOVA) using a computer-
based statistical program (SigmaStat, Jandel Corporation, San Rafael, CA).
Differences between individual means were assessed by Bonferronis method of
all pairwise multiple comparison.143


6
opportunity to determine which of several potentially important mediators are
responsible for the dysplastic, fibrotic, and hyperresponsive changes induced by
neonatal viral bronchiolitis. The studies outlined in this proposal are designed to
investigate the role of three potent mediators of pulmonary fibrosis, transforming
growth factor-IJ (TGF-IJ), tumor necrosis factor-a (TNF-a), and platelet-derived
growth factor (PDGF), in the pathogenesis of Sendai virus-induced bronchiolar
fibrosis, and to assess the ability of Sendai virus to directly induce expression of
these cytokines.
The Role of Cytokines in Pulmonary Disease
In recent years the role of cytokines in the regulation of both physiologic and
pathologic processes occurring in the lung has been extensively investigated.39'
45 Studies on naturally occurring and chemically induced pulmonary fibrosis
indicate that TGF-IJ,TNF-a, and PDGF are important mediators of pulmonary
fibrosis.46'54 In addition, the ability of infectious agents to directly effect the
expression of inflammatory and fibrogenic mediators, including TGF-IJ and TNF-
a, has been demonstrated and is believed to be an important aspect in the
pathogenesis of several viral diseases.55'60


145
108. Beutler B, Cerami A. 1986. Cachectin:more than a tumor necrosis factor.
N Engl J Med. 316:379-385.
109. Phan SH, Kunkel SL. 1992. Lung cytokine production in bleomycin-
induced pulmonary fibrosis. Exper Lung Res. 18:29-43.
110. Kips JC, Tavernier J, Pauwels RA. 1992.Tumor necrosis factor causes
bronchial hyperresponsiveness in rats. Am Rev Respir Dis. 145:332-336.
111. Jaattela M. 1991. Biologic activities and mechanisms of action of tumor
necrosis factor-a/cachectin. Lab Invest. 64:724-742.
112. Lamas AM, Mulroney CM, Schleimer RP. 1988. Studies on the adhesive
interaction between purified eosinophils and cultered vascular endothelial
cells. J Immunol. 141:1500-1505.
113. Caux C, Sacland S, Favre C, DuvertV, Mannoni P, Bancherau J.1990.
Tumor necrosis factor-alpha strongly potentiates interleukin-3 and
granulocyte-macrophage colony-stimulating factor-induced proliferation of
human CD34+ hematopoietic progenitor cells. Blood. 75:2292-2298.
114. Silberstein DS, David JR. 1986.TNF enhances eosinophil toxicity to
Schistosoma mansoni larvae. Proc Natl Acad Sci USA. 83:1055-1059.
115. Klein LM, Lavker RM, Matis WL, Murphy GF. 1989. Degranulation of mast
cells induces an endothelial antigen central to leukocyte adhesion. Proc
Natl Acad Sci USA. 86:8972-8976.
116. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M. 1991. Tumor
necrosis factor plays an essential role in determining hypersensitivity
pneumonitis in a mouse model. Am J Respir Cell Mol Biol. 5:477-483.
117. Ohkawara, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H,
Ohkuda K, Takishima. 1992. Human mast cells and pulmonary
macrophages produce tumor necrosis factor-a in sensitized lung tissue
after IgE receptor triggering. Amer Respir Cell Mol Biol.7:385-392.
118. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P.1989.Tumor
necrosis factor cachectin plays a key role in bleomycin-induced
pneumopathy and fibrosis. J Exp Med. 170:655-664.


97
Figure 5-4: The effect of p55sTNFR-lgG on BAL fluid total cell counts
from virus- and sham-inoculated BN rats (n=6).


10
is predominantly in bronchiolar and alveolar epithelial cells and deposited
extracellularly in subepithelial areas adjacent to the fibrotic lesions.85 Finally,
neutralization of TGF-li, in a mouse model of immune-induced lung fibrosis
caused by repeated intranasal exposure to heat-killed bacillus Calmette-Guerin
(BCG) resulted in substantial decreases in lung fibrosis and granulomatous
inflammation, which implies a role for TGF-li, in inducing inflammation and lung
fibrosis in response to an immune stimulus.86
In addition to its role in tissue fibrosis, TGF-li is an important modulator of the
immune response, with both immunosuppressive and proinflammatory effects
depending upon the context in which it is presented. In experimental acute and
chronic arthritis, for example, systemic administration of TGF-li nearly
obliterates the disease process87 whereas local administration exacerbates it.88
Systemically delivered TGF-li initially encounters the endothelium and its
primary action may be to decrease endothelial cell adhesion molecule
expression899' thus impairing leukocyte recruitment. TGF-li also can inhibit
activated T-cell proliferation and deactivate macrophages.92'95 These
immunosuppressive effects may not be predominant in all situations, however,
since TGF-li is strongly chemotactic for monocytes and macrophages and can
induce undifferentiated monocytes to express a variety of inflammatory
mediators including: IL-1, TNF-a, IL-6, and PDGF.96-98
The complex modulation of the immune response by TGF-li has been
partially characterized by studies of transgenic and gene knockout mice.


CHAPTER 3
INCREASED TRANSFORMING GROWTH FACTOR IS, (TGF-13,) GENE
EXPRESSION PRECEDES SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
Summary
Rats infected early in life with parainfluenza type 1 (Sendai) virus develop
bronchiolitis that is followed by long-term increases in airway resistance and
hyperresponsiveness. These virus-induced functional abnormalities are closely
associated with bronchiolar mural fibrosis and persistent increases in
bronchiolar inflammatory cells including macrophages and mast cells Brown
Norway (BN) rats are highly susceptible to virus-induced bronchiolar fibrosis and
airway function abnormalities, whereas Fischer-344 (F344) rats are resistant.
We hypothesized that bronchiolar fibrosis was regulated by the production of
TGF-p, by bronchiolar mural macrophages during the acute and chronic
inflammatory response induced by virus. Pulmonary and bronchiolar TGF-J,
gene expression was studied in BN and F344 rats following Sendai virus
infection by combined methods of Northern analysis and in situ hybridization for
TGF-IJ, mRNA and by immunocytochemistry for protein. Steady-state pulmonary
TGF-3, mRNA was increased in both BN and F344 rats at 7 days after
34


50
Days After Inoculation
Figure 3-2: Graphic presentation of the results of Northern analysis for
TGF -p,. Data points and bars represent the mean relative optical band
density (ROD) and standard error of the mean (SEM) for 4-6 rats.
Statistical comparisons of RODS were only made between sham- and
virus-inoculated groups represented on the same blot.


142
77. Shah, M, Foreman, DM, Ferguson, MWJ. 1992. Control of scarring in
adult wounds by antibody to transforming growth factor IS. Lancet.
239:213-214
78. Gruschwitz MP, Muller PU, Sepp N, Hofer E, Fontana A, Wick G.1990.
Transcription and expression of transforming growth factor type beta in
the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest
Dermatol. 94:197-203.
79. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L,
Zern MA 1989. In vitro and in vivo association of transforming growth
factor-IS1 with hepatic fibrosis J Cell Biol. 108:2477-2482.
80. Border WA, Ruoslahti E. 1992. Transforming growth factor-IS in disease:
the dark side of tissue repair. J Clin Invest. 90:1-7.
81. Khalil N, Bereznay O, Sporn M, Greenberg AH. 1989. Macrophage
production of transforming growth factor 8 and fibroblast collagen
synthesis in chronic pulmonary inflammation. J Exp Med. 170:727-737.
82. Schrier DJ, Kunkel RG, Phan SH. 1983. The role of strain variation in
murine bleomycin-induced pulmonary fibrosis. Am Rev Resp Dis. 127:63-
66.
83 Ross R, Raines EW, Bowen-Pope DF.1986.The biology pf platelet-
derived growth factor. Cell. 46:155-69.
84. Giri SN, Hyde DM, Hollinger MA. 1993. Effect of antibody to transforming
growth factor 8 on bleomycin induced accumulation of lung collagen in
mice. Thorax. 48:959-966.
85. Khalil N, OConnor RN, Unruh HW, Warren PW, Flanders KC, Kemp A,
Bereznay OH, Greenberg AH. 1991. Increased production and
immunohistochemical localization of transforming growth factor-8 in
idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 5:155-162.
86. Denis M. 1994. Neutralization of transforming growth factor-8, in a mouse
model of immune-induced lung fibrosis. Immunol. 82:584-590.
87. Brandes ME, Allen JB, Ogawa Y, Wahl SM. 1991. Transforming growth
factor-B, suppresses acute and chronic arthritis in experimental animals. J
Clin Invest. 87:1108-1113.


57
immunological response that is probably determined by a combination of genetic
and viral factors.2-6 Young rats develop similar pulmonary functional
abnormalities after infection with parainfluenza virus type I (Sendai) and are
being studied as an animal model to identify genetic and viral factors Important
In the pathogenesis of virus-induced lung Injury. 16,33,3538
The development of virus-induced pulmonary function abnormalities in rats is
associated with infection as neonates or weanlings and genetic susceptibility.
Brown Nonway (BN) rats develop virus-induced alterations in pulmonary
structure and function, while Fischer 344 (F344) rats are relatively resistant.18,35"
38 Comparative viral pathogenesis studies indicate there are differences in
duration of viral replication, magnitude of immune response, and severity of both
the acute and persistent inflammatory response between the virus-susceptible
BN and virus-resistant F344 rats.35-38 The virus-induced abnormalities in
pulmonary function consist of increased respiratory resistance, decreased
dynamic compliance and hyperresponsiveness to methacholine. These
functional abnormalities are associated with bronchiolar aggregates of
macrophages, mast cells, and eosinophils, and bronchiolar mural fibrosis.38
Bronchiolar mural fibrosis and the resulting airway wall thickening is
prominent in BN rats 15 to 30 days after being infected with Sendai virus.
Bronchial fibrosis is a common finding in human asthmatics.22'24,40 The
importance of mural fibrosis in the development of increased airway resistance is
indicated by airway modeling studies that demonstrate that moderate amounts of


300
250
200
150
100
50
0
CAF 48 hr Virus 24 hr Virus 48 hr
Hours After Inoculation 72 Hours After Inoculation
CAF Virus
Figure 6-3: Effects of Sendai virus infection on TNF-a protein levels
NR8383 cell supernatants. TNF-a protein was not detected in the
supernatants from CAF-treated cells.


134
RUN
CELLS/NUCLEI
RNA
PROBE
INCUBATION
LabeLHybrld
RESULT
10
2x107AJntx
*170gg/+
TGF-LP (46pg)
-:24 hr
TGF-IN (11 gg)
30mln/37:24hr/37
-:24 hr
TGF-BP (46gg)
-:24 hr
'170gg/+
TGF-LP (46pg)
-:24 hr
TGF-IN (11 |jg)
30min/37:24hr/37
-:24 hr
TGF-BP (46pg)
-:24 hr
11
2x107/VIRUS 1:10
'20gg/+
TGF-LP (293gg)
-:24 hr
TNF-LP (290pg)
30mln/37:24hr/37
-:24 hr
PB (290gg)
-:24 hr
2x107/CAF
*40pg/+
TGF-LP (293gg)
-:24 hr
TNF-LP (290|jg)
30mln/37 :24hr/37
-:24 hr
PB (290gg)
-:24 hr
Key
Unless indicated 10|jl of digoxigenin labeling mixture was used
*2pl Digoxigenin labeling mixture
'20 gl Digoxigenin labeling mixture
LP: linearized plasmid
IN:lnsert
PB:Plasmid backbone
RNA +: RNA dot blot positive


119
48 hre 72 hr
Hours After Inoculation
Figure 6-5: Effects of Sendai virus infection on TGF-p, protein levels in
NR8383 cell supernatants. Data points represent mean + sem (n=5 for
the 48 hour groups, n=2 for CAF at 72 hrs, n=3 for Virus at 72 hrs).


136
respiratory syncytial virus: role in obstructive airway disease. Pediatr Res.
24:504-507.
11. Frick OL, German DF, Mills J. 1979. Development of allergy in children, I:
association with virus infections. J Allergy Clin Immunol. 63:228-241.
12. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello S. 1984. Substance
P-immunoreactive sensory nerves in the lower respiratory tract of various
animals including man. Cell Tissue Res. 235:251-261.
13. Barnes PJ. 1987. Neuropeptides in the lung: localization, function and
pathophysiologic implications. J Allergy Clin Immunol. 79:285-295.
14. Piedimonte G, Nadel JA, Umeno E, McDonald DM. 1992. Sendai virus
infection potentiates neurogenic inflammation in the rat trachea. J Appl
Physiol. 68:754-760.
15. Woolcock AJ. 1988. Asthma What are the important experiments? Am
Rev Respir Dis. 138:730-744.
16. Folkerts G, Nijkamp FP. 1995. Virus-induced airway hyperresponsiveness
role of inflammatory cells and mediators. Am Rev Respir Crit Care Med.
151:1666-1674.
17. Folkerts G, van Esch B, Janssen M, Nijkamp FP. 1992. Virus-induced
airway hyperresponsiveness in guinea pigs in vivo: study of broncho-
alveolar cell number and activity. Eur J Pharmacol Environ Toxicol
Pharmacol. 228:219-227.
18. Castleman, W. L, R. L. Sorkness, R. F. Lemanske, P. K. McAllister. 1990.
Viral bronchiolitis during early life induces increased numbers of
bronchiolar mast cells and airway hyperresponsiveness. Am J.Pathol.
137:821-831.
19. Sibille Y, Reynolds Y. 1990. Macrophages and polymorphonuclear
neutrophils in lung defence and injury. Am Rev Respir Dis. 141:471-501.
20. Nathan CF. 1987. Secretory products of alveolar macrophages. J Clin
Invest. 79:319-329.
21. Fels A, Cohn ZA. 1986. The alveolar macrophage. J Appl Physiol.
60:353-369.


106
media. One tube was inoculated with Sendai virus (MOI=1:1); the other was
inoculated with an equal volume of sterile chorioallantoic fluid (CAF). Both tubes
were incubated at 37 C, 5% C02, shaking for 1 hour. The cells from each tube
were placed in two T-150 tissue culture flasks (Corning Glass Works, Corning,
NY), resuspended to a total of 25 mis of media and incubated at 37 C, 5% C02.
The virus-inoculated cultures and the CAF-inoculated cultures were kept in
different incubators.
UV-inactivated virus was produced by exposing virus to UV irradiation
overnight. Plaque assays were used to confirm viral inactivation. Cells were
inoculated with inactivated virus at an MOI of 1:1, and cytoplasmic RNA was
extracted 24 hours after virus-inoculation. For the actinomycin-D experiments,
cells were incubated with virus (MOI = 1:1) or CAF for 1 hour as described
above, media containing a final concentration of 5 mg/ml of actinomycin-D
(Sigma, St. Louis, MO) was added, and the cells were incubated at 37 C, 5%
C02) for 24 hours. Cytoplasmic RNA was extracted as described below.
Northern Analysis
Cells were pelleted (500xg, 4 C, 5 min), resuspended in 4 mis of nonidet P-
40 lysis buffer (Sigma, St. Louis, MO), and incubated on ice for 5 minutes.174
Nuclei were pelleted (500xg, 4 C, 5 min) and cytoplasmic RNA was extracted
from the supernatant using 2 mis of TRIzol reagent according to


150
159. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H,
Kirchner H. 1986. Antiviral effects of recombinant tumour necrosis factor
in vitro. Nature. 323:816-818.
160. Wong GH, Goeddel DV. 1986. Tumour necrosis factors a and p inhibit
virus replication and synergize with interferons. Nature. 323:819-822.
161. Feduchi E, Alonso MA, Carrasco L. 1989. Human gamma interferon
and tumor necrosis factor exert a synergistic blockade on the replication
of herpes simplex virus. J Virol. 63:1354-1359.
162. Heise MT, Virgin IV HW, 1995. The T-cell-dependent role of gamma
interferon and tumor necrosis factor alpha in macrophage activation
during murine cytomegalovirus and herpes simplex virus infections. J
Virol. 69:904-909.
163. Would WSM 1993. Adenovirus genes that modulate the sensitivity of
virus-infected cells to lysis by TNF. J Cell Biochem. 53:329-335.
164. Upton C, Macen JL, Schreiber M, McFadden G 1991. Mxyoma virus
expresses a secreted protein with homology to the tumor necrosis factor
gene family that contributes to viral virulence. Virol. 184:370-382.
165. Gooding LR. 1992. Virus proteins that counteract host immune defences.
Cell. 71:5-7.
166. Koff WC, Fann AV. 1986. Human tumor necrosis factor-alpha kills
herpesvirus-infected but not normal cells. Lymphokine Res.5:215-221.
167. Hernandez-Pando R, Rook GAW. 1994. The role of TNF-a in T-cell-
mediated inflammation depends on the Th1/Th2 cytokine balance.
Immunology 82:591-595.
168. Alwan WH, Kozlowska WJ, Openshaw PJM. 1994. Distinct types of
lung disease caused by functional subsets of antiviral T cells. J Exp Med.
179:81-89.
169. Bascom CC, Wolfshohl JR, Coffey RJ, Madisen L, Webb NR, Purchio AR,
Dertnck Moses HL. Complex regulation of transforming growth factor 81,
(12, and 83 m RNA expression in mouse fibroblasts and keratinocytes by
transforming growth factors 81 and 82. Molec Cellul Biol 1989;9:5508-
5515.


67
Discussion
The deposition of collagen in bronchiolar walls increases wall thickness and
may be a major factor accounting for persistent increases in airway resistance
observed in BN rats following viral infection.38 38 Two main observations of this
study support a potential role for TNF-a in the pathogenesis of this virus-
induced airway fibrosis. First, pulmonary TNF-a mRNA and protein expression
are elevated before the development of bronchiolar fibrosis at 14-30 days after
virus inoculation.33,38 Second, although increases in TNF-a mRNA and protein
were induced by viral infection in both rat strains, higher and more prolonged
TNF-a gene expression was observed in the rats that develop bronchiolar
fibrosis (BN) compared with that in the rats that do not (F344).
These observations are similar to those made in studies of chemically-
induced airway fibrosis in which susceptiblity and resistance to the development
of bleomycin-induced pulmonary fibrosis in mice was associated with the level of
TNF-a expression. As was observed in the virus-susceptible and -resistant rats
in this study, mice with a high level of TNF-a expression after exposure
developed fibrosis, while those exhibiting a low level did not.109 The significance
of elevated TNF-a mRNA and protein in the pathogenesis of pulmonary fibrosis
has been demonstrated in rodent studies in which both the development of
bleomycin-induced pulmonary fibrosis and the lesions of silicosis were
prevented by the adminstration of antibodies to TNF-a.1'8,120


118
Figure 6-4: TGF-B,cytoplasmic RNA levels in Sendai virus infected
NR8383 cells.


26
Tissue processing. All rats were anesthetized with sodium pentobarbital
(approximately 200 pg/g body weight) and were killed by exsangulnation via
intracardiac puncture. BALs were performed on the rats at the time they were
sacrificed, total and differential cell counts and the TNF-a protein content of the
BAL fluid was determined. Lungs were fixed by tracheal perfusion at 30 cm H20
pressure with 4% paraformaldehyde for 2 hours.
BrdU Labeling. Four transverse sections were taken from the fixed left
lungs of rats treated with BrdU: at the hilus, between the hilar section and the
cranial lung margin, and at points equidistant caudal from the hilar section and
cranial from the caudal lung margin. Tissue blocks were embedded in paraffin,
sectioned and immunocytochemical staining to detect BrdU was performed.
Data Analysis. Fibroblast proliferation was assessed by counting the
number of BrdU-labeled fibroblasts (identified by their spindloid shape) in 25
high power (400X) fields per slide. Three slides per animal were counted.
Differences In the density of labeled cells between sham- and virus-inoculated
and p55 sTNFR-lgG1 and human IgG treated animals were compared using
ANOVA and Tukey tests.


146
119. Piguet PF, Vesin C. 1994. Pulmonary platelet trapping induced by
bleomycin: correlation with fibrosis and involvement of the P2 integrins. Int
J Exp Path. 75:321-328.
120. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. 1990.
Requirement of tumor necrosis factor for the development of silica-
induced pulmonary fibrosis. Nature. 344:245-247.
121. Domke-Opiz I, Kirchner H. 1990. Stimulation of macrophages by
endotoxin results in the reactivation of persistant herpes simplex virus
infection. Scand J Immunol. 32:69.
122. Would WSM 1993. Adenovirus genes that modulate the sensitivity of
virus-infected cells to lysis by TNF. J Cell Biochem. 53:329-335.
123. Upton C, Macen JL, Schreiber M, McFadden G. 1991. Mxyoma virus
expresses a secreted protein with homology to the tumor necrosis factor
gene family that contributes to viral virulence. Virol. 184:370-382.
124. Gooding LR. 1992. Virus proteins that counteract host immune defences.
Cell. 71:5-7.
125. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci
AD. 1989. Tumor necrosis factor a induces expression of human
immunodeficiency virus in a chronically Infected T-cell clone. Proc Natl
Acad Sci USA. 86:2365.
126. Martinet Y, Rom WN, Grotendorst GR. 1987. Exaggerated spontaneous
release of platelet-derived growth factor by alveolar macrophages from
patients with idiopathic pulmonary fibrosis. N Engl J Med. 317:202-209.
127. Pledger WJ, Stiles CD, Antoniades HN, Scher CD. 1977. Induction of
DNA synthesis in BALB/C-3T3 cells by serum components: reevaluation
of the commitment process. Proc Natl Acad Sci. 74:4481 -4485.
128. Deuel TF. 1987. Polypeptide growth factors: roles in normal and abnormal
cell growth. Annu Rev Cell Biol. 3:443-492.
129. Raines EW, Dower SK. 1989. Interleukin-1 mitogenic activity for
fibroblasts and smooth muscle is due to PDGF-AA. Science. 243:393-
396.


93
dependent upon the Th1/Th2 cytokine profile. In studies using Mycobacterium
tuberculosis in dosing protocols designed to elicit a predominantly Th1
response, TNF-a was found to act as an additional macrophage-activating
factor.167 However, when the dosing regime was altered to elicit a predominantly
Th2 response, TNF-a contributed to tissue damage.167 Studies using T cells
stimulated by individual proteins of respiratory syncytial virus to secrete either a
Th1 or Th2 cytokine profile indicate that different forms of viral bronchiolitis can
be caused by functionally distinct types of antiviral T cells.166 These findings
imply that the underlying cytokine profile may determine the role of TNF-a in
viral pathogenesis and may explain the higher viral titers observed in BN rats in
the face of high pulmonary expression of TNF- a.
In conclusion, the results from this study indicate that TNF-a is a potentially
important mediator of virus-induced bronchiolar fibrosis, and is critical to the
immune/inflammatory response to parainfluenza type-1 infection.


inoculation (p<0.05, Figure 6-3). TNF-a protein was not detected in the
supernatants from CAF-treated cells at 48 or 72 hours after virus-inoculation.
110
TGF-B, Cytoplasmic RNA and Protein Levels in Sendai-virus Inoculated NR8383
Cells
At 72 hours after inoculation, there was an over 2-fold increase in the amount
of TGF-p, cytoplasmic RNA in the virus-inoculated cells compared to the level
present in the CAF-treated cells (Figure 6-4, p<0.05). However, TGF-p, protein
levels in cell supernatants from the CAF and virus-inoculated groups were not
significantly different at 48 or 72 hours after inoculation (Figure 6-5). The mean
band densities for p-actin were not significantly different for any of the groups
compared (Figure 6-8).
Effects of UV-inactivated Sendai virus and Actinomvcin-D Treatment on TNF-a
and TGF-P, Cytoplasmic RNA Levels in NR8383 Cells
TNF-a cytoplasmic RNA was not detectable in NR8383 cells incubated with
UV-inactivated Sendai virus 24 hours after inoculation (p<0.05, Figures 6-6 &6-
7). The mean band densities for p-actin did not vary significantly among these
groups (Figure 6-7). Virus-inoculated cells incubated with actinomycin-D also
had undetectable levels of TNF-a RNA (Figure 6-7), however the band densities


149
150. Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H,
Lesslauer W, Cohen J. 1994. Protective effect of 55- but not 75-kD
soluble tumor necrosis factor recepter-immunoglobulin G fusion proteins
in an animal model of gram-negative sepsis. J Exp Med. 180:2173-2179.
151. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP,
Madani H, Widmer MB. 1993. Soluable tumor necrosis factor (TNF)
receptors are effective therapeutic agents in lethal endotoxemia and
function simultaneously as both TNF carriers and TNF antagonists. J
Immunol. 151:1548-1561.
152. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowery SF.
1992. Tumor necrosis factor soluable receptors circulate during
experimental and clinical inflammation and can protect against excessive
tumor necrosis factor a in vitro and in vivo. Proc Natl Acad Sci USA.
89:4845-4849.
153. Castleman W.L, Owens SB, Brundage-Anguish LJ. 1989. Acute and
persistent alterations in pulmonary inflammatory cells and airway mast
cells induced by Sendai virus infection in neonatal rats. Vet Pathol.26:18-
25 (Erratum 26:187, 1989).
154. Ziegler-Heitbrock HWL, Reithmuller G. 1984. A rapid assay for
cytotoxicity of unstimulated human monocytes. JNCI. 72:23-29.
155. Ziegler-Heitbrock HWI, Munker R, Thiel E, Krebs I, Reithmuller
G.1985. Killer cell activity of human monoblastic leukemia cells as
detected with a monocyte-specific target cell. Blood.65:8-14.
156. Rollinghoff M, Warer NL. 1973. Specificity of in vivo tumor rejection
assessed by mixing immune spleen cells with target and unrelated tumor
cells. Proc Soc Exp Biol Med. 144:813-818.
157. Arizono N, Koreto O, Nakao S, Iwai Y, Kushima R, Takeoka O. 1987.
Phenotypic changes in mast cells proliferating in the rat lung following
infection with Nippostrongylus brasiliensis. Virchows Arch B. 54:1-7.
158. Sugarman BJ, Aggarwal BB, Figari IS, Palladino MA. 1985.
Recombinant human tumor necrosis factor-a: effects on proliferation of
normal and transformed cells in vitro. Science (Wash. DC). 230:943.


Abstract of Dissertation Presented to the Graduate School of the University of
Florida in Partial Fulfillment of the Requirements for the Degree of Doctor of
Philosophy
THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
By
Elizabeth Whitford Uhl
May 1996
Chairperson: Dr. William L. Castleman
Major Department: Veterinary Medicine
Viral bronchiolitis in children may induce persistent alterations in lung
function including increased airway resistance and airway hyperresponsiveness.
Similar pulmonary functional abnormalities induced in rats following infection
with parainfluenza type I (Sendai) virus are associated with bronchiolar mural
fibrosis. This observation led to the hypothesis that virus-induced bronchiolar
mural fibrosis is mediated through virus-induced increases in gene expression of
transforming growth factor-0,, (TGF-P,), platelet-derived growth factor-B (PDGF),
and/or tumor necrosis factor-a (TNF-a) in the bronchiolar microenvironment.
Pulmonary TGF-IJ, and TNF-a mRNA and protein expression were assessed
in rat strains that are susceptible (BN) and resistant (F344) to virus-induced
bronchiolar fibrosis. Northern analysis, in situ hybridization and protein
immunocytochemistry demonstrated that virus-inoculated BN rats had
significantly higher increases in TGF-I3, and TNF-a pulmonary mRNA and
increased numbers of bronchiolar macrophages and fibroblasts expressing
v


40
18s and 28s ribosomal RNA bands on gels and membranes. A 985 bp cDNA
fragment containing the major coding region of the rat TGF-1, gene (supplied by
Dr. Su Wen Quian, Laboratory of Chemoprevention, NIH, Bethesda, MD) and a
2.6 kb human cDNA fragment of platelet derived growth factor (PDGF)
(American Type Culture Collection, Rockville, MD) were labeled with 32P-dCTP
using the random primer method as described.140 Prehybridization (15 min,
60-65C) and hybridization (overnight, 65C) was in 0.5 M Na2HP04, 7% SDS,
1% BSA, and 10mM EDTA as described.141 The membranes were washed at the
hybridization temperature in 20mM phosphate, 1% SDS, and used to expose
Kodak XAR-5 film with Dupont Cronex intensifying screens. Film band densities
were quantified using a computerized video image analysis unit (Microcomputer
Imaging Device, Imaging Research Inc., St. Catharines, Ontario).
In Situ Hybridization and Immunocvtochemistrv
For in situ hybridization, the rat TGF-ft, cDNA probe in pBluescript II KS+
(Stratagene, La Jolla, CA) was linearized and used as a template for the
production of S-labeled RNA sense and antisense probes by a modified
version of the Riboprobe Gemini System II kit (Promega Biotech, Madison,
Wl).142 To synthesize the antisense probe, plasmids were linearized with Xba I
and incubated with T3 polymerase. The sense probe was made by linearizing
with Hind III and incubating with T7 polymerase. Lung sections were


151
170. Smith PD, Saini SS, Raffeld, Manischewitz JF, Wahl SM.1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest 90:1642-1648.
171. Goldfeld AE, Maniatis T. 1989. Coordinate induction of tumor necrosis
factor a and interferon p in human B cells and monocytes. Proc Natl Acad
Sci USA. 86:1490-1494.
172. Greenberg ME, Bender TP. 1992. Identification of newly transcribed
RNA, in Short Protocols in Molecular Biology 2nd Ed. John Wiley & Sons.
New York, pp 4-25 to 4-29.
173. Baeuerle PA, Henkel T. 1994. Function and activation of NK-kB in the
immune system. Annu Rev Immunol. 12:141-179
174. Pahl HL, Baeuerle PA. 1995. Expression of infuenza virus
hemagglutinin activates transcription factor NK-kB. J Virol. 69:1480-
1484.
175. Garoufalis E, Kwan I, Lin R, Mustafa A, Pepin N, Roulston A,
Lacoste J, Hiscott J. 1994. Viral induction of the human beta interferon
promoter: modulation of transcription of NK-kB/re/ proteins and interferon
regulatory factors. J Virol. 68:4707-4715.
176. Roulston A, Conti L, McKiel V, Wainberg MA, Hiscott J. 1994. Virus
induction of NK-KB/Rel proteins and type I interferon gene expression in
myelomonoblastic cells. Leukemia. 8 suppl 1:s170-s174.
177. Pahl HL, Baeuerle PA. 1995. A novel signal transduction pathway from
the ER to the nucleus is mediated by transcription factor NK-kB. Embo J.
14:2580-2588.
178. Kumar AJ, Haque J, Lacoste J, Hiscott J, Williams BRG. 1994. The
Double-stranded RNA dependent protein kinase PKR activates
transcription factor NK-kB by phosphorylating IkB. Proc Natl Acad Sci
USA. 91:6288-6292.


87
in their BAL fluid at 7 dpi compared to the IgG-treated virus-inoculated rats (data
not shown). At 9 dpi, the surviving virus-inoculated rats in the 1 mg/kg
p55sTNF-lgG treated group had slightly but not significantly increased levels of
TNF-a bioactivity in their BAL fluid (data not shown). TNF-a bioactivity was not
detected in the lavage fluid of any of the rats in the sham-inoculated groups
(Figure 5-3).
Bronchoalveolar Lavage Fluid: Cell Counts
The data from total and differential cell counts performed on BAL fluid
samples are presented in Figures 5-4, 5-5, 5-6, 5-7. The counts from the virus-
inoculated low and high dose p55sTNFR-lgG-treated groups were pooled.
Virus-inoculated rats treated with p55sTNF-lgG had 3.5 fold fewer total cells/g
present in their BAL fluid at 7 days after inoculation compared to virus-
inoculated rats receiving IgG (p55sTNF-lgG: 12714 2004 IgG: 44886 5415,
mean sem, p<0.05). Sixfold decreases in total cell numbers were present at 9
days after inoculation (p55sTNF-lgG: 8217 1542, IgG: 52782 13632, p<0.05)
(Figure 5-4). Differential counts at seven days after inoculation, revealed virus-
inoculated p55sTNF-lgG treated rats had fivefold fewer numbers of
macrophages/g (p55sTNF-lgG: 4036 720, IgG: 20981 2433, p<0.05) and
almost sixfold fewer lymphocytes/g (p55sTNF-lgG: 586 145, IgG: 3948 1371,
p<0.05) in their BAL fluid compared to virus-inoculated IgG-treated rats (Figures


Figure 2-2: Experimental design for Experiment 3.


116
Hours After Inoculation
Figure 6-2: TNF-a cytoplasmic RNA levels in Sendai virus infected
NR8383 cells. Comparisons were only made between RNA samples
run on the same gel. TNF-a bands were not observed in the CAF
treated cells.


46
Although the results are consistent with TGF-P, being an important regulator
of virus-induced bronchiolar fibrosis, they do not delineate the specific
mechanism for increased gene expression. Increased quantities of TGF-p,
mRNA in whole lung homogenates were associated with increased numbers of
macrophages and fibroblasts in airway walls and surrounding alveoli expressing
cytoplasmic mRNA and protein. Increased mRNA levels in lung could be due to
increased infiltration of cells containing TGF-p, mRNA, virus-induced gene
transcription and protein expression in macrophages and fibroblasts, or a
combination of the two mechanisms. Although the data do not clearly
distinguish the relative importance of these mechanisms, several findings
suggest that the increased TGF-P, mRNA and protein expression in cells around
virus-infected bronchioles may be due at least in part to virus-induced increases
in gene transcription and/or protein synthesis.
First, increased numbers of peribronchiolar fibroblasts expressing TGF-P,
protein were observed at 7 days after inoculation and prior to appreciable
increases in numbers of bronchiolar mural fibroblasts. Increases in fibroblast
numbers are observed at 15 to 30 days after viral inoculation. Second, if all the
increases in TGF-P, mRNA were due to infiltration of macrophages, we would
expect to see similar increases in mRNA for PDGF, another cytokine associated
with macrophages.40 Pulmonary steady-state levels of PDGF mRNA did not
increase following infection in either BN or F344 rats at 7, 10, and 14 days after
inoculation (Figure 2-1).


29
virus-inoculated cells (MOI = 1) at 4, 8, 24, 48, and 72 hours post inoculation.
Blots were re-probed with a 32P-labeled probe for human p-actin to assess the
equality of loading.
Studies with UV-inactivated Sendai virus. UV-inactivated virus was
produced by exposing virus to a 30 watt UV lamp overnight. Plaque assays
were used to confirm viral inactivation. Cells were inoculated with inactivated
virus at an MOI of 1:1, and cytoplasmic RNA extracted 24 hours after virus-
inoculation.
Actinomvcin-D Experiments. Cells were incubated with virus (MOI = 1:1) or
CAF for 1 hour, media containing a final concentration of 5 mg/ml of
actinomycin-D (Sigma, St. Louis, MO) was added, and the cells were incubated
at 37 C, 5% C02) for 24 hours. Cytoplasmic RNA was extracted and the
relative abundance of TNF-a and TGF-p RNA was determined using Northern
analysis.
Protein Assays. The secretion of TNF-a and TGF-p protein from CAF and
virus-inoculated macrophages was monitored by ELISA.
Data Analysis. Cytoplasmic TNF-a, TGF-p,, and p-actin RNA levels were
evaluated by comparing the relative optical densities (ROD) of bands on
Northern autoradiographs. Comparisons of band densities were only made
between bands in RNA run on the same gel. ROD values, TNF-a and TGF-p,
protein levels were normalized to cell counts. Statistical analysis of group
means was performed by one-way analysis of variance (one-way ANOVA) using


53
|_ 0
<0
p< 0.0001
£
A O F344 Control
!E
/1\ V F344 Infected
e -9
/ \ BN Control
S § <
/ \ BN Infected
I
/ \
§ c "
/ p< 0.0001
E Q)
/ V
1 io
-a x
- /no\
E ro
3 CO 10
Z
j Y T
0
5 10 15 20 25 SO
Days After Inoculation
Figure 3-5: Density of bronchiolar mural macrophages expressing
TGF-p, protein. Data points represent mean + SEM (n=4).


144
98. Turner M, Chantry D, Feldmann M. 1990. Transforming growth factor-8
induces the production of interleukin 6 by human peripheral blood
mononuclear cells. Cytokine 2:211-216.
99. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress
RE, Karlsson S. 1995. Transforming growth factor-8, null mice. An
animal model for inflammatory disorders. Amer J Pathol. 146:264-275.
100. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts
AB, Sporn MB Ward JM, Karlsson S. 1993. Transforming growth factor-8,
null mutation in mice causes excessive inflammatory response and early
death. Proc Natl Acad Sci USA. 90:770-774.
101. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R,
Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. 1992.
Targeted disruption of the mouse transforming growth factor-8, gene
results in multifocal inflammatory disease. Nature. 359:693-699.
102. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG.
1993. Transforming growth factor 8 as a virulence mechanism for
Leishmania braziliensis. Proc Natl Acad Sci. 90:3442-3446.
103. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, S. G. Reed SG. 1992.
Regulation of Trypanosoma cruzi infections in vitro and in vivo by
transforming growth factor 8. J Exp Med.175:169-174.
104. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. 1994. Enhancement
of intracellular growth of Mycobacterium tuberculosis in human monocytes
by transforming growth factor-B,. J Infect Dis. 170:1229-1237.
105. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. 1992. tat
protein stimulates production of transforming growth factor-p, by marrow
macrophages: A potential mechanism for human immunodeficiency virus-
1-induced hematopoietic suppression. Blood 12:3036-3043.
106. Lazdins JK, Klimkait T, Woods-Cook K, Walker M, Alteri E, Cox D,
Cerletti N, Shipman R, Bilbe G, McMaster G. 1991. In vitro effect of
transforming growth factor-8 on progession of HIV infection in primary
mononuclear phagocytes. J Immunol. 147:1201-1207.
107. Alcami J, Paya CV, Virelizier JL, Michelson S. 1993. Antagonistic
modulation of human cytomegalovirus replication by transforming growth
factor-8 and basic fibroblast growth factor. J General Virol. 74:269-274.


85
detection of bound peroxidase-conjugated antibody was performed as described
above.
Data Analysis
Fibroblast proliferation was assessed by counting the number of BrdU-
labeled bronchiolar fibroblasts in 100 high power (400X) fields per lung. Cells
counted as fibroblasts had elongated spindloid profiles, oval nuclei, and
eosinophilic cytoplasm. Only cells with nuclei within the plane of section were
counted. Mean values between groups were compared by one-way analysis of
variance (one-way ANOVA) using a microcomputer-based statistical program
(SigmaStat, Jandel Corporation, San Rafael, CA). Differences between
individual means were assessed by Bonferroni's method of all pairwise multiple
comparison.142 BAL fluid data were subjected to logarithmic transformation prior
to analysis.
Results
p55sTNFR-lgG Inhibits Virus-induced Proliferation of Bronchiolar Fibroblasts
Nine days after virus-inoculation, the mean number of BrdU-labeled
fibroblasts in the bronchiolar walls of virus-inoculated, p55sTNFR-lgG-treated


79
macrophages, mast cells and eosinophils, and bronchiolar mural fibrosis38 is
associated with the virus-induced abnormalities in pulmonary function.
Bronchiolar mural fibrosis and the resulting airway thickening is prominent in
BN rats 15 to 30 days after being infected with Sendai virus.38 Airway modeling
studies have shown that the dynamics of increased airway resistance can be
profoundly affected by mural fibrosis since even moderate amounts of airway
wall thickening can greatly accentuate airway luminal narrowing during smooth
muscle contraction.24 Bronchiolar fibrosis is a common finding in asthmatics,22,23
and has been linked to airway obstruction.
The pathogenesis of airway fibrosis is poorly understood, however, tumor
necrosis factor-a (TNF-a) has been implicated as an important mediator of
chemically-induced pulmonary fibrosis.109,118,120 In models of both silica- and
bleomycin-induced pulmonary fibrosis, the administration of antibodies to TNF-a
prevented the development of fibrotic lung lesions.118,120 In the silicosis model,
lung lesions were also enhanced by the infusion of recombinant TNF-a.120
The results of previous studies indicate that the development of Sendai virus-
induced bronchiolar fibrosis in BN rats is preceded by prolonged increases in
pulmonary TNF-a mRNA, and increases in the numbers of bronchiolar
macrophages and fibroblasts expressing TNF-a protein (see Chapter 4). The
objective of this study was to determine whether the inhibition of TNF-a
bioactivity during Sendai virus infection would prevent the development of
bronchiolar fibrosis in BN rats. Since preliminary studies indicated that


143
88. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM.1990.
Rapid onset synovial inflammation and hyperplasia induced by
transforming growth factor-13. J Exp Med. 177:225-230.
89. Gamble JR, Khew-Goodall Y, Vadas MA. 1993. Transforming growth
factor-13 inhibits E-selectin expression on human endothelial cells. J
Immunol. 150:4494-4503.
90. Lefer AM, Ma XL, Weyrich AS, Scalia R. 1993. Mechanism of the
cardioprotective effect of transforming growth factor-13, in feline myocarial
ischemia and reperfusion. Proc Natl Acad Sci USA. 90:1018-1022.
91. Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino
JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ. 1993. Studies on
the mechanism by which transforming growth factor-13 (TGF-13) protects
against allergic encephalomyelitis. J Immunol. 151:1116-1127.
92. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW. 1992
Modulation of the immune response by transforming growth factor beta.
Int Arch Allergy Immunol. 99:1-7.
93. Tsunawaki SM. Sporn A, Ding CF, Nathan. 1988. Deactivation of
macrophages by transforming growth factor-13. Nature (London)1988,
334:260-262.
94. Ding A, Nathan CF, Graycar J, Derynck R, Stuer DJ, Srimal S. 1990.
Macrophage deactivating factor and transforming growth factors-13,, -I32,
and -I33 inhibit induction of macrophage nitrogen oxide synthesis by IFN-
gamma. J Immunol. 145:940-944.
95. Barral-Netto M, Barral A, Brownell CE, Skeiky YAW, Ellingsworth LR,
Twardzik DR, Reed SG.1992. Transforming growth factor-13 in leishmanial
infection: a parasite escape mechanism. Science. 257:545-548.
96. McCartney-Francis N, Mizel D, Wong H, Wahl LM, Wahl SM. 1990. TGF-
p regulates production of growth factors and TGF-p by human peripheral
blood monocytes. Growth Factors. 4:27-35.
97. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. 1988. Transforming
growth factor-beta (TGF-I3) is chemotactic for human monocytes and
induces their expression of angiogenic activity. Biochem Biophys Res
Commun. 157:793-800.


36
including increased airway resistance and hyperresponsiveness.2'5 Viral lower
respiratory tract disease is also identified as a risk factor in the development of
asthma.3,6 However, it remains to be determined what direct role viral infection
plays in the pathogenesis of pulmonary function abnormalities and what genetic
factors may be contributing to adverse sequelae from viral and/or immunologic
lung injury during early life.6
Parainfluenza type 1 (Sendai) virus infection in young rats has been
developed as an animal model of bronchiolitis in children. Sendai virus induces
acute necrotizing bronchiolitis and pneumonia that is followed by persistent
alterations in pulmonary function. Functional alterations include elevated
respiratory resistance, decreased dynamic compliance, and
hyperresponsiveness to methacholine. s6 '8 37 38 35 Susceptibility to virus-induced
functional abnormalities has been demonstrated to be influenced both by the
age and by the strain of the rat. In rats inoculated with virus as 25 day old
weanlings, persistent airway lesions associated with long-term pulmonary
function abnormalities include bronchiolar mural fibrosis and inflammation
characterized by mural aggregates of macrophages, mast cells, and
eosinophils.35 Both BN and LEW rats appear to be more susceptible to virus-
induced alterations in pulmonary structure and function than are F344 rats.36'16'
37,38.35 Comparative viral pathogenesis studies with virus-susceptible BN rats
and resistant F344 rats indicate that genetic differences between the strains
influence important factors in host-virus interaction including duration of viral


71
18s -
[ SHAM ] [ 3 DPI ] [ 7 DPI ]
TNF-a
Figure 4-1: Northern blot of rat pulmonary total RNA hybridized with a 32P-
labeled cDNA probe for rat TNF-a. This blot contains pulmonary RNA extracted
from sham-inoculated F344 rats at 7 days after inoculation (Sham), and from
virus-inoculated F344 rats at 3 & 7 days after inoculation. Each lane was loaded
with 20 pg of RNA from an individual animal. The upper panel shows the
ethidium bromide-stained gel.


44
and venous smooth muscle cells were also positive for TGF-p, mRNA. In
control BN rats, the density of bronchiolar mural macrophages positive for TGF-
U, mRNA was 6.3 1.1 (mean sem) per mm bronchiolar basement membrane.
The density of alveolar macrophages positive for mRNA was 70.7 7.2 per mm
(data not shown). At 7 days after inoculation, there were approximately two-fold
increases in the density of bronchiolar mural macrophages positive for TGF-U,
mRNA as compared to control rats (11.7 1.8 per mm, p<0.05), and over 30-fold
increases in labeled alveolar macrophages (197.3 13.6 per mm, p<0.005)
(data not shown). Mean numbers of labeled macrophages at 10 days after
inoculation and labeled fibroblasts at 7 or 10 days after inoculation did not differ
significantly from controls (data not shown). Non-specific labeling was assessed
in tissue sections hybridized with the sense riboprobe.
Pulmonary TGF-U, protein expression
Seven days after viral inoculation there were significantly increased
numbers of macrophages expressing TGF-IJ, protein in the lungs of both BN and
F344 rats (Figures 3-4 & 3-5). In infected BN rats at 7 days after inoculation, the
increase was ten-fold (p<0.0001) over control BN rats and greater than two-fold
(p<0.0001) over the number observed in infected F344 rats at 7 days after
inoculation. At 10 days after inoculation, BN rats had three-fold increases in
macrophages and fibroblasts expressing TGF-U, protein as compared to


132
blocking solution (2 |jl in 10 ml). Incubate membrane in diluted antibody for
15 min at RT.
12) Wash the membrane twice, 15 min/wash, in maleate buffer at RT.
13) Incubate the membrane In Genius buffer 3 for 2 min.
14) Pour off Genius buffer 3 and add the color substrate solution (10 ml
Genius buffer 3 45 pi NBT + 35 pi X-phos: NBT and X-phos are in
Genius Kit # 4). Allow color development to occur in the dark. Monitor the
progress of the color development occasionally.
15) Once the RNA is detected, wash the membrane with di H20 to avoid over
development. Seal in plastic to prevent drying out.
Bind plasmids to nitrocellulose
1) Linearize cDNA plasmids. Denature DNA (200 pg in 440 pi) with 49 pi of 1
M NaOH 30 min at room temperature. Neutralize with 4.9 ml of 6xSSC and
place on Ice. (Alternative: Boil the DNA for 10 min and incubate in 0.5M
NaOH at 37 C for 20 min. Stop the reaction by equalizing to 0.5 M
ammonium acetate, pH 4.6.
2) Spot DNA onto nitrocellulose filters using a slot blot apparatus, applying 5
pg in 125 pl/slot. Rinse slots with 500 pi of 6xSSC. Remove filter and mark
slot location.
3) UV-link membrane. Pre-hybridize in Church-Gilbert for 15 min at 37-65 C.


39
embryonated chicken eggs was used. Control rats were exposed to sterile
chorioallantoic fluid also harvested from embryonated chicken eggs. Virus-
inoculated BN and F344 rats were processed at 3, 7, 10, 14 and 30 days after
inoculation. Sham-inoculated animals were sacrificed at 7, 14, and 30 days after
inoculation. The rats were deeply anesthetized with sodium pentobarbital and
killed by exsanguination via intracardiac puncture. For Northern analysis, the
lungs from six rats from each group were frozen in liquid nitrogen and stored at
-80C until processed. Lungs from four animals in each group were processed
for in situ hybridization and immunohistochemistry. These lungs were fixed for 2
hours via airway perfusion at 30 cm fixative pressure with 4%
paraformaldehyde-phosphate buffered saline (pH 7.4) and embedded in paraffin.
Northern Analysis
Lung tissue was lysed in guanidine thiocyanate, and total RNA was extracted,
precipitated and further processed to recover polyadenylated mRNA as
described.'39 Twenty pg of total RNA from each lung or 5 pg of mRNA extracted
from pooled lung tissue was electrophorectically separated on 1.2% (wt:vol)
agarose gels containing 6% (vol:vol) formaldehyde, transferred to a positively
charged nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN),
and fixed by UV-crosslinking. Equality of RNA loading between lanes was
evaluated by visually comparing the intensity of ethidium bromide staining of the


147
130. Paulsson Y, Austgulen R, Hofsli E, Heldin CH, Westermark B, Nissen-
Meyer J. 1989. Tumor necrosis factor-induced expression of platelet-
derived growth factor A-chain messenger RNA in fibroblasts. Exp Cell
Res 180:490-496.
131. Buch S, Jones C, Sweezey N, Tanswell K, Post M 1991. Platelet-derived
growth factor and growth-related genes in the rat lung. I. developmental
expression. Am J Respir Cell Mol Biol. 5:371-376.
132. Gersuk GM, Westermark B, Mohabeer AJ, Challita PM, Pattamakom S,
Pattengale PK. 1991. Inhibition of human natural killer cell activity by
PDGF. III. Membrane binding studies and differential biological effect of
recombinant PDGF isoforms. Scand J Immunol. 33:521-532.
133. Daynes RA, Dowell T, Araneo BA. 1991. Platlet-derived growth factor is a
potent biological response modifier of T cells. J Exp Med. 174:1323-1333.
134. Bach MK, Brashler JR, Stout BK, Johnson HG, Sanders ME, Lin AH,
Gorman RR, Bienkowski MJ, Ishizaka T. 1992. Activation of eosiophils by
PDGF. Int Arch Allergy Appl Immunol. 97:121-9.
135. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J,
Maxwell M, Selman M 1990. Platlet-derived growth factor in idiopathic
pulmonary fibrosis. J Clin Invest 1990;86:1055-1064.
136. Vignaud JM, Allam M, Martinet N, Pech M, Plenat F, Martinet Y. 1991.
Presence of platelet-derived growth factor in normal and fibrotic lung is
specifically associated with interstitial macrophages, while both interstitial
macrophages and alveolar epithelial cells express the c-sis proto
oncogene. Am J Respir Cell Mol Biol. 5:531-538.
137. Lasky JA, Coin PG, Lindroos PM, Ostrowski LE, Brody AR, Bonner JC.
1995. Chrysotile asbestos stimulates platelet-derived growth factor-AA
production by rat lung fibroblasts in vitro: evidence for an autocrine loop.
Am J Respir Cell Mol Biol. 12:162-170.
138. Gauldie J, Jordana M, Cox G. 1993. Cytokines and pulmonary fibrosis.
Thorax. 48:931-935.
139. Puissant C, Hondebine LM. 1990. An improvement of the single-step
method of RNA isolation by acid guanidium thiocyanate-phenol-
chloroform extraction. BioTechniques. 8:148-149.



15
upregulating endothelial expression of CD54, an adhesion molecule for
platelets."9 An association between increased levels of TNF-a mRNA and the
development of silicosis has been demonstrated in mice. In this model the
fibrotic changes were not only inhibited by antibodies to TNF-a, but also
enhanced by the infusion of recombinant TNF-a.120
Several viruses,121'59,60 including Sendai virus,57 directly induce the
expression and production of TNF-a; however, its role in the pathogenesis of
viral diseases is complex. TNF-a can inhibit the replication of several DNA and
RNA viruses including herpes simplex type II, vesicular stomatitis virus,
encephalomyocarditis virus and adenovirus type-2,58 and can kill virus-infected
cells originally resistant to its cytolytic actions.58 The importance of TNF-a as an
antiviral cytokine has also been emphasized by the discovery that several
viruses produce virulence factors that specifically inhibit TNF-a activity.122-124
TNF-a is not protective in all viral infections, however, as it can reactivate latent
herpes simplex infection in monocytes,125 and HIV infection in cell lines of T-cell
and monocyte origin.126,111 Viral infections also may act to prime cells for the
production of TNF-a. For example, influenza A virus infection of murine
macrophages resulted in a massive accumulation of TNF-a mRNA, including a
unique high molecular weight transcript, that was not translated to the bioactive
protein until the cells were exposed to small amounts of endotoxin.59
Based upon the studies demonstrating the importance of TNF-a in the
pathogenesis of airway fibrosis, its probable role in the development of airway


90
bleomycin.'09 "8120 This study investigated the significance of TNF-a in a rat
model of virus-induced bronchiolar fibrosis. We wanted to determine whether
inhibition of TNF-a bioactivity in virus-inoculated BN rats abrogated virus-
induced increases in bronchiolar fibroblast proliferation. Fibroblast proliferation
precedes virus-induced bronchiolar fibrosis, and is a well-characterized effect of
TNF-a.158
Although the results of this study are complicated by the profound effects the
inhibition of TNF-a bioactivity had on the immune/inflammatory response to the
virus, treatment with p55sTNFR-lgG blocked TNF-a activity and partially blocked
the virus-induced BrdU incorporation. Significantly fewer bronchiolar fibroblasts
were labeled with BrdU in the virus-inoculated p55sTNFR-lgG-treated rats
compared to the number labeled in the IgG-treated virus-inoculated animals.
This is consistent with the interpretation that TNF-a is stimulating fibroblast
proliferation.
The results of the TNF-a bioassays on BAL fluid from the virus-inoculated,
p55sTNFR-lgG-treated animals confirm that p55sTNFR-lgG did effectively
inhibit TNF-as biological activity, even though TNF-a protein levels as detected
by ELISA were elevated. The increased protein levels in the p55TNFR-lgG-
treated rats was probably due to decreased rate of breakdown of the bound
inactivated protein. The low level of TNF-a bioactivity observed at 9 days after
virus-inoculation in the rats given the low dose of p55sTNFR-lgG (1 mg/kg)
indicates that TNF-a was not completely inhibited in these animals at this dose.


CHAPTER 1
LITERATURE REVIEW
Viral Respiratory Infections and Asthma
The majority of individuals who develop viral respiratory infections recover
with normal airway function. However, following clinical resolution of acute viral
infections, a subgroup of patients develop airway functional abnormalities
ranging from persistent increases in airway resistance and airway
hyperresponsiveness to asthma.1'7 The potentiating impact of viral respiratory
infections on asthma appears to be dependent on the presence of underlying
risk factors, with young children, especially boys, being the most likely to
develop wheezing with a viral respiratory infection. Other risk factors include: a
family history of allergic disease, the development of an IgE-dominated immune
response, the severity of both the infection and the underlying asthma, and the
type of virus.1'7
Epidemiological studies have associated infection with respiratory syncytial
virus, parainfluenza viruses, adenoviruses, or rhinoviruses with the development
of asthma, and several pathogenic mechanisms have been proposed to explain
the development of virus-induced pulmonary functional abnormalities.1,7,8 In
1


CHAPTER 2
RESEARCH PROTOCOL
Hypothesis and Specific Aims
The goal of this research was to identify cytokines critical to the development
of bronchiolar fibrosis following bronchiolitis induced by parainfluenza (Sendai)
virus infection during early life. The hypothesis tested was that bronchiolar
mural fibrosis following viral bronchiolitis is mediated by virus-induced increases
in transcription and/or translation of transforming growth factor-IJ, (TGF-(5,),
platelet-derived growth factor-B (PDGF), and/or tumor necrosis factor-a (TNF-a)
in infiltrating bronchiolar and peribronchiolar macrophages. There were 4
specific objectives:
1) Determine whether Sendai virus-induced bronchiolar fibrosis in virus-
susceptible BN rats is preceded by increased gene expression of
fibrogenic cytokines TGF-p,, PDGF, and/or TNF-a in macrophages and
in other bronchiolar cells.
2) Determine whether rats susceptible to virus-induced bronchiolar fibrosis
(BN) have higher cellular expression of fibrogenic cytokines in
bronchioles after virus infection relative to virus-resistant (F344) rats.
19


99
g. 4000 -
E 3000 -
>.
_l
*
o
W 2000
a>
S3
E
= 1000
IgG
TNFR
Mean + SE
* p <0.05
i <0.05
Sham Vims: 7 dpi Vims: 9 dpi
Figure 5-6: Effects of p55sTNFR-lgG on the numbers of lymphocytes in
BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5 for
the 10 dpi sham-inoculated groups, and 8-9 for the infected p55sTNFR-
IgG-treated groups).


12
to TGF-R, reduced the intracellular bacterial growth, while treatment with TGF-U,
abrogated the bacteriostatic effects of TNF-a and interferon-y.104 TGF-li also
has been implicated as having a role in the pathogenesis of viral infections. In
acquired immunodeficiency syndrome (AIDS), a viral protein (tat) appears to
directly upregulate the production of TGF-IJ,105 setting up a potential feedback
loop since TGF-IJ enhances HIV-1 replication in some cell lines.106 TGF-li has
also been demonstrated to increase human cytomegalovirus replication in
human lung fibroblasts; in contrast, basic fibroblast growth factor repressed viral
replication.107
Considering the wide-ranging effects of TGF-S on both the inflammatory
response and the pathogenesis of fibrosis, excessive production of TGF-S in the
susceptible BN rats could be contributing both to the increased viral titers
observed in these rats at 7 dpi, and to the peribronchiolar fibrosis and the
epithelial hypoplasia.
Tumpf Necrosis Factor-a
TNF-a is a pro-inflammatory cytokine produced by monocytes and
macrophages.108 Its effects are complex, as it appears to play an important role
in both acute injury and in the fibroproliferative response.40,44'109'110 In the
inflammatory response, TNF-a stimulates the adhesion of leukocytes to the
endothelial surface by inducing the expression of adhesion molecules for


9
in rats with experimental glomerulonephritis.80 The importance of TGF-li in the
pathogenesis of glomerulonephritis in rats was confirmed by the ability of
injected neutralizing antibodies against TGF-li to suppress the disease.
Studies of chemically induced and naturally occurring pulmonary
fibrosis48,8' 82 have confirmed the importance of TGF-li in the pathogenesis of the
lung lesions. Bleomycin treatment of rat lung fibroblast cultures resulted in an
increase of TGF-li mRNA and an increased secretion of TGF-li protein. The
response could be blocked by treatment with an inhibitor of protein synthesis,
and by an inhibitor of RNA synthesis.83 In an in vivo study, Hoyt and Lazo48
demonstrated that the amount of TGF-li mRNA extracted from the lungs of mice
chronically exposed to bleomycin was five-times the amount extracted from the
lungs of control animals. This increase preceded changes in gene expression
for collagens and fibronectin and coincided with areas of active fibrosis. Of
particular interest is the observation that a mouse strain that does not develop
pulmonary fibrosis after bleomycin exposure had a decrease in total mRNA that
included a drop in TGF-li mRNA.48 Bleomycin also induced increases in lung
collagen accumulation which could be inhibited by the administration of
antibodies to TGF-li, confirming TGF-li has an important role in the etiology of
bleomycin induced pulmonary fibrosis.84 Immunocytochemical analysis has
identified macrophages as the most common pulmonary cell type expressing
TGF-li protein in bleomycin-treated rats.81 Patients with idiopathic pulmonary
fibrosis also have increased pulmonary expression of TGF-li protein; however, it


37
replication, magnitude of immune response, and severity of acute and persistent
inflammatory cell response.35 37,38
Bronchiolar mural fibrosis and associated airway wall thickening is a
prominent feature of virus-induced lung injury that is associated with lung
dysfunction in susceptible weanling BN rats.38 Fibrosis develops as early as 15
to 30 days after viral Inoculation. Airway wall thickening and fibrosis has also
been identified as a common lesion occurring in human asthma and may
contribute to exaggerated airway luminal obstruction following modest smooth
muscle contraction.22'24
A growing body of research has demonstrated that several cytokines,
including transforming growth factor-P (TGF-P), tumor necrosis factor-a (TNF-a),
and platelet-derived growth factor ( PDGF), play critical roles In regulating
pulmonary fibrosis following alveolar injury by toxins such as bleomycin or in
less well-defined spontaneous fibrosis.40,138,48,109,84,85 Furthermore, there is
evidence that genetic susceptibility to develop pulmonary fibrosis in response to
chemically-induced damage may be controlled at the level of TGF-P
expression.48 TGF-p upregulates both fibroblast proliferation and the synthesis
of collagens and glycosaminoglycans in the lung.40,138
Based on the preceding information, we hypothesized that virus-induced
airway fibrosis and thickening in virus-susceptible BN rats was due to greater
expression of TGF-P in airway walls following viral infection than in virus-
resistant F344 rats. The objectives of this study were to determine if Sendai


16
hyperresponsiveness, its importance in viral pathogenesis, and the observation
that Sendai virus induces the production of TNF-a in monocytes, TNF-a can be
predicted to play a role in the pathogenesis of the Sendai virus-induced
bronchiolar fibrosis and airway hyperresponsiveness observed in the susceptible
BN rats. The studies presented here were designed to test that prediction.
Platelet-Derived Growth Factor
PDGF is a highly cationic protein dimer composed of two chains, A&B, that
can exist as AA, AB, or BB depending upon the species, cellular source,83 and
transcriptional regulator. PDGF is secreted by platelets, endothelial cells,
activated monocytes, macrophages, and mesenchymal cells.83'127 It is a
competence or priming type growth factor for cells of mesenchymal origin,128 and
a chemoattractant for fibroblasts and smooth muscle cells.129 PDGF stimulates
collagen synthesis, and may act to carry out the fibro-proliferative actions of
TGF-G since ceils that cannot both synthesize and respond to PDGF remain
inhibited by TGF-li.49,50 Stimulation of fibroblast proliferation by both IL-1 and
TNF-a may also be mediated by the induction of PDGF.130,131
Expression of PDGF in normal cells is tightly regulated; it acts locally in low
concentration and is rapidly cleared. In the lung, PDGF accounts for most of the
mitogenic activity of alveolar macrophages,51 and there is evidence that it is
important in fetal lung development.132 At sites of tissue injury, PDGF-BB


41
prehybridized, hybridized, and washed as described.142 Briefly, the slides were
initially de-paraffinized in xylene, re-hydrated through a graded series of ethanol
washes, and denatured in 0.2 N HCI and in 2X SSC at 70C. Prehybridization
consisted of incubation in 0.001% proteinase K (30 min, 37 C), acetylation in
acetic anhydride, and dehydration in ascending concentrations of ethanol.
Hybridization was performed at 57 C overnight in a humidified chamber. The
slides were washed in 4X SSC, incubated in RNase A (30 min, 37C) and
washed in descending concentrations of SSC. A final high stringency wash was
performed using 0.1X SSC at 65C for 30 min. The slides were then dehydrated
and dried. Signal was detected by coating the slides with Ilford K.5D nuclear
emulsion (Polysciences, Inc., Warrington, PA), and development in Kodak D-19
developer (Kodak, Rochester, NY) after 7-14 days.142 Autoradiograms were
stained with hematoxylin and eosin. Specificity of the probes was determined by
comparison with slides hybridized with labeled sense transcripts. Only lungs
from BN rats were processed for in situ hybridization.
For immunocytochemistry, lung sections from BN and F344 rats were de-
paraffinized and re-hydrated as described above for in situ hybridization, washed
in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with
either chicken IgG against recombinant human TGF-B, (R&D Systems,
Minneapolis, MN), or normal chicken IgG (Sigma, St. Louis, MO), both at 0.01
mg/ml. Antibody binding was detected using an avidin-biotin alkaline
phosphatase system (Vectastain ABC-AP and substrate kits, Vector Lab,
Burlingame, CA) as described.81


125
Objective 4: Determine whether Sendai virus directly or indirectly induces
gene transcription and/or translation for TGF-p, and TNF-a in
pulmonary macrophages.
Sendai virus infection induced increases in TNF-a mRNA and protein in a rat
alveolar macrophage cell line. This increased gene expression or increased
transcription/stability was not induced in cells incubated with UV-inactivated
virus. In contrast, TGF-p, mRNA was elevated only at 72 hours after virus-
inoculation and protein levels were not increased in the virus-inoculated cells.
The results of these studies support the hypothesis that bronchiolar mural
fibrosis following viral bronchiolitis is mediated by virus-induced increases in
transcription and/or translation of TGF-P, and TNF-a in infiltrating bronchiolar
macrophages. It is concluded that:
1) Sendai virus-induced bronchiolar fibrosis is preceded by increased gene
expression of TGF-P, and TNF-a.
2) Sendai virus directly induces TNF-a mRNA transcription and protein
expression in macrophages.
3) Sendai virus-induced bronchiolar fibrosis is at least partially mediated by
TNF-a.
4) TNF-a has a critical role in the immune/inflammatory response to Sendai
virus in BN rats.


80
increases in the number of proliferating bronchiolar fibroblasts precede the
development of Sendai virus-induced airway fibrosis, bronchiolar fibroblast
proliferation was used as an indicator of fibrosis. The bioactivity of TNF-a was
inhibited using a fusion protein composed of the soluble part of the p55 TNF
receptor linked to the human IgG heavy chain constant region, a construct that
has been successfully used to block TNF activity in animal models of
endotoxemia.150'152
Materials and Methods
Animals. Infection Protocol
Twenty-two day old weanling male BN rats were purchased from Fiaran
Sprague Dawley Inc., Indianapolis, IN. They were negative for serum antibodies
to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat virus, and
sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic bacteria.
The sham- and virus-inoculated groups were separated and housed in
individually ventilated isolation units located in separate rooms. Three days
after arrival, the rats in the virus-inoculated groups were exposed to
parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units (PFU) per ml of gas for 15 minutes as previously described.32 33 Sham-
inoculated rats were exposed to sterile chorioallantoic fluid (CAF).


21
consists of interstitial structural proteins (collagens III & V), rather than of
basement membrane components (type IV collagen, and laminin).23 This study
investigated the role of fibrogenic cytokines in the development of viral-induced
bronchiolar fibrosis, and assessed the direct effects of virus infection on the
expression of these cytokines.
Experimental Design and Methods
Experiment 1: Pulmonary expression of TGF-iy PDGF, and TNF-a in Sendai
virus-infected BN and F344 rats
Objectives
1) To determine the magnitude and duration of pulmonary expression of TGF-
B,, PDGF, and TNF-a in control and Sendai virus-infected BN and F344
rats.
2) To determine the number and type of bronchiolar cells expressing
cytokine mRNA and protein in Sendai virus-infected BN and F344 rats.
Rationale
Increases in pulmonary mRNA for TGF-B, PDGF and TNF-a have been
demonstrated in several models of chemically-induced pulmonary fibrosis.55' 6870,
<8,77.81.82.128.129.52 N0rthern analyses were used to assess the overall magnitude


TGF-IJ, and TNF-a protein than virus-inoculated F344 rats. Pulmonary PDGF
mRNA levels were not altered by viral infection in either rat strain.
The significance of TNF-a in the development of virus-induced bronchiolar
fibrosis was determined by using a 55 kD soluble TNF receptor-immunoglobulin
G fusion protein (sTNFR-IgG) to inhibit TNF-a bioactivity in virus-inoculated BN
rats. Treated rats had fewer proliferating bronchiolar fibroblasts, as detected by
bromodeoxyuridine incorporation, compared to virus-inoculated control rats.
There was also significantly increased mortality in p55sTNFR-lgG-treated virus-
inoculated rats associated with increased viral replication and decreased
numbers of macrophages and lymphocytes in bronchioalveolar lavage fluid.
To assess the mechanism of the virus-induced increase in cytokine
expression in macrophages, a rat alveolar macrophage cell line (NR8383) was
inoculated with Sendai virus, and the levels of TNF-a and TGF-p, mRNA and
protein were determined. TNF-a mRNA and protein levels were significantly
elevated at 24, 48, and 72 hours after virus-inoculation. Cells incubated with
UV-inactivated virus did not have any detectable TNF-a mRNA 24 hours after
inoculation. TGF-p, mRNA and protein levels in virus-inoculated cells were not
consistantly elevated over those from control cells. The results of these
experiments indicate that TGF-p, and TNF-a are important mediators of virus-
induced bronchiolar fibrosis. They also demonstrate that Sendai virus can
directly upregulate TNF-a expression, and that TNF-a is critical to the immune
and inflammatory response to the virus.
VI


CHAPTER 4
INCREASED TUMOR NECROSIS FACTOR-a (TNF-a) GENE EXPRESSION IN
MACROPHAGES PRECEDES BRONCHIOLAR FIBROSIS IN VIRUS-
SUSCEPTIBLE BN RATS
Summary
Parainfluenza type I (Sendai) virus infection in genetically susceptible young
rats induces persistent increases in airway resistance and airway
hyperresponsiveness. In virus-susceptible BN rats, the pulmonary function
abnormalities are associated with bronchiolar mural fibrosis and recruitment and
persistence of inflammatory cells including mast cells and macrophages. We
hypothesized that TNF-a gene expression is an important regulatory event in
virus-induced bronchiolar fibrosis. Pulmonary TNF-a mRNA and protein
expression were assessed at 3, 7, 10, 14, and 30 days after virus-inoculation in
rat strains that are susceptible (BN) and resistant ( F344) to virus-induced
bronchiolar fibrosis. Northern analysis revealed elevated pulmonary TNF-a
mRNA levels In both rat strains at 3, 7, and 10 days after inoculation (p<0.01).
At 14 days after inoculation only the virus-susceptible BN rats had increased
levels of TNF-a mRNA In their lungs (p<0.01). Macrophages and fibroblasts
were identified as being the main bronchiolar cell types containing TNF-a mRNA
55


I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Anthony Barbet
Professor of Veterinary Medicine
This dissertation was submitted to the Graduate Faculty of the College of
Veterinary Medicine and to the Graduate School and was accepted as partial
fulfillment of the requirements for the degree of Doctor of Philosophy.
May, 1996
Dean, College of Veterinary
Medicine
Dean, Graduate School


45
controls (p<0.0001). At 10 days after inoculation In F344 rats, the numbers of
macrophages and fibroblasts positive for TGF-IJ, were not significantly different
than sham-inoculated animals (Figures 3-5 & 3-6). TGF-3, protein was also
detected in bronchiolar, venous, and arterial smooth muscle in both BN and
F344 rats.
Discussion
The goal of this study was to determine whether TGF-p, expression induced
by viral bronchiolitis might be an important stimulus for bronchiolar mural fibrosis
and thickening. The bronchiolar fibrosis that follows acute virus-induced injury
and Inflammation is associated with long-term airway dysfunction36'18'38 and,
therefore, is an important pathologic endpoint to investigate. Two main
observations from this study are consistent with the interpretation that increased
TGF-P, gene expression may be an important stimulus for virus-induced
bronchiolar fibrosis. First, increases in pulmonary steady-state mRNA levels
and in density of bronchiolar cells expressing mRNA and protein precede the
bronchiolar fibrosis that develops by 15 or 30 days following inoculation.33'38
Second, BN rats (high responders to Sendai virus-induced bronchiolar fibrosis)
have higher and more prolonged levels of increased TGF-p, protein and mRNA
expression in lung and airways than do F344 rats (low responders).38


Figure 6-6. Northern analysis for TNF-a and TGF-p, performed on cytoplasmic RNA extract from cells
treated with CAF, UV-inactivated virus and viable virus. Band densities were normalized to cell counts
before analysis.
ro
o


58
airway wall thickening markedly alter mechanical properties of airways and
accentuate airway luminal narrowing during smooth muscle contraction.24
Several cytokines including tumor necrosis factor-a (TNF-a), transforming
growth factor-p (TGF-P), and platelet-derived growth factor (PDGF) stimulate
pulmonary fibroblast proliferation and collagen synthesis and are upregulated in
both naturally occurring and chemically-induced pulmonary fibrosis.40,16,48,109,85,
84.ii8.i2o pu|monary expression of TGF-P, and PDGF during Sendai virus
infection has been assessed in both virus-susceptible BN and virus-resistant
F344 rats (see Chapter 3 and Figure 2-1). Virus-induced increases in
pulmonary PDGF mRNA were not observed. However, prolonged increases in
pulmonary TGF-P, mRNA, as well as increased numbers of bronchiolar
macrophages and fibroblasts expressing TGF-P, protein were present in infected
BN rats before the development of virus-induced fibrosis.
Increased pulmonary expression of TGF-p appears to be important in the
pathogenesis of some, but not all forms of pulmonary fibrosis. The
administration of antibodies to TGF-P significantly reduced bleomycin-induced
increases in lung collagen.84 In contrast, pulmonary TGF-P mRNA was not
increased in lungs during the development of silica-induced pulmonary
fibrosis.120 TNF-a has been shown to be increased in both silica-induced
pulmonary fibrosis and bleomycin-induced fibrosis.118,120 The importance of
TNF-a in these two forms of fibrosis further emphasized by studies showing that
TNF-a inhibition with antibody reduces severity of fibrosis.118,120 Furthermore,


86
rats was significantly lower than that of virus-inoculated IgG-treated controls
(p55sTNFR-lgG: 12.3 2.3, IgG: 48.7 5.2, p<0.05) (Figure 5-1). Virus-
inoculated IgG-treated rats also had higher numbers of BrdU-labeled bronchiolar
fibroblasts than the sham-inoculated rats (p<0.05). The number of labeled
fibroblasts in the virus-inoculated p55sTNF-lgG treated rats was not significantly
different from that of the sham-inoculated rats. The numbers of BrdU-labeled
bronchiolar fibroblasts in the p55sTNF-lgG and IgG treated sham-inoculated rats
were not significantly different.
Bronchoalveolar Lavage Fluid: TNF-g Protein and Bioassavs
The mean pg/ml of TNF-a protein in the BAL fluid of virus-inoculated
p55sTNFR-lgG-treated rats was over four-fold higher than that of the virus-
inoculated IgG-treated rats at 7 days after inoculation (p< 0.003, Figure 5-2).
However, the level of TNF-a bioactivity in the BAL fluid of virus-inoculated rats
treated with 10 mg/kg of p55sTNF-lgG was significantly lower at 7 dpi than that
present in the virus-inoculated IgG-treated controls (p55sTNF-lgG: 2.5 1.41
pg/ml, IgG: 95.5 54.58 pg/ml, mean + sem, p<0.05) (Figure 5-3). TNF-a
bioactivity was also decreased in the virus-inoculated rats treated with 10 mg/kg
p55sTNF-lgG at 9 dpi, but the means between the two virus-inoculated groups
were not significantly different. The virus-inoculated rats given 1 mg/kg
p55sTNF-lgG also had decreased, but not significantly lower, TNF-a bioactivity


98
Figure 5-5: Effects of p55sTNFR-lgG on the numbers of macrophages
in BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5
for the 10 dpi sham-inoculated groups, and 8-9 for the infected
p55sTNFR-lgG-treated groups).


74
Figure 4-4: TNF-a protein in bronchiolar macrophages. Both micrographs are of
sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
upper section was incubated with 0.001 mg/ml normal rabbit sera and the lower
with 0.001 mg/ml polyclonal rabbit anti-mouse TNF-a (x600).


126
Both TGF-p, and TNF-a have wide ranging effects on the immune and
inflammatory response, which means that it would be difficult to try to prevent
airway fibrosis simply by totally blocking their activity. This problem was very
apparent in the high mortality that occurred when TNF-a was inhibited during
the active phase of viral infection. It also means that it is difficult to determine
the exact mechanism by which these cytokines may act to induce bronchiolar
fibrosis. Indeed, the development of virus-induced airway fibrosis is probably
determined by a complex cascade of mediators with numerous potential
pathways.
In spite of the difficulties, there are several approaches that could be taken to
try to further characterize the significance of TGF-P, and TNF-a in the
development of Sendai virus-induced bronchiolar fibrosis. Inhibiting TGF-P, in
experiments similar to those described in chapter 6 would indicate whether TGF-
P, expression is also critical to the development of virus-induced bronchiolar
fibrosis.
Blocking TNF-a activity at different, specific time points over the period of
active viral infection could determine exactly when TNF-a is necessary for
bronchiolar fibrosis to develop. Careful manipulation of the timing or level of
TNF-a inhibition might also make it possible to separate the protective antiviral
effects of TNF-a from its fibrogenic potential. For example, in BN rats, partial
inhibition of TNF-a during the active phase of viral infection between 3-10 days
after inoculation, and blocking prolonged expression from 10-14 days, would


115
O 20 40 60 80 100 120 140
Hours After Inoculation
Figure 6-1: NR8383 cells support Sendai virus replication. The highest
titers of infectious virus were present in cell supernants at 48 hours
after inoculation.


CHAPTER 5: FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF
SENDAI VIRUS-INDUCED BRONCHIOLAR FIBROSIS IN BN
RATS IS INHIBITED BY A SOLUBLE TNF RECEPTOR
Summary 77
Introduction 78
Materials and Methods 80
Results 85
Discussion 89
CHAPTER 6: SENDAI VIRUS DIRECTLY UPREGULATES TUMOR NECROSIS
FACTOR-a (TNF-a), BUT NOT TRANSFORMING GROWTH
FACTOR-P, (TGF-3,) GENE EXPRESSION IN RAT ALVEOLAR
MACROPHAGES
Summary 102
Introduction 103
Materials and Methods 105
Results 109
Discussion 111
CHAPTER 7: GENERAL SUMMARY 123
APPENDIX 129
REFERENCES 135
BIOGRAPHICAL SKETCH 152
IV


UNIVERSITY OF FLORIDA
3 1262 08554 6249


4
epithelial damage, autonomic nervous system dysfunction, modulation of the
immune response, and the induction of structural abnormalities. The purpose of
the studies presented here was to investigate the potential role of fibrogenic
cytokines in the pathogenesis of virus-induced bronchiolar fibrosis using
parainfluenza type I (Sendai) virus infection in rats as the experimental model.
Sendai Virus Infection in Rats: Summary of Previous Studies
Sendai virus is a common pathogen of rodents that can induce either clinical
disease or inapparent infection in laboratory rats, mice, guinea pigs, and
hamsters.25"27 Spontaneous disease associated with Sendai virus infection is
well documented,28 and the pathological features have been defined
experimentally.29'31 Following aerosol infection, CD (Sprague-Dawley) rats
develop multifocal necrotizing bronchiolitis associated with viral replication in
bronchiolar epithelial cells. Infection of neonatal (5 day old) rats produces the
most severe pneumonia at seven days post infection (dpi), with epithelial repair
and resolution of the bronchiolitis being largely complete at 17 dpi.29 30 Neonatal
CD rats infected with Sendai virus develop long term pathological sequelae
consisting of bronchiolar hypoplasia and fibrosis, alveolar dysplasia, and
bronchiolar mastocytosis.30 32'32 These morphological changes are associated
with pulmonary functional abnormalities including increased pulmonary
resistance, decreased arterial P02, and airway hyperresponsiveness to
aerosolized methacholine.35,36


88
5-5 & 5-6). Ninefold fewer numbers of macrophages (p55sTNF-lgG: 2674 384,
IgG: 26153 6042, p<0.05) and fourteen-fold fewer lymphocytes (p55sTNF-lgG:
233 66, IgG: 3381 1068, p<0.05) were observed at 9 days after virus-
inoculation (Figures 5-5 & 5-6). Neutrophil counts were also two- and sixfold
lower in the p55sTNF-lgG treated virus-inoculated rats at 7 and 9 dpi
respectively, however the difference was not statistically significant (Figure 5-7).
The virus-inoculated, IgG-treated rats had more total cells, with increased
numbers of macrophages, lymphocytes, and neutrophils in their BAL fluid than
did the rats in either of the sham-inoculated groups (p<0.05). In contrast, virus-
inoculated, p55sTNF-lgG treated rats did not have increased numbers of
macrophages or lymphocytes in their BAL fluid compared to the sham-inoculated
rats. However, they did have increased numbers of neutrophils compared to
both groups of sham-inoculated rats, and higher total cell numbers than the
p55sTNF-lgG treated sham-inoculated rats (p<0.05). There were no significant
differences in the BAL fluid total or differential cell counts between the p55sTNF-
IgG and the IgG-treated sham inoculated rats.
Increased Mortality and Pulmonary Lesions in the Sendai Virus-Inoculated
p55sTNF-lqG Treated Rats
All of the virus-inoculated rats treated with 10 mg/kg p55sTNF-lgG died or
were found moribund and were sacrificed 8-9 days after virus-inoculation. Four


100
O)
!E
CL
£
3
O
0)
r¡
E
3
igG
TNFR
Mean + SE
Sham Virus: 7 dpi Virus: 9 dpi
Figure 5-7: Effects of p55sTNFR-lgG on the numbers of neutrophils in
BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5 for
the 10 dpi sham-inoculated groups, and n=8-9forthe infected
p55sTNFR-lgG-treated groups).


73
Figure 4-3: TNF-a mRNA in bronchiolar macrophages. These serial sections
were taken from a virus-inoculated BN rat at 7 days after inoculation. The top
section was incubated with 50 ng of a digoxigenin-labeled antisense riboprobe
for rat TNF-a and the bottom with 50 ng of the digoxigenin-labeled sense
riboprobe (x600).


60
Experimental Protocol
Three days after arrival, the rats in the experimental group were exposed to
parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units (PFU) per ml of gas for 15 minutes in a Tri-R aerosol exposure apparatus
(Tri-R Instruments, Rockville Center, NY). Viral assays to calibrate exposure
were performed as previously described.33,37 Sendai virus strain P3193
produced in embryonated chicken eggs was used. Control rats were exposed to
sterile chorioallantoic fluid. Virus-inoculated BN and F344 rats were processed
at 3, 7, 10, 14 and 30 dpi. Sham inoculated animals were sacrificed at 7, 14,
and 30 dpi. The rats were deeply anesthetized with sodium pentobarbital and
killed by exsanguination via intracardiac puncture. For Northern analysis, the
lungs of six rats from each group were frozen in liquid nitrogen and stored at
-80C until processed. Lungs from four animals in each group were processed
for in situ hybridization and immunohistochemistry. These lungs were fixed for 2
hours via airway perfusion with 4% paraformaldehyde-PBS (pH 7.4), at 30 cm
perfusion pressure, and embedded in paraffin for in situ hybridization and
immunocytochemistry.


5
Inbred rat strains that are susceptible ( Brown Norway: BN) and resistant
(Fischer 344: F344) to Sendai virus induced bronchiolar hypoplasia, fibrosis,
mastocytosis and the associated pulmonary function abnormalities have been
identified.37 At 7 days after Sendai virus infection, BN rats had higher pulmonary
viral titers, and increased numbers of neutrophils in the bronchoalveolar lavage
fluid compared to F344 rats.37 Significantly increased numbers of bronchioles
with aggregates of lymphocytes and macrophages were observed in BN rats at
14 days post infection.37 Neonatally infected BN rats also had an over 3-fold
increase in the area of bronchiolar wall per unit length of bronchiolar basement
membrane by 65 days dpi.38 This peribronchiolar increase in tissue was largely
accounted for by a 1. 5-fold increase in the number of fibroblasts per mm2 of
bronchiolar basement membrane (b.m.) as well as by a 4-fold increase in
collagen fiber density, and a 4.7 fold increase in extracellular matrix (urn3 /urn2
b.m.).38 Active proliferation of fibroblasts, assessed by bromodeoxyuridine
labeling, demonstrated significant increases (p<0.05) in the percentages of
labeled bronchiolar fibroblasts in BN rats at 7, 10, & 14 dpi (unpublished data).
In contrast, neonatally infected F344 rats did not have evidence of diffuse
bronchiolar fibrosis.38
The results of these studies indicate that bronchiolar fibrosis is an important
component of Sendai virus-induced increases in bronchiolar wall thickness and
therefore could explain the persistently increased airway resistance noted in
neonatally infected BN rats. Comparison of BN and F344 rats allows an unique


59
the infusion of recombinant TNF-a accentuated the severity of pulmonary
fibrosis in silica-treated mice.120
Based upon these observations, we hypothesized that the development of
Sendai virus-induced bronchiolar fibrosis in susceptible BN rats also may be
regulated by bronchiolar expression of TNF-a. The objectives of this study were
to determine if Sendai virus infection induces increases in pulmonary TNF-a
mRNA levels prior to the development of fibrosis and to determine whether rats
susceptible to virus-induced bronchiolar fibrosis (BN) have increased numbers
of bronchiolar cells expressing TNF-a protein compared to the virus-resistant
(F344) rats.
Materials and Methods
Animals
Twenty-two day old weanling male BN and F344 rats were purchased from
Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum
antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat
virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic
bacteria. The control and experimental groups were separated and housed in
adjacent individually ventilated isolation units.


139
45. Elias JA, Freundlich B, Kern JA, Rosenbloom J. 1990. Cytokine networks
in the regulation of inflammation and fibrosis in the lung. Chest. 97:1439-
1445.
46. Lund LR, Riccio A, Andreasen PA. 1987. Tranforming growth factor-beta
is a strong and fast acting positive regulator of the level of type-1
plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
Embo J 6:1281-1286.
47. Whitby, DJ, Ferguson, MWJ. 1991. Immunohistochemical localization of
growth factors in fetal wound healing. Devel Biol. 147:207-215.
48. Hoyt DG, Lazo JS. 1988. Alterations in pulmonary mRNA encoding
procollagens, fibronectin and transforming growth factor-6 precede
bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther.
246:765-771.
49. Anzano MA, Roberts AB, Sporn MB. 1986. Anchorage-independent
growth of primary rat embryo cells Is Induced by platelet-derived growth
factor and inhibited by type-beta transforming growth factor. J Cell
Physiol. 126:312-318.
50. Leof EB, Proper JA, Goustin AS. 1986. Induction of c-sis mRNA and
activity similar to platelet-derived growth factor by transforming growth
factor 6:a proposed model for indirect mitogenesis involving autocrine
activity. Proc Natl Acad Sci. 83:2453-2457.
51. Schimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R.
1985. A significant part of macrophage-derived growth factor consists of
at least two forms of PDGF. Cell. 43:277-286.
52. Pierce GF, Brown D, Mustoe TA. 1991. Quantitative analysis of
inflammatory cell influx, procollagen type I synthesis, and collagen cross-
linking in excisional wounds: influence of PDGF-BB and TGF-beta 1
therapy. J Lab Clin Med. 117:373-382.
53. Fabisiak JP, Evans JN, Kelley J. 1989. Increased expression of PDGF-B
(c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during
chronic hyperoxia. Am J Respir Cell Mol Biol. 1:181-9.
54. Brant RPW, Smith S, Hemminki K, Koskinen H, Vainio H, Niman H, Ford
J. 1992. Serum oncoproteins and growth factors in asbestosis and
silicosis patients. Int J Cancer. 50:881-885.


63
Mannheim, Indianapolis, IN). Specificity of the probes was determined by
comparison with slides hybridized with equivalent quantities of labeled sense
transcripts.
For immunocytochemistry, lung sections from BN and F344 rats were de-
paraffinized and re-hydrated as described above for in situ hybridization, washed
in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with
either rabbit sera (Sigma, St. Louis, MO) or polyclonal rabbit anti-mouse TNF-a
(Genzyme, Cambridge, MA) both at 0.001 mg/ml. Antibody binding was
detected using an avidin-biotin alkaline phosphatase system (Vectastain ABC-
AP and substrate kits, Vector Lab, Burlingame, CA).
Protein Analysis on BAL Fluid
Bronchioalveolar lavage fluid (BAL) was collected from sham- and virus-
inoculated BN and F344 rats at 7 and 10 dpi using two phosphate-buffered
saline lavages as described.35 The amount of rat TNF-a protein in each sample
was determined by enzyme-linked immuno-absorbance assays (ELISA) using an
immunoassay kit according to the manufactures instructions (BioSource
International, Inc. Camarillo, CA).


114
the peak in viral replication at 48 hours. Corresponding increases in TGF-p,
protein at 72 hours after virus-inoculation were not observed, suggesting post-
transcriptional regulation of TGF-p, may be occurring, and suggesting that
increases in TGF-p, expression is not a direct effect of Sendai virus infection. At
this stage of viral infection the the death of infected cells and the release of
TNF-a and probably other cytokines such as IL-1, could be indirectly inducing
TGF-p, through activation of macrophages. Elevations in pulmonary TGF-p,
mRNA and increases in the number of bronchiolar macrophages and fibroblasts
expressing TGF-p, protein are associated with the development of Sendai virus-
induced bronchiolar fibrosis in BN rats.
In conclusion, Sendai virus can directly upregulate TNF-a mRNA and protein
expression in rat alveolar macrophages by a mechanism that requires infectious
virus.


66
The number of bronchiolar macrophages positive for TNF-a protein peaked
at 7 days after inoculation in both rat strains (p<0.0001, Figures 4-4 & 4-5).
Infected virus-sensitive BN rats had almost twice as many labeled macrophages
in their bronchiolar walls as infected F344 rats (p<0.0001). The number of
labeled macrophages was still elevated in infected BN rats at 10 days after
inoculation (p<0.05). The number of bronchiolar fibroblasts positive for TNF-a
protein increased over two-fold in both rat strains at 7 days after inoculation
(p<0.001, Figure 4-6). The largest number of labeled fibroblasts observed in the
virus-resistant F344 rats was at 7 dpi, while in the virus-susceptible BN rats, the
numbers increased until 10 days after inoculation (p<0.0001, Figure 4-6). TNF-
a protein was also observed in epithelial cells and in BALT lymphocytes.
Effects of Sendai virus infection on TNF-a protein levels in BAL fluid
TNF-a protein levels in the BAL fluid harvested from infected BN rats at 7 dpi
were elevated at 346.7 47.5 pg/ml (mean sem) compared to 55.83 36.38
pg/ml for infected F344 rats (p<0.05). At 10 dpi, the levels of TNF-a protein
were not significantly different between the two rat strains (BN = 104.7 24.3
pg/ml, F344 = 74.5 41.5 pg/ml).


82
Bronchoalveolar Lavage
Phosphate-buffered saline (PBS) was used to perform bronchoalveolar
lavage (BAL) as previously described.153 Total cell counts were made using a
hemacytometer. Cytocentrifuge cell samples of lavage fluid were made with a
Cytospin 2 (Shandon Southern Instruments, Inc, Swickley, PA), fixed in
methanol, and stained with Giemsa solution. A cell differential was calculated
after evaluating 200 cells. Total cell numbers recovered per lung were
calculated (macrophages, neutrophils, and lymphocytes) and normalized per
100 g body weight. The levels of TNF-a protein and bioactivity in the BAL fluid
were determined as described below.
TNF-a Protein and Bioassavs
The amount of TNF-a protein present in the BAL fluid samples was
determined using an enzyme-linked immunoabsorbance assay (ELISA) kit
(Biosource International Inc. Camarillo, CA) performed according to the
manufacters instructions. The level of TNF-a bioactivity in BAL fluid samples
was determined by cytotoxicity assays.154-156 Briefly, 50,000 cells from the
mouse cell line Wehi 164, a BALB/c fibrosarcoma156 were plated per microtiter
well in 200 pi RPMI media with Glutamine, penicillin (50 lU/ml) streptomycin (50
mcg/ml) and incubated over-night at 37, 5% C02. Eighty pi of a 1.2 pg/ml


111
for p-actin were also significantly reduced in the actinomycin-D-treated groups
(Figure 6-7). TGF-p, cytoplasmic RNA levels in cells inoculated with UV-
inactivated virus were not significantly different from those of cells incubated
with viable virus or CAF (Figures 6-6 & 6-8). The mean band densities for p-
actin in the UV-inactivated, CAF, and virus-inoculated groups were not
significantly different (Figure 6-8). The mean band densities for TGF-p, and p-
actin in both the CAF- and virus-inoculated groups incubated with actinomycin D
were significantly decreased (data not shown).
Piscussion
Previous studies associated the development of Sendai virus-induced
bronchiolar fibrosis with increased gene expression of TNF-a and TGF-P, in
bronchiolar macrophages (see Chapters 3, 4, 5). The purpose of this study was
to determine if at least part of the virus-induced increases in macrophage
expression of these cytokines was the result of direct upregulation by the virus.
The results indicate that Sendai virus can directly upregulate TNF-a mRNA and
protein levels in macrophages, but direct upregulation of TGF-p, gene
expression is inconsistent.
Several viruses directly stimulate the production of TNF-a mRNA and
protein.170 57'59 Influenza A virus has the ability to prime cells for TNF-a
production by inducing the accumulation of large amounts of TNF-a mRNA


8
TGF-li is a potent inducer of tissue fibrosis,55 with a variety of both paracrine
and autocrine effects. It can increase the tissue levels of collagen and other
matrix proteins66 by increasing the transcription of fibronectin and procollagen
genes,69-70 through postranscriptional regulation of steady-state levels of
fibroblast collagen and fibronectin mRNA,71 and by inhibiting the degradation of
existing extracellular matrix by both decreasing the biosynthesis of proteases72
and increasing the synthesis of protease inhibitors.46 TGF-li, along with TNF-a,
can also enhance the development of pulmonary fibrosis by impairing the ability
of lung fibroblasts to degrade fibrin,73 thus stabilizing a transitional matrix on
which fibroblasts can proliferate and secrete collagen. In addition, TGF-li has
effects on the expression of other fibrogenic growth factors including; PDGF,
TNF-a, and basic fibroblast growth factor (bFGF).74-76
Evidence that TGF-li is one of the most potent fibrogenic agents known has
come from studies of several different models of tissue fibrosis (see reference 67
for review). Investigations of fetal wounds, which heal without the formation of a
scar, revealed that unlike in neonates or adults, TGF-li was not associated with
the wound, while the injection of TGF-li into fetal wounds led to scarring.47 The
significance of this finding was followed up by the observation that the injection
of antibodies to TGF-li into wounds in adults resulted in healing without the
formation of a scar.77 In models of pathological fibrosis increased TGF-li
expression has been observed in humans with liver cirrhosis, idiopathic
pulmonary fibrosis,75 or systemic sclerosis,76 in mice with hepatic fibrosis,79 and


127
produce a pattern of TNF-a expression similar to that observed in the virus-
resistant F344 rats. Assuming TGF-P, expression remained unchanged, the
relative significance of TNF-a would be determined by whether these rats
developed bronchiolar fibrosis.
There also may be significant strain differences in either the magnitude or
duration of TNF-a gene expression directly induced by Sendai virus in infected
cells. Such differences might at least partially account for the differences in
gene expression observed in vivo. Establishing alveolar macrophage cell lines
from both BN and F344 rats, and comparing the levels of TNF-a mRNA and
protein induced by Sendai virus at various time points after inoculation, would
determine if strain differences in TNF-a gene expression exist at the cellular
level.
Finally, the dramatic increase in mortality induced when TNF-a was blocked
during viral infection was an unexpected, but not entirely unpredictable finding in
these studies. The increased mortality was associated with suppression of the
inflammatory response and increased viral replication, but the exact mechanism
behind it was not apparent. Comparative pathogenesis studies using both BN
and F344 rats could be performed to try to elucidate this mechanism, and may
also provide insight into the factors important in the genetic susceptibility and
resistance to viral infections.
In conclusion, the results of these experiments implicate TGF-p, and TNF-a
as important mediators of virus-induced bronchiolar fibrosis. They also


43
Results
Effect of Sendai virus infection on total lung levels of TGF-IJ, mRNA
At 7 days after inoculation, viral infection resulted in significant increases in
pulmonary TGF-IJ, mRNA in both rat strains (Figures 3-1 and 3-2). Virus-
susceptible BN rats had a greater than two-fold increase in TGF-IJ, mRNA as
compared to the peak elevation observed in the virus-resistant F344 rats
(p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-IJ, mRNA levels
remained elevated in the virus-inoculated BN rats, whereas in virus-inoculated
F344 rats the levels were not significantly increased over those of control rats.
The level of pulmonary TGF-IJ, mRNA in lungs of virus-inoculated BN rats was
equivalent to that of the control animals by 30 days after inoculation. Pulmonary
PDGF mRNA was not increased in either rat strain at 7, 10, & 14 days after
inoculation (see Figure 2-1).
Identification of pulmonary cell types expressing TGF-IJ, mRNA
Macrophages and fibroblasts were the main cell types expressing TGF-IJ,
mRNA as detected by in situ hybridization in both control and virus-inoculated
rats (Figure 3-3). Macrophages in bronchiolar walls and alveolar macrophages
hybridized antisense probe. Bronchiolar smooth muscle cells as well as arterial


133
Table A-1: Digoxigenin Nuclear Run on Assays:
Summary of Results
RUN
CELLS/NUCLEI
RNA
PROBE
INCUBATION
Label:Hybrid
RESULT
1
4x1O'/Untx
TGF-LP (23gg)
2hr/37:20hr/65
+:2hr
2
4x107/Untx
+
TGF-IN (5 gg)
2hr/37:48hr/65
-:24hr
3
5x107/Untx

TGF-LP (16gg)
2hr/37:24hr/65
+:2hr
4
2x107/LPS & Untx

TNF-LP (11 gg)
TNF-PB (11 gg)
2hr/37:48hr/57
-:24hr
p-Actin-IN (27 gg)
5
2x107/LPS & Untx

TNF-LP (7)
3hr/37:24hr/57
-:24hr
TGF-LP (?)
6
2x107/LPS & Untx
160gg/+
TNF-LP (92 gg)
30 mln/37:24hr/37
-:24hr
TGF-LP (115 gg)
7
2.7x107/Untx
138pg/+
TGF-LP (92gg)
30mln/37 :24hr/37
+:2hr
8
2.7x107/Untx
204(jg/+
TGF-LP (120gg)
30min/37:24hr/37
+:1 wk
9
2.7x107/Untx
*191gg/+
TGF-LP (116gg)
TGF-IN (11 gg)
30mln/37:24hr/37
-:24 hr
TGF-BP (116gg)
'192gg/+
TGF-LP (116gg)
+:24 hr
TGF-IN (11 gg)
30mln/37:24hr/37
-:24 hr
TGF-BP (116M9)
-:24 hr


24
The RODs of the total RNA from individual lungs were compared, both between
and within groups, to assess the amount of individual animal variation.
Statistical analysis was performed using a microcomputer-based statistical
program (Systat version 4, Evanston IL). Density of mRNA and protein labeling
were assessed by counting and classifying the number of labeled cells per mm
bronchiolar basement membrane in 25 high power (400X) fields per slide. Three
slides per animal were counted. Differences in the density of stained cells
between the infected and control, BN and F344 rats were compared using
ANOVA and Tukey tests.
Experiment 2: The effects of cytokine inhibition on the development of viral-
induced bronchiolar fibrosis.
Objective
1) To determine if the development of Sendai virus-induced bronchiolar
fibrosis in BN rats can be inhibited by blocking the activity of a
single highly expressed cytokine identified in the above experiments.
Rationale
TNF-a was chosen to block because: 1) Its transcription is directly induced
by the virus, 2) TNF-a pulmonary mRNA is elevated earlier in both rat strains


107
manufacturer's instructions (Gibco BRL Life Technologies, Inc. Gaithersburg,
MD). Cytoplasmic RNA was electrophorectially fractionated on a series of 1.2%
(wt:vol) agarose gels containing 6% (vokvol) formaldehyde, transferred to a
positively charged nylon membrane (Boehringer Mannheim Corporation,
Indianapolis, IN), and fixed by UV-crosslinking. Equality of RNA loading
between lanes was assessed by visually comparing the intensity of ethidium
bromide staining of the gels and membranes, and by re-probing the membranes
with a 32P-dCTP-labeled cDNA probe for p-actin. Band densities were compared
as described below.
cDNA probes for rat TNF-a (generously supplied by Dr. T. Shirai, Laboratory
for Chemical Research, Asahi Chemical Industry Co. Ltd, Tagata-gun, Shizuoka,
Japan), rat TGF-IJ,: a 985 bp cDNA fragment containing the major coding region
of the gene (generously supplied by Dr. Su Wen Quian, Laboratory of
Chemoprevention, NIH Bethesda, MD) and human p-actin (American Type
Culture Collection Rockville, MD) were labeled with P-dCTP using the random
primer method as described.140 Prehybridization (TNF-a and p-actin : 15 min,
58C; TGF-IJ,: 15 min 65C) and hybridization (overnight at the same
temperature as prehybridization) was in 0.5 M Na2HP04, 7% SDS, 1% BSA, and
10mM EDTA as described.141 The membranes were washed at the hybridization
temperature in 40mM phosphate (TNF-a and p-actin) or 20 mM phosphate
(TGF-IJ,), 1% SDS, and exposed to Kodak (Rochester, NY) XLS-5 film with
Dupont Cronex intensifying screens. Film band densities were quantified using


a computer-based statistical program (SigmaStat, Jandel Corporation, San
Rafael, CA). Differences between individual means were assessed by
Bonferronis method of all pairwise multiple comparison.143


20
3) Determine if the development of virus-induced bronchiolar fibrosis in BN
rats can be blocked by neutralizing cytokine activity.
4) Determine whether parainfluenza virus directly or indirectly induces gene
transcription and/or translation for TGF-P,, PDGF, and/or TNF-a in
pulmonary macrophages.
Backaround/Sianifi canee
Epidemiological studies have associated childhood viral bronchiolitis,
especially as the result of infection with respiratory syncytial virus, parainfluenza
viruses, adenoviruses, or rhinovirus, with the subsequent development of
persistent increases in airway resistance and recurrent wheezing or airway
hyperresponsiveness.1-8 A rat model of parainfluenza virus-induced bronchiolar
hyperresponsiveness and increased airway resistance has been characterized,
and both susceptible and resistant inbred rat strains have been identified.33,341
36,37 In this model, the increased airway resistance observed in the susceptible
rats is associated with collagen deposition in the bronchiolar walls, and
increases in the number of peribronchiolar fibroblasts.36
Airway wall thickening and fibrosis has also been identified as a common
lesion occurring in human asthma and may contribute to exaggerated airway
luminal obstruction following smooth muscle contraction.8,22,23 In asthmatics,
collagen deposition is most likely the result of fibroblast activation, because it


7
Transforming Growth Factor-p (TGF-li )
TGF-li is a multifunctional growth factor, having growth regulatory activities
on essentially all cell types. The cellular response to TGF-li is complex, being
dependent on cell type, the presence of other growth factors, level of
differentiation, and the state of cell activation.61 It is a potent inhibitor of
epithelial cell growth,62 probably through inhibition of the c-myc proto
oncogene,63 while in combination with PDGF it is mitogenic for cells of
mesenchymal origin.64 TGF-li is also an important regulator of differentiation for
mesenchymal cells.64
In the normal lung, TGF-li is postulated to have a role in the stabilization of
the structural cell populations;65 however, if regulation of its biosynthesis is
disrupted, high protein levels could suppress repair processes by inhibiting
epithelial cell proliferation. All three isoforms of TGF-li (-li-li2,-li3) are
constitutively expressed in the lung. mRNA transcripts are found in
macrophages, smooth muscle cells and fibroblasts, while protein expression
also may be associated with the bronchiolar epithelium.65 There are cell type-
specific differences in the number and type of TGF-li receptors as well as
subtypes of receptors with different affinities for the different TGF-li isoforms.
Rat lung fibroblasts, for example, have receptors with a higher affinity for TGF-li,
than for TGF-lij.66 This finding correlates well with the fact that TGF-li, is the
isoform most implicated in fibrosis.67


105
induction of cytokine gene expression required inoculation with live virus; and 4)
to determine whether any observed increase in cytokine mRNA is due to
transcriptional upregulation.
Materials and Methods
Cell Line and Experimental Protocol
A rat pulmonary alveolar macrophage cell line (NR8383), generously
supplied by Ronald J. Helmke (University of Texas Health Science Center, San
Antonio, TX), was maintained in Hams F-12 media (Sigma, St. Louis, MO) with
12% fetal bovine serum (Sigma, St. Louis, MO) and 1% antibiotic/antimycotic
solution (10,000 units penicillin, 10 mg streptomycin and 25 pg amphotericin
B/ml in 0.9% sodium chloride, Sigma, St. Louis, MO). Cells were passaged
twice a week. Baseline infection assays were performed using Sendai virus
strain P3193, produced in embryonated chicken eggs as previously
described,3233 at multiplicity of infection (MOI) of 1:1 and 1:10. Plaque assays
and immunocytochemical staining for viral antigens were performed as
previously described, 32 33 and were used to confirm the presence of productive
infection.
The inoculation protocol for each experiment was as follows: 2 x108 cells
were equally divided and placed into two 50 ml tubes each containing 25 ml of


13
neutrophils, monocytes and lymphocytes.11 Other pro-inflammatory effects on
endothelial cells Include alterations in the transcription and cell surface
expression of class I MHC antigens and induction of IL-1 secretion.1 TNF-a
also has direct stimulatory effects on neutrophils, acting to enhance the
phagocytic capacity, antibody-dependent cytotoxicity, degranulation, and
production of reactive oxygen species.111 In the repair process, a role for TNF-a
is suggested by Its growth stimulatory effect on fibroblasts, which is thought to
be mediated by the increased cell surface expression of epithelial growth factor
receptors, and by its ability to induce angiogenesis.111
Several of the pro-inflammatory effects of TNF-a, for example: its ability to
increase the adhesion of both neutrophils and eosinophils to vascular
endothelium,1112 the potentiation of interleukin-3 and granulocyte/macrophage-
colony stimulating factor induced proliferation of hemopoietic progenitor cells,113
the enhancement of eosinophil cytotoxicity,114 and its mechanistic role in the
activation of dermal endothelium triggered by mast cell degranulation,115 suggest
TNF-a may be important in the pathogenesis of allergic inflammation. In the
lung, this importance has been implicated by studies of airway
hyperresponsiveness.
Bronchial hyperresponsiveness and inflammation, induced by the
administration of aerosolized endotoxin to rats, has been demonstrated to be
mediated by TNF-a.110 Pretreatment of rats with antibodies against TNF-a
decreased the hyperresponsiveness, while administration of recombinant TNF-a


42
Quantitation Methods and Data Analysis
Evaluation of pulmonary cytokine mRNA levels In control and virus-
inoculated BN and F344 rat strains was made by comparing the relative optical
densities (ROD) of bands on Northern autoradiograms. The density of cells
expressing mRNA and protein was assessed by counting and classifying the
number of labeled cells per millimeter of bronchiolar basement membrane in 25
consecutive fields at 400X per slide.38 Macrophages and fibroblasts were the
cells most consistently labeled by the TGF-P, immunocytochemistry and in situ
hybridization procedures. Vascular and airway smooth muscle cells also
contained TGF-P, mRNA and protein, while epithelial cells were occasionally
positive for TGF-P, protein. Macrophages and fibroblasts were counted in the
bronchiolar wall. In addition, macrophages in immediately adjacent alveolar
spaces were counted in the same microscopic fields. Three lung sections from
each rat were evaluated in the immunocytochemistry procedures. In more
limited quantitative procedures for the in situ hybridization of BN rats, one slide
per rat was counted. Cells that had round profiles, central round to ovoid nuclei,
and abundant eosinophilic cytoplasm were counted as macrophages. Cells
were counted as fibroblasts when they had elongated ovoid nuclei and
elongated, spindle-shaped cytoplasm. Statistical analysis among group means
was performed using ANOVA and Tukey's HSD multiple comparison
procedure143 in a computer-based statistical program (Systat version 4,
Evanston, IL).


18
implies a causal role for PDGF in the fibroblast proliferation induced by
hyperoxic injury to the lung.53
The role of PDGF in the pathogenesis of viral-induced tissue damage has not
been investigated. However, the prolonged induction of PDGF production either
by direct transcriptional upregulation by the virus, or some other factor (ie TGF-
II), may be contributing to the airway fibrosis observed in BN rats following
Sendai virus infection.


140
55. Wahl, SM. 1992. Transforming growth factor beta (TGF-B) in
inflammation: a cause and a cure. J Clin Immunol. 12:61.
56. Poli G, Fauci AS. 1992. The effect of cytokines and pharmacologic agents
on chronic HIV infection. AIDS Research Human Retroviruses. 2:191-
197.
57. Aderka D, Holtmann H, Toker L, Hahn T, Wallach D. 1986. Tumor
necrosis factor induction by Sendai virus. J Immunol. 136:2938-2942.
58. Wong GHW, Goeddel DV. 1986.Tumor necrosis factor a and 6 inhibit
viral replication and synergize with interferons. Nature. 232:819.
59. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M,
Gemsa D. 1991. Influenza A virus infection of macrophages: enhanced
tumor necrosis factor-a (TGF-a) gene expression and
lipopolysaccharide-triggered TNF-a release. J Immunol. 147:3507-3513.
60. Smith PD, Saini SS, Raffeld, Manischewitz JF, Wahl SM. 1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest. 90:1642-1648.
61. Roberts AB, Anzano MA, Wakefield LM 1985. Type-IJ transforming growth
factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci.
82:119-23.
62. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr, Halper J, Shipley GD.
1985. Type (J tranforming growth factor is a growth stimulator and a
growth inhibitor. In: Feramisco J, Ozanne B, Stiles B, eds. Growth
factors and tranformation. Cancer cells 3. Cold Spring Harbor, NY: Cold
Spring Harbor Press. pp:65-71.
63. Takizawa H, Beckman JD, Yoshida M, Romberger D, Rennard SI. 1991.
Regulation of bovine bronchial epithelial cell proliferation and proto
oncogene expression by growth factors. Am J Respir Cell Mol Biol. 5:548-
555.
64. Pelton RW, Moses HL. 1990. The beta-type tranforming growth factor.
Am Rev Respir Dis. 142:S31-S35.
65. Pelton RW, Johnson MD, Perkett EA, Gold LI, Moses HL. 1991.
Expression of transforming growth factor-13,, -fl2 and -li3 mRNA and
protein in the murine lung. Am J Respir Cell Mol Biol. 5:522-530.


72
8
c
CD
T3
C
_Q
<
cr
E
Days After Inoculation
Figure 4-2: Graphic presentation of the results of Northern analysis for
TNF-a. Data points and bars represent the mean % maximum relative
optical band density (ROD) and standard error of the mean (SEM) for
4-6 rats. The maximum ROD for each blot was determined from
positive control RNA. Statisical comparisons of RODS were only made
between bands from sham- and virus-inoculated rats present on the
same autoradiograph.


95
Figure 5-2: TNF-g protein levels in the BAL fluid of infected BN rats as
determined by ELISA. Data points represent group means + SEM
(n=3).


22
and duration of pulmonary cytokine expression in infected rats. In situ
hybridization and immunohistochemistry were used to identify the pulmonary cell
types expressing cytokine mRNA and protein after viral infection, and to
determine their association with areas of inflammation and fibrosis.
Design and Methods
Twenty-two day old weanling male BN and F344 rats were inoculated with
Sendai virus or sterile chorioallantoic fluid, and studied according to the
schedule outlined in Table 2-1.
Necropsy and tissue processing. The rats were deeply anesthetized with
sodium pentobarbital and killed by exsanguination via intracardiac puncture. For
Northern analyses, the lungs were frozen in liquid nitrogen after removal and
stored at -80C until processed. Lungs were harvested and fixed by 2 hour
perfusion via the trachea with 4% paraformaldehyde-PBS (pH 7.4) and
embedded in paraffin, for ¡Q situ hybridization and immunohistochemistry.
cDNA probes. 1) A 985 bp cDNA fragment including the major coding
region of rat TGF-B, precursor (supplied by Dr. Su Wen Quian, Laboratory of
Chemoprevention, NIH). 2) PDGF-B: cDNA (human) 2.6 kb ATCC; and 3) TNF-
a: cDNA (rat supplied by Dr. T. Shirai, Laboratory for Chemical Research,
Asahi Chemical Industry Co. Ltd, Tagata-gun, Shizuoka).


31
Northern Analysis
Immunocvtochemistrv
Days
BN Rats
F344 Rats
BN Rats/ F344 Rats
After
Control
Virus
Control
Virus
Control
Virus
Inoculation
3
-
6
-
6
-
4
7
6
6
6
6
4
4
10
-
6
-
6
-
4
14
6
6
6
6
4
4
30
6
6
_
_
4
4
* The blots were re-probed wherever possible
Table 2-1. Experimental design for Northern analysis and immunocytochemlcal
studies


I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
William L. Castleman, Chair
Professor of Veterinary Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Hoy A £>.
Claus D. Buergelt f
Professor of Veterinary Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
yy\x-
Mary Browlm
Associate Professor of Veterinary
Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Rosalia C. M. Simmen
Professor of Animal Science


81
Experimental Design
One group of eighteen 25-day-old, male BN rats were inoculated with Sendai
virus, while a second group of 12 were sham-inoculated with CAF. Six rats from
the sham and 9 from the virus-inoculated rats were injected intraperitoneally (ip)
with 10 mg/kg of p55 sTNFR-IgG fusion protein (generously supplied by
Hoffman- La Roche, Basel, Switzerland) on 0, 2, 4, 6, & 8 days post inoculation
(dpi). The remaining animals: 6 sham-inoculated and 9 virus-inoculated rats,
were injected ip withIO mg/kg of human IgG according to the same schedule.
Three rats from each of the virus-inoculated groups were sacrificed at 7 dpi.
The rest of the rats were given 200 pg/g 5-bromo-2' -deoxyuridine (BrdU, Sigma,
St Louis, MO, 2 mg/ml in PBS) ip 12 hours before they were processed at 9 dpi
(Figure 2-2).
In a separate infection run, an additional group of 12 virus-inoculated rats
received 1 mg/kg of p55 sTNFR-IgG on the same schedule as above. These
animals were injected with BrdU 12 hours before being sacrificed at 7 dpi (n=6)
and 8 dpi (n=6). All rats were anesthetized with sodium pentobarbital
(approximately 200 pg/g body weight) and were killed by exsanguination via
intra cardiac puncture. Bronchoalveolar lavages (BAL) were performed, and the
lungs were fixed by tracheal perfusion with 4% paraformaldehyde at 30 cm H20
pressure for 2 hours.


122
= 12
0)
O
o
O 10
B.
O
CAF UV-Virus Vims
24 Hours After Inoculation
Figure 6-8: TGF-p, cytoplasmic RNA levels in NR8383 cells inoculated
with UV-inactivated and viable Sendai virus.


64
Quantitation Methods and Data Analysis
Pulmonary TNF-a mRNA levels were evaluated by comparing the relative
optical densities (ROD) of the bands on Northern autoradiographs.
Comparisons of TNF-a bands detected in pulmonary RNA were only made
between bands in RNA run on the same gel. RODS of the bands were
expressed as percentages of the band density of a positive standard (30 pg of
pooled pulmonary poly-A mRNA from Sendai virus-inoculated BN rats harvested
at 7 dpi) run on each gel. The density of cells expressing TNF-a protein was
assessed by counting and classifying the number of labeled cells per millimeter
of bronchiolar basement membrane in 25 high power (400X) fields per slide.
Round cells with central round to ovoid nuclei and abundant cytoplasm were
counted as macrophages, cells with elongated ovoid nuclei and spindle-shaped
cytoplasm were counted as fibroblasts, and culsters of round cells with central
round nuclei and sparse cytoplasm were identified as lymphocytes. Labeled
macrophages in the bronchiolar wall and immediately adjacent alveolar spaces
and labeled fibroblasts in the bronchiolar wall were counted in the same
microscopic field. Three slides from each of 4 animals per group were counted.
Statistical analysis of group means was performed using ANOVA and Tukey's
HSD multiple comparison procedure143 in a computer-based statistical program
(Systat version 4).


61
Northern Analysis
Lung tissue was lysed in guanidine thiocyanate, and total RNA extracted and
precipitated as described.139 Twenty micrograms (pg) of total RNA from each
lung was electrophorectially fractionated on a series of 1.2% (wt:vol) agarose
gels containing 6% (vol:vol) formaldehyde, transferred to a positively charged
nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN), and
fixed by UV-crosslinking. Equality of RNA loading between lanes was assessed
by visually comparing the intensity of ethidium bromide staining of ribosomal
RNA bands in the gels and membranes. A cDNA probe for rat TNF-a (supplied
by Dr. T. Shirai, Laboratory for Chemical Research, Asahi Chemical Industry Co.
Ltd, Tagata-gun, Shizuoka, Japan) was labeled with 32P-dCTP using the random
primer method as described.140 Prehybridization (15 min, 58C) and
hybridization (overnight, 58C) was in 0.5 M Na2HP04, 7% SDS, 1% BSA, and
10mM EDTA as described.141 The membranes were washed at the hybridization
temperature in 40mM phosphate, 1% SDS, and exposed to Kodak (Rochester,
NY) XLS-5 film with Dupont Cronex intensifying screens. Film band densities
were quantified using a computerized video image analysis unit (Microcomputer
Imaging Device, Imaging Research Inc., St Catharines, Ontario).


induced it. The same study also demonstrated that the increase in neutrophil
numbers observed after the administration of endotoxin was partially inhibited by
antibodies to TNF-a.110 Treatment with antibodies to TNF-a was also used In a
mouse model of hypersensitivity pneumonitis induced by intranasal inoculation
with the actinomycete Faenia rectiviroula (farmer's lung).116 Such treatment
blocked inflammatory cell recruitment to the lungs, completely abolished TNF-a
secretion by bronchiolar associated lymphoid tissue, and prevented the
development of fibrosis.116 At the cellular level, in vitro studies have
demonstrated the production of TNF-a in pulmonary mast cells, alveolar
macrophages, and bronchiolar epithelial cells in lung fragments following IgE
receptor triggering.117
Several studies have indicated the importance of TNF-a in fibrotic pulmonary
disorders. For example, significant increases in TNF-a mRNA have been
observed in the lungs of treated mice susceptible to bleomycin induced
pulmonary fibrosis, but not in the lungs of treated non-responder mice.109 In rats,
the importance of bleomycin-induced increases in the pulmonary expression of
TNF-a was further emphasized by the finding that the development of fibrosis
could be blocked by the administration of antibodies to TNF-a.116 In bleomycin-
induced pulmonary fibrosis there is a strong correlation between collagen
deposition and platelet trapping, which is probably due to the fact that platelets
are rich sources of fibrogenic mediators such as TGF-p and PDGF. TNF-a may
contribute to bleomycin-induced pulmonary fibrosis through platelet trapping by


BIOGRAPHICAL SKETCH
I was born on February 22, 1957, to Charles Harrison and Natalie Whitford
Uhl, and named Elizabeth Whitford Uhl. Both of my parents are botanists and
Cornell professors, which inspired me with a love of science, and a special
interest in animals that eat plants, particularly horses. I was born and raised in
Ithaca, New York, and was the youngest of four children. Every summer of my
childhood was spend on plant collecting trips throughout Canada, Mexico, and
the United States. I received my B.S. for Cornell University, and went to New
York City to work as a research assistant in the Arrhythmia Control Unit at
Columbia-Presbyterian Medical Center. From there I went back to Ithaca to
attend veterinary school, where I became interested in pathology. To pursue
this interest, I came to University of Florida to take a residency in anatomic
pathology. Upon completion of the residency, I entered the graduate program.
152


69
observed in infected rats. Direct upregulation of TNF-a gene transcription and
translation by Sendai virus infection could also account for some of the
differences in the pathologic responses of BN and F344 rats. Viral replication
persists for several days longer in the lungs of weanling BN rats than in those of
F344 rats.37 Persisting viral replication could be an important stimulus for
prolonged cytokine expression and result in airway fibrosis in BN rats.
The mechanism by which TNF-a contributes to the development of
pulmonary fibrosis is not completely understood. TNF-a can upregulate the
Inflammatory response through its ability to activate macrophages, stimulate
lymphocyte proliferation, and increase the adhesion of both neutrophils and
eosinophils.47 '48 It has also been shown to induce necrosis of alveolar
epithelial and endothelial cells when given intravenously.19,149 Both of these
effects contribute to the development of fibrosis by increasing the extent of
tissue damage. In addition, TNF-a can directly stimulate fibroblast proliferation
and collagen deposition, and induce the expression of other fibrogenic cytokines
such as PDGF.'30
Recently, it has been found that pulmonary platelet trapping strongly
correlates with collagen deposition in bleomycin-induced pulmonary fibrosis.9
The same study also found that antibodies to TNF-a, as well as other treatments


148
140. Farmer SJ, Fliss AE, Simmen RCM. 1990. Complementary DNA cloning
and regulation of expression of the messenger RNA encoding a
pregnancy-associated porcine uterine protein related to human
antileukoproteinase. Molec Endocrin. 4:1095-1104.
141. Church GM, Gilbert W. 1984. Genomic sequencing. Proc Natl Acad Sci
USA. 81:1991-1995.
142. Simmons DM, Arriza JL, Swanson LW. 1984. A complete protocol for in
situ hybridization of messenger RNAs in brain and other tissues with
radio-labeled single stranded RNA probes. J Histotechnol. 12:169-181.
143. Zar JH: Biostatistical Analysis, 2nd ed. 1984. Englewood Cliffs, NJ,
Prentice Hall. pp. 130-131.
144. Sprenger H, Bacher M, Rischkowsky E, Bender A, Nain M, Gemsa D.
1994. Characterization of a high molecular weight tumor necrosis factor-a
mRNA in influenza A virus-infected macrophages. J Immunol. 152:280-
289.
145. Smith PD, Saini S, Raffeld S, Manischewitz JF, Wahl SM.1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest 90:1642-1648.
146. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M,
Gemsa D.1991. Influenza A virus infection of macrophages: enhanced
tumor necrosis factor-a (TGF-a) gene expression and
lipopolysaccharide-triggered TNF-a release. J Immunol 147:3507-3513.
147. Hajjar KA, Hajjar DP, Silversteln RL, Nachman RL. 1987. Tumor
necrosis factor-mediated release of platelet-derived growth factor from
cultured endothelial cells. J Exp Med. 166:235.
148. Sugarman BJ, Aggarwal BB, Figari IS, Palladino MA. 1985.
Recombinant human tumor necrosis factor-a: effects on proliferation of
normal and transformed cells in vitro. Science (Wash. DC). 230:943.
149. Tracy KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo
GC, Beutler B, Cotran RS, Cerami A, Lowry SF. 1988.
Cachectin/tumor necrosis factor induces cachexia, anemia, and
inflammation. J Exp Med 167:1211.


Days After Inoculation
Figure 5-8: Pulmonary viral titers of infected control and p55sTNFR-
IgG-treated rats.


Figure 4-6: Density of bronchiolar fibroblasts expressing TNF-a
protein. Data points represent group mean + SEM (n=4).


17
enhances the inflammatory phase by: increasing the directed migration of
macrophages, inhibiting natural killer cell activity,133 and stimulating T
lymphocytes to secrete IL-1, while decreasing their secretion of IL-4, IL-5, and
interferon.134 In the repair phase of tissue injury, PDGF triggers an earlier, more
sustained influx of procollagen type I fibroblasts than that produced by TGF-IJ.52
PDGF-BB has also been found to activate eosinophils, and has been speculated
to play a role in the pathogenesis of asthma.135
Clinical and experimental evidence of the importance of PDGF in the
pathogenesis of pulmonary fibrosis consists of investigations of its role in
idiopathic and chemically-induced pulmonary fibrosis.136,137,53 Patients with
idiopathic pulmonary fibrosis (IPF) were demonstrated to have a 3-fold increase
in the percentages of interstitial macrophages expressing PDGF compared to
normal individuals.138 PDGF was also aberrantly expressed in the alveolar
epithelial cells of IPF patients.139 Pulmonary PDGF levels have also been
measured in patients with asbestosis and silicosis and those positive for PDGF
experienced progression of their disease.54 There is also evidence that
chrysotile asbestos may stimulate a PDGF-AA-mediated autocrine loop leading
to hyperplasia in rat lung fibroblasts.140
In the rat, measurement of pulmonary PDGF mRNA levels indicate that it is
constitutively expressed at a low level. However, during continuous exposure to
85% oxygen, the steady state levels of PDGF-BB mRNA rose 2.5 fold above
control levels. This increase preceded an increase in DNA synthesis and


52
Figure 3-4. TGF-IJ, protein in bronchiolar macrophages. Both micrographs are
of sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
top was incubated with 0.01 mg/ml normal chicken IgG and the bottom with 0.01
mg/ml chicken anti-human TGF-IJ, IgG (x600).


62
In Situ Hvbridization/lmmunocvtochemistrv
In situ hybridization was performed by subcloning the rat TNF-a cDNA probe
into pBluescript II KS+ (Stratagene, La Jolla, CA) as a template for the
production of digoxigenin-labeled RNA probes. Sense and antisense riboprobes
were made according to manufacturer's instructions (The Genius System,
Boehringer Mannheim, Indianapolis,IN). Lung sections were initially de-
paraffinized in xylene, re-hydrated through a graded series of ethanol washes,
and denatured in 0.2 N HCI. Prehybridization treatment consisted of: incubation
in 0.001% proteinase K (30 min, 37C), acetylation in acetic anhydride, and
dehydration in ascending concentrations of ethanol. The probe was added to
the hybridization solution (62.5% formamide, 12.5% dextran sulfate, 0.3 M NaCI,
0.025X Denhart's solution [Sigma, St. Louis, MO] 12.5 mM Tris-HCI pH 8.0, 1.25
mM EDTA pH 8.0) and denatured at 65 C for 10 minutes. Approximately 50 ng
of probe was added to each slide, coverslips were applied and the slides were
placed in a 65 C oven for 10 minutes. Hybridization was then performed at
37C overnight in a humidified chamber. The slides were washed in 2 X SSC
(10 min, 37C), 1 X SSC (10 min, 37C), and 0.1 X SSC (10 min, 37C). The
sections were blocked in 2% normal sheep sera (30 min, room temperature) and
incubated (2 hours, room temperature) with an alkaline phosphatase-conjugated
antibody to digoxigenin (Boehringer Mannheim, Indianapolis, IN). Signal was
detected using nitroblue tetrazolium (4-8 hours, room temperature) (Boehringer


112
(including a unique high molecular weight transcript) that is not translated into
protein until cells are exposed to a second stimulus, such as small amounts of
endotoxin.59'144 In contrast Sendai virus-induced TNF-a mRNA and protein
expression were comparatively increased.
The mechanisms by which viral infections elicit TNF-a gene expression are
not completely understood, but several appear to involve the release of the
transcription factor NF-kB from its inhibitory subunit IkB.173-176 NF-kB initiates
the transcription of numerous genes including those encoding TNF-a, TNF-p,
interleukin 1 (IL-1), IL-2, IL-6 and granulocyte macrophage colony stimulating
factor (GM-CSF).173,174 Activation of NF-kB occurs when it is released from its
inhibitory subunit IkB and is translocated to the nucleus.143 Sendai virus
infection has been associated with decreases in the amount of IkB in
cytoplasmic extracts of infected human renal carcinoma cells,177 and with
increased binding of NF-kB to DNA.176 However, the virus-induced decreases in
IkB levels only lasted from 2-8 hours after infection,175 while in this study TNF-a
mRNA and protein levels were increased out to at least 72 hours after
inoculation. This prolonged increase in gene expression may be related to the
peak in viral replication at 48 hours after inoculation, or may be due to continued
stimulation of TNF-a transcription by either TNF-a itself or some other virus-
induced mediator (ie: IL-1).111
Inoculation of macrophages with UV-inactivated virus did not stimulate the
production of TNF-a mRNA, indicating that infectious virus is necessary for the


54
Figure 3-6: Density of bronchiolar mural fibroblasts expressing TGF-p,
protein. Data points represent mean + SEM (n=4).


25
(3 dpi) than is TGF-p, mRNA, 3) Inhibition of TNF-a has been more effective in
blocking the development of chemically-induced pulmonary fibrosis. The basic
plan was to treat infected BN rats with a 55 kD soluble TNF-a receptor
immunoglobulin G fusion protein (p55 sTNFR-IgG), a treatment which has been
used to successfully block TNF-a activity in animal models of gram-negative
sepsis, and to assess the amount of fibroblast proliferation present at 10 dpi by
counting BrdU labeled fibroblasts.
Design and Methods
Experimental Design. One group of eighteen 25-day-old, male BN rats
were infected with Sendai virus, while a second group of 12 were sham-
inoculated with CAF (see Figure 2 -2). Six rats from the control and 9 from the
virus-inoculated rats were injected intraperitoneally (ip) with 10 mg/kg of p55
sTNFR-IgG 1 fusion protein on days 0, 2, 4, 6, & 8 days post inoculation (dpi).
The remaining rats were injected ip with an equivalent volume of human IgG
according to the same schedule. At 7dpi, bronchoalveolar lavage fluid (BAL)
was taken from 3 of the virus-inoculated, p55 sTNFR-lgG1 fusion protein-treated
rats, and 3 of the virus-inoculated, human IgG treated animals. The TNF-a
protein content of this fluid was determined using a mouse TNF-a ELISA kit and
by bioassay. On day 9 post inoculation, 6 rats from each of the four groups were
given 200 pg/g 5-bromo-2' -deoxyuridine (BrdU, 2 mg/ml in PBS) ip 12 hours
before they were sacrificed at 10 dpi.


109
Results
NR8383 Cells Support Sendai Virus Replication
Plaque assays confirmed that NR8383 cells could support Sendai virus
replication (Figure 6-1). The highest titers of infectious virus at both MOI=1:1
and 1:10, were present in cell supernatants at 48 hours after virus-inoculation.
Sendai virus-inoculated NR8383 cells were also positive for viral antigens by
immunocytochemical staining (data not shown).
Sendai Virus-Inoculation Induces Increased TNF-a RNA and Protein Levels in
NR8383 Cells
TNF-a mRNA was initially detected in virus-inoculated NR8383 cells at 4 and
8 hours after virus inoculation, and was significantly elevated at 24, 48 and 72
hours after virus inoculation (p<0.05, Figure 6-2). TNF-a mRNA was not
detected in CAF-treated cells at any of the time points studied. There were no
significant differences in the mean relative optical band densities for p-actin
between CAF and virus-inoculated groups (Figure 6-7). The amount of TNF-a
protein in the cell supernatants was significantly elevated in the virus-inoculated
cells 24 hours after inoculation, and was further increased 48 and 72 hours after


96
Sham Virus: 7 dpi Virus: 9 dpi
Figure 5-3: TNF-a bioactivity in BAL fluid samples from sham- and
virus-inoculated groups treated with 10 mg/kg IgG or 10 mg/kg
p55sTNFR-lgG (n=4 or 6 for the IgG-treated infected and the sham-
inoculated groups; n=3 for the p55sTNFR-lgG-treated infected group).


35
inoculation (p<0.001). BN rats had over two-fold greater increases than F344
rats (p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-B, mRNA
remained elevated In BN rats, but not in F344 rats (p<0.001). TGF-IJ, mRNA
was identified by in situ hybridization in bronchiolar mural macrophages and
fibroblasts. Seven days after inoculation, BN rats had over two-fold greater
numbers of bronchiolar mural macrophages positive for TGF-S, mRNA than did
control BN rats (p<0.05). Pulmonary TGF-B, protein expression was assessed
by immunocytochemistry at 3, 7, 10, 14, and 30 days after inoculation. BN rats
had over a two-fold increase in numbers of bronchiolar macrophages expressing
TGF-B, protein at 7 days after inoculation as compared to both sham-inoculated
BN and virus-inoculated F344 rats (p<0.0001). At 10 days after inoculation,
virus-inoculated BN rats had three-fold increases in numbers of bronchiolar
macrophages and fibroblasts expressing TGF-B, protein as compared to the
control animals (p<0.0001). We conclude that virus-induced bronchiolar TGF-B,
gene expression precedes bronchiolar mural fibrosis and may play an important
pathogenetic role in virus-induced bronchiolar fibrosis and airway function
abnormalities.
Introduction
Clinical and epidemiological studies have linked severe viral bronchiolitis
during infancy with subsequent long-term pulmonary function abnormalities


70
mediate the development of fibrosis.119 The importance of platelet trapping in
the pathogenesis of Sendai virus-induced bronchiolar fibrosis is uncertain.
Elevations in pulmonary TGF-P mRNA and protein expression were found in the
infected susceptible BN rats, but the increases were associated with the peak
macrophage infiltration at 7 days after inoculation, and pulmonary PDGF mRNA
levels were not increased by viral infection.
The results of this study demonstrate that virus-induced bronchiolar TNF-a
gene expression precedes bronchiolar mural fibrosis and suggest that it may
play an important pathogenetic role in bronchiolar fibrosis and the associated
airway function abnormalities.


128
demonstrate that Sendai virus can directly upregulate TNF-a expression, and
that TNF-a is critical to the immune/inflammatory response to the virus.


THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
By
ELIZABETH WHITFORD UHL
A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL
OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
UNIVERSITY OF FLORIDA
1996


23
Northern analysis. Lung tissue was lysed in guanidium thiocyanate, and
total RNA extracted and precipitated.139 Preliminary Northerns for TGF-p,, TNF-
a, and PDGF were performed on poly (A) RNA pooled from 3-5 animals per
group. Virus-induced increases in pulmonary TGF-p, and TNF-a RNA were
present (data not shown), but pulmonary PDGF RNA levels were not increased
in the virus-inoculated rats of either strain (see Figure 2-1). Northern analysis for
TGF-p, and TNF-a RNA was performed on total RNA extracted from the lungs of
individual animals.
In Silu hybridization. The TGF-P, and TNF-a cDNA probes used above
were subcloned and used as templates for the production of the RNA probes.
Digoxigenin- (TNF-a) and 35S-(TGF-P,) labeled antisense riboprobes were made
and used to qualitatively determine which bronchiolar cell types were expressing
cytokine mRNA in lung sections taken from virus- or sham-inoculated rats.
Control sections were incubated with labeled sense riboprobes.
Immunohistochemistrv. Antibodies against TGF-I3, and TNF-a were used
to detect bronchiolar cell expression of cytokine protein using
immunocytochemical techniques. The labeled bronchiolar macrophages and
fibroblasts were quantitated and the numbers of cells positive for cytokine
protein were compared between treatment groups.
Data analysis. Comparisons of pulmonary cytokine mRNA levels between
BN and F344 rat strains pre- and postinfection, were made by comparing the
relative optical densities (ROD) of the bands on the Northern autoradiographs.


84
rinsed in PBS, covered with antibody diluent (1.0% BSA and 0.5% Tween 20 in
PBS) for 30 min to block nonspecific binding, blotted and incubated for 1 hour in
mouse anti-BrdU monoclonal antibody (Becton-Dickinson, Mountain View, CA)
diluted 1:100 in antibody diluent. Sections were washed and covered with
peroxidase-conjugated goat anti-mouse IgG (Fc specific, Sigma, St Louis, MO)
diluted 1:100 in antibody diluent for 1 hour. Bound peroxidase-conjugated
antibody was detected by development in the chromogen diaminobenzidine
(Sigma, St. Louis, MO) in 0.25 mg/ml in 0.025 M Tris, pH 7.6 and 0.01% H202 for
20 min. The slides were counter-stained with hematoxylin and eosin.
Virology
Following bronchoalveolar lavage, the right lungs of virus-inoculated rats
treated with 1 mg/kg of p55 sTNFR-IgG were collected aseptically, frozen in
liquid nitrogen, and stored at -80 C until viral assays were run. Plaque assays
for infectious virus were performed on lung homogenates using Madin-Darby
bovine kidney cells as previously described.32 The presence of viral antigens in
paraffin-embedded lung sections from infected p55sTNFR-lgG-treated rats was
detected by immunocytochemistry. Tissue sections were pretreated as
described above for the detection of BrdU, and incubated with a mouse
monoclonal antibody to parainfluenza type 1 virus (Chemicon, Temecula, CA).
Application of peroxidase-conjugated Cappel goat anti-mouse antibody and the


Days After Inoculation
Figure 4-5: Density of bronchiolar mural macrophages expressing
TNF-a protein. Data points represent group mean + SEM (n=4).


CHAPTER 5
FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF SENDAI VIRUS-
INDUCED BRONCHIOLAR FIBROSIS IN BN RATS IS INHIBITED BY A
SOLUBLE TNF RECEPTOR
Summary
Sendai virus infection in virus-susceptible BN rats induces bronchiolar
fibrosis associated with airway hyperresponsiveness and persistent increases in
airway resistance. This study investigated the significance of TNF-a in the
pathogenesis of Sendai virus-induced bronchiolar fibrosis by determining
whether the numbers of proliferating bronchiolar fibroblasts induced by virus
infection could be reduced by inhibition of TNF-a bioactivity. Virus-susceptible
BN rats were treated with a 55 kD soluble TNF receptor-immunoglobulin G
fusion protein (p55sTNFR-lgG) following either sham- or virus-inoculation.
Control sham- and virus-inoculated animals were treated with human IgG.
Proliferating bronchiolar fibroblasts were labeled with bromodeoxyuridine
(BrdU), detected by immunocytochemical staining and quantitated. At 8 to 9
days after virus-inoculation, rats treated with p55sTNFR-lgG had decreased
numbers of bronchiolar fibroblasts incorporating BrdU compared to virus-
77


at 24, 48, and 72 hours after virus-inoculation (p<0.05). Cells incubated with
UV-inactivated virus and virus-inoculated cells incubated with actinomycin-D
also did not have any detectable TNF-a mRNA (p<0.05) 24 hours after
103
inoculation. TGF-p, mRNA was present in the sham-inoculated cells. The level
of expression was increased in the virus-inoculated cells at 72 hours after
inoculation (p< 0.05). TGF-p, protein levels were not significantly elevated over
those of the controls at 48 or 72 hours after virus-inoculation. In conclusion,
Sendai virus can directly upregulate TNF-a mRNA and protein expression in rat
alveolar macrophages by a mechanism that requires infectious virus. The virus-
induced upregulation of pulmonary TGF-p, mRNA and protein expression may
be mediated by indirect mechanisms.
Introduction
Parainfluenza type I (Sendai) virus infection in rats is an animal model of
virus-induced airway abnormalities including persistent increases in airway
resistance and airway hyperresponsiveness.18'33'36-38 Previous studies have
associated the development of virus-induced bronchiolar fibrosis in susceptible
Brown Norway (BN) rats with increased expression of TNF-a and TGF-p, in
bronchiolar macrophages, and have established TNF-a as an important
mediator of bronchiolar fibrosis (see Chapters 3, 4, & 5). Expression of TNF-a
and TGF-p is induced by a variety of stimuli, and is controlled by a complex


65
Results
Sendai virus infection causes an increase in total lung levels of TNF-a mRNA
TNF-a transcripts were not detected in pulmonary mRNA extracted from
sham-inoculated animals. Viral infection resulted in increased total lung levels
of TNF-a mRNA in both rat strains at 3, 7, and 10 days after inoculation
(p<0.01). Pulmonary TNF-a mRNA levels peaked at 3 dpi in the F344 rats and
at 7 dpi in the BN rats. Virus-susceptible BN rats still had increased levels of
TNF-a mRNA in their lungs 14 days after inoculation (p<0.01), while in the virus-
resistant F344 rats levels were not significantly above those of the sham-
inoculated rats. Pulmonary TNF-a mRNA levels in the BN rats did not return to
baseline levels until 30 days after inoculation (Figures 4-1 & 4-2).
Identification of pulmonary cell types expressing TNF-g mRNA and protein
In situ hybridization identified macrophages and fibroblasts as the main
bronchiolar cells expressing TNF-a mRNA in infected BN rats (Figure 4-3).
Epithelial cells and occasional scattered aggregates of lymphocytes around
bronchi (BALT) were also labeled in sections hybridized with the anti-sense
TNF-a riboprobe.


3
Most of these inflammatory cells were macrophages, which have the capacity to
release a vast array of inflammatory mediators and cytokines including
leukotrienes, thromboxanes, platelet activating factor, tumor necrosis factor-a
(TNF-a), interleukin-2 (IL-2), and prostaglandin F2a that can modulate airway
smooth muscle contraction, affect mucus secretion and alter vascular
permeability.19,20'21
Viral infections may also induce abnormalities in pulmonary structure. Airway
wall thickening with fibrosis is a common lesion in asthmatics that can contribute
to the development of increased airway resistance by altering the mechanical
properties of airways.22'24 Viral infections may enhance the development of
airway fibrosis by causing epithelial necrosis, which leads to the build up of
necrotic debris, inflammatory cells, mucus, and plasma exudate in airways.
Subsequent organization of this material leads to the deposition of fibrous
connective tissue and can result in irreversible peripheral airway loss and airway
obstruction. The stimulation of aberrant or exuberant repair processes following
viral infection may also result in mural fibrosis, which can be significant even if
airways are not completely occluded, since the deposition of connective tissue in
airway walls dramatically affects the degree of luminal narrowing during smooth
muscle contraction.24
The development of persistent pulmonary functional abnormalities associated
with viral respiratory infections is dependent upon a complex interplay of
mechanisms that include IgE-dependent reactions, enhanced inflammation,


92
infection.159,160,166 In addition, several viruses produce virulence factors that
specifically inhibit TNF-a.163-165 For example, adenoviruses inhibit the action of
TNF by blocking signal transduction from its receptor163 while several pox
viruses contain genes that encode a soluble TNF receptor similar to the one
used in this study.164 TNF-a is also able to activate macrophages independent
of T and B cells in murine cytomegalovirus and herpes simplex virus
infections.162
The importance of TNF-a in the inflammatory response to Sendai virus
infection is indicated by the high mortality in the virus-inoculated, p55sTNFR-
IgG-treated rats. The increased mortality was associated with significant
reductions in the numbers of macrophages and lymphocytes in the BAL fluid, the
tendency towards higher pulmonary viral titers and the presence of numerous
hyperplastic epithelial cells that were positive for viral antigens. These findings
suggest that inhibition of TNF-a activity decreased the inflammatory cell
response to the virus, prevented the destruction of infected epithelial cells and
allowed prolonged viral replication. Paradoxically, however, BN rats have
prolonged elevations of pulmonary TNF-a expression but also higher pulmonary
viral titers compared to Fischer 344 rats, which are resistant to virus-induced
airway abnormalities.37 These observations suggest that TNF-a may be
protective early in the course of Sendai virus infection, while prolonged
expression may be harmful.
There is evidence that the role of TNF-a in T-cel I-mediated inflammation is


130
3) Incubate lysed cells on ice for 5 min, centrifuge 5 min at 500xg, 4C, and
save supernatant for step 5.
4) Resuspend nuclear pellet (step 3) in 4 ml NP-40 lysis buffer by vortexing
as described in step 2. Centrifuge 5 min at 500 xg, 4C. Resuspend pellet
in 100 to 200 pi glycerol storage buffer by gently vortexing. Freeze nuclei
in liquid nitrogen (stable for >1 year).
5) Add 2 ml of TRIzol reagent to the supernatant saved in step 3, mix well,
and incubate at RT for 5 min.
6) Add 0.4 ml of chloroform, mix for 15 sec and incubate at RT for 2-3 min.
Centrifuge the samples at no more than 12,000 x g for 15 min at 4 C.
7) Remove colorless upper phase to a fresh 15 ml tube. Add 1 ml isopropyl
alcohol, mix well, and percipitate over night at -80 C.
8) Pellet RNA at 1800 rpm, 30 min, 4 C. Wash in 70% EtOH.
9) Remove EtOH, and allow pellet to dry briefly (do not let the pellet
completely dry out, or it will be hard to get it back into solution). Dissolve
RNA in 100-200 pi autoclaved, millique H20.
Nuclear Run On Transcription Assay
1) Thaw 200 pi frozen nuclei at room temperature and transfer to a 15 ml
polypropylene tube. Immediately add 200 pi of 2 x reaction buffer (250 ml 2
x buffer + 2-20 pi NTP labeling mixture vial 7, Genius 4). React 30 min at
37C with shaking.


48
fibronectin mRNA,71 and inhibits the degradation of existing extracellular
matrix.71 Studies of naturally occurring and chemically-induced fibrotic lung
lesions indicate that TGF-IJ, is an important mediator of pulmonary fibrosis.40,138,
4, 109.85,m |n t^js stUCjy the prolonged upregulation of TGF-IJ, in the susceptible
rats implies that such increases may also be important in the regulation of virus-
induced bronchiolar fibrosis and airway function abnormalities.
In addition to its regulatory effects on repair and fibrosis, TGF-IJ, can
suppress both T- and B-lymphocytes, decrease cytotoxic and lymphokine-
activated killer cell production, and down-regulate macrophage activity.92-95 In
several models of infectious disease, these immunosuppressive effects have
resulted in direct correlations between the level of TGF-IJ, expression, the
prolonged survival of infectious agents and the extent of tissue damage.92'95,102'
103 It is reasonable to speculate that prolonged and excessive TGF-P,
expression in infected BN rats may be contributing to less effective immunity and
to virus-induced tissue damage and abnormal repair marked by fibrosis.
In conclusion, the results of this study demonstrate that virus-induced
bronchiolar TGF-IJ, gene expression precedes bronchiolar mural fibrosis and
suggest that it may play an important pathogenetic role in virus-induced
bronchiolar fibrosis and airway function abnormalities.


56
and protein by in situ hybridization and immunocytochemistry. Macrophage
expression of TNF-a protein peaked at 7 days after inoculation in both rat
strains (p<0.0001). Virus-inoculated BN rats had almost twice the density of
TNF-a-positive macrophages in their bronchiolar walls as infected F344 rats
(p<0.0001). The number of macrophages positive for TNF-a protein remained
significantly elevated in infected BN rats at 10 dpi (p<0.05). Over two-fold
increases in the number of labeled bronchiolar fibroblasts were observed in
infected rats of both strains at 7 dpi (p<0.001) compared to the control rats. At
10 dpi the mean number of fibroblasts positive for TNF-a protein had increased
to over 5-fold that of the control in the infected BN rats (pO.0001), but was not
significantly elevated in the infected F344 rats. The data suggest that increased
TNF-a gene expression may be important in the pathogenesis of virus-induced
bronchiolar fibrosis.
Introduction
Viral bronchiolitis in early childhood has been linked with persisting
pulmonary functional abnormalities including increased airway resistance and
airway hyperresponsiveness and has been identified as a risk factor for the
development of asthma.2-6 The development of asthma-like symptoms following
viral infection appears to be associated with an aberrant, IgE-dominated


Figure 3-1. Northern blot of rat pulmonary total RNA hybridized with a 32P-labeled cDNA probe for rat TGF-
B,. This blot was performed on pulmonary RNA extracted from sham-inoculated F344 rats at 7 days after
inoculation, and from virus-inoculated F344 rats at 3 & 7 days after inoculation. Each lane was loaded with
20 pg of RNA from an individual animal. The lower panel shows equality of RNA loading on the ethidium
bromide-stained gel.
-P*
VO


68
The results of this study imply that TNF-a is also important in the
pathogenesis of virus-induced airway fibrosis. However, the mechanism of the
increased gene expression is unclear. The initial increase in the amount of
TNF-a mRNA present In whole lung homogenates was observed at 3 days after
inoculation, while Increases in the numbers of cells (mostly macrophages and
fibroblasts) expressing cytoplasmic protein were not noted until 7-10 days post
inoculation. This finding indicates that not all of the increased expression was
the result of the inflammatory cell Infllltrate, especially since macrophages do not
Infiltrate until 4-5 days after virus-inoculation.37 Epithelial cells and and
lymphocytes In the airway associated lymphoid tissue (BALT) were also positive
for TNF-a mRNA and protein and are the most likely sources of the initial
increase in TNF-a mRNA levels observed in the whole lung homogenates.
Epithelial cells are also the first cells infected by Sendai virus, and the induction
of TNF-a expression may be a direct effect of infection.
Several viruses can directly increase TNF-a mRNA and protein expression.57'
111,112,145,146 |nf|uenza a virus infection of murine macrophages results in a
massive accumulation of TNF-a mRNA, including a unique high molecular
weight transcript that is not translated into protein until the cells are exposed to a
secondary trigger, such as small amounts of endotoxin.143 Although unique
species of TNF-a mRNA were not observed In this study, Sendai virus has been
found to stimulate TNF-a protein production In monocytes57 and direct
upregulation of TNF-a transcription may contribute to the increased expression


47
Transcriptional upregulation of TGF-IJ, gene expression could be a direct
result of viral infection. The ability of viruses to directly increase expression of
inflammatory cytokines is considered to be an important mechanism in the
pathogenesis of several viral diseases.105,57 In acquired immunodeficiency
syndrome (AIDS), a viral protein (tat) appears to directly upregulate the
production of TGF-IJ.105 More complex viral effects on host cell gene regulation
are also recognized. Influenza A virus infection of murine macrophages not only
increases transcription of tumor necrosis factor-a (TNF-a), but also induces the
production of a unique TNF-a transcript.144 Sendai virus infection of cultured
macrophages has been shown to directly stimulate the production of TNF-a.57 In
Sendai virus infected rats, pulmonary viral titers peak around 5 days after
inoculation,38 before the peak expression of TGF-IJ at 7 days after inoculation.
Direct upregulation of TGF-P, gene transcription and protein synthesis by
Sendai virus infection could explain some of the differences in the pathologic
response of BN and F344 rats to viral infection. Pulmonary Sendai viral
replication persists for several days longer in weanling BN rats than in F344
rats.37 Persisting viral replication could be an important stimulus of persisting
cytokine expression and more severe fibrosis in BN rats.
TGF-IJ, is a major regulator of fibrosis and other tissue repair mechanisms. It
contributes to increasing tissue levels of collagen and other matrix proteins by
several mechanisms. TGF-IJ, increases transcription of fibronectin and
procollagen genes69, post-transcriptionally regulates fibroblast, collagen and


89
of the six virus-inoculated rats given 1 mg/kg p55sTNF-lgG also died 8-9 days
after virus-inoculation. Three rats from these two groups (one received 10
mg/kg, two were treated with 1 mg/kg) were labeled with BrdU. Unexpected
mortality did not occur in the other experimental groups. Compared to virus-
inoculated control animals, many of the airways in the virus-inoculated
p55sTNFR-lgG-treated rats were characterized by hyperplastic bronchiolar and
alveolar epithelial cells, which were heavily labeled in the BrdU-stained sections.
Virus-inoculated p55sTNFR-lgG rats also had subjectively fewer inflammatory
cells with proportionally fewer lymphocytes than the virus-inoculated controls.
Viral antigens were detected in the hyperplastic epithelial cells using
immunocytochemistry.
Pulmonary Viral Titers
The virus-inoculated rats treated with 1 mg/kg of p55sTNFR-lgG had mean
pulmonary viral titers that were 5-fold higher at both 7 and 9 dpi than those of
comparable groups of untreated virus-inoculated rats (Figure 5-8), however the
increase did not reach statistical significance.
Discussion
TNF-a has been implicated as an important mediator in the pathogenesis of
the pulmonary fibrosis induced by pneumotoxins such as silica and


78
inoculated IgG-treated rats (p<0.05). There was significantly increased mortality
in p55sTNFR-lgG-treated virus-inoculated rats associated with increased viral
replication and decreased numbers of macrophages and lymphocytes (p<0.05),
in bronchioalveolar lavage fluid. In conclusion, TNF-a is an important mediator
of bronchiolar fibrosis and has a critical role in the termination of Sendai viral
replication in the lung.
Introduction
Viral bronchiolitis in early childhood is associated with the development of
chronic respiratory disease and has been identified as a risk factor for the
development of asthma.2-6 After Inoculation with parainfluenza virus type I
(Sendai), weanling rats develop persistent increases in airway resistance,
decreased dynamic compliance and airway hyperresponsiveness; and are a
useful model to determine which genetic, inflammatory and immunological
factors are important in the pathogenesis of virus-induced airway
abnormalities.18, 35-38
The development of virus-induced pulmonary function abnormalities in
rats is determined by age at Infection and genetic susceptibility.18,35-38 Neonatal
and weanling Brown Norway (BN) rats are susceptible to persistent virus-
induced alterations in pulmonary structure and function. Fischer 344 (F344) rats
are resistant.18,35-38 Bronchiolar inflammation composed of aggregates of


CHAPTER 7
GENERAL SUMMARY
The goal of this research was to identify cytokines critical to the development
of bronchiolar fibrosis following bronchiolitis induced by parainfluenza (Sendai)
virus infection during early life. The hypothesis tested was that bronchiolar
mural fibrosis following viral bronchiolitis is mediated by virus-induced increases
in transcription and/or translation of transforming growth factor-11, (TGF-3,),
platelet-derived growth factor-B (PDGF), and/or tumor necrosis factor-a (TNF-a)
in infiltrating bronchiolar macrophages. This hypothesis was tested by fulfilling 4
specific objectives.
Objective 1: Determine whether Sendai virus-induced bronchiolar fibrosis in
virus-susceptible BN rats is preceded by increased gene
expression of fibrogenic cytokines TGF-P PDGF, and/or TNF-a
in macrophages and in other bronchiolar cells.
Northern analysis and protein immunocytochemistry revealed virus-
inoculated BN rats had increases in pulmonary TGF-P, and TNF-a mRNA levels
and higher numbers of bronchiolar macrophages and fibroblasts expressing
123


121
24 Hours After Inoculation
Figure 6-7: TNF-a cytoplasmic RNA levels in NR8383 cells treated with
actinomycin-D or inoculated with UV-inactivated virus Sendai virus.


137
22. Cutz, E., H. Levison, D. M. Cooper. 1978. Ultrastructure of airways in
children with asthma. Histopathology. 2:407-421.
23. Roche, W. R., R. Beasley, J. H. Williams, S. T. Holgate. 1989.
Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:520-524.
24. Wiggs, B. R., C. Bosken, P. D. Pare, A. James, J. C. Hogg. 1992. A
model of airway narrowing in asthma and in chronic obstructive
pulmonary disease. Am Rev Respir Dis. 145:1251-1258.
25. Brownstein DG. Sendai virus. In: Bhatt PN, Jacoby RO, Morse HC, New
AE, eds. 1986. Viral and mycoplasmal infections of laboratory rodents:
effects on biomedical research. Orlando: Academic Press, pp: 37-61.
26. Boorman GA, Hickman RL, Davis GW, Rhodes LS, White NW, Griffin TA,
Mayo J, Hamm TE. 1985. Serological titers to murine viruses in 90-day
and 2-year studies. In: Hamm TE, ed. Complications of Viral and
mycoplasmal infections in rodents to toxicology and research testing.
Washington: Hemisphere. pp:11-23.
27. Casebolt DB, Lindsey JR, Cassell GH. 1988. Prevalence rates of
infectious agents among commercial breeding populations of rats and
mice. Lab Anim Sci 38:327-329.
28. Burek JD, Zurcher C, Van Nunen MCJ, Hollander CF. 1977. A naturally
occurring epizootic caused by Sendai virus in breeding and aging rodent
colonies. II. Infection in the rat. Lab Anim Sci. 27:963-971.
29. Castleman WL. 1983. Respiratory tract lesions in weanling outbred rats
infected with Sendai virus. Am J Vet Res. 44:1024-1031.
30. Castleman WL, Brundage-Anguish LJ, Kreitzer L, Neuenschwander SB
1987. Pathogenesis of bronchiolitis and pneumonia induced in neonatal
and weanling rats by parainfluenza (Sendai) virus. Am J Pathol. 129:277-
286.
31. Giddens WE, Van Hoosier GL, Garlinghouse LE. 1987. Experimental
Sendai virus infection in laboratory rats. II. Pathology and
immunocytochemistry. Lab Anim Sci. 37:442-448.
32. Castleman WL. 1984. Alterations in pulmonary ultrastructure and
morphometric parameters induced by parainfluenza (Sendai) virus in rats
during postnatal growth. Am J Pathol. 114:322-335.


51
Figure 3-3. TGF-B, mRNA in lung sections was detected by in situ hybridization.
Top panel: brightfield and darkfield micrographs from a sham-inoculated BN rat.
The bottom panel shows a bronchiole from an infected BN rat at 10 days after
inoculation. (x200).


32
18s-
, j aV
w #
- PDGF
BN F344 BN
F344
BN
7V 10V 10V 14S 14V 14S 14V
Figure 2-1: Northern analysis of PDGF pulmonary RNA levels in sham- and
virus-inoculated BN and F344 rats. Each lane was loaded with 5 pg of pooled
mRNA from sham- and virus-inoculated rats. No significant differences in band
densities were noted in either rat strain at 7, 10, or 14 days after inoculation
(F344 expression at 7 days is not shown). Based upon these results, PDGF
gene expression was not studied further.


CHAPTER 6
SENDAI VIRUS DIRECTLY UPREGULATES TUMOR NECROSIS FACTOR-a
(TNF-a), BUT NOT TRANSFORMING GROWTH FACTOR-P, (TGF-p,) GENE
EXPRESSION IN RAT ALVEOLAR MACROPHAGES
Summary
Parainfluenza virus type I (Sendai) infection in rats induces bronchiolar
fibrosis associated with persistent pulmonary functional abnormalities, and is
being studied as a model of virus-induced airway abnormalities. Rats
susceptible to Sendai virus-induced bronchiolar fibrosis (BN) have prolonged
elevations in pulmonary TNF-a and TGF-p, mRNA and increased numbers of
bronchiolar macrophages and fibroblasts expressing TNF-a and TGF-p, protein
compared to rats that are resistant (F344). The objective of this study was to
determine if at least part of the upregulation of TNF-a and TGF-p, gene
expression in macrophages observed in vivo was directly induced by viral
infection. A rat alveolar macrophage cell line (NR8383) was inoculated with
Sendai virus, and the levels of TNF-a and TGF-p, mRNA and protein were
determined at 4, 8, 24, 48, and 72 hours after virus- or sham-inoculation. TNF-a
mRNA and protein were not detected in the sham-inoculated cells, while in the
virus-inoculated cells both mRNA and protein levels were significantly elevated
102


REFERENCES
1. Bjornsdottir US, Busse WW. 1992. Respiratory infections and asthma.
The Medical Clinics of North America. 76:895-915.
2. Macek V, Sorli J, Kopriva S, Marin J. 1994. Persistent adenoviral
infection and chronic airway obstruction in children. Am J Respir Crit Care
Med. 150:7-10.
3. Sly PD, Hibbert ME. 1989. Childhood asthma following hospitalization
with acute viral bronchiolitis in infancy. Pediatr Pulmonol. 7:153-158.
4. Webb MS, Henry RL, Milner AD, Stokes GM, Swarbrick AS. 1985.
Continuing respiratory problems three and a half years after acute viral
bronchiolitis. Arch Dis Child. 60:1064-1067.
5. Tepper RS, Rosenberg D, Eigen H. 1992. Airway responsiveness in
infants following bronchiolitis. Pediatr Pulmonol. 13:6-10.
6. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Haonen M, Morgan
WJ. Group Health Medical Associates. 1995. Asthma and wheezing in the
first six years of life. New Engl J Med. 332:133-138
7. Bardin PG, Johnston SL, Pattemore PK. 1992. Viruses as precipitants of
asthma symptoms II. Physiology and mechanisms. Clin Exper Allergy.
22:809-822.
8. Hegele RG, Hayashi S, Hogg JC, Pare PD. 1995. Mechanisms of airway
narrowing and hyperresponsiveness in viral respiratory tract infections.
Am J Respir Crit Care Med. 151:1659-1665.
9. Welliver RC, Sun M, Rinaldo D, Ogra PL. 1986. Predictive value of
respiratory syncytial virus-specific IgE responses for recurrent wheezing
following bronchiolitis. J Pediatr. 109:776-780.
10. Volovitz B, Welliver RC, de Castro G, Krystofik DA, Ogra PL 1988. The
release of leukotrienes in the respiratory tract during infection with
135


138
33. Castleman WL, Sorkness RL, Lemanske RF, Grasee G, Suyemoto MM.
1988. Neonatal bronchiolitis and pneumonia induces bronchiolar
hypoplasia and alveolar dysplasia in rats. Lab Invest. 59:387-396.
34. Castleman WL. 1990. Effects of neonatal viral bronchiolitis on airway
development In rats. Seminars in Respiratory Medicine. 11:314-320.
35. Sorden SD, Castleman WL: Virus-induced increases in airway mast cells
in Brown Norway rats are associated with enhanced pulmonary viral
replication and persisting lymphocytic infiltration. Exp Lung Res 1995,
21:197-213
36. Sorkness RL, Lemanske RF, Castleman WL. 1991.Persistent airway
hyperresponsiveness following neonatal viral bronchiolitis in rats. J Appl
Physiol. 70:375-383.
37. Sorden SD, Castleman WL. 1991. Brown Norway rats are high
responders to bronchiolitis, pneumonia, and bronchiolar mastocytosis
induced by parainfluenza virus. Exper Lung Research. 17:1025-1045.
38. Uhl, EW, WL Castleman, RL Sorkness, WW Busse, RF Lemanske, Jr.,
PK McAllister. Viral bronchiolitis in young BN rats induces persistent
airway dysfunction associated with bronchiolar fibrosis, persistent
inflammatory cell inflitration, and Increased transforming growth factor E,
(TGF-E,) expression. Amer J Resp Crit Care Med, In press.
39. Goldstein RH. 1991. Control of type I Collagen formation in the lung. Am
J Physiol. 261 :L29-L40.
40. Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am J Physiol
259:L159-L181.
41 Burkhardt A, Cottier H. 1989. Cellular events in alveolitis and the
evolution of pulmonary fibrosis. Virchows Arch B Cell Pathol Incl Mol
Pathol. 58:1-13.
42. Jetten AM. 1991. Growth and differentiation factors in tracheobronchial
epithelium. Am J Physiol. 260:L361-L373.
43. King RJ, Jones MB, Minoo P. 1989. Regulation of lung cell proliferation
by polypeptide growth factors. Am J Physiol. 257:L23-L38.
44. Kelly J. 1990. Cytokines of the lung. Am Rev Respir Dis. 141:765-788.


ACKNOWLEDGMENTS
I cannot begin to thank my family for their support: my parents for their
example and their encouragement, my sisters, Jean and Mary, and brother
Charlie, for never letting me feel too sorry for myself when going got tough, and
especially my husband Frank for his unfailing support and for covering for the
many times I was not there. Special thanks go to William Castleman for giving
me the opportunity to do the work, and for setting and maintaining high
standards. I thank my the members of my commitee Claus Buergelt, Mary
Brown, Anthony Barbet and especially Rosalia Simmen for their interest and
assistance. I would also like to acknowledge Lyle Moldawer for providing the
TNF receptor fusion protein and for his enthusiasm. Roberta O'Connor, Karen
Dukes, Allison Mays, Christine Klein and especially Tracy Jack provided both
help with the laboratory work and friendship, without which this project would
have been much more difficult.
n


27
Experiment 3: Assessing the ability of Sendai virus to induce increased cytokine
gene expression.
Objectives
The original objectives for experiment 3 were as follows:
1) To determine whether Sendai virus induces TGF-fl,, TNF-a, and/or PDGF
gene transcription and translation in pulmonary macrophages isolated from
BN rats and whether the induction of cytokine gene transcription is
dependent on protein synthesis, and/or is associated with an increase in
the stability of cytokine mRNA.
2) To determine if pulmonary macrophages isolated from F344 rats have the
same Sendai virus-induced pattern of cytokine expression as BN rats.
Because of the high number of animals required to obtain adequate cell
numbers for these experiments, and the fact that PDGF mRNA levels were not
elevated in the virus-inoculated rats, the objectives were revised:
1) Determine whether Sendai virus directly or indirectly induces gene
expression for TGF-p, and TNF-a in a rat alveolar macrophage cell line
NR8383 by: comparing cytokine mRNA and protein levels in virus infected
NR8383 cells with those incubated with chorioallantoic fluid (CAF).
2) Determine whether live virus is required for any increase in TGF-p, and
TNF-a gene expression observed in virus-inoculated cells.


28
3) Determine whether there is an increase in the stability of cytokine mRNA in
NR8383 cells associated with Sendai virus infection.
Rationale:
Several viruses, including Sendai virus, have been shown to directly
upregulate the production of cytokines.127,131,73,74 Macrophages are major
sources for TGF-B, and TNF-a, and can be infected with Sendai virus. Nuclear
run on assays were attempted (see Appendix), but produced inconsistent
results. The objectives were addressed by using Northern analysis and enzyme-
linked immunoabsorbant assays.
Design and Methods
Baseline Studies NR8383 cells were Infected with Sendai virus at
multiplicity of infection (MOI) of 1:1 and 1:10. The viral titer of culture
supernatants was determined at 4, 12, 24, 48, 72, 96, and 120 hours after
infection by performing plaque assays. These assays were done to verify that
the cells could support a productive viral infection, and to determine the time of
peak viral replication. Immunoperoxidase staining for viral antigens was also
performed on the Infected cells to confirm infection.
Northern analysis. Northern analysis for TGF-P, and TNF-a was
performed on cytoplasmic RNA isolated from chorioallantoic fluid (CAF) and


104
network of mediators acting both transcriptionally and post-transcriptlonally.111,
149, es Qjrect upregulation of mRNA and protein by viral proteins has been
demonstrated for both of these cytokines and has been implicated as a
potentially important pathogenic mechanism in several viral diseases.57,105 170
For example, cytomegalovirus (CMV) induction of TNF-a in mucosal
macrophages may be a critical factor in CMV-induced inflammation;10 and the
induction of TGF-p production by bone marrow macrophages by the tat protein
of human immunodeficiency virus-1 is a potential mechanism for the
hematopoietic suppression associated with acquired immunodeficiency
syndrome.105
Viruses can also prime cells for the production of cytokine protein. Influenza
A virus Infection in murine macrophages induces the accumulation of large
amounts of TNF-a mRNA, including a unique high molecular weight transcript,
that is not translated into protein until cells are exposed to small amounts of
endotoxin.59 114 While Sendai virus has been demonstrated to upregulate TNF-a
gene expression in human monocyte cell lines,57,171 the correlations between
mRNA and protein levels have not been investigated. The effects of Sendai
virus on TGF-p, expression has not been characterized. The objectives of this
study were: 1) to determine whether Sendai virus-inoculation directly increased
TNF-a and/or TGF-p mRNA and protein levels in a rat macrophage cell line
(NR8383); 2) to determine whether increases in mRNA expression were
associated with increased protein expression; 3) to determine whether viral


124
TGF-P, and TNF-a protein starting at 3-7 days after inoculation. These
increases in cytokine gene expression occur before the development of
bronchiolar fibrosis, which develops 15-30 days after virus inoculation.38
Pulmonary PDGF mRNA levels were not elevated in the virus-inoculated BN
rats, and PDGF expression was not assessed in further studies.
Objective 2: Determine whether rats susceptible to virus-induced bronchiolar
fibrosis (BN) have higher cellular expression of fibrogenic
cytokines in bronchioles after virus infection relative to virus-
resistant (F344) rats.
Northern analysis and protein immunocytochemistry demonstrated virus-
inoculated BN rats had prolonged increases in TGF-P, and TNF-a pulmonary
mRNA levels and higher numbers of bronchiolar macrophages and fibroblasts
expressing TGF-3, and TNF-a protein compared to virus-inoculated F344 rats.
Objective 3: Determine if the development of virus-induced bronchiolar fibrosis
in BN rats can be blocked by neutralizing cytokine activity.
Inhibition of the bioactivity of TNF-a in virus-inoculated BN rats resulted in
decreased numbers of proliferating bronchiolar fibroblasts at 9 days after
inoculation. There was also increased mortality associated with blocking TNF-a
during viral infection.


11
Targeted disruption of the TGF-IJ, gene in mice results in a multifocal
inflammatory disease in many tissues, especially the heart and lungs.99'101 The
nature of the inflammatory response varied depending upon the tissue, for
example: the lungs had interstitial inflammatory infiltrates consisting of T and B
lymphocytes associated with increased vascular expression of major
histocompatibility complex class I and II antigens, while macrophages were the
major type of inflammatory cell in the heart. Surprisingly, inflammatory lesions
were also prominent in transgenic mice overexpressing TGF-IJ.76 TGF-IJ can
activate immature monocytes and T lymphocytes while inhibiting macrophages
and activated lymphocytes.76 In the normal inflammatory response this means
immature cells are turned on to participate in inflammation, while mature,
activated cells are switched off, promoting resolution of the inflammatory process
and tissue repair. The unexpected similarities in the phenotypes of the
transgenic and gene knockout mice is probably the result of TGF-IJs ability to
both accelerate and inhibit the inflammatory response.
In several infectious diseases, the immunosuppressive effects of TGF-IJ
predominate, resulting in prolonged survival of the pathogen and increased
tissue damage.55,56 In Leishmania infection the down-regulation of macrophages
by TGF-IJ is a virulence factor that determines in vivo susceptibility.95-102 During
acute Trypanosoma cruzi infection in mice, TGF-IJ inhibited the protective,
macrophage activating effects of interferon-y and exacerbated infection.103 In
Mycobacterium tuberculosis infection in human monocytes, neutralizing antibody


THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
By
ELIZABETH WHITFORD UHL
A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL
OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
UNIVERSITY OF FLORIDA
1996

ACKNOWLEDGMENTS
I cannot begin to thank my family for their support: my parents for their
example and their encouragement, my sisters, Jean and Mary, and brother
Charlie, for never letting me feel too sorry for myself when going got tough, and
especially my husband Frank for his unfailing support and for covering for the
many times I was not there. Special thanks go to William Castleman for giving
me the opportunity to do the work, and for setting and maintaining high
standards. I thank my the members of my commitee Claus Buergelt, Mary
Brown, Anthony Barbet and especially Rosalia Simmen for their interest and
assistance. I would also like to acknowledge Lyle Moldawer for providing the
TNF receptor fusion protein and for his enthusiasm. Roberta O'Connor, Karen
Dukes, Allison Mays, Christine Klein and especially Tracy Jack provided both
help with the laboratory work and friendship, without which this project would
have been much more difficult.
n

TABLE OF CONTENTS
ACKNOWLEDGMENTS ii
ABSTRACT v
CHAPTER 1 LITERATURE REVIEW
Viral Respiratory Infections and Asthma 1
Sendai Virus Infection in Rats 4
The Role of Cytokines in Pulmonary Disease 6
TGF-p 7
TNF-cc 12
PDGF 16
CHAPTER 2: RESEARCH PROTOCOL
Hypothesis and Specific Aims 19
Background/Significance 20
Experimental Design 21
CHAPTER 3: INCREASED TRANSFORMING GROWTH FACTOR P,
(TGF-P,) GENE EXPRESSION PRECEDES SENDAI
VIRUS-INDUCED BRONCHIOLAR FIBROSIS
Summary 34
Introduction 35
Materials and Methods 38
Results 43
Discussion 45
CHAPTER 4: INCREASED TUMOR NECROSIS FACTOR-a (TNF-a)
GENE EXPRESSION IN MACROPHAGES PRECEDES
BRONCHIOLAR FIBROSIS IN VIRUS-SUSCEPTIBLE BN RATS
Summary 55
Introduction 56
Materials and Methods 59
Results 65
Discussion 67

CHAPTER 5: FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF
SENDAI VIRUS-INDUCED BRONCHIOLAR FIBROSIS IN BN
RATS IS INHIBITED BY A SOLUBLE TNF RECEPTOR
Summary 77
Introduction 78
Materials and Methods 80
Results 85
Discussion 89
CHAPTER 6: SENDAI VIRUS DIRECTLY UPREGULATES TUMOR NECROSIS
FACTOR-a (TNF-a), BUT NOT TRANSFORMING GROWTH
FACTOR-P, (TGF-3,) GENE EXPRESSION IN RAT ALVEOLAR
MACROPHAGES
Summary 102
Introduction 103
Materials and Methods 105
Results 109
Discussion 111
CHAPTER 7: GENERAL SUMMARY 123
APPENDIX 129
REFERENCES 135
BIOGRAPHICAL SKETCH 152
IV

Abstract of Dissertation Presented to the Graduate School of the University of
Florida in Partial Fulfillment of the Requirements for the Degree of Doctor of
Philosophy
THE ROLE OF CYTOKINES IN SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
By
Elizabeth Whitford Uhl
May 1996
Chairperson: Dr. William L. Castleman
Major Department: Veterinary Medicine
Viral bronchiolitis in children may induce persistent alterations in lung
function including increased airway resistance and airway hyperresponsiveness.
Similar pulmonary functional abnormalities induced in rats following infection
with parainfluenza type I (Sendai) virus are associated with bronchiolar mural
fibrosis. This observation led to the hypothesis that virus-induced bronchiolar
mural fibrosis is mediated through virus-induced increases in gene expression of
transforming growth factor-0,, (TGF-P,), platelet-derived growth factor-B (PDGF),
and/or tumor necrosis factor-a (TNF-a) in the bronchiolar microenvironment.
Pulmonary TGF-li, and TNF-a mRNA and protein expression were assessed
in rat strains that are susceptible (BN) and resistant (F344) to virus-induced
bronchiolar fibrosis. Northern analysis, in situ hybridization and protein
immunocytochemistry demonstrated that virus-inoculated BN rats had
significantly higher increases in TGF-I3, and TNF-a pulmonary mRNA and
increased numbers of bronchiolar macrophages and fibroblasts expressing
v

TGF-IJ, and TNF-a protein than virus-inoculated F344 rats. Pulmonary PDGF
mRNA levels were not altered by viral infection in either rat strain.
The significance of TNF-a in the development of virus-induced bronchiolar
fibrosis was determined by using a 55 kD soluble TNF receptor-immunoglobulin
G fusion protein (sTNFR-IgG) to inhibit TNF-a bioactivity in virus-inoculated BN
rats. Treated rats had fewer proliferating bronchiolar fibroblasts, as detected by
bromodeoxyuridine incorporation, compared to virus-inoculated control rats.
There was also significantly increased mortality in p55sTNFR-lgG-treated virus-
inoculated rats associated with increased viral replication and decreased
numbers of macrophages and lymphocytes in bronchioalveolar lavage fluid.
To assess the mechanism of the virus-induced increase in cytokine
expression in macrophages, a rat alveolar macrophage cell line (NR8383) was
inoculated with Sendai virus, and the levels of TNF-a and TGF-p, mRNA and
protein were determined. TNF-a mRNA and protein levels were significantly
elevated at 24, 48, and 72 hours after virus-inoculation. Cells incubated with
UV-inactivated virus did not have any detectable TNF-a mRNA 24 hours after
inoculation. TGF-p, mRNA and protein levels in virus-inoculated cells were not
consistantly elevated over those from control cells. The results of these
experiments indicate that TGF-p, and TNF-a are important mediators of virus-
induced bronchiolar fibrosis. They also demonstrate that Sendai virus can
directly upregulate TNF-a expression, and that TNF-a is critical to the immune
and inflammatory response to the virus.
VI

CHAPTER 1
LITERATURE REVIEW
Viral Respiratory Infections and Asthma
The majority of individuals who develop viral respiratory infections recover
with normal airway function. However, following clinical resolution of acute viral
infections, a subgroup of patients develop airway functional abnormalities
ranging from persistent increases in airway resistance and airway
hyperresponsiveness to asthma.1'7 The potentiating impact of viral respiratory
infections on asthma appears to be dependent on the presence of underlying
risk factors, with young children, especially boys, being the most likely to
develop wheezing with a viral respiratory infection. Other risk factors include: a
family history of allergic disease, the development of an IgE-dominated immune
response, the severity of both the infection and the underlying asthma, and the
type of virus.1'7
Epidemiological studies have associated infection with respiratory syncytial
virus, parainfluenza viruses, adenoviruses, or rhinoviruses with the development
of asthma, and several pathogenic mechanisms have been proposed to explain
the development of virus-induced pulmonary functional abnormalities.1,7,8 In
1

2
children with acute respiratory syncytial virus (RSV) bronchiolitis, for example,
prospective studies have shown that titers of RSV-specific IgE are independent
predictors of airway hyperresponsiveness,9 and rising titers correlate with
increased leukotriene C4 (LTC4) levels in nasopharyngeal washes during
subsequent RSV infections.10 These results suggest that RSV itself may act as
an allergen in susceptible patients. Viral respiratory infections also may
facilitate sensitization to non-viral antigens in genetically predisposed individuals
since virus-induced epithelial damage permits exposure of allergens to the host
immune system.11
A further consequence of epithelial damage Is exposure of nerves In the
airway wall. There is an extensive network of afferent nerves situated
immediately below the epithelial tight junctions.12 Exposure of these nerves to
the environment can result in the release of neuropeptides such as substance P
and neurokinin A, both of which can stimulate smooth muscle contraction.12,13
Viral infections also can have effects on neuropeptide release and metabolism
as well as nerve conduction and receptor function.14,15
Inflammation of the airways is a characteristic feature of asthma, and
increased recruitment and persistence of inflammatory cells in airways may be
potential mechanisms by which viral infections contribute to the development of
airway functional abnormalities.8,16 Studies using animal models of virus-
induced hyperresponsiveness have correlated the appearance of airway
hyperresponsiveness induced by viruses with the influx of inflammatory cells.17,18

3
Most of these inflammatory cells were macrophages, which have the capacity to
release a vast array of inflammatory mediators and cytokines including
leukotrienes, thromboxanes, platelet activating factor, tumor necrosis factor-a
(TNF-a), interleukin-2 (IL-2), and prostaglandin F2a that can modulate airway
smooth muscle contraction, affect mucus secretion and alter vascular
permeability.'9,20,21
Viral infections may also induce abnormalities in pulmonary structure. Airway
wall thickening with fibrosis is a common lesion in asthmatics that can contribute
to the development of increased airway resistance by altering the mechanical
properties of airways.22'24 Viral infections may enhance the development of
airway fibrosis by causing epithelial necrosis, which leads to the build up of
necrotic debris, inflammatory cells, mucus, and plasma exudate in airways.
Subsequent organization of this material leads to the deposition of fibrous
connective tissue and can result in irreversible peripheral airway loss and airway
obstruction. The stimulation of aberrant or exuberant repair processes following
viral infection may also result in mural fibrosis, which can be significant even if
airways are not completely occluded, since the deposition of connective tissue in
airway walls dramatically affects the degree of luminal narrowing during smooth
muscle contraction.24
The development of persistent pulmonary functional abnormalities associated
with viral respiratory infections is dependent upon a complex interplay of
mechanisms that include IgE-dependent reactions, enhanced inflammation,

4
epithelial damage, autonomic nervous system dysfunction, modulation of the
immune response, and the induction of structural abnormalities. The purpose of
the studies presented here was to investigate the potential role of fibrogenic
cytokines in the pathogenesis of virus-induced bronchiolar fibrosis using
parainfluenza type I (Sendai) virus infection in rats as the experimental model.
Sendai Virus Infection in Rats: Summary of Previous Studies
Sendai virus is a common pathogen of rodents that can induce either clinical
disease or inapparent infection in laboratory rats, mice, guinea pigs, and
hamsters.25"27 Spontaneous disease associated with Sendai virus infection is
well documented,28 and the pathological features have been defined
experimentally.29'31 Following aerosol infection, CD (Sprague-Dawley) rats
develop multifocal necrotizing bronchiolitis associated with viral replication in
bronchiolar epithelial cells. Infection of neonatal (5 day old) rats produces the
most severe pneumonia at seven days post infection (dpi), with epithelial repair
and resolution of the bronchiolitis being largely complete at 17 dpi.29 30 Neonatal
CD rats infected with Sendai virus develop long term pathological sequelae
consisting of bronchiolar hypoplasia and fibrosis, alveolar dysplasia, and
bronchiolar mastocytosis.30 32'32 These morphological changes are associated
with pulmonary functional abnormalities including increased pulmonary
resistance, decreased arterial P02, and airway hyperresponsiveness to
aerosolized methacholine.35,36

5
Inbred rat strains that are susceptible ( Brown Norway: BN) and resistant
(Fischer 344: F344) to Sendai virus induced bronchiolar hypoplasia, fibrosis,
mastocytosis and the associated pulmonary function abnormalities have been
identified.37 At 7 days after Sendai virus infection, BN rats had higher pulmonary
viral titers, and increased numbers of neutrophils in the bronchoalveolar lavage
fluid compared to F344 rats.37 Significantly increased numbers of bronchioles
with aggregates of lymphocytes and macrophages were observed in BN rats at
14 days post infection.37 Neonatally infected BN rats also had an over 3-fold
increase in the area of bronchiolar wall per unit length of bronchiolar basement
membrane by 65 days dpi.38 This peribronchiolar increase in tissue was largely
accounted for by a 1. 5-fold increase in the number of fibroblasts per mm2 of
bronchiolar basement membrane (b.m.) as well as by a 4-fold increase in
collagen fiber density, and a 4.7 fold increase in extracellular matrix (urn3 /urn2
b.m.).38 Active proliferation of fibroblasts, assessed by bromodeoxyuridine
labeling, demonstrated significant increases (p<0.05) in the percentages of
labeled bronchiolar fibroblasts in BN rats at 7, 10, & 14 dpi (unpublished data).
In contrast, neonatally infected F344 rats did not have evidence of diffuse
bronchiolar fibrosis.38
The results of these studies indicate that bronchiolar fibrosis is an important
component of Sendai virus-induced increases in bronchiolar wall thickness and
therefore could explain the persistently increased airway resistance noted in
neonatally infected BN rats. Comparison of BN and F344 rats allows an unique

6
opportunity to determine which of several potentially important mediators are
responsible for the dysplastic, fibrotic, and hyperresponsive changes induced by
neonatal viral bronchiolitis. The studies outlined in this proposal are designed to
investigate the role of three potent mediators of pulmonary fibrosis, transforming
growth factor-fJ (TGF-IJ), tumor necrosis factor-a (TNF-a), and platelet-derived
growth factor (PDGF), in the pathogenesis of Sendai virus-induced bronchiolar
fibrosis, and to assess the ability of Sendai virus to directly induce expression of
these cytokines.
The Role of Cytokines in Pulmonary Disease
In recent years the role of cytokines in the regulation of both physiologic and
pathologic processes occurring in the lung has been extensively investigated.39'
45 Studies on naturally occurring and chemically induced pulmonary fibrosis
indicate that TGF-IJ,TNF-a, and PDGF are important mediators of pulmonary
fibrosis.46'54 In addition, the ability of infectious agents to directly effect the
expression of inflammatory and fibrogenic mediators, including TGF-IJ and TNF-
a, has been demonstrated and is believed to be an important aspect in the
pathogenesis of several viral diseases.55'60

7
Transforming Growth Factor-p (TGF-li )
TGF-li is a multifunctional growth factor, having growth regulatory activities
on essentially all cell types. The cellular response to TGF-li is complex, being
dependent on cell type, the presence of other growth factors, level of
differentiation, and the state of cell activation.61 It is a potent inhibitor of
epithelial cell growth,62 probably through inhibition of the c-myc proto¬
oncogene,63 while in combination with PDGF it is mitogenic for cells of
mesenchymal origin.64 TGF-li is also an important regulator of differentiation for
mesenchymal cells.64
In the normal lung, TGF-li is postulated to have a role in the stabilization of
the structural cell populations;65 however, if regulation of its biosynthesis is
disrupted, high protein levels could suppress repair processes by inhibiting
epithelial cell proliferation. All three isoforms of TGF-li (-li„-li2,-li3) are
constitutively expressed in the lung. mRNA transcripts are found in
macrophages, smooth muscle cells and fibroblasts, while protein expression
also may be associated with the bronchiolar epithelium.65 There are cell type-
specific differences in the number and type of TGF-li receptors as well as
subtypes of receptors with different affinities for the different TGF-li isoforms.
Rat lung fibroblasts, for example, have receptors with a higher affinity for TGF-li,
than for TGF-lij.66 This finding correlates well with the fact that TGF-li, is the
isoform most implicated in fibrosis.67

8
TGF-li is a potent inducer of tissue fibrosis,55 with a variety of both paracrine
and autocrine effects. It can increase the tissue levels of collagen and other
matrix proteins66 by increasing the transcription of fibronectin and procollagen
genes,69-70 through postranscriptional regulation of steady-state levels of
fibroblast collagen and fibronectin mRNA,71 and by inhibiting the degradation of
existing extracellular matrix by both decreasing the biosynthesis of proteases72
and increasing the synthesis of protease inhibitors.46 TGF-li, along with TNF-a,
can also enhance the development of pulmonary fibrosis by impairing the ability
of lung fibroblasts to degrade fibrin,73 thus stabilizing a transitional matrix on
which fibroblasts can proliferate and secrete collagen. In addition, TGF-li has
effects on the expression of other fibrogenic growth factors including; PDGF,
TNF-a, and basic fibroblast growth factor (bFGF).74-76
Evidence that TGF-li is one of the most potent fibrogenic agents known has
come from studies of several different models of tissue fibrosis (see reference 67
for review). Investigations of fetal wounds, which heal without the formation of a
scar, revealed that unlike in neonates or adults, TGF-li was not associated with
the wound, while the injection of TGF-li into fetal wounds led to scarring.47 The
significance of this finding was followed up by the observation that the injection
of antibodies to TGF-li into wounds in adults resulted in healing without the
formation of a scar.77 In models of pathological fibrosis increased TGF-li
expression has been observed in humans with liver cirrhosis, idiopathic
pulmonary fibrosis,75 or systemic sclerosis,76 in mice with hepatic fibrosis,79 and

in rats with experimental glomerulonephritis.80 The importance of TGF-li in the
pathogenesis of glomerulonephritis in rats was confirmed by the ability of
injected neutralizing antibodies against TGF-li to suppress the disease.
Studies of chemically induced and naturally occurring pulmonary
fibrosis48,8' 82 have confirmed the importance of TGF-li in the pathogenesis of the
lung lesions. Bleomycin treatment of rat lung fibroblast cultures resulted in an
increase of TGF-li mRNA and an increased secretion of TGF-li protein. The
response could be blocked by treatment with an inhibitor of protein synthesis,
and by an inhibitor of RNA synthesis.83 In an in vivo study, Hoyt and Lazo48
demonstrated that the amount of TGF-li mRNA extracted from the lungs of mice
chronically exposed to bleomycin was five-times the amount extracted from the
lungs of control animals. This increase preceded changes in gene expression
for collagens and fibronectin and coincided with areas of active fibrosis. Of
particular interest is the observation that a mouse strain that does not develop
pulmonary fibrosis after bleomycin exposure had a decrease in total mRNA that
included a drop in TGF-li mRNA.48 Bleomycin also induced increases in lung
collagen accumulation which could be inhibited by the administration of
antibodies to TGF-li, confirming TGF-li has an important role in the etiology of
bleomycin induced pulmonary fibrosis.84 Immunocytochemical analysis has
identified macrophages as the most common pulmonary cell type expressing
TGF-li protein in bleomycin-treated rats.81 Patients with idiopathic pulmonary
fibrosis also have increased pulmonary expression of TGF-li protein; however, it

10
is predominantly in bronchiolar and alveolar epithelial cells and deposited
extracellularly in subepithelial areas adjacent to the fibrotic lesions.85 Finally,
neutralization of TGF-li, in a mouse model of immune-induced lung fibrosis
caused by repeated intranasal exposure to heat-killed bacillus Calmette-Guerin
(BCG) resulted in substantial decreases in lung fibrosis and granulomatous
inflammation, which implies a role for TGF-li, in inducing inflammation and lung
fibrosis in response to an immune stimulus.86
In addition to its role in tissue fibrosis, TGF-li is an important modulator of the
immune response, with both immunosuppressive and proinflammatory effects
depending upon the context in which it is presented. In experimental acute and
chronic arthritis, for example, systemic administration of TGF-li nearly
obliterates the disease process87 whereas local administration exacerbates it.88
Systemically delivered TGF-li initially encounters the endothelium and its
primary action may be to decrease endothelial cell adhesion molecule
expression89’9' thus impairing leukocyte recruitment. TGF-li also can inhibit
activated T-cell proliferation and deactivate macrophages.92'95 These
immunosuppressive effects may not be predominant in all situations, however,
since TGF-li is strongly chemotactic for monocytes and macrophages and can
induce undifferentiated monocytes to express a variety of inflammatory
mediators including: IL-1, TNF-a, IL-6, and PDGF.96-98
The complex modulation of the immune response by TGF-li has been
partially characterized by studies of transgenic and gene knockout mice.

11
Targeted disruption of the TGF-IJ, gene in mice results in a multifocal
inflammatory disease in many tissues, especially the heart and lungs.99'101 The
nature of the inflammatory response varied depending upon the tissue, for
example: the lungs had interstitial inflammatory infiltrates consisting of T and B
lymphocytes associated with increased vascular expression of major
histocompatibility complex class I and II antigens, while macrophages were the
major type of inflammatory cell in the heart. Surprisingly, inflammatory lesions
were also prominent in transgenic mice overexpressing TGF-IJ.76 TGF-IJ can
activate immature monocytes and T lymphocytes while inhibiting macrophages
and activated lymphocytes.76 In the normal inflammatory response this means
immature cells are turned on to participate in inflammation, while mature,
activated cells are switched off, promoting resolution of the inflammatory process
and tissue repair. The unexpected similarities in the phenotypes of the
transgenic and gene knockout mice is probably the result of TGF-IJ’s ability to
both accelerate and inhibit the inflammatory response.
In several infectious diseases, the immunosuppressive effects of TGF-IJ
predominate, resulting in prolonged survival of the pathogen and increased
tissue damage.55,56 In Leishmania infection the down-regulation of macrophages
by TGF-IJ is a virulence factor that determines in vivo susceptibility.95-102 During
acute Trypanosoma cruzi infection in mice, TGF-IJ inhibited the protective,
macrophage activating effects of interferon-y and exacerbated infection.103 In
Mycobacterium tuberculosis infection in human monocytes, neutralizing antibody

12
to TGF-B, reduced the intracellular bacterial growth, while treatment with TGF-B,
abrogated the bacteriostatic effects of TNF-a and interferon-y.104 TGF-B also
has been implicated as having a role in the pathogenesis of viral infections. In
acquired immunodeficiency syndrome (AIDS), a viral protein (tat) appears to
directly upregulate the production of TGF-B,105 setting up a potential feedback
loop since TGF-B enhances HIV-1 replication in some cell lines.106 TGF-B has
also been demonstrated to increase human cytomegalovirus replication in
human lung fibroblasts; in contrast, basic fibroblast growth factor repressed viral
replication.107
Considering the wide-ranging effects of TGF-B on both the inflammatory
response and the pathogenesis of fibrosis, excessive production of TGF-B in the
susceptible BN rats could be contributing both to the increased viral titers
observed in these rats at 7 dpi, and to the peribronchiolar fibrosis and the
epithelial hypoplasia.
Tumpf Necrosis Factor-a
TNF-a is a pro-inflammatory cytokine produced by monocytes and
macrophages.108 Its effects are complex, as it appears to play an important role
in both acute injury and in the fibroproliferative response.40,44'109'110 In the
inflammatory response, TNF-a stimulates the adhesion of leukocytes to the
endothelial surface by inducing the expression of adhesion molecules for

13
neutrophils, monocytes and lymphocytes.’11 Other pro-inflammatory effects on
endothelial cells Include alterations in the transcription and cell surface
expression of class I MHC antigens and induction of IL-1 secretion.”1 TNF-a
also has direct stimulatory effects on neutrophils, acting to enhance the
phagocytic capacity, antibody-dependent cytotoxicity, degranulation, and
production of reactive oxygen species.111 In the repair process, a role for TNF-a
is suggested by Its growth stimulatory effect on fibroblasts, which is thought to
be mediated by the increased cell surface expression of epithelial growth factor
receptors, and by its ability to induce angiogenesis.111
Several of the pro-inflammatory effects of TNF-a, for example: its ability to
increase the adhesion of both neutrophils and eosinophils to vascular
endothelium,111”2 the potentiation of interleukin-3 and granulocyte/macrophage-
colony stimulating factor induced proliferation of hemopoietic progenitor cells,113
the enhancement of eosinophil cytotoxicity,"4 and its mechanistic role in the
activation of dermal endothelium triggered by mast cell degranulation,115 suggest
TNF-a may be important in the pathogenesis of allergic inflammation. In the
lung, this importance has been implicated by studies of airway
hyperresponsiveness.
Bronchial hyperresponsiveness and inflammation, induced by the
administration of aerosolized endotoxin to rats, has been demonstrated to be
mediated by TNF-a.110 Pretreatment of rats with antibodies against TNF-a
decreased the hyperresponsiveness, while administration of recombinant TNF-a

induced it. The same study also demonstrated that the increase in neutrophil
numbers observed after the administration of endotoxin was partially inhibited by
antibodies to TNF-a.110 Treatment with antibodies to TNF-a was also used In a
mouse model of hypersensitivity pneumonitis induced by intranasal inoculation
with the actinomycete Faenia rectiviroula (farmer's lung).116 Such treatment
blocked inflammatory cell recruitment to the lungs, completely abolished TNF-a
secretion by bronchiolar associated lymphoid tissue, and prevented the
development of fibrosis.116 At the cellular level, in vitro studies have
demonstrated the production of TNF-a in pulmonary mast cells, alveolar
macrophages, and bronchiolar epithelial cells in lung fragments following IgE
receptor triggering.117
Several studies have indicated the importance of TNF-a in fibrotic pulmonary
disorders. For example, significant increases in TNF-a mRNA have been
observed in the lungs of treated mice susceptible to bleomycin induced
pulmonary fibrosis, but not in the lungs of treated non-responder mice.109 In rats,
the importance of bleomycin-induced increases in the pulmonary expression of
TNF-a was further emphasized by the finding that the development of fibrosis
could be blocked by the administration of antibodies to TNF-a.118 In bleomycin-
induced pulmonary fibrosis there is a strong correlation between collagen
deposition and platelet trapping, which is probably due to the fact that platelets
are rich sources of fibrogenic mediators such as TGF-p and PDGF. TNF-a may
contribute to bleomycin-induced pulmonary fibrosis through platelet trapping by

15
upregulating endothelial expression of CD54, an adhesion molecule for
platelets."9 An association between increased levels of TNF-a mRNA and the
development of silicosis has been demonstrated in mice. In this model the
fibrotic changes were not only inhibited by antibodies to TNF-a, but also
enhanced by the infusion of recombinant TNF-a.120
Several viruses,121'59,60 including Sendai virus,57 directly induce the
expression and production of TNF-a; however, its role in the pathogenesis of
viral diseases is complex. TNF-a can inhibit the replication of several DNA and
RNA viruses including herpes simplex type II, vesicular stomatitis virus,
encephalomyocarditis virus and adenovirus type-2,58 and can kill virus-infected
cells originally resistant to its cytolytic actions.58 The importance of TNF-a as an
antiviral cytokine has also been emphasized by the discovery that several
viruses produce virulence factors that specifically inhibit TNF-a activity.122-124
TNF-a is not protective in all viral infections, however, as it can reactivate latent
herpes simplex infection in monocytes,125 and HIV infection in cell lines of T-cell
and monocyte origin.126,111 Viral infections also may act to prime cells for the
production of TNF-a. For example, influenza A virus infection of murine
macrophages resulted in a massive accumulation of TNF-a mRNA, including a
unique high molecular weight transcript, that was not translated to the bioactive
protein until the cells were exposed to small amounts of endotoxin.59
Based upon the studies demonstrating the importance of TNF-a in the
pathogenesis of airway fibrosis, its probable role in the development of airway

16
hyperresponsiveness, its importance in viral pathogenesis, and the observation
that Sendai virus induces the production of TNF-a in monocytes, TNF-a can be
predicted to play a role in the pathogenesis of the Sendai virus-induced
bronchiolar fibrosis and airway hyperresponsiveness observed in the susceptible
BN rats. The studies presented here were designed to test that prediction.
Platelet-Derived Growth Factor
PDGF is a highly cationic protein dimer composed of two chains, A&B, that
can exist as AA, AB, or BB depending upon the species, cellular source,83 and
transcriptional regulator. PDGF is secreted by platelets, endothelial cells,
activated monocytes, macrophages, and mesenchymal cells.83'127 It is a
competence or priming type growth factor for cells of mesenchymal origin,128 and
a chemoattractant for fibroblasts and smooth muscle cells.129 PDGF stimulates
collagen synthesis, and may act to carry out the fibro-proliferative actions of
TGF-G since ceils that cannot both synthesize and respond to PDGF remain
inhibited by TGF-li.49,50 Stimulation of fibroblast proliferation by both IL-1 and
TNF-a may also be mediated by the induction of PDGF.130,131
Expression of PDGF in normal cells is tightly regulated; it acts locally in low
concentration and is rapidly cleared. In the lung, PDGF accounts for most of the
mitogenic activity of alveolar macrophages,51 and there is evidence that it is
important in fetal lung development.132 At sites of tissue injury, PDGF-BB

17
enhances the inflammatory phase by: increasing the directed migration of
macrophages, inhibiting natural killer cell activity,133 and stimulating T
lymphocytes to secrete IL-1, while decreasing their secretion of IL-4, IL-5, and
interferon.134 In the repair phase of tissue injury, PDGF triggers an earlier, more
sustained influx of procollagen type I fibroblasts than that produced by TGF-IJ.52
PDGF-BB has also been found to activate eosinophils, and has been speculated
to play a role in the pathogenesis of asthma.135
Clinical and experimental evidence of the importance of PDGF in the
pathogenesis of pulmonary fibrosis consists of investigations of its role in
idiopathic and chemically-induced pulmonary fibrosis.136,137,53 Patients with
idiopathic pulmonary fibrosis (IPF) were demonstrated to have a 3-fold increase
in the percentages of interstitial macrophages expressing PDGF compared to
normal individuals.138 PDGF was also aberrantly expressed in the alveolar
epithelial cells of IPF patients.139 Pulmonary PDGF levels have also been
measured in patients with asbestosis and silicosis and those positive for PDGF
experienced progression of their disease.54 There is also evidence that
chrysotile asbestos may stimulate a PDGF-AA-mediated autocrine loop leading
to hyperplasia in rat lung fibroblasts.140
In the rat, measurement of pulmonary PDGF mRNA levels indicate that it is
constitutively expressed at a low level. However, during continuous exposure to
85% oxygen, the steady state levels of PDGF-BB mRNA rose 2.5 fold above
control levels. This increase preceded an increase in DNA synthesis and

18
implies a causal role for PDGF in the fibroblast proliferation induced by
hyperoxic injury to the lung.53
The role of PDGF in the pathogenesis of viral-induced tissue damage has not
been investigated. However, the prolonged induction of PDGF production either
by direct transcriptional upregulation by the virus, or some other factor (ie TGF-
II), may be contributing to the airway fibrosis observed in BN rats following
Sendai virus infection.

CHAPTER 2
RESEARCH PROTOCOL
Hypothesis and Specific Aims
The goal of this research was to identify cytokines critical to the development
of bronchiolar fibrosis following bronchiolitis induced by parainfluenza (Sendai)
virus infection during early life. The hypothesis tested was that bronchiolar
mural fibrosis following viral bronchiolitis is mediated by virus-induced increases
in transcription and/or translation of transforming growth factor-IJ, (TGF-(5,),
platelet-derived growth factor-B (PDGF), and/or tumor necrosis factor-a (TNF-a)
in infiltrating bronchiolar and peribronchiolar macrophages. There were 4
specific objectives:
1) Determine whether Sendai virus-induced bronchiolar fibrosis in virus-
susceptible BN rats is preceded by increased gene expression of
fibrogenic cytokines TGF-p,, PDGF, and/or TNF-a in macrophages and
in other bronchiolar cells.
2) Determine whether rats susceptible to virus-induced bronchiolar fibrosis
(BN) have higher cellular expression of fibrogenic cytokines in
bronchioles after virus infection relative to virus-resistant (F344) rats.
19

20
3) Determine if the development of virus-induced bronchiolar fibrosis in BN
rats can be blocked by neutralizing cytokine activity.
4) Determine whether parainfluenza virus directly or indirectly induces gene
transcription and/or translation for TGF-P,, PDGF, and/or TNF-a in
pulmonary macrophages.
Backaround/Sianifi canee
Epidemiological studies have associated childhood viral bronchiolitis,
especially as the result of infection with respiratory syncytial virus, parainfluenza
viruses, adenoviruses, or rhinovirus, with the subsequent development of
persistent increases in airway resistance and recurrent wheezing or airway
hyperresponsiveness. A rat model of parainfluenza virus-induced bronchiolar
hyperresponsiveness and increased airway resistance has been characterized,
and both susceptible and resistant inbred rat strains have been identified.33,341 “■
36,37 In this model, the increased airway resistance observed in the susceptible
rats is associated with collagen deposition in the bronchiolar walls, and
increases in the number of peribronchiolar fibroblasts.36
Airway wall thickening and fibrosis has also been identified as a common
lesion occurring in human asthma and may contribute to exaggerated airway
luminal obstruction following smooth muscle contraction.8,22,23 In asthmatics,
collagen deposition is most likely the result of fibroblast activation, because it

21
consists of interstitial structural proteins (collagens III & V), rather than of
basement membrane components (type IV collagen, and laminin).23 This study
investigated the role of fibrogenic cytokines in the development of viral-induced
bronchiolar fibrosis, and assessed the direct effects of virus infection on the
expression of these cytokines.
Experimental Design and Methods
Experiment 1: Pulmonary expression of TGF-iy PDGF, and TNF-a in Sendai
virus-infected BN and F344 rats
Objectives
1) To determine the magnitude and duration of pulmonary expression of TGF-
B,, PDGF, and TNF-a in control and Sendai virus-infected BN and F344
rats.
2) To determine the number and type of bronchiolar cells expressing
cytokine mRNA and protein in Sendai virus-infected BN and F344 rats.
Rationale
Increases in pulmonary mRNA for TGF-B, PDGF and TNF-a have been
demonstrated in several models of chemically-induced pulmonary fibrosis.55' 68‘70,
48,77.81.82.128,129.52 Northern analyses were used to assess the overall magnitude

22
and duration of pulmonary cytokine expression in infected rats. In situ
hybridization and immunohistochemistry were used to identify the pulmonary cell
types expressing cytokine mRNA and protein after viral infection, and to
determine their association with areas of inflammation and fibrosis.
Design and Methods
Twenty-two day old weanling male BN and F344 rats were inoculated with
Sendai virus or sterile chorioallantoic fluid, and studied according to the
schedule outlined in Table 2-1.
Necropsy and tissue processing. The rats were deeply anesthetized with
sodium pentobarbital and killed by exsanguination via intracardiac puncture. For
Northern analyses, the lungs were frozen in liquid nitrogen after removal and
stored at -80°C until processed. Lungs were harvested and fixed by 2 hour
perfusion via the trachea with 4% paraformaldehyde-PBS (pH 7.4) and
embedded in paraffin, for in situ hybridization and immunohistochemistry.
cDNA probes. 1) A 985 bp cDNA fragment including the major coding
region of rat TGF-B, precursor (supplied by Dr. Su Wen Quian, Laboratory of
Chemoprevention, NIH). 2) PDGF-B: cDNA (human) 2.6 kb ATCC; and 3) TNF-
a: cDNA (rat - supplied by Dr. T. Shirai, Laboratory for Chemical Research,
Asahi Chemical Industry Co. Ltd, Tagata-gun, Shizuoka).

23
Northern analysis. Lung tissue was lysed in guanidium thiocyanate, and
total RNA extracted and precipitated.139 Preliminary Northerns for TGF-p,, TNF-
a, and PDGF were performed on poly (A) RNA pooled from 3-5 animals per
group. Virus-induced increases in pulmonary TGF-p, and TNF-a RNA were
present (data not shown), but pulmonary PDGF RNA levels were not increased
in the virus-inoculated rats of either strain (see Figure 2-1). Northern analysis for
TGF-p, and TNF-a RNA was performed on total RNA extracted from the lungs of
individual animals.
In Silu hybridization. The TGF-P, and TNF-a cDNA probes used above
were subcloned and used as templates for the production of the RNA probes.
Digoxigenin- (TNF-a) and 35S-(TGF-P,) labeled antisense riboprobes were made
and used to qualitatively determine which bronchiolar cell types were expressing
cytokine mRNA in lung sections taken from virus- or sham-inoculated rats.
Control sections were incubated with labeled sense riboprobes.
Immunohistochemistrv. Antibodies against TGF-I3, and TNF-a were used
to detect bronchiolar cell expression of cytokine protein using
immunocytochemical techniques. The labeled bronchiolar macrophages and
fibroblasts were quantitated and the numbers of cells positive for cytokine
protein were compared between treatment groups.
Data analysis. Comparisons of pulmonary cytokine mRNA levels between
BN and F344 rat strains pre- and postinfection, were made by comparing the
relative optical densities (ROD) of the bands on the Northern autoradiographs.

24
The RODs of the total RNA from individual lungs were compared, both between
and within groups, to assess the amount of individual animal variation.
Statistical analysis was performed using a microcomputer-based statistical
program (Systat version 4, Evanston IL). Density of mRNA and protein labeling
were assessed by counting and classifying the number of labeled cells per mm
bronchiolar basement membrane in 25 high power (400X) fields per slide. Three
slides per animal were counted. Differences in the density of stained cells
between the infected and control, BN and F344 rats were compared using
ANOVA and Tukey tests.
Experiment 2: The effects of cytokine inhibition on the development of viral-
induced bronchiolar fibrosis.
Objective
1) To determine if the development of Sendai virus-induced bronchiolar
fibrosis in BN rats can be inhibited by blocking the activity of a
single highly expressed cytokine identified in the above experiments.
Rationale
TNF-a was chosen to block because: 1) Its transcription is directly induced
by the virus, 2) TNF-a pulmonary mRNA is elevated earlier in both rat strains

25
(3 dpi) than is TGF-0, mRNA, 3) Inhibition of TNF-a has been more effective in
blocking the development of chemically-induced pulmonary fibrosis. The basic
plan was to treat infected BN rats with a 55 kD soluble TNF-a receptor
immunoglobulin G fusion protein (p55 sTNFR-IgG), a treatment which has been
used to successfully block TNF-a activity in animal models of gram-negative
sepsis, and to assess the amount of fibroblast proliferation present at 10 dpi by
counting BrdU labeled fibroblasts.
Design and Methods
Experimental Pesian. One group of eighteen 25-day-old, male BN rats
were infected with Sendai virus, while a second group of 12 were sham-
inoculated with CAF (see Figure 2 -2). Six rats from the control and 9 from the
virus-inoculated rats were injected intraperitoneally (ip) with 10 mg/kg of p55
sTNFR-IgG 1 fusion protein on days 0, 2, 4, 6, & 8 days post inoculation (dpi).
The remaining rats were injected ip with an equivalent volume of human IgG
according to the same schedule. At 7dpi, bronchoalveolar lavage fluid (BAL)
was taken from 3 of the virus-inoculated, p55 sTNFR-lgG1 fusion protein-treated
rats, and 3 of the virus-inoculated, human IgG treated animals. The TNF-a
protein content of this fluid was determined using a mouse TNF-a ELISA kit and
by bioassay. On day 9 post inoculation, 6 rats from each of the four groups were
given 200 pg/g 5-bromo-2' -deoxyuridine (BrdU, 2 mg/ml in PBS) ip 12 hours
before they were sacrificed at 10 dpi.

26
Tissue processing. All rats were anesthetized with sodium pentobarbital
(approximately 200 pg/g body weight) and were killed by exsangulnation via
intracardiac puncture. BAL’s were performed on the rats at the time they were
sacrificed, total and differential cell counts and the TNF-a protein content of the
BAL fluid was determined. Lungs were fixed by tracheal perfusion at 30 cm H20
pressure with 4% paraformaldehyde for 2 hours.
BrdU Labeling. Four transverse sections were taken from the fixed left
lungs of rats treated with BrdU: at the hilus, between the hilar section and the
cranial lung margin, and at points equidistant caudal from the hilar section and
cranial from the caudal lung margin. Tissue blocks were embedded in paraffin,
sectioned and immunocytochemical staining to detect BrdU was performed.
Data Analysis. Fibroblast proliferation was assessed by counting the
number of BrdU-labeled fibroblasts (identified by their spindloid shape) in 25
high power (400X) fields per slide. Three slides per animal were counted.
Differences In the density of labeled cells between sham- and virus-inoculated
and p55 sTNFR-lgG1 and human IgG treated animals were compared using
ANOVA and Tukey tests.

27
Experiment 3: Assessing the ability of Sendai virus to induce increased cytokine
gene expression.
Objectives
The original objectives for experiment 3 were as follows:
1) To determine whether Sendai virus induces TGF-fl,, TNF-a, and/or PDGF
gene transcription and translation in pulmonary macrophages isolated from
BN rats and whether the induction of cytokine gene transcription is
dependent on protein synthesis, and/or is associated with an increase in
the stability of cytokine mRNA.
2) To determine if pulmonary macrophages isolated from F344 rats have the
same Sendai virus-induced pattern of cytokine expression as BN rats.
Because of the high number of animals required to obtain adequate cell
numbers for these experiments, and the fact that PDGF mRNA levels were not
elevated in the virus-inoculated rats, the objectives were revised:
1) Determine whether Sendai virus directly or indirectly induces gene
expression for TGF-p, and TNF-a in a rat alveolar macrophage cell line
NR8383 by: comparing cytokine mRNA and protein levels in virus infected
NR8383 cells with those incubated with chorioallantoic fluid (CAF).
2) Determine whether live virus is required for any increase in TGF-p, and
TNF-a gene expression observed in virus-inoculated cells.

28
3) Determine whether there is an increase in the stability of cytokine mRNA in
NR8383 cells associated with Sendai virus infection.
Rationale:
Several viruses, including Sendai virus, have been shown to directly
upregulate the production of cytokines.127,131,73,74 Macrophages are major
sources for TGF-B, and TNF-a, and can be infected with Sendai virus. Nuclear
run on assays were attempted (see Appendix), but produced inconsistent
results. The objectives were addressed by using Northern analysis and enzyme-
linked Immunoabsorbant assays.
Design and Methods
Baseline Studies NR8383 cells were Infected with Sendai virus at
multiplicity of infection (MOI) of 1:1 and 1:10. The viral titer of culture
supernatants was determined at 4, 12, 24, 48, 72, 96, and 120 hours after
infection by performing plaque assays. These assays were done to verify that
the cells could support a productive viral infection, and to determine the time of
peak viral replication. Immunoperoxidase staining for viral antigens was also
performed on the Infected cells to confirm infection.
Northern analysis. Northern analysis for TGF-P, and TNF-a was
performed on cytoplasmic RNA isolated from chorioallantoic fluid (CAF) and

29
virus-inoculated cells (MOI = 1) at 4, 8, 24, 48, and 72 hours post inoculation.
Blots were re-probed with a 32P-labeled probe for human p-actin to assess the
equality of loading.
Studies with UV-inactivated Sendai virus. UV-inactivated virus was
produced by exposing virus to a 30 watt UV lamp overnight. Plaque assays
were used to confirm viral inactivation. Cells were inoculated with inactivated
virus at an MOI of 1:1, and cytoplasmic RNA extracted 24 hours after virus-
inoculation.
Actinomvcin-D Experiments. Cells were incubated with virus (MOI = 1:1) or
CAF for 1 hour, media containing a final concentration of 5 mg/ml of
actinomycin-D (Sigma, St. Louis, MO) was added, and the cells were incubated
at 37° C, 5% C02) for 24 hours. Cytoplasmic RNA was extracted and the
relative abundance of TNF-a and TGF-p RNA was determined using Northern
analysis.
Protein Assays. The secretion of TNF-a and TGF-p protein from CAF and
virus-inoculated macrophages was monitored by ELISA.
Data Analysis. Cytoplasmic TNF-a, TGF-p,, and p-actin RNA levels were
evaluated by comparing the relative optical densities (ROD) of bands on
Northern autoradiographs. Comparisons of band densities were only made
between bands in RNA run on the same gel. ROD values, TNF-a and TGF-p,
protein levels were normalized to cell counts. Statistical analysis of group
means was performed by one-way analysis of variance (one-way ANOVA) using

a computer-based statistical program (SigmaStat, Jandel Corporation, San
Rafael, CA). Differences between individual means were assessed by
Bonferroni’s method of all pairwise multiple comparison.143

31
Northern Analysis
Immunocvtochemistrv
Days
BN Rats
F344 Rats
BN Rats/ F344 Rats
After
Control
Virus
Control
Virus
Control
Virus
Inoculation
3
-
6
-
6
-
4
7
6
6
6
6
4
4
10
-
6
-
6
-
4
14
6
6
6
6
4
4
30
6
6
_
_
4
4
* The blots were re-probed wherever possible
Table 2-1. Experimental design for Northern analysis and immunocytochemical
studies

32
* r*u
18s -
mm —
- PDGF
BN F344 BN
F344
BN
7V 10V 10V 14S 14V 14S 14V
Figure 2-1: Northern analysis of PDGF pulmonary RNA levels in sham- and
virus-inoculated BN and F344 rats. Each lane was loaded with 5 pg of pooled
mRNA from sham- and virus-inoculated rats. No significant differences in band
densities were noted in either rat strain at 7, 10, or 14 days after inoculation
(F344 expression at 7 days is not shown). Based upon these results, PDGF
gene expression was not studied further.

Figure 2-2: Experimental design for Experiment 3.

CHAPTER 3
INCREASED TRANSFORMING GROWTH FACTOR IS, (TGF-13,) GENE
EXPRESSION PRECEDES SENDAI VIRUS-INDUCED BRONCHIOLAR
FIBROSIS
Summary
Rats infected early in life with parainfluenza type 1 (Sendai) virus develop
bronchiolitis that is followed by long-term increases in airway resistance and
hyperresponsiveness. These virus-induced functional abnormalities are closely
associated with bronchiolar mural fibrosis and persistent increases in
bronchiolar inflammatory cells including macrophages and mast cells Brown
Norway (BN) rats are highly susceptible to virus-induced bronchiolar fibrosis and
airway function abnormalities, whereas Fischer-344 (F344) rats are resistant.
We hypothesized that bronchiolar fibrosis was regulated by the production of
TGF-p, by bronchiolar mural macrophages during the acute and chronic
inflammatory response induced by virus. Pulmonary and bronchiolar TGF-ÍJ,
gene expression was studied in BN and F344 rats following Sendai virus
infection by combined methods of Northern analysis and in situ hybridization for
TGF-B, mRNA and by immunocytochemistry for protein. Steady-state pulmonary
TGF-3, mRNA was increased in both BN and F344 rats at 7 days after
34

35
inoculation (p<0.001). BN rats had over two-fold greater increases than F344
rats (p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-B, mRNA
remained elevated in BN rats, but not in F344 rats (p<0.001). TGF-IJ, mRNA
was identified by in situ hybridization in bronchiolar mural macrophages and
fibroblasts. Seven days after inoculation, BN rats had over two-fold greater
numbers of bronchiolar mural macrophages positive for TGF-S, mRNA than did
control BN rats (p<0.05). Pulmonary TGF-B, protein expression was assessed
by immunocytochemistry at 3, 7, 10, 14, and 30 days after inoculation. BN rats
had over a two-fold increase in numbers of bronchiolar macrophages expressing
TGF-B, protein at 7 days after inoculation as compared to both sham-inoculated
BN and virus-inoculated F344 rats (p<0.0001). At 10 days after inoculation,
virus-inoculated BN rats had three-fold increases in numbers of bronchiolar
macrophages and fibroblasts expressing TGF-B, protein as compared to the
control animals (p<0.0001). We conclude that virus-induced bronchiolar TGF-B,
gene expression precedes bronchiolar mural fibrosis and may play an important
pathogenetic role in virus-induced bronchiolar fibrosis and airway function
abnormalities.
Introduction
Clinical and epidemiological studies have linked severe viral bronchiolitis
during infancy with subsequent long-term pulmonary function abnormalities

36
including increased airway resistance and hyperresponsiveness.2'5 Viral lower
respiratory tract disease is also identified as a risk factor in the development of
asthma.3,6 However, it remains to be determined what direct role viral infection
plays in the pathogenesis of pulmonary function abnormalities and what genetic
factors may be contributing to adverse sequelae from viral and/or immunologic
lung injury during early life.6
Parainfluenza type 1 (Sendai) virus infection in young rats has been
developed as an animal model of bronchiolitis in children. Sendai virus induces
acute necrotizing bronchiolitis and pneumonia that is followed by persistent
alterations in pulmonary function. Functional alterations include elevated
respiratory resistance, decreased dynamic compliance, and
hyperresponsiveness to methacholine.361,8'37'38'35 Susceptibility to virus-induced
functional abnormalities has been demonstrated to be influenced both by the
age and by the strain of the rat. In rats inoculated with virus as 25 day old
weanlings, persistent airway lesions associated with long-term pulmonary
function abnormalities include bronchlolar mural fibrosis and inflammation
characterized by mural aggregates of macrophages, mast cells, and
eosinophils.35 Both BN and LEW rats appear to be more susceptible to virus-
induced alterations in pulmonary structure and function than are F344 rats.36'13'
37,38.35 Comparative viral pathogenesis studies with virus-susceptible BN rats
and resistant F344 rats indicate that genetic differences between the strains
influence important factors in host-virus interaction including duration of viral

37
replication, magnitude of immune response, and severity of acute and persistent
inflammatory cell response.35 37,38
Bronchiolar mural fibrosis and associated airway wall thickening is a
prominent feature of virus-induced lung injury that is associated with lung
dysfunction in susceptible weanling BN rats.38 Fibrosis develops as early as 15
to 30 days after viral Inoculation. Airway wall thickening and fibrosis has also
been identified as a common lesion occurring in human asthma and may
contribute to exaggerated airway luminal obstruction following modest smooth
muscle contraction.22'24
A growing body of research has demonstrated that several cytokines,
including transforming growth factor-3 (TGF-P), tumor necrosis factor-a (TNF-a),
and platelet-derived growth factor ( PDGF), play critical roles In regulating
pulmonary fibrosis following alveolar injury by toxins such as bleomycin or in
less well-defined spontaneous fibrosis.40,138,48,109,84,85 Furthermore, there is
evidence that genetic susceptibility to develop pulmonary fibrosis in response to
chemically-induced damage may be controlled at the level of TGF-3
expression.48 TGF-3 upregulates both fibroblast proliferation and the synthesis
of collagens and glycosaminoglycans in the lung.40,138
Based on the preceding information, we hypothesized that virus-induced
airway fibrosis and thickening in virus-susceptible BN rats was due to greater
expression of TGF-3 in airway walls following viral infection than in virus-
resistant F344 rats. The objectives of this study were to determine if Sendai

38
virus infection induces increased expression of TGF-ft, in bronchiolar walls prior
to fibrosis and to determine whether TGF-p, gene expression induced by viral
bronchiolitis is greater in BN rats that are susceptible to virus-induced fibrosis
than in F344 rats that are resistant to this virus-induced effect.
Materials and Methods
Animals
Twenty-two day old weanling male BN and F344 rats were purchased from
Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum
antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat
virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic
bacteria. The control and experimental groups were separated and housed in
adjacent isolation cubicles.
Experimental Protocol
Three days after arrival, the rats in the experimental group were inoculated
with parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units per ml of gas in an aerosol exposure apparatus (Tri-R Instruments,
Rockville Center, NY) for 15 minutes. Viral assays to calibrate exposure were
performed as previously described.33'32 Sendai virus strain P3193 produced in

39
embryonated chicken eggs was used. Control rats were exposed to sterile
chorioallantoic fluid also harvested from embryonated chicken eggs. Virus-
inoculated BN and F344 rats were processed at 3, 7, 10, 14 and 30 days after
inoculation. Sham-inoculated animals were sacrificed at 7, 14, and 30 days after
inoculation. The rats were deeply anesthetized with sodium pentobarbital and
killed by exsanguination via intracardiac puncture. For Northern analysis, the
lungs from six rats from each group were frozen in liquid nitrogen and stored at
-80°C until processed. Lungs from four animals in each group were processed
for in situ hybridization and immunohistochemistry. These lungs were fixed for 2
hours via airway perfusion at 30 cm fixative pressure with 4%
paraformaldehyde-phosphate buffered saline (pH 7.4) and embedded in paraffin.
Northern Analysis
Lung tissue was lysed in guanidine thiocyanate, and total RNA was extracted,
precipitated and further processed to recover polyadenylated mRNA as
described.'39 Twenty pg of total RNA from each lung or 5 pg of mRNA extracted
from pooled lung tissue was electrophorectically separated on 1.2% (wt:vol)
agarose gels containing 6% (vol:vol) formaldehyde, transferred to a positively
charged nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN),
and fixed by UV-crosslinking. Equality of RNA loading between lanes was
evaluated by visually comparing the intensity of ethidium bromide staining of the

40
18s and 28s ribosomal RNA bands on gels and membranes. A 985 bp cDNA
fragment containing the major coding region of the rat TGF-Í1, gene (supplied by
Dr. Su Wen Quian, Laboratory of Chemoprevention, NIH, Bethesda, MD) and a
2.6 kb human cDNA fragment of platelet derived growth factor (PDGF)
(American Type Culture Collection, Rockville, MD) were labeled with 32P-dCTP
using the random primer method as described.140 Prehybridization (15 min,
60-65°C) and hybridization (overnight, 65°C) was in 0.5 M Na2HP04, 7% SDS,
1% BSA, and 10mM EDTA as described.141 The membranes were washed at the
hybridization temperature in 20mM phosphate, 1% SDS, and used to expose
Kodak XAR-5 film with Dupont Cronex intensifying screens. Film band densities
were quantified using a computerized video image analysis unit (Microcomputer
Imaging Device, Imaging Research Inc., St. Catharines, Ontario).
In Situ Hybridization and Immunocvtochemistrv
For in situ hybridization, the rat TGF-ft, cDNA probe in pBluescript II KS+
(Stratagene, La Jolla, CA) was linearized and used as a template for the
production of “S-labeled RNA sense and antisense probes by a modified
version of the Riboprobe Gemini System II kit (Promega Biotech, Madison,
Wl).142 To synthesize the antisense probe, plasmids were linearized with Xba I
and incubated with T3 polymerase. The sense probe was made by linearizing
with Hind III and incubating with T7 polymerase. Lung sections were

41
prehybridized, hybridized, and washed as described.142 Briefly, the slides were
initially de-paraffinized in xylene, re-hydrated through a graded series of ethanol
washes, and denatured in 0.2 N HCI and in 2X SSC at 70°C. Prehybridization
consisted of incubation in 0.001% proteinase K (30 min, 37 °C), acetylation in
acetic anhydride, and dehydration in ascending concentrations of ethanol.
Hybridization was performed at 57 °C overnight in a humidified chamber. The
slides were washed in 4X SSC, incubated in RNase A (30 min, 37°C) and
washed in descending concentrations of SSC. A final high stringency wash was
performed using 0.1X SSC at 65°C for 30 min. The slides were then dehydrated
and dried. Signal was detected by coating the slides with Ilford K.5D nuclear
emulsion (Polysciences, Inc., Warrington, PA), and development in Kodak D-19
developer (Kodak, Rochester, NY) after 7-14 days.142 Autoradiograms were
stained with hematoxylin and eosin. Specificity of the probes was determined by
comparison with slides hybridized with labeled sense transcripts. Only lungs
from BN rats were processed for in situ hybridization.
For immunocytochemistry, lung sections from BN and F344 rats were de-
paraffinized and re-hydrated as described above for in situ hybridization, washed
in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with
either chicken IgG against recombinant human TGF-B, (R&D Systems,
Minneapolis, MN), or normal chicken IgG (Sigma, St. Louis, MO), both at 0.01
mg/ml. Antibody binding was detected using an avidin-biotin alkaline
phosphatase system (Vectastain ABC-AP and substrate kits, Vector Lab,
Burlingame, CA) as described.81

42
Quantitation Methods and Data Analysis
Evaluation of pulmonary cytokine mRNA levels In control and virus-
inoculated BN and F344 rat strains was made by comparing the relative optical
densities (ROD) of bands on Northern autoradiograms. The density of cells
expressing mRNA and protein was assessed by counting and classifying the
number of labeled cells per millimeter of bronchiolar basement membrane in 25
consecutive fields at 400X per slide.38 Macrophages and fibroblasts were the
cells most consistently labeled by the TGF-P, immunocytochemistry and in situ
hybridization procedures. Vascular and airway smooth muscle cells also
contained TGF-P, mRNA and protein, while epithelial cells were occasionally
positive for TGF-P, protein. Macrophages and fibroblasts were counted in the
bronchiolar wall. In addition, macrophages in immediately adjacent alveolar
spaces were counted in the same microscopic fields. Three lung sections from
each rat were evaluated in the immunocytochemistry procedures. In more
limited quantitative procedures for the in situ hybridization of BN rats, one slide
per rat was counted. Cells that had round profiles, central round to ovoid nuclei,
and abundant eosinophilic cytoplasm were counted as macrophages. Cells
were counted as fibroblasts when they had elongated ovoid nuclei and
elongated, spindle-shaped cytoplasm. Statistical analysis among group means
was performed using ANOVA and Tukey's HSD multiple comparison
procedure143 in a computer-based statistical program (Systat version 4,
Evanston, IL).

43
Results
Effect of Sendai virus infection on total lung levels of TGF-B, mRNA
At 7 days after inoculation, viral infection resulted in significant increases in
pulmonary TGF-B, mRNA in both rat strains (Figures 3-1 and 3-2). Virus-
susceptible BN rats had a greater than two-fold increase in TGF-B, mRNA as
compared to the peak elevation observed in the virus-resistant F344 rats
(p<0.05). At 10 and 14 days after inoculation, pulmonary TGF-B, mRNA levels
remained elevated in the virus-inoculated BN rats, whereas in virus-inoculated
F344 rats the levels were not significantly increased over those of control rats.
The level of pulmonary TGF-B, mRNA in lungs of virus-inoculated BN rats was
equivalent to that of the control animals by 30 days after inoculation. Pulmonary
PDGF mRNA was not increased in either rat strain at 7, 10, & 14 days after
inoculation (see Figure 2-1).
Identification of pulmonary cell types expressing TGF-B, mRNA
Macrophages and fibroblasts were the main cell types expressing TGF-B,
mRNA as detected by in situ hybridization in both control and virus-inoculated
rats (Figure 3-3). Macrophages in bronchiolar walls and alveolar macrophages
hybridized antisense probe. Bronchiolar smooth muscle cells as well as arterial

44
and venous smooth muscle cells were also positive for TGF-p, mRNA. In
control BN rats, the density of bronchiolar mural macrophages positive for TGF-
U, mRNA was 6.3 ±1.1 (mean ± sem) per mm bronchiolar basement membrane.
The density of alveolar macrophages positive for mRNA was 70.7 ± 7.2 per mm
(data not shown). At 7 days after inoculation, there were approximately two-fold
increases in the density of bronchiolar mural macrophages positive for TGF-U,
mRNA as compared to control rats (11.7 ± 1.8 per mm, p<0.05), and over 30-fold
increases in labeled alveolar macrophages (197.3 ± 13.6 per mm, p<0.005)
(data not shown). Mean numbers of labeled macrophages at 10 days after
inoculation and labeled fibroblasts at 7 or 10 days after inoculation did not differ
significantly from controls (data not shown). Non-specific labeling was assessed
in tissue sections hybridized with the sense riboprobe.
Pulmonary TGF-U, protein expression
Seven days after viral inoculation there were significantly increased
numbers of macrophages expressing TGF-IJ, protein in the lungs of both BN and
F344 rats (Figures 3-4 & 3-5). In infected BN rats at 7 days after inoculation, the
increase was ten-fold (p<0.0001) over control BN rats and greater than two-fold
(p<0.0001) over the number observed in infected F344 rats at 7 days after
inoculation. At 10 days after inoculation, BN rats had three-fold increases in
macrophages and fibroblasts expressing TGF-U, protein as compared to

45
controls (p<0.0001). At 10 days after inoculation In F344 rats, the numbers of
macrophages and fibroblasts positive for TGF-IJ, were not significantly different
than sham-inoculated animals (Figures 3-5 & 3-6). TGF-3, protein was also
detected in bronchiolar, venous, and arterial smooth muscle in both BN and
F344 rats.
Discussion
The goal of this study was to determine whether TGF-p, expression induced
by viral bronchiolitis might be an important stimulus for bronchiolar mural fibrosis
and thickening. The bronchiolar fibrosis that follows acute virus-induced injury
and inflammation is associated with long-term airway dysfunction36'18'38 and,
therefore, is an important pathologic endpoint to investigate. Two main
observations from this study are consistent with the interpretation that increased
TGF-P, gene expression may be an important stimulus for virus-induced
bronchiolar fibrosis. First, increases in pulmonary steady-state mRNA levels
and in density of bronchiolar cells expressing mRNA and protein precede the
bronchiolar fibrosis that develops by 15 or 30 days following inoculation.33'38
Second, BN rats (high responders to Sendai virus-induced bronchiolar fibrosis)
have higher and more prolonged levels of increased TGF-p, protein and mRNA
expression in lung and airways than do F344 rats (low responders).38

46
Although the results are consistent with TGF-P, being an important regulator
of virus-induced bronchiolar fibrosis, they do not delineate the specific
mechanism for increased gene expression. Increased quantities of TGF-p,
mRNA in whole lung homogenates were associated with increased numbers of
macrophages and fibroblasts in airway walls and surrounding alveoli expressing
cytoplasmic mRNA and protein. Increased mRNA levels in lung could be due to
increased infiltration of cells containing TGF-p, mRNA, virus-induced gene
transcription and protein expression in macrophages and fibroblasts, or a
combination of the two mechanisms. Although the data do not clearly
distinguish the relative importance of these mechanisms, several findings
suggest that the increased TGF-P, mRNA and protein expression in cells around
virus-infected bronchioles may be due at least in part to virus-induced increases
in gene transcription and/or protein synthesis.
First, increased numbers of peribronchiolar fibroblasts expressing TGF-P,
protein were observed at 7 days after inoculation and prior to appreciable
increases in numbers of bronchiolar mural fibroblasts. Increases in fibroblast
numbers are observed at 15 to 30 days after viral inoculation. Second, if all the
increases in TGF-P, mRNA were due to infiltration of macrophages, we would
expect to see similar increases in mRNA for PDGF, another cytokine associated
with macrophages.''0 Pulmonary steady-state levels of PDGF mRNA did not
increase following infection in either BN or F344 rats at 7, 10, and 14 days after
inoculation (Figure 2-1).

47
Transcriptional upregulation of TGF-IJ, gene expression could be a direct
result of viral infection. The ability of viruses to directly increase expression of
inflammatory cytokines is considered to be an important mechanism in the
pathogenesis of several viral diseases.105,57 In acquired immunodeficiency
syndrome (AIDS), a viral protein (tat) appears to directly upregulate the
production of TGF-IJ.105 More complex viral effects on host cell gene regulation
are also recognized. Influenza A virus infection of murine macrophages not only
increases transcription of tumor necrosis factor-a (TNF-a), but also induces the
production of a unique TNF-a transcript.144 Sendai virus infection of cultured
macrophages has been shown to directly stimulate the production of TNF-a.57 In
Sendai virus infected rats, pulmonary viral titers peak around 5 days after
inoculation,38 before the peak expression of TGF-IJ at 7 days after inoculation.
Direct upregulation of TGF-P, gene transcription and protein synthesis by
Sendai virus infection could explain some of the differences in the pathologic
response of BN and F344 rats to viral infection. Pulmonary Sendai viral
replication persists for several days longer in weanling BN rats than in F344
rats.37 Persisting viral replication could be an important stimulus of persisting
cytokine expression and more severe fibrosis in BN rats.
TGF-IJ, is a major regulator of fibrosis and other tissue repair mechanisms. It
contributes to increasing tissue levels of collagen and other matrix proteins by
several mechanisms. TGF-IJ, increases transcription of fibronectin and
procollagen genes69, post-transcriptionally regulates fibroblast, collagen and

48
fibronectin mRNA,71 and inhibits the degradation of existing extracellular
matrix.71 Studies of naturally occurring and chemically-induced fibrotic lung
lesions indicate that TGF-IJ, is an important mediator of pulmonary fibrosis.40,138,
4«, 109.85,m |n t^js stu(jy prolonged upregulation of TGF-IJ, in the susceptible
rats implies that such increases may also be important in the regulation of virus-
induced bronchiolar fibrosis and airway function abnormalities.
In addition to its regulatory effects on repair and fibrosis, TGF-IJ, can
suppress both T- and B-lymphocytes, decrease cytotoxic and lymphokine-
activated killer cell production, and down-regulate macrophage activity.92-95 In
several models of infectious disease, these immunosuppressive effects have
resulted in direct correlations between the level of TGF-IJ, expression, the
prolonged survival of infectious agents and the extent of tissue damage.92,95,102,
103 It is reasonable to speculate that prolonged and excessive TGF-P,
expression in infected BN rats may be contributing to less effective immunity and
to virus-induced tissue damage and abnormal repair marked by fibrosis.
In conclusion, the results of this study demonstrate that virus-induced
bronchiolar TGF-IJ, gene expression precedes bronchiolar mural fibrosis and
suggest that it may play an important pathogenetic role in virus-induced
bronchiolar fibrosis and airway function abnormalities.

18s-
mm -». «• - TGF-B,
28s-
[ SHAM ] [ 3 DPI ] [ 7 DPI ]
Figure 3-1. Northern blot of rat pulmonary total RNA hybridized with a 32P-labeled cDNA probe for rat TGF-
IJ,. This blot was performed on pulmonary RNA extracted from sham-inoculated F344 rats at 7 days after
inoculation, and from virus-inoculated F344 rats at 3 & 7 days after inoculation. Each lane was loaded with
20 pg of RNA from an individual animal. The lower panel shows equality of RNA loading on the ethidium
bromide-stained gel.
-P*
VO

50
Days After Inoculation
Figure 3-2: Graphic presentation of the results of Northern analysis for
TGF -pv Data points and bars represent the mean relative optical band
density (ROD) and standard error of the mean (SEM) for 4-6 rats.
Statistical comparisons of ROD’S were only made between sham- and
virus-inoculated groups represented on the same blot.

51
Figure 3-3. TGF-B, mRNA in lung sections was detected by in situ hybridization.
Top panel: brightfield and darkfield micrographs from a sham-inoculated BN rat.
The bottom panel shows a bronchiole from an infected BN rat at 10 days after
inoculation. (x200).

52
Figure 3-4. TGF-IJ, protein in bronchiolar macrophages. Both micrographs are
of sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
top was incubated with 0.01 mg/ml normal chicken IgG and the bottom with 0.01
mg/ml chicken anti-human TGF-IJ, IgG (x600).

53
Figure 3-5: Density of bronchiolar mural macrophages expressing
TGF-p, protein. Data points represent mean + SEM (n=4).

54
Figure 3-6: Density of bronchiolar mural fibroblasts expressing TGF-p,
protein. Data points represent mean + SEM (n=4).

CHAPTER 4
INCREASED TUMOR NECROSIS FACTOR-a (TNF-a) GENE EXPRESSION IN
MACROPHAGES PRECEDES BRONCHIOLAR FIBROSIS IN VIRUS-
SUSCEPTIBLE BN RATS
Summary
Parainfluenza type I (Sendai) virus infection in genetically susceptible young
rats induces persistent increases in airway resistance and airway
hyperresponsiveness. In virus-susceptible BN rats, the pulmonary function
abnormalities are associated with bronchiolar mural fibrosis and recruitment and
persistence of inflammatory cells including mast cells and macrophages. We
hypothesized that TNF-a gene expression is an important regulatory event in
virus-induced bronchiolar fibrosis. Pulmonary TNF-a mRNA and protein
expression were assessed at 3, 7, 10, 14, and 30 days after virus-inoculation in
rat strains that are susceptible (BN) and resistant ( F344) to virus-induced
bronchiolar fibrosis. Northern analysis revealed elevated pulmonary TNF-a
mRNA levels In both rat strains at 3, 7, and 10 days after inoculation (p<0.01).
At 14 days after inoculation only the virus-susceptible BN rats had increased
levels of TNF-a mRNA In their lungs (p<0.01). Macrophages and fibroblasts
were identified as being the main bronchiolar cell types containing TNF-a mRNA
55

56
and protein by in situ hybridization and immunocytochemistry. Macrophage
expression of TNF-a protein peaked at 7 days after inoculation in both rat
strains (p<0.0001). Virus-inoculated BN rats had almost twice the density of
TNF-a-positive macrophages in their bronchiolar walls as infected F344 rats
(p<0.0001). The number of macrophages positive for TNF-a protein remained
significantly elevated in infected BN rats at 10 dpi (p<0.05). Over two-fold
increases in the number of labeled bronchiolar fibroblasts were observed in
infected rats of both strains at 7 dpi (p<0.001) compared to the control rats. At
10 dpi the mean number of fibroblasts positive for TNF-a protein had increased
to over 5-fold that of the control in the infected BN rats (pO.0001), but was not
significantly elevated in the infected F344 rats. The data suggest that increased
TNF-a gene expression may be important in the pathogenesis of virus-induced
bronchiolar fibrosis.
Introduction
Viral bronchiolitis in early childhood has been linked with persisting
pulmonary functional abnormalities including increased airway resistance and
airway hyperresponsiveness and has been identified as a risk factor for the
development of asthma.2-6 The development of asthma-like symptoms following
viral infection appears to be associated with an aberrant, IgE-dominated

57
immunological response that is probably determined by a combination of genetic
and viral factors.2-6 Young rats develop similar pulmonary functional
abnormalities after infection with parainfluenza virus type I (Sendai) and are
being studied as an animal model to identify genetic and viral factors Important
In the pathogenesis of virus-induced lung Injury. 16,33,35‘38
The development of virus-induced pulmonary function abnormalities in rats is
associated with infection as neonates or weanlings and genetic susceptibility.
Brown Nonway (BN) rats develop virus-induced alterations in pulmonary
structure and function, while Fischer 344 (F344) rats are relatively resistant.18,35"
38 Comparative viral pathogenesis studies indicate there are differences in
duration of viral replication, magnitude of immune response, and severity of both
the acute and persistent inflammatory response between the virus-susceptible
BN and virus-resistant F344 rats.35-38 The virus-induced abnormalities in
pulmonary function consist of increased respiratory resistance, decreased
dynamic compliance and hyperresponsiveness to methacholine. These
functional abnormalities are associated with bronchiolar aggregates of
macrophages, mast cells, and eosinophils, and bronchiolar mural fibrosis.38
Bronchiolar mural fibrosis and the resulting airway wall thickening is
prominent in BN rats 15 to 30 days after being infected with Sendai virus.
Bronchial fibrosis is a common finding in human asthmatics.22'24,40 The
importance of mural fibrosis in the development of increased airway resistance is
indicated by airway modeling studies that demonstrate that moderate amounts of

58
airway wall thickening markedly alter mechanical properties of airways and
accentuate airway luminal narrowing during smooth muscle contraction.24
Several cytokines including tumor necrosis factor-a (TNF-a), transforming
growth factor-p (TGF-P), and platelet-derived growth factor (PDGF) stimulate
pulmonary fibroblast proliferation and collagen synthesis and are upregulated in
both naturally occurring and chemically-induced pulmonary fibrosis.40,16,48,109,85,
84.ii8.i2o pu|monary expression of TGF-P, and PDGF during Sendai virus
infection has been assessed in both virus-susceptible BN and virus-resistant
F344 rats (see Chapter 3 and Figure 2-1). Virus-induced increases in
pulmonary PDGF mRNA were not observed. However, prolonged increases in
pulmonary TGF-P, mRNA, as well as increased numbers of bronchiolar
macrophages and fibroblasts expressing TGF-P, protein were present in infected
BN rats before the development of virus-induced fibrosis.
Increased pulmonary expression of TGF-p appears to be important in the
pathogenesis of some, but not all forms of pulmonary fibrosis. The
administration of antibodies to TGF-P significantly reduced bleomycin-induced
increases in lung collagen.84 In contrast, pulmonary TGF-P mRNA was not
increased in lungs during the development of silica-induced pulmonary
fibrosis.120 TNF-a has been shown to be increased in both silica-induced
pulmonary fibrosis and bleomycin-induced fibrosis.118,120 The importance of
TNF-a in these two forms of fibrosis further emphasized by studies showing that
TNF-a inhibition with antibody reduces severity of fibrosis.118,120 Furthermore,

59
the infusion of recombinant TNF-a accentuated the severity of pulmonary
fibrosis in silica-treated mice.120
Based upon these observations, we hypothesized that the development of
Sendai virus-induced bronchiolar fibrosis in susceptible BN rats also may be
regulated by bronchiolar expression of TNF-a. The objectives of this study were
to determine if Sendai virus infection induces increases in pulmonary TNF-a
mRNA levels prior to the development of fibrosis and to determine whether rats
susceptible to virus-induced bronchiolar fibrosis (BN) have increased numbers
of bronchiolar cells expressing TNF-a protein compared to the virus-resistant
(F344) rats.
Materials and Methods
Animals
Twenty-two day old weanling male BN and F344 rats were purchased from
Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum
antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat
virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic
bacteria. The control and experimental groups were separated and housed in
adjacent individually ventilated isolation units.

60
Experimental Protocol
Three days after arrival, the rats in the experimental group were exposed to
parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units (PFU) per ml of gas for 15 minutes in a Tri-R aerosol exposure apparatus
(Tri-R Instruments, Rockville Center, NY). Viral assays to calibrate exposure
were performed as previously described.33,37 Sendai virus strain P3193
produced in embryonated chicken eggs was used. Control rats were exposed to
sterile chorioallantoic fluid. Virus-inoculated BN and F344 rats were processed
at 3, 7, 10, 14 and 30 dpi. Sham inoculated animals were sacrificed at 7, 14,
and 30 dpi. The rats were deeply anesthetized with sodium pentobarbital and
killed by exsanguination via intracardiac puncture. For Northern analysis, the
lungs of six rats from each group were frozen in liquid nitrogen and stored at
-80°C until processed. Lungs from four animals in each group were processed
for in situ hybridization and immunohistochemistry. These lungs were fixed for 2
hours via airway perfusion with 4% paraformaldehyde-PBS (pH 7.4), at 30 cm
perfusion pressure, and embedded in paraffin for in situ hybridization and
immunocytochemistry.

61
Northern Analysis
Lung tissue was lysed in guanidine thiocyanate, and total RNA extracted and
precipitated as described.139 Twenty micrograms (pg) of total RNA from each
lung was electrophorectially fractionated on a series of 1.2% (wt:vol) agarose
gels containing 6% (vol:vol) formaldehyde, transferred to a positively charged
nylon membrane (Boehringer Mannheim Corporation, Indianapolis, IN), and
fixed by UV-crosslinking. Equality of RNA loading between lanes was assessed
by visually comparing the intensity of ethidium bromide staining of ribosomal
RNA bands in the gels and membranes. A cDNA probe for rat TNF-a (supplied
by Dr. T. Shirai, Laboratory for Chemical Research, Asahi Chemical Industry Co.
Ltd, Tagata-gun, Shizuoka, Japan) was labeled with 32P-dCTP using the random
primer method as described.140 Prehybridization (15 min, 58°C) and
hybridization (overnight, 58°C) was in 0.5 M Na2HP04, 7% SDS, 1% BSA, and
10mM EDTA as described.141 The membranes were washed at the hybridization
temperature in 40mM phosphate, 1% SDS, and exposed to Kodak (Rochester,
NY) XLS-5 film with Dupont Cronex intensifying screens. Film band densities
were quantified using a computerized video image analysis unit (Microcomputer
Imaging Device, Imaging Research Inc., St Catharines, Ontario).

62
In Situ Hvbridization/lmmunocvtochemistrv
In situ hybridization was performed by subcloning the rat TNF-a cDNA probe
into pBluescript II KS+ (Stratagene, La Jolla, CA) as a template for the
production of digoxigenin-labeled RNA probes. Sense and antisense riboprobes
were made according to manufacturer's instructions (The Genius System,
Boehringer Mannheim, Indianapolis,IN). Lung sections were initially de-
paraffinized in xylene, re-hydrated through a graded series of ethanol washes,
and denatured in 0.2 N HCI. Prehybridization treatment consisted of: incubation
in 0.001% proteinase K (30 min, 37°C), acetylation in acetic anhydride, and
dehydration in ascending concentrations of ethanol. The probe was added to
the hybridization solution (62.5% formamide, 12.5% dextran sulfate, 0.3 M NaCI,
0.025X Denhart's solution [Sigma, St. Louis, MO] 12.5 mM Tris-HCI pH 8.0, 1.25
mM EDTA pH 8.0) and denatured at 65° C for 10 minutes. Approximately 50 ng
of probe was added to each slide, coverslips were applied and the slides were
placed in a 65° C oven for 10 minutes. Hybridization was then performed at
37°C overnight in a humidified chamber. The slides were washed in 2 X SSC
(10 min, 37°C), 1 X SSC (10 min, 37°C), and 0.1 X SSC (10 min, 37°C). The
sections were blocked in 2% normal sheep sera (30 min, room temperature) and
incubated (2 hours, room temperature) with an alkaline phosphatase-conjugated
antibody to digoxigenin (Boehringer Mannheim, Indianapolis, IN). Signal was
detected using nitroblue tetrazolium (4-8 hours, room temperature) (Boehringer

63
Mannheim, Indianapolis, IN). Specificity of the probes was determined by
comparison with slides hybridized with equivalent quantities of labeled sense
transcripts.
For immunocytochemistry, lung sections from BN and F344 rats were de-
paraffinized and re-hydrated as described above for in situ hybridization, washed
in 0.01 M Tris-buffered saline, blocked with normal goat sera, and incubated with
either rabbit sera (Sigma, St. Louis, MO) or polyclonal rabbit anti-mouse TNF-a
(Genzyme, Cambridge, MA) both at 0.001 mg/ml. Antibody binding was
detected using an avidin-biotin alkaline phosphatase system (Vectastain ABC-
AP and substrate kits, Vector Lab, Burlingame, CA).
Protein Analysis on BAL Fluid
Bronchioalveolar lavage fluid (BAL) was collected from sham- and virus-
inoculated BN and F344 rats at 7 and 10 dpi using two phosphate-buffered
saline lavages as described.35 The amount of rat TNF-a protein in each sample
was determined by enzyme-linked immuno-absorbance assays (ELISA) using an
immunoassay kit according to the manufacture's instructions (BioSource
International, Inc. Camarillo, CA).

64
Quantitation Methods and Data Analysis
Pulmonary TNF-a mRNA levels were evaluated by comparing the relative
optical densities (ROD) of the bands on Northern autoradiographs.
Comparisons of TNF-a bands detected in pulmonary RNA were only made
between bands in RNA run on the same gel. ROD’S of the bands were
expressed as percentages of the band density of a positive standard (30 pg of
pooled pulmonary poly-A mRNA from Sendai virus-inoculated BN rats harvested
at 7 dpi) run on each gel. The density of cells expressing TNF-a protein was
assessed by counting and classifying the number of labeled cells per millimeter
of bronchiolar basement membrane in 25 high power (400X) fields per slide.
Round cells with central round to ovoid nuclei and abundant cytoplasm were
counted as macrophages, cells with elongated ovoid nuclei and spindle-shaped
cytoplasm were counted as fibroblasts, and culsters of round cells with central
round nuclei and sparse cytoplasm were identified as lymphocytes. Labeled
macrophages in the bronchiolar wall and immediately adjacent alveolar spaces
and labeled fibroblasts in the bronchiolar wall were counted in the same
microscopic field. Three slides from each of 4 animals per group were counted.
Statistical analysis of group means was performed using ANOVA and Tukey's
HSD multiple comparison procedure143 in a computer-based statistical program
(Systat version 4).

65
Results
Sendai virus infection causes an increase in total lung levels of TNF-a mRNA
TNF-a transcripts were not detected in pulmonary mRNA extracted from
sham-inoculated animals. Viral infection resulted in increased total lung levels
of TNF-a mRNA in both rat strains at 3, 7, and 10 days after inoculation
(p<0.01). Pulmonary TNF-a mRNA levels peaked at 3 dpi in the F344 rats and
at 7 dpi in the BN rats. Virus-susceptible BN rats still had increased levels of
TNF-a mRNA in their lungs 14 days after inoculation (p<0.01), while in the virus-
resistant F344 rats levels were not significantly above those of the sham-
inoculated rats. Pulmonary TNF-a mRNA levels in the BN rats did not return to
baseline levels until 30 days after inoculation (Figures 4-1 & 4-2).
Identification of pulmonary cell types expressing TNF-g mRNA and protein
In situ hybridization identified macrophages and fibroblasts as the main
bronchiolar cells expressing TNF-a mRNA in infected BN rats (Figure 4-3).
Epithelial cells and occasional scattered aggregates of lymphocytes around
bronchi (BALT) were also labeled in sections hybridized with the anti-sense
TNF-a riboprobe.

66
The number of bronchiolar macrophages positive for TNF-a protein peaked
at 7 days after inoculation in both rat strains (p<0.0001, Figures 4-4 & 4-5).
Infected virus-sensitive BN rats had almost twice as many labeled macrophages
in their bronchiolar walls as infected F344 rats (p<0.0001). The number of
labeled macrophages was still elevated in infected BN rats at 10 days after
inoculation (p<0.05). The number of bronchiolar fibroblasts positive for TNF-a
protein increased over two-fold in both rat strains at 7 days after inoculation
(p<0.001, Figure 4-6). The largest number of labeled fibroblasts observed in the
virus-resistant F344 rats was at 7 dpi, while in the virus-susceptible BN rats, the
numbers increased until 10 days after inoculation (p<0.0001, Figure 4-6). TNF-
a protein was also observed in epithelial cells and in BALT lymphocytes.
Effects of Sendai virus infection on TNF-a protein levels in BAL fluid
TNF-a protein levels in the BAL fluid harvested from infected BN rats at 7 dpi
were elevated at 346.7 ± 47.5 pg/ml (mean ± sem) compared to 55.83 ± 36.38
pg/ml for infected F344 rats (p<0.05). At 10 dpi, the levels of TNF-a protein
were not significantly different between the two rat strains (BN = 104.7 ± 24.3
pg/ml, F344 = 74.5 ± 41.5 pg/ml).

67
Discussion
The deposition of collagen in bronchiolar walls increases wall thickness and
may be a major factor accounting for persistent increases in airway resistance
observed in BN rats following viral infection.38 ’38 Two main observations of this
study support a potential role for TNF-a in the pathogenesis of this virus-
induced airway fibrosis. First, pulmonary TNF-a mRNA and protein expression
are elevated before the development of bronchiolar fibrosis at 14-30 days after
virus inoculation.33,38 Second, although increases in TNF-a mRNA and protein
were induced by viral infection in both rat strains, higher and more prolonged
TNF-a gene expression was observed in the rats that develop bronchiolar
fibrosis (BN) compared with that in the rats that do not (F344).
These observations are similar to those made in studies of chemically-
induced airway fibrosis in which susceptiblity and resistance to the development
of bleomycin-induced pulmonary fibrosis in mice was associated with the level of
TNF-a expression. As was observed in the virus-susceptible and -resistant rats
in this study, mice with a high level of TNF-a expression after exposure
developed fibrosis, while those exhibiting a low level did not.109 The significance
of elevated TNF-a mRNA and protein in the pathogenesis of pulmonary fibrosis
has been demonstrated in rodent studies in which both the development of
bleomycin-induced pulmonary fibrosis and the lesions of silicosis were
prevented by the adminstration of antibodies to TNF-a.1'8,120

68
The results of this study imply that TNF-a is also important in the
pathogenesis of virus-induced airway fibrosis. However, the mechanism of the
increased gene expression is unclear. The initial increase in the amount of
TNF-a mRNA present In whole lung homogenates was observed at 3 days after
inoculation, while Increases in the numbers of cells (mostly macrophages and
fibroblasts) expressing cytoplasmic protein were not noted until 7-10 days post
inoculation. This finding indicates that not all of the Increased expression was
the result of the inflammatory cell Infllltrate, especially since macrophages do not
Infiltrate until 4-5 days after virus-inoculation.37 Epithelial cells and and
lymphocytes In the airway associated lymphoid tissue (BALT) were also positive
for TNF-a mRNA and protein and are the most likely sources of the initial
increase in TNF-a mRNA levels observed in the whole lung homogenates.
Epithelial cells are also the first cells infected by Sendai virus, and the induction
of TNF-a expression may be a direct effect of infection.
Several viruses can directly increase TNF-a mRNA and protein expression.57'
111,112,145,146 |nf|uenza a virus infection of murine macrophages results in a
massive accumulation of TNF-a mRNA, including a unique high molecular
weight transcript that is not translated into protein until the cells are exposed to a
secondary trigger, such as small amounts of endotoxin.143 Although unique
species of TNF-a mRNA were not observed in this study, Sendai virus has been
found to stimulate TNF-a protein production In monocytes57 and direct
upregulation of TNF-a transcription may contribute to the increased expression

69
observed in infected rats. Direct upregulation of TNF-a gene transcription and
translation by Sendai virus infection could also account for some of the
differences in the pathologic responses of BN and F344 rats. Viral replication
persists for several days longer in the lungs of weanling BN rats than in those of
F344 rats.37 Persisting viral replication could be an important stimulus for
prolonged cytokine expression and result in airway fibrosis in BN rats.
The mechanism by which TNF-a contributes to the development of
pulmonary fibrosis is not completely understood. TNF-a can upregulate the
Inflammatory response through its ability to activate macrophages, stimulate
lymphocyte proliferation, and increase the adhesion of both neutrophils and
eosinophils.147 '48 It has also been shown to induce necrosis of alveolar
epithelial and endothelial cells when given intravenously."9,149 Both of these
effects contribute to the development of fibrosis by increasing the extent of
tissue damage. In addition, TNF-a can directly stimulate fibroblast proliferation
and collagen deposition, and induce the expression of other fibrogenic cytokines
such as PDGF.130
Recently, it has been found that pulmonary platelet trapping strongly
correlates with collagen deposition in bleomycin-induced pulmonary fibrosis.119
The same study also found that antibodies to TNF-a, as well as other treatments

70
mediate the development of fibrosis.119 The importance of platelet trapping in
the pathogenesis of Sendai virus-induced bronchiolar fibrosis is uncertain.
Elevations in pulmonary TGF-P mRNA and protein expression were found in the
infected susceptible BN rats, but the increases were associated with the peak
macrophage infiltration at 7 days after inoculation, and pulmonary PDGF mRNA
levels were not increased by viral infection.
The results of this study demonstrate that virus-induced bronchiolar TNF-a
gene expression precedes bronchiolar mural fibrosis and suggest that it may
play an important pathogenetic role in bronchiolar fibrosis and the associated
airway function abnormalities.

71
18s -
[ SHAM ] [ 3 DPI ] [ 7 DPI ]
TNF-a
Figure 4-1: Northern blot of rat pulmonary total RNA hybridized with a 32P-
labeled cDNA probe for rat TNF-a. This blot contains pulmonary RNA extracted
from sham-inoculated F344 rats at 7 days after inoculation (Sham), and from
virus-inoculated F344 rats at 3 & 7 days after inoculation. Each lane was loaded
with 20 pg of RNA from an individual animal. The upper panel shows the
ethidium bromide-stained gel.

72
8
c
CD
T3
C
-O
<
cr
E
Days After Inoculation
Figure 4-2: Graphic presentation of the results of Northern analysis for
TNF-a. Data points and bars represent the mean % maximum relative
optical band density (ROD) and standard error of the mean (SEM) for
4-6 rats. The maximum ROD for each blot was determined from
positive control RNA. Statisical comparisons of ROD’S were only made
between bands from sham- and virus-inoculated rats present on the
same autoradiograph.

73
Figure 4-3: TNF-a mRNA in bronchiolar macrophages. These serial sections
were taken from a virus-inoculated BN rat at 7 days after inoculation. The top
section was incubated with 50 ng of a digoxigenin-labeled antisense riboprobe
for rat TNF-a and the bottom with 50 ng of the digoxigenin-labeled sense
riboprobe (x600).

74
Figure 4-4: TNF-a protein in bronchiolar macrophages. Both micrographs are of
sections taken from a virus-inoculated BN rat at 7 days after inoculation. The
upper section was incubated with 0.001 mg/ml normal rabbit sera and the lower
with 0.001 mg/ml polyclonal rabbit anti-mouse TNF-a (x600).

Days After Inoculation
Figure 4-5: Density of bronchiolar mural macrophages expressing
TNF-a protein. Data points represent group mean + SEM (n=4).

Figure 4-6: Density of bronchiolar fibroblasts expressing TNF-a
protein. Data points represent group mean + SEM (n=4).

CHAPTER 5
FIBROBLAST PROLIFERATION IN THE DEVELOPMENT OF SENDAI VIRUS-
INDUCED BRONCHIOLAR FIBROSIS IN BN RATS IS INHIBITED BY A
SOLUBLE TNF RECEPTOR
Summary
Sendai virus infection in virus-susceptible BN rats induces bronchiolar
fibrosis associated with airway hyperresponsiveness and persistent increases in
airway resistance. This study investigated the significance of TNF-a in the
pathogenesis of Sendai virus-induced bronchiolar fibrosis by determining
whether the numbers of proliferating bronchiolar fibroblasts induced by virus
infection could be reduced by inhibition of TNF-a bioactivity. Virus-susceptible
BN rats were treated with a 55 kD soluble TNF receptor-immunoglobulin G
fusion protein (p55sTNFR-lgG) following either sham- or virus-inoculation.
Control sham- and virus-inoculated animals were treated with human IgG.
Proliferating bronchiolar fibroblasts were labeled with bromodeoxyuridine
(BrdU), detected by immunocytochemical staining and quantitated. At 8 to 9
days after virus-inoculation, rats treated with p55sTNFR-lgG had decreased
numbers of bronchiolar fibroblasts incorporating BrdU compared to virus-
77

78
inoculated IgG-treated rats (p<0.05). There was significantly increased mortality
in p55sTNFR-lgG-treated virus-inoculated rats associated with increased viral
replication and decreased numbers of macrophages and lymphocytes (p<0.05),
in bronchioalveolar lavage fluid. In conclusion, TNF-a is an important mediator
of bronchiolar fibrosis and has a critical role in the termination of Sendai viral
replication in the lung.
Introduction
Viral bronchiolitis in early childhood is associated with the development of
chronic respiratory disease and has been identified as a risk factor for the
development of asthma.2-6 After Inoculation with parainfluenza virus type I
(Sendai), weanling rats develop persistent increases in airway resistance,
decreased dynamic compliance and airway hyperresponsiveness; and are a
useful model to determine which genetic, inflammatory and immunological
factors are important in the pathogenesis of virus-induced airway
abnormalities.18, ”■35-38
The development of virus-induced pulmonary function abnormalities in
rats is determined by age at infection and genetic susceptibility.18,35-38 Neonatal
and weanling Brown Norway (BN) rats are susceptible to persistent virus-
induced alterations in pulmonary structure and function. Fischer 344 (F344) rats
are resistant.18,35-38 Bronchiolar inflammation composed of aggregates of

79
macrophages, mast cells and eosinophils, and bronchiolar mural fibrosis38 is
associated with the virus-induced abnormalities in pulmonary function.
Bronchiolar mural fibrosis and the resulting airway thickening is prominent in
BN rats 15 to 30 days after being infected with Sendai virus.38 Airway modeling
studies have shown that the dynamics of increased airway resistance can be
profoundly affected by mural fibrosis since even moderate amounts of airway
wall thickening can greatly accentuate airway luminal narrowing during smooth
muscle contraction.24 Bronchiolar fibrosis is a common finding in asthmatics,22,23
and has been linked to airway obstruction.
The pathogenesis of airway fibrosis is poorly understood, however, tumor
necrosis factor-a (TNF-a) has been implicated as an important mediator of
chemically-induced pulmonary fibrosis.109,118,120 In models of both silica- and
bleomycin-induced pulmonary fibrosis, the administration of antibodies to TNF-a
prevented the development of fibrotic lung lesions.118,120 In the silicosis model,
lung lesions were also enhanced by the infusion of recombinant TNF-a.120
The results of previous studies indicate that the development of Sendai virus-
induced bronchiolar fibrosis in BN rats is preceded by prolonged increases in
pulmonary TNF-a mRNA, and increases in the numbers of bronchiolar
macrophages and fibroblasts expressing TNF-a protein (see Chapter 4). The
objective of this study was to determine whether the inhibition of TNF-a
bioactivity during Sendai virus infection would prevent the development of
bronchiolar fibrosis in BN rats. Since preliminary studies indicated that

80
increases in the number of proliferating bronchiolar fibroblasts precede the
development of Sendai virus-induced airway fibrosis, bronchiolar fibroblast
proliferation was used as an indicator of fibrosis. The bioactivity of TNF-a was
inhibited using a fusion protein composed of the soluble part of the p55 TNF
receptor linked to the human IgG heavy chain constant region, a construct that
has been successfully used to block TNF activity in animal models of
endotoxemia.150'152
Materials and Methods
Animals. Infection Protocol
Twenty-two day old weanling male BN rats were purchased from Fiarían
Sprague Dawley Inc., Indianapolis, IN. They were negative for serum antibodies
to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat virus, and
sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic bacteria.
The sham- and virus-inoculated groups were separated and housed in
individually ventilated isolation units located in separate rooms. Three days
after arrival, the rats in the virus-inoculated groups were exposed to
parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units (PFU) per ml of gas for 15 minutes as previously described.32 33 Sham-
inoculated rats were exposed to sterile chorioallantoic fluid (CAF).

81
Experimental Design
One group of eighteen 25-day-old, male BN rats were inoculated with Sendai
virus, while a second group of 12 were sham-inoculated with CAF. Six rats from
the sham and 9 from the virus-inoculated rats were injected intraperitoneally (ip)
with 10 mg/kg of p55 sTNFR-IgG fusion protein (generously supplied by
Hoffman- La Roche, Basel, Switzerland) on 0, 2, 4, 6, & 8 days post inoculation
(dpi). The remaining animals: 6 sham-inoculated and 9 virus-inoculated rats,
were injected ip withIO mg/kg of human IgG according to the same schedule.
Three rats from each of the virus-inoculated groups were sacrificed at 7 dpi.
The rest of the rats were given 200 pg/g 5-bromo-2' -deoxyuridine (BrdU, Sigma,
St Louis, MO, 2 mg/ml in PBS) ip 12 hours before they were processed at 9 dpi
(Figure 2-2).
In a separate infection run, an additional group of 12 virus-inoculated rats
received 1 mg/kg of p55 sTNFR-IgG on the same schedule as above. These
animals were injected with BrdU 12 hours before being sacrificed at 7 dpi (n=6)
and 8 dpi (n=6). All rats were anesthetized with sodium pentobarbital
(approximately 200 pg/g body weight) and were killed by exsanguination via
intra cardiac puncture. Bronchoalveolar lavages (BAL) were performed, and the
lungs were fixed by tracheal perfusion with 4% paraformaldehyde at 30 cm H20
pressure for 2 hours.

82
Bronchoalveolar Lavage
Phosphate-buffered saline (PBS) was used to perform bronchoalveolar
lavage (BAL) as previously described.153 Total cell counts were made using a
hemacytometer. Cytocentrifuge cell samples of lavage fluid were made with a
Cytospin 2 (Shandon Southern Instruments, Inc, Swickley, PA), fixed in
methanol, and stained with Giemsa solution. A cell differential was calculated
after evaluating 200 cells. Total cell numbers recovered per lung were
calculated (macrophages, neutrophils, and lymphocytes) and normalized per
100 g body weight. The levels of TNF-a protein and bioactivity in the BAL fluid
were determined as described below.
TNF-a Protein and Bioassavs
The amount of TNF-a protein present in the BAL fluid samples was
determined using an enzyme-linked immunoabsorbance assay (ELISA) kit
(Biosource International Inc. Camarillo, CA) performed according to the
manufacter’s instructions. The level of TNF-a bioactivity in BAL fluid samples
was determined by cytotoxicity assays.154-156 Briefly, 50,000 cells from the
mouse cell line Wehi 164, a BALB/c fibrosarcoma156 were plated per microtiter
well in 200 pi RPMI media with Glutamine, penicillin (50 lU/ml) streptomycin (50
mcg/ml) and incubated over-night at 37°, 5% C02. Eighty pi of a 1.2 pg/ml

83
actinomycin D/RPMI solution, followed by 20 of the appropriate standard or
sample was then added to each well and the plates were incubated over-night at
37°, 5% C02. Ten //I of a freshly prepared 6 mg/ml MTT solution in RPMI was
then added to each well and the plates were incubated for 4 hours at 37°, 5%
C02. At the end of this incubation, 100 tú of 2-propanol was added to each
well, the plates were shaken at room temperature for 30 min, and 100 pi of
water/well was added. The optical densities of the standard and sample wells
was read at 570/690 nm, and the amount of TNF-a bioactivity present in the
samples was determined from the standard curve.
BrdU Labeling
Four transverse sections were taken from the fixed left lungs of rats treated
with BrdU. Sections were taken at the hilus, between the hilar section and the
cranial lung margin, and at points equidistant caudal to the hilar section and
cranial to the caudal lung margin. Tissue blocks were embedded in paraffin the
same day. Five pm-thick sections were cut, mounted on slides, deparaffinized in
xylene, rehydrated, and washed in distilled water. Immunocytochemical staining
for BrdU was performed using a method modified from that previously
described.157 Slides were placed in 3.0% H202 for 10 minutes to quench
endogenous peroxidase, washed twice in PBS, and pretreated in both 2N HCI
(30 min, 37° C) and 0.1 % w/v trypsin in PBS (20 min, 37° C). Sections were

84
rinsed in PBS, covered with antibody diluent (1.0% BSA and 0.5% Tween 20 in
PBS) for 30 min to block nonspecific binding, blotted and incubated for 1 hour in
mouse anti-BrdU monoclonal antibody (Becton-Dickinson, Mountain View, CA)
diluted 1:100 in antibody diluent. Sections were washed and covered with
peroxidase-conjugated goat anti-mouse IgG (Fc specific, Sigma, St Louis, MO)
diluted 1:100 in antibody diluent for 1 hour. Bound peroxidase-conjugated
antibody was detected by development in the chromogen diaminobenzidine
(Sigma, St. Louis, MO) in 0.25 mg/ml in 0.025 M Tris, pH 7.6 and 0.01% H202 for
20 min. The slides were counter-stained with hematoxylin and eosin.
Virology
Following bronchoalveolar lavage, the right lungs of virus-inoculated rats
treated with 1 mg/kg of p55 sTNFR-IgG were collected aseptically, frozen in
liquid nitrogen, and stored at -80° C until viral assays were run. Plaque assays
for infectious virus were performed on lung homogenates using Madin-Darby
bovine kidney cells as previously described.32 The presence of viral antigens in
paraffin-embedded lung sections from infected p55sTNFR-lgG-treated rats was
detected by immunocytochemistry. Tissue sections were pretreated as
described above for the detection of BrdU, and incubated with a mouse
monoclonal antibody to parainfluenza type 1 virus (Chemicon, Temecula, CA).
Application of peroxidase-conjugated Cappel goat anti-mouse antibody and the

85
detection of bound peroxidase-conjugated antibody was performed as described
above.
Data Analysis
Fibroblast proliferation was assessed by counting the number of BrdU-
labeled bronchiolar fibroblasts in 100 high power (400X) fields per lung. Cells
counted as fibroblasts had elongated spindloid profiles, oval nuclei, and
eosinophilic cytoplasm. Only cells with nuclei within the plane of section were
counted. Mean values between groups were compared by one-way analysis of
variance (one-way ANOVA) using a microcomputer-based statistical program
(SigmaStat, Jandel Corporation, San Rafael, CA). Differences between
individual means were assessed by Bonferroni's method of all pairwise multiple
comparison.142 BAL fluid data were subjected to logarithmic transformation prior
to analysis.
Results
p55sTNFR-lgG Inhibits Virus-induced Proliferation of Bronchiolar Fibroblasts
Nine days after virus-inoculation, the mean number of BrdU-labeled
fibroblasts in the bronchiolar walls of virus-inoculated, p55sTNFR-lgG-treated

86
rats was significantly lower than that of virus-inoculated IgG-treated controls
(p55sTNFR-lgG: 12.3 ± 2.3, IgG: 48.7 ± 5.2, p<0.05) (Figure 5-1). Virus-
inoculated IgG-treated rats also had higher numbers of BrdU-labeled bronchiolar
fibroblasts than the sham-inoculated rats (p<0.05). The number of labeled
fibroblasts in the virus-inoculated p55sTNF-lgG treated rats was not significantly
different from that of the sham-inoculated rats. The numbers of BrdU-labeled
bronchiolar fibroblasts in the p55sTNF-lgG and IgG treated sham-inoculated rats
were not significantly different.
Bronchoalveolar Lavage Fluid: TNF-g Protein and Bioassavs
The mean pg/ml of TNF-a protein in the BAL fluid of virus-inoculated
p55sTNFR-lgG-treated rats was over four-fold higher than that of the virus-
inoculated IgG-treated rats at 7 days after inoculation (p< 0.003, Figure 5-2).
However, the level of TNF-a bioactivity in the BAL fluid of virus-inoculated rats
treated with 10 mg/kg of p55sTNF-lgG was significantly lower at 7 dpi than that
present in the virus-inoculated IgG-treated controls (p55sTNF-lgG: 2.5 ±1.41
pg/ml, IgG: 95.5 ±54.58 pg/ml, mean ± sem, p<0.05) (Figure 5-3). TNF-a
bioactivity was also decreased in the virus-inoculated rats treated with 10 mg/kg
p55sTNF-lgG at 9 dpi, but the means between the two virus-inoculated groups
were not significantly different. The virus-inoculated rats given 1 mg/kg
p55sTNF-lgG also had decreased, but not significantly lower, TNF-a bioactivity

87
in their BAL fluid at 7 dpi compared to the IgG-treated virus-inocuiated rats (data
not shown). At 9 dpi, the surviving virus-inoculated rats in the 1 mg/kg
p55sTNF-lgG treated group had slightly but not significantly increased levels of
TNF-a bioactivity in their BAL fluid (data not shown). TNF-a bioactivity was not
detected in the lavage fluid of any of the rats in the sham-inoculated groups
(Figure 5-3).
Bronchoalveolar Lavage Fluid: Cell Counts
The data from total and differential cell counts performed on BAL fluid
samples are presented in Figures 5-4, 5-5, 5-6, 5-7. The counts from the virus-
inoculated low and high dose p55sTNFR-lgG-treated groups were pooled.
Virus-inoculated rats treated with p55sTNF-lgG had 3.5 fold fewer total cells/g
present in their BAL fluid at 7 days after inoculation compared to virus-
inoculated rats receiving IgG (p55sTNF-lgG: 12714 ± 2004 IgG: 44886 ± 5415,
mean ± sem, p<0.05). Sixfold decreases in total cell numbers were present at 9
days after inoculation (p55sTNF-lgG: 8217 ± 1542, IgG: 52782 ± 13632, p<0.05)
(Figure 5-4). Differential counts at seven days after inoculation, revealed virus-
inoculated p55sTNF-lgG treated rats had fivefold fewer numbers of
macrophages/g (p55sTNF-lgG: 4036 ± 720, IgG: 20981 ± 2433, p<0.05) and
almost sixfold fewer lymphocytes/g (p55sTNF-lgG: 586 ± 145, IgG: 3948 ± 1371,
p<0.05) in their BAL fluid compared to virus-inoculated IgG-treated rats (Figures

88
5-5 & 5-6). Ninefold fewer numbers of macrophages (p55sTNF-lgG: 2674 ± 384,
IgG: 26153 ± 6042, p<0.05) and fourteen-fold fewer lymphocytes (p55sTNF-lgG:
233 ± 66, IgG: 3381 ± 1068, p<0.05) were observed at 9 days after virus-
inoculation (Figures 5-5 & 5-6). Neutrophil counts were also two- and sixfold
lower in the p55sTNF-lgG treated virus-inoculated rats at 7 and 9 dpi
respectively, however the difference was not statistically significant (Figure 5-7).
The virus-inoculated, IgG-treated rats had more total cells, with increased
numbers of macrophages, lymphocytes, and neutrophils in their BAL fluid than
did the rats in either of the sham-inoculated groups (p<0.05). In contrast, virus-
inoculated, p55sTNF-lgG treated rats did not have increased numbers of
macrophages or lymphocytes in their BAL fluid compared to the sham-inoculated
rats. However, they did have increased numbers of neutrophils compared to
both groups of sham-inoculated rats, and higher total cell numbers than the
p55sTNF-lgG treated sham-inoculated rats (p<0.05). There were no significant
differences in the BAL fluid total or differential cell counts between the p55sTNF-
IgG and the IgG-treated sham inoculated rats.
Increased Mortality and Pulmonary Lesions in the Sendai Virus-Inoculated
p55sTNF-lqG Treated Rats
All of the virus-inoculated rats treated with 10 mg/kg p55sTNF-lgG died or
were found moribund and were sacrificed 8-9 days after virus-inoculation. Four

89
of the six virus-inoculated rats given 1 mg/kg p55sTNF-lgG also died 8-9 days
after virus-inoculation. Three rats from these two groups (one received 10
mg/kg, two were treated with 1 mg/kg) were labeled with BrdU. Unexpected
mortality did not occur in the other experimental groups. Compared to virus-
inoculated control animals, many of the airways in the virus-inoculated
p55sTNFR-lgG-treated rats were characterized by hyperplastic bronchiolar and
alveolar epithelial cells, which were heavily labeled in the BrdU-stained sections.
Virus-inoculated p55sTNFR-lgG rats also had subjectively fewer inflammatory
cells with proportionally fewer lymphocytes than the virus-inoculated controls.
Viral antigens were detected in the hyperplastic epithelial cells using
immunocytochemistry.
Pulmonary Viral Titers
The virus-inoculated rats treated with 1 mg/kg of p55sTNFR-lgG had mean
pulmonary viral titers that were 5-fold higher at both 7 and 9 dpi than those of
comparable groups of untreated virus-inoculated rats (Figure 5-8), however the
increase did not reach statistical significance.
Discussion
TNF-a has been implicated as an important mediator in the pathogenesis of
the pulmonary fibrosis induced by pneumotoxins such as silica and

90
bleomycin.109"8,120 This study investigated the significance of TNF-a in a rat
model of virus-induced bronchiolar fibrosis. We wanted to determine whether
inhibition of TNF-a bioactivity in virus-inoculated BN rats abrogated virus-
induced increases in bronchiolar fibroblast proliferation. Fibroblast proliferation
precedes virus-induced bronchiolar fibrosis, and is a well-characterized effect of
TNF-a.158
Although the results of this study are complicated by the profound effects the
inhibition of TNF-a bioactivity had on the immune/inflammatory response to the
virus, treatment with p55sTNFR-lgG blocked TNF-a activity and partially blocked
the virus-induced BrdU incorporation. Significantly fewer bronchiolar fibroblasts
were labeled with BrdU in the virus-inoculated p55sTNFR-lgG-treated rats
compared to the number labeled in the IgG-treated virus-inoculated animals.
This is consistent with the interpretation that TNF-a is stimulating fibroblast
proliferation.
The results of the TNF-a bioassays on BAL fluid from the virus-inoculated,
p55sTNFR-lgG-treated animals confirm that p55sTNFR-lgG did effectively
inhibit TNF-a’s biological activity, even though TNF-a protein levels as detected
by ELISA were elevated. The increased protein levels in the p55TNFR-lgG-
treated rats was probably due to decreased rate of breakdown of the bound
inactivated protein. The low level of TNF-a bioactivity observed at 9 days after
virus-inoculation in the rats given the low dose of p55sTNFR-lgG (1 mg/kg)
indicates that TNF-a was not completely inhibited in these animals at this dose.

91
The mechanism by which TNF-a may be inducing fibroblast proliferation in
this model is unclear. TNF-a is a mitogen for certain fibroblasts,158 and could
therefore be directly stimulating bronchiolar fibroblast proliferation. TNF-a could
also be affecting fibroblast proliferation indirectly through several different
mechanisms. It is a potent activator and chemoattractant for macrophages,111'159
and induces expression of adhesion molecules for platelets,119 both of which are
important sources of other fibroblast mitogens such as transforming growth
factor-p (TGF-P), and platelet-derived growth factor (PDGF). The results of
previous studies have identified an influx of macrophages expressing TGF-p,
mRNA and protein into bronchioles as a prominent feature of rats developing
virus-induced bronchiolar fibrosis (see Chapter 3), and the depression in
macrophage numbers observed in the BAL fluid of the infected p55sTNFR-lgG-
treated rats confirms that TNF-a is critical to the virus-induced macrophage
recruitment. Other indirect effects of TNF-a on fibroblast proliferation and the
development of bronchiolar fibrosis include its ability to increase the expression
of adhesion molecules for both neutrophils and eosinophils,111,112 and to depress
fibrinolysis.73 These effects enhance the inflammatory response, increase the
extent of tissue damage, and therefore contribute to fibroblast proliferation and
fibrosis.
TNF-a is a potent antiviral cytokine.159-166 The results of in vitro studies using
several different cell and virus systems indicate TNF-a has both the ability to
enhance the killing of virus-infected cells and protect uninfected cells from

92
infection.159,160,166 In addition, several viruses produce virulence factors that
specifically inhibit TNF-a.163-165 For example, adenoviruses inhibit the action of
TNF by blocking signal transduction from its receptor163 while several pox
viruses contain genes that encode a soluble TNF receptor similar to the one
used in this study.164 TNF-a is also able to activate macrophages independent
of T and B cells in murine cytomegalovirus and herpes simplex virus
infections.162
The importance of TNF-a in the inflammatory response to Sendai virus
infection is indicated by the high mortality in the virus-inoculated, p55sTNFR-
IgG-treated rats. The increased mortality was associated with significant
reductions in the numbers of macrophages and lymphocytes in the BAL fluid, the
tendency towards higher pulmonary viral titers and the presence of numerous
hyperplastic epithelial cells that were positive for viral antigens. These findings
suggest that inhibition of TNF-a activity decreased the inflammatory cell
response to the virus, prevented the destruction of infected epithelial cells and
allowed prolonged viral replication. Paradoxically, however, BN rats have
prolonged elevations of pulmonary TNF-a expression but also higher pulmonary
viral titers compared to Fischer 344 rats, which are resistant to virus-induced
airway abnormalities.37 These observations suggest that TNF-a may be
protective early in the course of Sendai virus infection, while prolonged
expression may be harmful.
There is evidence that the role of TNF-a in T-cel I-mediated inflammation is

93
dependent upon the Th1/Th2 cytokine profile. In studies using Mycobacterium
tuberculosis in dosing protocols designed to elicit a predominantly Th1
response, TNF-a was found to act as an additional macrophage-activating
factor.167 However, when the dosing regime was altered to elicit a predominantly
Th2 response, TNF-a contributed to tissue damage.167 Studies using T cells
stimulated by individual proteins of respiratory syncytial virus to secrete either a
Th1 or Th2 cytokine profile indicate that different forms of viral bronchiolitis can
be caused by functionally distinct types of antiviral T cells.166 These findings
imply that the underlying cytokine profile may determine the role of TNF-a in
viral pathogenesis and may explain the higher viral titers observed in BN rats in
the face of high pulmonary expression of TNF- a.
In conclusion, the results from this study indicate that TNF-a is a potentially
important mediator of virus-induced bronchiolar fibrosis, and is critical to the
immune/inflammatory response to parainfluenza type-1 infection.

Figure 5-1: Density of BrdU-labeled bronchiolar mural fibroblasts in
sham- and virus-inoculated BN rats (n=5 or 6 for sham and infected
IgG-treated groups; n=3 for the infected p55sTNFR-lgG-treated group).

95
Figure 5-2: TNF-g protein levels in the BAL fluid of infected BN rats as
determined by ELISA. Data points represent group means + SEM
(n=3).

96
1-10
120
g 100
DI
80
f
LL
Z 60
40
20
0
Sham Virus: 7 dpi Virus: 9 dpi
mm igG
I 1 TNFR
Mean + SE
Figure 5-3: TNF-a bioactivity in BAL fluid samples from sham- and
virus-inoculated groups treated with 10 mg/kg IgG or 10 mg/kg
p55sTNFR-lgG (n=4 or 6 for the IgG-treated infected and the sham-
inoculated groups; n=3 for the p55sTNFR-lgG-treated infected group).

97
Figure 5-4: The effect of p55sTNFR-lgG on BAL fluid total cell counts
from virus- and sham-inoculated BN rats (n=6).

98
Figure 5-5: Effects of p55sTNFR-lgG on the numbers of macrophages
in BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5
for the 10 dpi sham-inoculated groups, and 8-9 for the infected
p55sTNFR-lgG-treated groups).

99
g. 4000 -
E 3000 -
>.
_l
*—
o
W 2000
a>
a
E
= 1000
IgG
TNFR
Mean + SE
* p <0.05
i <0.05
Sham Vims: 7 dpi Vims: 9 dpi
Figure 5-6: Effects of p55sTNFR-lgG on the numbers of lymphocytes in
BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5 for
the 10 dpi sham-inoculated groups, and 8-9 for the infected p55sTNFR-
IgG-treated groups).

100
O)
!E
CL
£
3
O
W
£>
E
3
igG
TNFR
Mean + SE
Sham Virus: 7 dpi Virus: 9 dpi
Figure 5-7: Effects of p55sTNFR-lgG on the numbers of neutrophils in
BAL fluid samples (n=3 for the 7 dpi IgG-treated infected group, n=5 for
the 10 dpi sham-inoculated groups, and n=8-9forthe infected
p55sTNFR-lgG-treated groups).

Days After Inoculation
Figure 5-8: Pulmonary viral titers of infected control and p55sTNFR-
IgG-treated rats.

CHAPTER 6
SENDAI VIRUS DIRECTLY UPREGULATES TUMOR NECROSIS FACTOR-a
(TNF-a), BUT NOT TRANSFORMING GROWTH FACTOR-P, (TGF-p,) GENE
EXPRESSION IN RAT ALVEOLAR MACROPHAGES
Summary
Parainfluenza virus type I (Sendai) infection in rats induces bronchiolar
fibrosis associated with persistent pulmonary functional abnormalities, and is
being studied as a model of virus-induced airway abnormalities. Rats
susceptible to Sendai virus-induced bronchiolar fibrosis (BN) have prolonged
elevations in pulmonary TNF-a and TGF-p, mRNA and increased numbers of
bronchiolar macrophages and fibroblasts expressing TNF-a and TGF-p, protein
compared to rats that are resistant (F344). The objective of this study was to
determine if at least part of the upregulation of TNF-a and TGF-p, gene
expression in macrophages observed in vivo was directly induced by viral
infection. A rat alveolar macrophage cell line (NR8383) was inoculated with
Sendai virus, and the levels of TNF-a and TGF-p, mRNA and protein were
determined at 4, 8, 24, 48, and 72 hours after virus- or sham-inoculation. TNF-a
mRNA and protein were not detected in the sham-inoculated cells, while in the
virus-inoculated cells both mRNA and protein levels were significantly elevated
102

at 24, 48, and 72 hours after virus-inoculation (p<0.05). Cells incubated with
UV-inactivated virus and virus-inoculated cells incubated with actinomycin-D
also did not have any detectable TNF-a mRNA (p<0.05) 24 hours after
103
inoculation. TGF-p, mRNA was present in the sham-inoculated cells. The level
of expression was increased in the virus-inoculated cells at 72 hours after
inoculation (p< 0.05). TGF-p, protein levels were not significantly elevated over
those of the controls at 48 or 72 hours after virus-inoculation. In conclusion,
Sendai virus can directly upregulate TNF-a mRNA and protein expression in rat
alveolar macrophages by a mechanism that requires infectious virus. The virus-
induced upregulation of pulmonary TGF-p, mRNA and protein expression may
be mediated by indirect mechanisms.
Introduction
Parainfluenza type I (Sendai) virus infection in rats is an animal model of
virus-induced airway abnormalities including persistent increases in airway
resistance and airway hyperresponsiveness.18'33'36-38 Previous studies have
associated the development of virus-induced bronchiolar fibrosis in susceptible
Brown Norway (BN) rats with increased expression of TNF-a and TGF-p, in
bronchiolar macrophages, and have established TNF-a as an important
mediator of bronchiolar fibrosis (see Chapters 3, 4, & 5). Expression of TNF-a
and TGF-p is induced by a variety of stimuli, and is controlled by a complex

104
network of mediators acting both transcriptionally and post-transcriptlonally.111,
149, íes Qjrect upregulation of mRNA and protein by viral proteins has been
demonstrated for both of these cytokines and has been implicated as a
potentially important pathogenic mechanism in several viral diseases.57,105 170
For example, cytomegalovirus (CMV) induction of TNF-a in mucosal
macrophages may be a critical factor in CMV-induced inflammation;10 and the
induction of TGF-p production by bone marrow macrophages by the tat protein
of human immunodeficiency virus-1 is a potential mechanism for the
hematopoietic suppression associated with acquired immunodeficiency
syndrome.105
Viruses can also prime cells for the production of cytokine protein. Influenza
A virus infection in murine macrophages induces the accumulation of large
amounts of TNF-a mRNA, including a unique high molecular weight transcript,
that is not translated into protein until cells are exposed to small amounts of
endotoxin.59 114 While Sendai virus has been demonstrated to upregulate TNF-a
gene expression in human monocyte cell lines,57,171 the correlations between
mRNA and protein levels have not been investigated. The effects of Sendai
virus on TGF-p, expression has not been characterized. The objectives of this
study were: 1) to determine whether Sendai virus-inoculation directly increased
TNF-a and/or TGF-p mRNA and protein levels in a rat macrophage cell line
(NR8383); 2) to determine whether increases in mRNA expression were
associated with increased protein expression; 3) to determine whether viral

105
induction of cytokine gene expression required inoculation with live virus; and 4)
to determine whether any observed increase in cytokine mRNA is due to
transcriptional upregulation.
Materials and Methods
Cell Line and Experimental Protocol
A rat pulmonary alveolar macrophage cell line (NR8383), generously
supplied by Ronald J. Helmke (University of Texas Health Science Center, San
Antonio, TX), was maintained in Ham’s F-12 media (Sigma, St. Louis, MO) with
12% fetal bovine serum (Sigma, St. Louis, MO) and 1% antibiotic/antimycotic
solution (10,000 units penicillin, 10 mg streptomycin and 25 pg amphotericin
B/ml in 0.9% sodium chloride, Sigma, St. Louis, MO). Cells were passaged
twice a week. Baseline infection assays were performed using Sendai virus
strain P3193, produced in embryonated chicken eggs as previously
described,3233 at multiplicity of infection (MOI) of 1:1 and 1:10. Plaque assays
and immunocytochemical staining for viral antigens were performed as
previously described, 32 33 and were used to confirm the presence of productive
infection.
The inoculation protocol for each experiment was as follows: 2 x108 cells
were equally divided and placed into two 50 ml tubes each containing 25 ml of

106
media. One tube was inoculated with Sendai virus (MOI=1:1); the other was
inoculated with an equal volume of sterile chorioallantoic fluid (CAF). Both tubes
were incubated at 37° C, 5% C02, shaking for 1 hour. The cells from each tube
were placed in two T-150 tissue culture flasks (Corning Glass Works, Corning,
NY), resuspended to a total of 25 mis of media and incubated at 37° C, 5% C02.
The virus-inoculated cultures and the CAF-inoculated cultures were kept in
different incubators.
UV-inactivated virus was produced by exposing virus to UV irradiation
overnight. Plaque assays were used to confirm viral inactivation. Cells were
inoculated with inactivated virus at an MOI of 1:1, and cytoplasmic RNA was
extracted 24 hours after virus-inoculation. For the actinomycin-D experiments,
cells were incubated with virus (MOI = 1:1) or CAF for 1 hour as described
above, media containing a final concentration of 5 mg/ml of actinomycin-D
(Sigma, St. Louis, MO) was added, and the cells were incubated at 37° C, 5%
C02) for 24 hours. Cytoplasmic RNA was extracted as described below.
Northern Analysis
Cells were pelleted (500xg, 4° C, 5 min), resuspended in 4 mis of nonidet P-
40 lysis buffer (Sigma, St. Louis, MO), and incubated on ice for 5 minutes.174
Nuclei were pelleted (500xg, 4° C, 5 min) and cytoplasmic RNA was extracted
from the supernatant using 2 mis of TRIzolâ„¢ reagent according to

107
manufacturer's instructions (Gibco BRL Life Technologies, Inc. Gaithersburg,
MD). Cytoplasmic RNA was electrophorectially fractionated on a series of 1.2%
(wt:vol) agarose gels containing 6% (vokvol) formaldehyde, transferred to a
positively charged nylon membrane (Boehringer Mannheim Corporation,
Indianapolis, IN), and fixed by UV-crosslinking. Equality of RNA loading
between lanes was assessed by visually comparing the intensity of ethidium
bromide staining of the gels and membranes, and by re-probing the membranes
with a 32P-dCTP-labeled cDNA probe for p-actin. Band densities were compared
as described below.
cDNA probes for rat TNF-a (generously supplied by Dr. T. Shirai, Laboratory
for Chemical Research, Asahi Chemical Industry Co. Ltd, Tagata-gun, Shizuoka,
Japan), rat TGF-IJ,: a 985 bp cDNA fragment containing the major coding region
of the gene (generously supplied by Dr. Su Wen Quian, Laboratory of
Chemoprevention, NIH Bethesda, MD) and human p-actin (American Type
Culture Collection Rockville, MD) were labeled with “P-dCTP using the random
primer method as described.1''0 Prehybridization (TNF-a and p-actin : 15 min,
58°C; TGF-IJ,: 15 min 65°C) and hybridization (overnight at the same
temperature as prehybridization) was in 0.5 M Na2HP04, 7% SDS, 1% BSA, and
10mM EDTA as described.141 The membranes were washed at the hybridization
temperature in 40mM phosphate (TNF-a and p-actin) or 20 mM phosphate
(TGF-IJ,), 1% SDS, and exposed to Kodak (Rochester, NY) XLS-5 film with
Dupont Cronex intensifying screens. Film band densities were quantified using

108
a computerized video image analysis unit (Image Store 7500, Ultra Violet
Product Ltd San Gabriel, CA).
Protein Assays
The amount of TNF-a and TGF-p, protein present in cell culture supernatants
was determined using enzyme-linked immunoabsorbance assay (ELISA) kits
(TNF-a: Biosource International Inc. Camarillo, CA; TGF-P,: R&D Systems
Minneapolis, MN) performed according to the manufacters’ instructions.
Quantitation Methods and Data Analysis
Cytoplasmic TNF-a, TGF-p,, and p-actin RNA levels were evaluated by
comparing the relative optical densities (ROD) of bands on Northern
autoradiographs. Comparisons of band densities were only made between
bands in RNA run on the same gel. ROD values, TNF-a and TGF-p, protein
levels were normalized to cell counts. Statistical analysis of group means was
performed by one-way analysis of variance (one-way ANOVA) using a computer-
based statistical program (SigmaStat, Jandel Corporation, San Rafael, CA).
Differences between individual means were assessed by Bonferroni’s method of
all pairwise multiple comparison.143

109
Results
NR8383 Cells Support Sendai Virus Replication
Plaque assays confirmed that NR8383 cells could support Sendai virus
replication (Figure 6-1). The highest titers of infectious virus at both MOI=1:1
and 1:10, were present in cell supernatants at 48 hours after virus-inoculation.
Sendai virus-inoculated NR8383 cells were also positive for viral antigens by
immunocytochemical staining (data not shown).
Sendai Virus-Inoculation Induces Increased TNF-a RNA and Protein Levels in
NR8383 Cells
TNF-a mRNA was initially detected in virus-inoculated NR8383 cells at 4 and
8 hours after virus inoculation, and was significantly elevated at 24, 48 and 72
hours after virus inoculation (p<0.05, Figure 6-2). TNF-a mRNA was not
detected in CAF-treated cells at any of the time points studied. There were no
significant differences in the mean relative optical band densities for p-actin
between CAF and virus-inoculated groups (Figure 6-7). The amount of TNF-a
protein in the cell supernatants was significantly elevated in the virus-inoculated
cells 24 hours after inoculation, and was further increased 48 and 72 hours after

inoculation (p<0.05, Figure 6-3). TNF-a protein was not detected in the
supernatants from CAF-treated cells at 48 or 72 hours after virus-inoculation.
110
TGF-B, Cytoplasmic RNA and Protein Levels in Sendai-virus Inoculated NR8383
Cells
At 72 hours after inoculation, there was an over 2-fold increase in the amount
of TGF-p, cytoplasmic RNA in the virus-inoculated cells compared to the level
present in the CAF-treated cells (Figure 6-4, p<0.05). However, TGF-p, protein
levels in cell supernatants from the CAF and virus-inoculated groups were not
significantly different at 48 or 72 hours after inoculation (Figure 6-5). The mean
band densities for p-actin were not significantly different for any of the groups
compared (Figure 6-8).
Effects of UV-inactivated Sendai virus and Actinomvcin-D Treatment on TNF-a
and TGF-P, Cytoplasmic RNA Levels in NR8383 Cells
TNF-a cytoplasmic RNA was not detectable in NR8383 cells incubated with
UV-inactivated Sendai virus 24 hours after inoculation (p<0.05, Figures 6-6 &6-
7). The mean band densities for p-actin did not vary significantly among these
groups (Figure 6-7). Virus-inoculated cells incubated with actinomycin-D also
had undetectable levels of TNF-a RNA (Figure 6-7), however the band densities

111
for (3-actin were also significantly reduced in the actinomycin-D-treated groups
(Figure 6-7). TGF-p, cytoplasmic RNA levels in cells inoculated with UV-
inactivated virus were not significantly different from those of cells incubated
with viable virus or CAF (Figures 6-6 & 6-8). The mean band densities for p-
actin in the UV-inactivated, CAF, and virus-inoculated groups were not
significantly different (Figure 6-8). The mean band densities for TGF-p, and p-
actin in both the CAF- and virus-inoculated groups incubated with actinomycin D
were significantly decreased (data not shown).
Piscussion
Previous studies associated the development of Sendai virus-induced
bronchiolar fibrosis with increased gene expression of TNF-a and TGF-P, in
bronchiolar macrophages (see Chapters 3, 4, 5). The purpose of this study was
to determine if at least part of the virus-induced increases in macrophage
expression of these cytokines was the result of direct upregulation by the virus.
The results indicate that Sendai virus can directly upregulate TNF-a mRNA and
protein levels in macrophages, but direct upregulation of TGF-p, gene
expression is inconsistent.
Several viruses directly stimulate the production of TNF-a mRNA and
protein.170 57'59 Influenza A virus has the ability to prime cells for TNF-a
production by inducing the accumulation of large amounts of TNF-a mRNA

112
(including a unique high molecular weight transcript) that is not translated into
protein until cells are exposed to a second stimulus, such as small amounts of
endotoxin.59'144 In contrast Sendai virus-induced TNF-a mRNA and protein
expression were comparatively increased.
The mechanisms by which viral infections elicit TNF-a gene expression are
not completely understood, but several appear to involve the release of the
transcription factor NF-kB from its inhibitory subunit IkB.173-176 NF-kB initiates
the transcription of numerous genes including those encoding TNF-a, TNF-p,
interleukin 1 (IL-1), IL-2, IL-6 and granulocyte macrophage colony stimulating
factor (GM-CSF).173,174 Activation of NF-kB occurs when it is released from its
inhibitory subunit IkB and is translocated to the nucleus.143 Sendai virus
infection has been associated with decreases in the amount of IkB in
cytoplasmic extracts of infected human renal carcinoma cells,177 and with
increased binding of NF-kB to DNA.176 However, the virus-induced decreases in
IkB levels only lasted from 2-8 hours after infection,175 while in this study TNF-a
mRNA and protein levels were increased out to at least 72 hours after
inoculation. This prolonged increase in gene expression may be related to the
peak in viral replication at 48 hours after inoculation, or may be due to continued
stimulation of TNF-a transcription by either TNF-a itself or some other virus-
induced mediator (ie: IL-1).111
Inoculation of macrophages with UV-inactivated virus did not stimulate the
production of TNF-a mRNA, indicating that infectious virus is necessary for the

113
induction of TNF-a gene expression. Recently, the viral surface hemagglutinin
of murine influenza virus was found to strongly activate NF-kB DNA binding and
transactivation.174 The mechanism by which a structural viral protein could
activate NF-kB is unclear, but it has been postulated to be associated with the
synthesis of large amounts of hemagglutinin during viral infection, since
intracellular accumulation of proteins can activate NF-kB.177 Another proposed
mechanism is the phosphorylation-dependent degradation of IkB by viral
induction of double-stranded RNA-dependent kinase (double-stranded RNA-
dependent kinase has been shown to phosphorylate IkB and induce NF-kB
binding activity).178
The significance of direct viral induction of TNF-a gene expression in the
pathogenesis of Sendai virus infection in rats is unclear, since TNF-a production
is also stimulated by numerous inflammatory and immunological mediators.111
Early induction of TNF-a by virus-induced transcriptional upregulation may be a
critical factor in controlling viral replication and determining the extent of virus-
induced airway damage. In contrast, if viral replication is prolonged, as occurs
in the virus-susceptible BN rats, continued viral induction of TNF-a transcription
may contribute to, or be a stimulus for the prolonged expression of TNF-a that is
associated with the development of Sendai virus-induced bronchiolar fibrosis.
In contrast to TNF-a, TGF-p, gene expression in macrophages does not
appear to be directly upregulated by Sendai virus. Significant increases in TGF-
p, mRNA were not observed until 72 hours after virus-inoculation, which is after

114
the peak in viral replication at 48 hours. Corresponding increases in TGF-p,
protein at 72 hours after virus-inoculation were not observed, suggesting post-
transcriptional regulation of TGF-p, may be occurring, and suggesting that
increases in TGF-p, expression is not a direct effect of Sendai virus infection. At
this stage of viral infection the the death of infected cells and the release of
TNF-a and probably other cytokines such as IL-1, could be indirectly inducing
TGF-p, through activation of macrophages. Elevations in pulmonary TGF-p,
mRNA and increases in the number of bronchiolar macrophages and fibroblasts
expressing TGF-p, protein are associated with the development of Sendai virus-
induced bronchiolar fibrosis in BN rats.
In conclusion, Sendai virus can directly upregulate TNF-a mRNA and protein
expression in rat alveolar macrophages by a mechanism that requires infectious
virus.

115
O 20 40 60 80 100 120 140
Hours After Inoculation
Figure 6-1: NR8383 cells support Sendai virus replication. The highest
titers of Infectious virus were present in cell supernants at 48 hours
after Inoculation.

116
Hours After Inoculation
Figure 6-2: TNF-a cytoplasmic RNA levels in Sendai virus infected
NR8383 cells. Comparisons were only made between RNA samples
run on the same gel. TNF-a bands were not observed in the CAF
treated cells.

300
250
200
150
100
50
0
CAF 48 hr Virus 24 hr Virus 48 hr
Hours After Inoculation 72 Hours After Inoculation
CAF Virus
Figure 6-3: Effects of Sendai virus infection on TNF-a protein levels
NR8383 cell supernatants. TNF-a protein was not detected in the
supernatants from CAF-treated cells.

118
Figure 6-4: TGF-B,cytoplasmic RNA levels in Sendai virus infected
NR8383 cells.

119
48 hre 72 hr
Hours After Inoculation
Figure 6-5: Effects of Sendai virus infection on TGF-p, protein levels in
NR8383 cell supernatants. Data points represent mean + sem (n=5 for
the 48 hour groups, n=2 for CAF at 72 hrs, n=3 for Virus at 72 hrs).

Figure 6-6. Northern analysis for TNF-a and TGF-p, performed on cytoplasmic RNA extract from cells
treated with CAF, UV-inactivated virus and viable virus. Band densities were normalized to cell counts
before analysis.
ro
o

121
24 Hours After Inoculation
Figure 6-7: TNF-a cytoplasmic RNA levels in NR8383 cells treated with
actinomycin-D or inoculated with UV-inactivated virus Sendai virus.

122
= 12
0)
O
o
O 10
B.
O
CAF UV-Virus Virus
24 Hours After Inoculation
Figure 6-8: TGF-p, cytoplasmic RNA levels in NR8383 cells inoculated
with UV-inactivated and viable Sendai virus.

CHAPTER 7
GENERAL SUMMARY
The goal of this research was to identify cytokines critical to the development
of bronchiolar fibrosis following bronchiolitis induced by parainfluenza (Sendai)
virus infection during early life. The hypothesis tested was that bronchiolar
mural fibrosis following viral bronchiolitis is mediated by virus-induced increases
in transcription and/or translation of transforming growth factor-11, (TGF-3,),
platelet-derived growth factor-B (PDGF), and/or tumor necrosis factor-a (TNF-a)
in infiltrating bronchiolar macrophages. This hypothesis was tested by fulfilling 4
specific objectives.
Objective 1: Determine whether Sendai virus-induced bronchiolar fibrosis in
virus-susceptible BN rats is preceded by increased gene
expression of fibrogenic cytokines TGF-P„ PDGF, and/or TNF-a
in macrophages and in other bronchiolar cells.
Northern analysis and protein immunocytochemistry revealed virus-
inoculated BN rats had increases in pulmonary TGF-P, and TNF-a mRNA levels
and higher numbers of bronchiolar macrophages and fibroblasts expressing
123

124
TGF-P, and TNF-a protein starting at 3-7 days after inoculation. These
increases in cytokine gene expression occur before the development of
bronchiolar fibrosis, which develops 15-30 days after virus inoculation.38
Pulmonary PDGF mRNA levels were not elevated in the virus-inoculated BN
rats, and PDGF expression was not assessed in further studies.
Objective 2: Determine whether rats susceptible to virus-induced bronchiolar
fibrosis (BN) have higher cellular expression of fibrogenic
cytokines in bronchioles after virus infection relative to virus-
resistant (F344) rats.
Northern analysis and protein immunocytochemistry demonstrated virus-
inoculated BN rats had prolonged increases in TGF-P, and TNF-a pulmonary
mRNA levels and higher numbers of bronchiolar macrophages and fibroblasts
expressing TGF-3, and TNF-a protein compared to virus-inoculated F344 rats.
Objective 3: Determine if the development of virus-induced bronchiolar fibrosis
in BN rats can be blocked by neutralizing cytokine activity.
Inhibition of the bioactivity of TNF-a in virus-inoculated BN rats resulted in
decreased numbers of proliferating bronchiolar fibroblasts at 9 days after
inoculation. There was also increased mortality associated with blocking TNF-a
during viral infection.

125
Objective 4: Determine whether Sendai virus directly or indirectly induces
gene transcription and/or translation for TGF-p, and TNF-a in
pulmonary macrophages.
Sendai virus infection induced increases in TNF-a mRNA and protein in a rat
alveolar macrophage cell line. This increased gene expression or increased
transcription/stability was not induced in cells incubated with UV-inactivated
virus. In contrast, TGF-p, mRNA was elevated only at 72 hours after virus-
inoculation and protein levels were not increased in the virus-inoculated cells.
The results of these studies support the hypothesis that bronchiolar mural
fibrosis following viral bronchiolitis is mediated by virus-induced increases in
transcription and/or translation of TGF-P, and TNF-a in infiltrating bronchiolar
macrophages. It is concluded that:
1) Sendai virus-induced bronchiolar fibrosis is preceded by increased gene
expression of TGF-P, and TNF-a.
2) Sendai virus directly induces TNF-a mRNA transcription and protein
expression in macrophages.
3) Sendai virus-induced bronchiolar fibrosis is at least partially mediated by
TNF-a.
4) TNF-a has a critical role in the immune/inflammatory response to Sendai
virus in BN rats.

126
Both TGF-p, and TNF-a have wide ranging effects on the immune and
inflammatory response, which means that it would be difficult to try to prevent
airway fibrosis simply by totally blocking their activity. This problem was very
apparent in the high mortality that occurred when TNF-a was inhibited during
the active phase of viral infection. It also means that it is difficult to determine
the exact mechanism by which these cytokines may act to induce bronchiolar
fibrosis. Indeed, the development of virus-induced airway fibrosis is probably
determined by a complex cascade of mediators with numerous potential
pathways.
In spite of the difficulties, there are several approaches that could be taken to
try to further characterize the significance of TGF-P, and TNF-a in the
development of Sendai virus-induced bronchiolar fibrosis. Inhibiting TGF-P, in
experiments similar to those described in chapter 6 would indicate whether TGF-
P, expression is also critical to the development of virus-induced bronchiolar
fibrosis.
Blocking TNF-a activity at different, specific time points over the period of
active viral infection could determine exactly when TNF-a is necessary for
bronchiolar fibrosis to develop. Careful manipulation of the timing or level of
TNF-a inhibition might also make it possible to separate the protective antiviral
effects of TNF-a from its fibrogenic potential. For example, in BN rats, partial
inhibition of TNF-a during the active phase of viral infection between 3-10 days
after inoculation, and blocking prolonged expression from 10-14 days, would

127
produce a pattern of TNF-a expression similar to that observed in the virus-
resistant F344 rats. Assuming TGF-P, expression remained unchanged, the
relative significance of TNF-a would be determined by whether these rats
developed bronchiolar fibrosis.
There also may be significant strain differences in either the magnitude or
duration of TNF-a gene expression directly induced by Sendai virus in infected
cells. Such differences might at least partially account for the differences in
gene expression observed in vivo. Establishing alveolar macrophage cell lines
from both BN and F344 rats, and comparing the levels of TNF-a mRNA and
protein induced by Sendai virus at various time points after inoculation, would
determine if strain differences in TNF-a gene expression exist at the cellular
level.
Finally, the dramatic increase in mortality induced when TNF-a was blocked
during viral infection was an unexpected, but not entirely unpredictable finding in
these studies. The increased mortality was associated with suppression of the
inflammatory response and increased viral replication, but the exact mechanism
behind it was not apparent. Comparative pathogenesis studies using both BN
and F344 rats could be performed to try to elucidate this mechanism, and may
also provide insight into the factors important in the genetic susceptibility and
resistance to viral infections.
In conclusion, the results of these experiments implicate TGF-p, and TNF-a
as important mediators of virus-induced bronchiolar fibrosis. They also

128
demonstrate that Sendai virus can directly upregulate TNF-a expression, and
that TNF-a is critical to the immune/inflammatory response to the virus.

APPENDIX
ATTEMPTED DIGOXIGENIN NUCLEAR RUN ON ASSAYS
Protocol
This protocol was extensively modified from one using 32P outlined by M E.
Greenberg and T.P. Bender in Short Protocols in Molecular Biology. 2nd
Ed. 1992. pp 4-25.
Isolate nuclei and cytoplasmic RNA
1) Pellet the cells from one to five 175-cm2 tissue culture flasks (approx 5 x
107 cells), 5 min at 500xg (1500rpm), 4°C. Remove the supernatant
completely, and loosen pellet by vortexing at half maximal speed for 5 sec.
Gently resuspend cells in 5 ml PBS, add 45 ml PBS, and collect again by
centrifugation. Wash twice more; remove sample to count cells from the
last suspension.
2) Add 4 ml NP-40 lysis buffer, and continue vortexing as buffer is added.
When lysis buffer is completely added, vortex cells at half maximal speed
for 10 sec.
129

130
3) Incubate lysed cells on ice for 5 min, centrifuge 5 min at 500xg, 4°C, and
save supernatant for step 5.
4) Resuspend nuclear pellet (step 3) in 4 ml NP-40 lysis buffer by vortexing
as described in step 2. Centrifuge 5 min at 500 xg, 4°C. Resuspend pellet
in 100 to 200 pi glycerol storage buffer by gently vortexing. Freeze nuclei
in liquid nitrogen (stable for >1 year).
5) Add 2 ml of TRIzol reagent to the supernatant saved in step 3, mix well,
and incubate at RT for 5 min.
6) Add 0.4 ml of chloroform, mix for 15 sec and incubate at RT for 2-3 min.
Centrifuge the samples at no more than 12,000 x g for 15 min at 4° C.
7) Remove colorless upper phase to a fresh 15 ml tube. Add 1 ml isopropyl
alcohol, mix well, and percipitate over night at -80° C.
8) Pellet RNA at 1800 rpm, 30 min, 4° C. Wash in 70% EtOH.
9) Remove EtOH, and allow pellet to dry briefly (do not let the pellet
completely dry out, or it will be hard to get it back into solution). Dissolve
RNA in 100-200 pi autoclaved, millique H20.
Nuclear Run On Transcription Assay
1) Thaw 200 pi frozen nuclei at room temperature and transfer to a 15 ml
polypropylene tube. Immediately add 200 pi of 2 x reaction buffer (250 ml 2
x buffer + 2-20 pi NTP labeling mixture - vial 7, Genius 4). React 30 min at
37°C with shaking.

131
2) Add 1 ml of TRIzol reagent and mix well, and incubate at RT for 5 min.
3) Add 0.2 ml of chloroform, mix for 15 sec and incubate at RT for 2-3 min.
Centrifuge the samples at no more than 12,000 x g for 15 min at 4° C.
4) Remove colorless upper phase to a fresh microfuge tube. Add 0.5 ml
isopropyl alcohol, mix well, and percipitate 15 min at RT.
5) Pellet RNA at no more than 12,000 x g, 10 min, 4° C. Wash in 70% EtOH.
6) Remove EtOH, and allow pellet to dry briefly (do not let the pellet
completely dry out, or it will be hard to get it back into solution). Dissolve
RNA in 100-200 pi autoclaved, millique H20. Use 1:200 (5 pl:995 pi) to
determine RNA yield. Dot 3-5 pi on a strip of membrane and uv-link it to
the membrane. This will be developed along with the NRO as a positive
control.
7) Hybridize RNA to DNA immobilized on strips of nylon membrane (see
below) in 5 ml of Church-Gilbert solution. Incubate hybridization mixture by
shaking in small 5-ml plastic scintillation vials for 24 hr at 37-65°C.
8) Wash each filter 2X in 5 ml of 20 or 40 mM phosphate, 0.1 % SDS for 15
min at 37-65°C.
9) Wet the membrane with a small amount of maleate buffer.
10) Incubate the membrane in 1X blocking solution for 15 min at RT (make 20
ml: 4 ml 5X blocking soln + 16 ml maleate buffer. Use 10 ml here and 10 ml
in step 13).
11) Dilute anti-DIG-alkaline phosphatase (Vial 3, Genius Kit #3) 1:5,000 in 1X

132
blocking solution (2 |jl in 10 ml). Incubate membrane in diluted antibody for
15 min at RT.
12) Wash the membrane twice, 15 min/wash, in maleate buffer at RT.
13) Incubate the membrane In Genius buffer 3 for 2 min.
14) Pour off Genius buffer 3 and add the color substrate solution (10 ml
Genius buffer 3 45 pi NBT + 35 pi X-phos: NBT and X-phos are in
Genius Kit # 4). Allow color development to occur in the dark. Monitor the
progress of the color development occasionally.
15) Once the RNA is detected, wash the membrane with di H20 to avoid over
development. Seal in plastic to prevent drying out.
Bind plasmids to nitrocellulose
1) Linearize cDNA plasmids. Denature DNA (200 pg in 440 pi) with 49 pi of 1
M NaOH 30 min at room temperature. Neutralize with 4.9 ml of 6xSSC and
place on Ice. (Alternative: Boil the DNA for 10 min and incubate in 0.5M
NaOH at 37° C for 20 min. Stop the reaction by equalizing to 0.5 M
ammonium acetate, pH 4.6.
2) Spot DNA onto nitrocellulose filters using a slot blot apparatus, applying 5
pg in 125 pl/slot. Rinse slots with 500 pi of 6xSSC. Remove filter and mark
slot location.
3) UV-link membrane. Pre-hybridize in Church-Gilbert for 15 min at 37-65° C.

133
Table A-1: Digoxigenin Nuclear Run on Assays:
Summary of Results
RUN
CELLS/NUCLEI
RNA
PROBE
INCUBATION
Label:Hybrid
RESULT
1
4x1O'/Untx
TGF-LP (23gg)
2hr/37°:20hr/65°
+:2hr
2
4x107/Untx
+
TGF-IN (5 gg)
2hr/37°:48hr/65°
-:24hr
3
5x107/Untx
—
TGF-LP (16gg)
2hr/37°:24hr/65°
+:2hr
4
2x1 OVLPS & Untx
—
TNF-LP (11 gg)
TNF-PB (11 M9)
2hr/37°:48hr/57“
-:24hr
p-Actin-IN (27 M9)
5
2x107/LPS & Untx
—
TNF-LP (7)
3hr/37°:24hr/57°
-:24hr
TGF-LP (?)
6
2x107/LPS & Untx
160pg/+
TNF-LP (92 gg)
30 mln/37°:24hr/37“
-:24hr
TGF-LP (115 gg)
7
2.7x107/Untx
138pg/+
TGF-LP (92gg)
30mln/37° :24hr/37 °
+:2hr
8
2.7x107/Untx
204(jg/+
TGF-LP (120Mg)
30min/37°:24hr/37“
+:1 wk
9
2.7x107/Untx
*191gg/+
TGF-LP (116gg)
TGF-IN (11 gg)
30mln/37°:24hr/37°
-:24 hr
TGF-BP (116Mg)
'192gg/+
TGF-LP (116gg)
+:24 hr
TGF-IN (11 Mg)
30mln/37“:24hr/37“
-:24 hr
TGF-BP (116M9)
-:24 hr

134
RUN
CELLS/NUCLEI
RNA
PROBE
INCUBATION
LabeLHybrld
RESULT
10
2x107AJntx
*170gg/+
TGF-LP (46pg)
-:24 hr
TGF-IN (11 gg)
30mln/37°:24hr/37°
-:24 hr
TGF-BP (46gg)
-:24 hr
'170pg/+
TGF-LP (46pg)
-:24 hr
TGF-IN (11 |jg)
30min/37°:24hr/37°
-:24 hr
TGF-BP (46pg)
-:24 hr
11
2x107/VIRUS 1:10
'20gg/+
TGF-LP (293gg)
-:24 hr
TNF-LP (290pg)
30mln/37“:24hr/37°
-:24 hr
PB (290gg)
-:24 hr
2x107/CAF
*40pg/+
TGF-LP (293gg)
-:24 hr
TNF-LP (290|jg)
30mln/37 ° :24hr/37°
-:24 hr
PB (290gg)
-:24 hr
Key
Unless indicated 10|jl of digoxigenin labeling mixture was used
*2pl Digoxigenin labeling mixture
'20 gl Digoxigenin labeling mixture
LP: linearized plasmid
IN:lnsert
PB:Plasmid backbone
RNA +: RNA dot blot positive

REFERENCES
1. Bjornsdottir US, Busse WW. 1992. Respiratory infections and asthma.
The Medical Clinics of North America. 76:895-915.
2. Macek V, Sorli J, Kopriva S, Marin J. 1994. Persistent adenoviral
infection and chronic airway obstruction in children. Am J Respir Crit Care
Med. 150:7-10.
3. Sly PD, Hibbert ME. 1989. Childhood asthma following hospitalization
with acute viral bronchiolitis in infancy. Pediatr Pulmonol. 7:153-158.
4. Webb MS, Henry RL, Milner AD, Stokes GM, Swarbrick AS. 1985.
Continuing respiratory problems three and a half years after acute viral
bronchiolitis. Arch Dis Child. 60:1064-1067.
5. Tepper RS, Rosenberg D, Eigen H. 1992. Airway responsiveness in
infants following bronchiolitis. Pediatr Pulmonol. 13:6-10.
6. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Haonen M, Morgan
WJ. Group Health Medical Associates. 1995. Asthma and wheezing in the
first six years of life. New Engl J Med. 332:133-138
7. Bardin PG, Johnston SL, Pattemore PK. 1992. Viruses as precipitants of
asthma symptoms II. Physiology and mechanisms. Clin Exper Allergy.
22:809-822.
8. Hegele RG, Hayashi S, Hogg JC, Pare PD. 1995. Mechanisms of airway
narrowing and hyperresponsiveness in viral respiratory tract infections.
Am J Respir Crit Care Med. 151:1659-1665.
9. Welliver RC, Sun M, Rinaldo D, Ogra PL. 1986. Predictive value of
respiratory syncytial virus-specific IgE responses for recurrent wheezing
following bronchiolitis. J Pediatr. 109:776-780.
10. Volovitz B, Welliver RC, de Castro G, Krystofik DA, Ogra PL 1988. The
release of leukotrienes in the respiratory tract during infection with
135

136
respiratory syncytial virus: role in obstructive airway disease. Pediatr Res.
24:504-507.
11. Frick OL, German DF, Mills J. 1979. Development of allergy in children, I:
association with virus infections. J Allergy Clin Immunol. 63:228-241.
12. Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello S. 1984. Substance
P-immunoreactive sensory nerves in the lower respiratory tract of various
animals including man. Cell Tissue Res. 235:251-261.
13. Barnes PJ. 1987. Neuropeptides in the lung: localization, function and
pathophysiologic Implications. J Allergy Clin Immunol. 79:285-295.
14. Piedimonte G, Nadel JA, Umeno E, McDonald DM. 1992. Sendai virus
infection potentiates neurogenic inflammation in the rat trachea. J Appl
Physiol. 68:754-760.
15. Woolcock AJ. 1988. Asthma - What are the important experiments? Am
Rev Respir Dis. 138:730-744.
16. Folkerts G, Nijkamp FP. 1995. Virus-induced airway hyperresponsiveness
role of inflammatory cells and mediators. Am Rev Respir Crit Care Med.
151:1666-1674.
17. Folkerts G, van Esch B, Janssen M, Nijkamp FP. 1992. Virus-induced
airway hyperresponsiveness in guinea pigs in vivo: study of broncho-
alveolar cell number and activity. Eur J Pharmacol Environ Toxicol
Pharmacol. 228:219-227.
18. Castleman, W. L, R. L. Sorkness, R. F. Lemanske, P. K. McAllister. 1990.
Viral bronchiolitis during early life induces increased numbers of
bronchiolar mast cells and airway hyperresponsiveness. Am J.Pathol.
137:821-831.
19. Sibille Y, Reynolds Y. 1990. Macrophages and polymorphonuclear
neutrophils in lung defence and injury. Am Rev Respir Dis. 141:471-501.
20. Nathan CF. 1987. Secretory products of alveolar macrophages. J Clin
Invest. 79:319-329.
21. Fels A, Cohn ZA. 1986. The alveolar macrophage. J Appl Physiol.
60:353-369.

137
22. Cutz, E., H. Levison, D. M. Cooper. 1978. Ultrastructure of airways in
children with asthma. Histopathology. 2:407-421.
23. Roche, W. R., R. Beasley, J. H. Williams, S. T. Holgate. 1989.
Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:520-524.
24. Wiggs, B. R., C. Bosken, P. D. Pare, A. James, J. C. Hogg. 1992. A
model of airway narrowing in asthma and in chronic obstructive
pulmonary disease. Am Rev Respir Dis. 145:1251-1258.
25. Brownstein DG. Sendai virus. In: Bhatt PN, Jacoby RO, Morse HC, New
AE, eds. 1986. Viral and mycoplasmal infections of laboratory rodents:
effects on biomedical research. Orlando: Academic Press, pp: 37-61.
26. Boorman GA, Hickman RL, Davis GW, Rhodes LS, White NW, Griffin TA,
Mayo J, Hamm TE. 1985. Serological titers to murine viruses in 90-day
and 2-year studies. In: Hamm TE, ed. Complications of Viral and
mycoplasmal infections in rodents to toxicology and research testing.
Washington: Hemisphere. pp:11-23.
27. Casebolt DB, Lindsey JR, Cassell GH. 1988. Prevalence rates of
infectious agents among commercial breeding populations of rats and
mice. Lab Anim Sci 38:327-329.
28. Burek JD, Zurcher C, Van Nunen MCJ, Hollander CF. 1977. A naturally
occurring epizootic caused by Sendai virus in breeding and aging rodent
colonies. II. Infection in the rat. Lab Anim Sci. 27:963-971.
29. Castleman WL. 1983. Respiratory tract lesions in weanling outbred rats
infected with Sendai virus. Am J Vet Res. 44:1024-1031.
30. Castleman WL, Brundage-Anguish LJ, Kreitzer L, Neuenschwander SB
1987. Pathogenesis of bronchiolitis and pneumonia induced in neonatal
and weanling rats by parainfluenza (Sendai) virus. Am J Pathol. 129:277-
286.
31. Giddens WE, Van Hoosier GL, Garlinghouse LE. 1987. Experimental
Sendai virus infection in laboratory rats. II. Pathology and
immunocytochemistry. Lab Anim Sci. 37:442-448.
32. Castleman WL. 1984. Alterations in pulmonary ultrastructure and
morphometric parameters induced by parainfluenza (Sendai) virus in rats
during postnatal growth. Am J Pathol. 114:322-335.

138
33. Castleman WL, Sorkness RL, Lemanske RF, Grasee G, Suyemoto MM.
1988. Neonatal bronchiolitis and pneumonia induces bronchiolar
hypoplasia and alveolar dysplasia in rats. Lab Invest. 59:387-396.
34. Castleman WL. 1990. Effects of neonatal viral bronchiolitis on airway
development In rats. Seminars in Respiratory Medicine. 11:314-320.
35. Sorden SD, Castleman WL: Virus-induced increases in airway mast cells
in Brown Norway rats are associated with enhanced pulmonary viral
replication and persisting lymphocytic infiltration. Exp Lung Res 1995,
21:197-213
36. Sorkness RL, Lemanske RF, Castleman WL. 1991.Persistent airway
hyperresponsiveness following neonatal viral bronchiolitis in rats. J Appl
Physiol. 70:375-383.
37. Sorden SD, Castleman WL. 1991. Brown Norway rats are high
responders to bronchiolitis, pneumonia, and bronchiolar mastocytosis
induced by parainfluenza virus. Exper Lung Research. 17:1025-1045.
38. Uhl, EW, WL Castleman, RL Sorkness, WW Busse, RF Lemanske, Jr.,
PK McAllister. Viral bronchiolitis in young BN rats induces persistent
airway dysfunction associated with bronchiolar fibrosis, persistent
inflammatory cell inflitration, and Increased transforming growth factor B,
(TGF-B,) expression. Amer J Resp Crit Care Med, In press.
39. Goldstein RH. 1991. Control of type I Collagen formation in the lung. Am
J Physiol. 261 :L29-L40.
40. Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am J Physiol
259:L159-L181.
41 Burkhardt A, Cottier H. 1989. Cellular events in alveolitis and the
evolution of pulmonary fibrosis. Virchows Arch B Cell Pathol Incl Mol
Pathol. 58:1-13.
42. Jetten AM. 1991. Growth and differentiation factors in tracheobronchial
epithelium. Am J Physiol. 260:L361-L373.
43. King RJ, Jones MB, Minoo P. 1989. Regulation of lung cell proliferation
by polypeptide growth factors. Am J Physiol. 257:L23-L38.
44. Kelly J. 1990. Cytokines of the lung. Am Rev Respir Dis. 141:765-788.

139
45. Elias JA, Freundlich B, Kern JA, Rosenbloom J. 1990. Cytokine networks
in the regulation of inflammation and fibrosis in the lung. Chest. 97:1439-
1445.
46. Lund LR, Riccio A, Andreasen PA. 1987. Tranforming growth factor-beta
is a strong and fast acting positive regulator of the level of type-1
plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
Embo J 6:1281-1286.
47. Whitby, DJ, Ferguson, MWJ. 1991. Immunohistochemical localization of
growth factors in fetal wound healing. Devel Biol. 147:207-215.
48. Hoyt DG, Lazo JS. 1988. Alterations in pulmonary mRNA encoding
procollagens, fibronectin and transforming growth factor-6 precede
bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther.
246:765-771.
49. Anzano MA, Roberts AB, Sporn MB. 1986. Anchorage-independent
growth of primary rat embryo cells Is Induced by platelet-derived growth
factor and inhibited by type-beta transforming growth factor. J Cell
Physiol. 126:312-318.
50. Leof EB, Proper JA, Goustin AS. 1986. Induction of c-sis mRNA and
activity similar to platelet-derived growth factor by transforming growth
factor 6:a proposed model for indirect mitogenesis involving autocrine
activity. Proc Natl Acad Sci. 83:2453-2457.
51. Schimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R.
1985. A significant part of macrophage-derived growth factor consists of
at least two forms of PDGF. Cell. 43:277-286.
52. Pierce GF, Brown D, Mustoe TA. 1991. Quantitative analysis of
inflammatory cell influx, procollagen type I synthesis, and collagen cross-
linking in excisional wounds: influence of PDGF-BB and TGF-beta 1
therapy. J Lab Clin Med. 117:373-382.
53. Fabisiak JP, Evans JN, Kelley J. 1989. Increased expression of PDGF-B
(c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during
chronic hyperoxia. Am J Respir Cell Mol Biol. 1:181-9.
54. Brant RPW, Smith S, Hemminki K, Koskinen H, Vainio H, Niman H, Ford
J. 1992. Serum oncoproteins and growth factors in asbestosis and
silicosis patients. Int J Cancer. 50:881-885.

140
55. Wahl, SM. 1992. Transforming growth factor beta (TGF-B) in
inflammation: a cause and a cure. J Clin Immunol. 12:61.
56. Poli G, Fauci AS. 1992. The effect of cytokines and pharmacologic agents
on chronic HIV infection. AIDS Research Human Retroviruses. 2:191-
197.
57. Aderka D, Holtmann H, Toker L, Hahn T, Wallach D. 1986. Tumor
necrosis factor induction by Sendai virus. J Immunol. 136:2938-2942.
58. Wong GHW, Goeddel DV. 1986.Tumor necrosis factor a and 6 inhibit
viral replication and synergize with interferons. Nature. 232:819.
59. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M,
Gemsa D. 1991. Influenza A virus infection of macrophages: enhanced
tumor necrosis factor-a (TGF-a) gene expression and
lipopolysaccharide-triggered TNF-a release. J Immunol. 147:3507-3513.
60. Smith PD, Saini SS, Raffeld, Manischewitz JF, Wahl SM. 1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest. 90:1642-1648.
61. Roberts AB, Anzano MA, Wakefield LM 1985. Type-IJ transforming growth
factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci.
82:119-23.
62. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr, Halper J, Shipley GD.
1985. Type (J tranforming growth factor is a growth stimulator and a
growth inhibitor. In: Feramisco J, Ozanne B, Stiles B, eds. Growth
factors and tranformation. Cancer cells 3. Cold Spring Harbor, NY: Cold
Spring Harbor Press. pp:65-71.
63. Takizawa H, Beckman JD, Yoshida M, Romberger D, Rennard SI. 1991.
Regulation of bovine bronchial epithelial cell proliferation and proto¬
oncogene expression by growth factors. Am J Respir Cell Mol Biol. 5:548-
555.
64. Pelton RW, Moses HL. 1990. The beta-type tranforming growth factor.
Am Rev Respir Dis. 142:S31-S35.
65. Pelton RW, Johnson MD, Perkett EA, Gold LI, Moses HL. 1991.
Expression of transforming growth factor-13,, -fl2 and -li3 mRNA and
protein in the murine lung. Am J Respir Cell Mol Biol. 5:522-530.

141
66. Kalter VG, Brody AR. Receptors for transforming growth factor-p (TGF-p)
on rat lung fibroblasts have higher affinity for TGF-p, than for TGF-p2. Am
J Respir Cell Mol Biol. 4:397-407.
67. Border WA, Noble NA.1994. Transforming growth factor-p in tissue
fibrosis. New Eng J Med. 331:1286-1292.
68. Fine A, Goldstein RH. 1987. The effect of transforming growth factor-13 on
cell proliferation and collagen formation by lung fibroblasts. J Biol Chem.
262:3897-3902.
69. Ignotz RA, Endo R, Massague J. 1987. Regulation of fibronectin and type
I collagen mRNA levels by tranforming growth factor-6. J Biol Chem. 262-
6443-6446.
70. Roberts CJ, Birkenmeier TM, McQuillan JJ. 1988. Transforming growth
factor beta stimulates the expression of fibronectin and of both subunits of
the human fibronectin receptor by cultured human lung fibroblasts. J Biol
Chem. 263:4586-4592.
71. Raghow, R Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. 1987.
Transforming growth factor beta increases steady state levels of type I
procollogen and fibronectin messenger RNAs posttranscriptionally in
cultured human dermal fibroblasts. J Clin Invest. 79:1285-1288.
72. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel
P, Heath JK. 1987. Transforming growth factor beta modulates the
expression of collagenase and metalloproteinase inhibitor. Embo J.
6:1899-1904.
73. Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. 1992.
Mechanisms of fibrin formation and lysis by human lung fibroblasts:
influence of TGF-6 and TNF-a. Am J Physiol. 263:L487-L494.
74. Goldsmith KT, Gammon RB, Garver Rl. 1991. Modulation of bFGF in lung
fibroblasts by TGF-6 and PDGF. Am J Physiol. 261 :L378-L385.
75. Khalil N, Greenberg AH. 1991. The role of TGF-6 in pulmonary fibrosis.
In: Clinical applications of TGF-6. Wiley, Chichester (Ciba Foundation
Symposium 157) p 194-211.
76. McCartney-Francis NL, Wahl SM. 1994. Transforming growth factor-6: a
matter of life and death. J Leukocyte Biol. 55:401-409.

142
77. Shah, M, Foreman, DM, Ferguson, MWJ. 1992. Control of scarring in
adult wounds by antibody to transforming growth factor R. Lancet.
239:213-214
78. Gruschwitz MP, Muller PU, Sepp N, Hofer E, Fontana A, Wick G.1990.
Transcription and expression of transforming growth factor type beta in
the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest
Dermatol. 94:197-203.
79. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L,
Zern MA 1989. In vitro and in vivo association of transforming growth
factor -R1 with hepatic fibrosis J Cell Biol. 108:2477-2482.
80. Border WA, Ruoslahti E. 1992. Transforming growth factor-R in disease:
the dark side of tissue repair. J Clin Invest. 90:1-7.
81. Khalil N, Bereznay O, Sporn M, Greenberg AH. 1989. Macrophage
production of transforming growth factor R and fibroblast collagen
synthesis in chronic pulmonary inflammation. J Exp Med. 170:727-737.
82. Schrier DJ, Kunkel RG, Phan SH. 1983. The role of strain variation in
murine bleomycin-induced pulmonary fibrosis. Am Rev Resp Dis. 127:63-
66.
83 Ross R, Raines EW, Bowen-Pope DF.1986.The biology pf platelet-
derived growth factor. Cell. 46:155-69.
84. Giri SN, Hyde DM, Hollinger MA. 1993. Effect of antibody to transforming
growth factor R on bleomycin induced accumulation of lung collagen in
mice. Thorax. 48:959-966.
85. Khalil N, O’Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A,
Bereznay OH, Greenberg AH. 1991. Increased production and
immunohistochemical localization of transforming growth factor-R in
idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 5:155-162.
86. Denis M. 1994. Neutralization of transforming growth factor-R, in a mouse
model of immune-induced lung fibrosis. Immunol. 82:584-590.
87. Brandes ME, Allen JB, Ogawa Y, Wahl SM. 1991. Transforming growth
factor-R, suppresses acute and chronic arthritis in experimental animals. J
Clin Invest. 87:1108-1113.

143
88. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM.1990.
Rapid onset synovial inflammation and hyperplasia induced by
transforming growth factor-13. J Exp Med. 177:225-230.
89. Gamble JR, Khew-Goodall Y, Vadas MA. 1993. Transforming growth
factor-13 inhibits E-selectin expression on human endothelial cells. J
Immunol. 150:4494-4503.
90. Lefer AM, Ma XL, Weyrich AS, Scalia R. 1993. Mechanism of the
cardioprotective effect of transforming growth factor-13, in feline myocarial
ischemia and reperfusion. Proc Natl Acad Sci USA. 90:1018-1022.
91. Santambrogio L, Hochwald GM, Saxena B, Leu CH, Martz JE, Carlino
JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ. 1993. Studies on
the mechanism by which transforming growth factor-13 (TGF-13) protects
against allergic encephalomyelitis. J Immunol. 151:1116-1127.
92. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW. 1992
Modulation of the immune response by transforming growth factor beta.
Int Arch Allergy Immunol. 99:1-7.
93. Tsunawaki SM. Sporn A, Ding CF, Nathan. 1988. Deactivation of
macrophages by transforming growth factor-13. Nature (London)1988,
334:260-262.
94. Ding A, Nathan CF, Graycar J, Derynck R, Stuer DJ, Srimal S. 1990.
Macrophage deactivating factor and transforming growth factors-13,, -I32,
and -I33 inhibit induction of macrophage nitrogen oxide synthesis by IFN-
gamma. J Immunol. 145:940-944.
95. Barral-Netto M, Barral A, Brownell CE, Skeiky YAW, Ellingsworth LR,
Twardzik DR, Reed SG.1992. Transforming growth factor-13 in leishmanial
infection: a parasite escape mechanism. Science. 257:545-548.
96. McCartney-Francis N, Mizel D, Wong H, Wahl LM, Wahl SM. 1990. TGF-
p regulates production of growth factors and TGF-p by human peripheral
blood monocytes. Growth Factors. 4:27-35.
97. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. 1988. Transforming
growth factor-beta (TGF-I3) is chemotactic for human monocytes and
induces their expression of angiogenic activity. Biochem Biophys Res
Commun. 157:793-800.

144
98. Turner M, Chantry D, Feldmann M. 1990. Transforming growth factor-8
induces the production of interleukin 6 by human peripheral blood
mononuclear cells. Cytokine 2:211-216.
99. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress
RE, Karlsson S. 1995. Transforming growth factor-8, null mice. An
animal model for inflammatory disorders. Amer J Pathol. 146:264-275.
100. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts
AB, Sporn MB Ward JM, Karlsson S. 1993. Transforming growth factor-8,
null mutation in mice causes excessive inflammatory response and early
death. Proc Natl Acad Sci USA. 90:770-774.
101. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R,
Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. 1992.
Targeted disruption of the mouse transforming growth factor-8, gene
results in multifocal inflammatory disease. Nature. 359:693-699.
102. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG.
1993. Transforming growth factor 8 as a virulence mechanism for
Leishmania braziliensis. Proc Natl Acad Sci. 90:3442-3446.
103. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, S. G. Reed SG. 1992.
Regulation of Trypanosoma cruzi infections in vitro and in vivo by
transforming growth factor 8. J Exp Med. 175:169-174.
104. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. 1994. Enhancement
of intracellular growth of Mycobacterium tuberculosis in human monocytes
by transforming growth factor-B,. J Infect Dis. 170:1229-1237.
105. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. 1992. tat
protein stimulates production of transforming growth factor-p, by marrow
macrophages: A potential mechanism for human immunodeficiency virus-
1-induced hematopoietic suppression. Blood 12:3036-3043.
106. Lazdins JK, Klimkait T, Woods-Cook K, Walker M, Alteri E, Cox D,
Cerletti N, Shipman R, Bilbe G, McMaster G. 1991. In vitro effect of
transforming growth factor-8 on progession of HIV infection in primary
mononuclear phagocytes. J Immunol. 147:1201-1207.
107. Alcami J, Paya CV, Virelizier JL, Michelson S. 1993. Antagonistic
modulation of human cytomegalovirus replication by transforming growth
factor-8 and basic fibroblast growth factor. J General Virol. 74:269-274.

145
108. Beutler B, Cerami A. 1986. Cachectin:more than a tumor necrosis factor.
N Engl J Med. 316:379-385.
109. Phan SH, Kunkel SL. 1992. Lung cytokine production in bleomycin-
induced pulmonary fibrosis. Exper Lung Res. 18:29-43.
110. Kips JC, Tavernier J, Pauwels RA. 1992.Tumor necrosis factor causes
bronchial hyperresponsiveness in rats. Am Rev Respir Dis. 145:332-336.
111. Jaattela M. 1991. Biologic activities and mechanisms of action of tumor
necrosis factor-a/cachectin. Lab Invest. 64:724-742.
112. Lamas AM, Mulroney CM, Schleimer RP. 1988. Studies on the adhesive
interaction between purified eosinophils and cultered vascular endothelial
cells. J Immunol. 141:1500-1505.
113. Caux C, Sacland S, Favre C, DuvertV, Mannoni P, Bancherau J.1990.
Tumor necrosis factor-alpha strongly potentiates interleukin-3 and
granulocyte-macrophage colony-stimulating factor-induced proliferation of
human CD34+ hematopoietic progenitor cells. Blood. 75:2292-2298.
114. Silberstein DS, David JR. 1986.TNF enhances eosinophil toxicity to
Schistosoma mansoni larvae. Proc Natl Acad Sci USA. 83:1055-1059.
115. Klein LM, Lavker RM, Matis WL, Murphy GF. 1989. Degranulation of mast
cells induces an endothelial antigen central to leukocyte adhesion. Proc
Natl Acad Sci USA. 86:8972-8976.
116. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M. 1991. Tumor
necrosis factor plays an essential role in determining hypersensitivity
pneumonitis in a mouse model. Am J Respir Cell Mol Biol. 5:477-483.
117. Ohkawara, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H,
Ohkuda K, Takishima. 1992. Human mast cells and pulmonary
macrophages produce tumor necrosis factor-a in sensitized lung tissue
after IgE receptor triggering. Amer Respir Cell Mol Biol.7:385-392.
118. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P.1989.Tumor
necrosis factor cachectin plays a key role in bleomycin-induced
pneumopathy and fibrosis. J Exp Med. 170:655-664.

146
119. Piguet PF, Vesin C. 1994. Pulmonary platelet trapping induced by
bleomycin: correlation with fibrosis and involvement of the P2 integrins. Int
J Exp Path. 75:321-328.
120. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. 1990.
Requirement of tumor necrosis factor for the development of silica-
induced pulmonary fibrosis. Nature. 344:245-247.
121. Domke-Opiz I, Kirchner H. 1990. Stimulation of macrophages by
endotoxin results in the reactivation of persistant herpes simplex virus
infection. Scand J Immunol. 32:69.
122. Would WSM 1993. Adenovirus genes that modulate the sensitivity of
virus-infected cells to lysis by TNF. J Cell Biochem. 53:329-335.
123. Upton C, Macen JL, Schreiber M, McFadden G. 1991. Mxyoma virus
expresses a secreted protein with homology to the tumor necrosis factor
gene family that contributes to viral virulence. Virol. 184:370-382.
124. Gooding LR. 1992. Virus proteins that counteract host immune defences.
Cell. 71:5-7.
125. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci
AD. 1989. Tumor necrosis factor a induces expression of human
immunodeficiency virus in a chronically Infected T-cell clone. Proc Natl
Acad Sci USA. 86:2365.
126. Martinet Y, Rom WN, Grotendorst GR. 1987. Exaggerated spontaneous
release of platelet-derived growth factor by alveolar macrophages from
patients with idiopathic pulmonary fibrosis. N Engl J Med. 317:202-209.
127. Pledger WJ, Stiles CD, Antoniades HN, Scher CD. 1977. Induction of
DNA synthesis in BALB/C-3T3 cells by serum components: reevaluation
of the commitment process. Proc Natl Acad Sci. 74:4481 -4485.
128. Deuel TF. 1987. Polypeptide growth factors: roles in normal and abnormal
cell growth. Annu Rev Cell Biol. 3:443-492.
129. Raines EW, Dower SK. 1989. Interleukin-1 mitogenic activity for
fibroblasts and smooth muscle is due to PDGF-AA. Science. 243:393-
396.

147
130. Paulsson Y, Austgulen R, Hofsli E, Heldin CH, Westermark B, Nissen-
Meyer J. 1989. Tumor necrosis factor-induced expression of platelet-
derived growth factor A-chain messenger RNA in fibroblasts. Exp Cell
Res 180:490-496.
131. Buch S, Jones C, Sweezey N, Tanswell K, Post M 1991. Platelet-derived
growth factor and growth-related genes in the rat lung. I. developmental
expression. Am J Respir Cell Mol Biol. 5:371-376.
132. Gersuk GM, Westermark B, Mohabeer AJ, Challita PM, Pattamakom S,
Pattengale PK. 1991. Inhibition of human natural killer cell activity by
PDGF. III. Membrane binding studies and differential biological effect of
recombinant PDGF isoforms. Scand J Immunol. 33:521-532.
133. Daynes RA, Dowell T, Araneo BA. 1991. Platlet-derived growth factor is a
potent biological response modifier of T cells. J Exp Med. 174:1323-1333.
134. Bach MK, Brashler JR, Stout BK, Johnson HG, Sanders ME, Lin AH,
Gorman RR, Bienkowski MJ, Ishizaka T. 1992. Activation of eosiophils by
PDGF. Int Arch Allergy Appl Immunol. 97:121-9.
135. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J,
Maxwell M, Selman M 1990. Platlet-derived growth factor in idiopathic
pulmonary fibrosis. J Clin Invest 1990;86:1055-1064.
136. Vignaud JM, Allam M, Martinet N, Pech M, Plenat F, Martinet Y. 1991.
Presence of platelet-derived growth factor in normal and fibrotic lung is
specifically associated with interstitial macrophages, while both interstitial
macrophages and alveolar epithelial cells express the c-sis proto¬
oncogene. Am J Respir Cell Mol Biol. 5:531-538.
137. Lasky JA, Coin PG, Lindroos PM, Ostrowski LE, Brody AR, Bonner JC.
1995. Chrysotile asbestos stimulates platelet-derived growth factor-AA
production by rat lung fibroblasts in vitro: evidence for an autocrine loop.
Am J Respir Cell Mol Biol. 12:162-170.
138. Gauldie J, Jordana M, Cox G. 1993. Cytokines and pulmonary fibrosis.
Thorax. 48:931-935.
139. Puissant C, Hondebine LM. 1990. An improvement of the single-step
method of RNA isolation by acid guanidium thiocyanate-phenol-
chloroform extraction. BioTechniques. 8:148-149.
Á

148
140. Farmer SJ, Fliss AE, Simmen RCM. 1990. Complementary DNA cloning
and regulation of expression of the messenger RNA encoding a
pregnancy-associated porcine uterine protein related to human
antileukoproteinase. Molec Endocrin. 4:1095-1104.
141. Church GM, Gilbert W. 1984. Genomic sequencing. Proc Natl Acad Sci
USA. 81:1991-1995.
142. Simmons DM, Arriza JL, Swanson LW. 1984. A complete protocol for in
situ hybridization of messenger RNAs in brain and other tissues with
radio-labeled single stranded RNA probes. J Histotechnol. 12:169-181.
143. Zar JH: Biostatistical Analysis, 2nd ed. 1984. Englewood Cliffs, NJ,
Prentice Hall. pp. 130-131.
144. Sprenger H, Bacher M, Rischkowsky E, Bender A, Nain M, Gemsa D.
1994. Characterization of a high molecular weight tumor necrosis factor-a
mRNA in influenza A virus-infected macrophages. J Immunol. 152:280-
289.
145. Smith PD, Saini S, Raffeld S, Manischewitz JF, Wahl SM.1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest 90:1642-1648.
146. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M,
Gemsa D.1991. Influenza A virus infection of macrophages: enhanced
tumor necrosis factor-a (TGF-a) gene expression and
lipopolysaccharide-triggered TNF-a release. J Immunol 147:3507-3513.
147. Hajjar KA, Hajjar DP, Silversteln RL, Nachman RL. 1987. Tumor
necrosis factor-mediated release of platelet-derived growth factor from
cultured endothelial cells. J Exp Med. 166:235.
148. Sugarman BJ, Aggarwal BB, Figarl IS, Palladino MA. 1985.
Recombinant human tumor necrosis factor-a: effects on proliferation of
normal and transformed cells in vitro. Science (Wash. DC). 230:943.
149. Tracy KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo
GC, Beutler B, Cotran RS, Cerami A, Lowry SF. 1988.
Cachectin/tumor necrosis factor induces cachexia, anemia, and
inflammation. J Exp Med 167:1211.

149
150. Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H,
Lesslauer W, Cohen J. 1994. Protective effect of 55- but not 75-kD
soluble tumor necrosis factor recepter-immunoglobulin G fusion proteins
in an animal model of gram-negative sepsis. J Exp Med. 180:2173-2179.
151. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP,
Madani H, Widmer MB. 1993. Soluable tumor necrosis factor (TNF)
receptors are effective therapeutic agents in lethal endotoxemia and
function simultaneously as both TNF carriers and TNF antagonists. J
Immunol. 151:1548-1561.
152. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowery SF.
1992. Tumor necrosis factor soluable receptors circulate during
experimental and clinical inflammation and can protect against excessive
tumor necrosis factor a in vitro and in vivo. Proc Natl Acad Sci USA.
89:4845-4849.
153. Castleman W.L, Owens SB, Brundage-Anguish LJ. 1989. Acute and
persistent alterations in pulmonary inflammatory cells and airway mast
cells induced by Sendai virus infection in neonatal rats. Vet Pathol.26:18-
25 (Erratum 26:187, 1989).
154. Ziegler-Heitbrock HWL, Reithmuller G. 1984. A rapid assay for
cytotoxicity of unstimulated human monocytes. JNCI. 72:23-29.
155. Ziegler-Heitbrock HWI, Munker R, Thiel E, Krebs I, Reithmuller
G.1985. Killer cell activity of human monoblastic leukemia cells as
detected with a monocyte-specific target cell. Blood.65:8-14.
156. Rollinghoff M, Warer NL. 1973. Specificity of in vivo tumor rejection
assessed by mixing immune spleen cells with target and unrelated tumor
cells. Proc Soc Exp Biol Med. 144:813-818.
157. Arizono N, Koreto O, Nakao S, Iwai Y, Kushima R, Takeoka O. 1987.
Phenotypic changes in mast cells proliferating in the rat lung following
infection with Nippostrongylus brasiliensis. Virchows Arch B. 54:1-7.
158. Sugarman BJ, Aggarwal BB, Figari IS, Palladino MA. 1985.
Recombinant human tumor necrosis factor-a: effects on proliferation of
normal and transformed cells in vitro. Science (Wash. DC). 230:943.

150
159. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H,
Kirchner H. 1986. Antiviral effects of recombinant tumour necrosis factor
in vitro. Nature. 323:816-818.
160. Wong GH, Goeddel DV. 1986. Tumour necrosis factors a and p inhibit
virus replication and synergize with interferons. Nature. 323:819-822.
161. Feduchi E, Alonso MA, Carrasco L. 1989. Human gamma interferon
and tumor necrosis factor exert a synergistic blockade on the replication
of herpes simplex virus. J Virol. 63:1354-1359.
162. Heise MT, Virgin IV HW, 1995. The T-cell-dependent role of gamma
interferon and tumor necrosis factor alpha in macrophage activation
during murine cytomegalovirus and herpes simplex virus infections. J
Virol. 69:904-909.
163. Would WSM 1993. Adenovirus genes that modulate the sensitivity of
virus-infected cells to lysis by TNF. J Cell Biochem. 53:329-335.
164. Upton C, Macen JL, Schreiber M, McFadden G . 1991. Mxyoma virus
expresses a secreted protein with homology to the tumor necrosis factor
gene family that contributes to viral virulence. Virol. 184:370-382.
165. Gooding LR. 1992. Virus proteins that counteract host immune defences.
Cell. 71:5-7.
166. Koff WC, Fann AV. 1986. Human tumor necrosis factor-alpha kills
herpesvirus-infected but not normal cells. Lymphokine Res.5:215-221.
167. Hernandez-Pando R, Rook GAW. 1994. The role of TNF-a in T-cell-
mediated inflammation depends on the Th1/Th2 cytokine balance.
Immunology 82:591-595.
168. Alwan WH, Kozlowska WJ, Openshaw PJM. 1994. Distinct types of
lung disease caused by functional subsets of antiviral T cells. J Exp Med.
179:81-89.
169. Bascom CC, Wolfshohl JR, Coffey RJ, Madisen L, Webb NR, Purchio AR,
Dertnck Moses HL. Complex regulation of transforming growth factor 81,
(12, and 83 m RNA expression in mouse fibroblasts and keratinocytes by
transforming growth factors 81 and 82. Molec Cellul Biol 1989;9:5508-
5515.

151
170. Smith PD, Saini SS, Raffeld, Manischewitz JF, Wahl SM.1992.
Cytomegalovirus induction of tumor necrosis factor-a by human
monocytes and mucosal macrophages. J Clin Invest 90:1642-1648.
171. Goldfeld AE, Maniatis T. 1989. Coordinate induction of tumor necrosis
factor a and interferon p in human B cells and monocytes. Proc Natl Acad
Sci USA. 86:1490-1494.
172. Greenberg ME, Bender TP. 1992. Identification of newly transcribed
RNA, in Short Protocols in Molecular Biology 2nd Ed. John Wiley & Sons.
New York, pp 4-25 to 4-29.
173. Baeuerle PA, Henkel T. 1994. Function and activation of NK-kB in the
immune system. Annu Rev Immunol. 12:141-179
174. Pahl HL, Baeuerle PA. 1995. Expression of infuenza virus
hemagglutinin activates transcription factor NK-kB. J Virol. 69:1480-
1484.
175. Garoufalis E, Kwan I, Lin R, Mustafa A, Pepin N, Roulston A,
Lacoste J, Hiscott J. 1994. Viral induction of the human beta interferon
promoter: modulation of transcription of NK-kBIrel proteins and interferon
regulatory factors. J Virol. 68:4707-4715.
176. Roulston A, Conti L, McKiel V, Wainberg MA, Hiscott J. 1994. Virus
induction of NK-KB/Rel proteins and type I interferon gene expression in
myelomonoblastic cells. Leukemia. 8 suppl 1:s170-s174.
177. Pahl HL, Baeuerle PA. 1995. A novel signal transduction pathway from
the ER to the nucleus is mediated by transcription factor NK-kB. Embo J.
14:2580-2588.
178. Kumar AJ, Haque J, Lacoste J, Hiscott J, Williams BRG. 1994. The
Double-stranded RNA dependent protein kinase PKR activates
transcription factor NK-kB by phosphorylating IkB. Proc Natl Acad Sci
USA. 91:6288-6292.

BIOGRAPHICAL SKETCH
I was born on February 22, 1957, to Charles Harrison and Natalie Whitford
Uhl, and named Elizabeth Whitford Uhl. Both of my parents are botanists and
Cornell professors, which inspired me with a love of science, and a special
interest in animals that eat plants, particularly horses. I was born and raised in
Ithaca, New York, and was the youngest of four children. Every summer of my
childhood was spend on plant collecting trips throughout Canada, Mexico, and
the United States. I received my B.S. for Cornell University, and went to New
York City to work as a research assistant in the Arrhythmia Control Unit at
Columbia-Presbyterian Medical Center. From there I went back to Ithaca to
attend veterinary school, where I became interested in pathology. To pursue
this interest, I came to University of Florida to take a residency in anatomic
pathology. Upon completion of the residency, I entered the graduate program.
152

I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
William L. Castleman, Chair
Professor of Veterinary Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
¿Hoy A ■£>.
Claus D. Buergelt f
Professor of Veterinary Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Ml-\.^r —
Mary Brovin
Associate Professor of Veterinary
Medicine
I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Rosalia C. M. Simmen
Professor of Animal Science

I certify that I have read this study and that in my opinion it conforms to
acceptable standards of scholarly presentation and is adequate, in scope and
quality, as a dissertation for the degree of Doctor of Philosophy.
Anthony Barbet
Professor of Veterinary Medicine
This dissertation was submitted to the Graduate Faculty of the College of
Veterinary Medicine and to the Graduate School and was accepted as partial
fulfillment of the requirements for the degree of Doctor of Philosophy.
May, 1996
Dean, College of Veterinary
Medicine
Dean, Graduate School

UNIVERSITY OF FLORIDA
3 1262 08554 6249



113
induction of TNF-a gene expression. Recently, the viral surface hemagglutinin
of murine influenza virus was found to strongly activate NF-kB DNA binding and
transactivation.174 The mechanism by which a structural viral protein could
activate NF-kB is unclear, but it has been postulated to be associated with the
synthesis of large amounts of hemagglutinin during viral infection, since
intracellular accumulation of proteins can activate NF-kB.177 Another proposed
mechanism is the phosphorylation-dependent degradation of IkB by viral
induction of double-stranded RNA-dependent kinase (double-stranded RNA-
dependent kinase has been shown to phosphorylate IkB and induce NF-kB
binding activity).178
The significance of direct viral induction of TNF-a gene expression in the
pathogenesis of Sendai virus infection in rats is unclear, since TNF-a production
is also stimulated by numerous inflammatory and immunological mediators.111
Early induction of TNF-a by virus-induced transcriptional upregulation may be a
critical factor in controlling viral replication and determining the extent of virus-
induced airway damage. In contrast, if viral replication is prolonged, as occurs
in the virus-susceptible BN rats, continued viral induction of TNF-a transcription
may contribute to, or be a stimulus for the prolonged expression of TNF-a that is
associated with the development of Sendai virus-induced bronchiolar fibrosis.
In contrast to TNF-a, TGF-p, gene expression in macrophages does not
appear to be directly upregulated by Sendai virus. Significant increases in TGF-
p, mRNA were not observed until 72 hours after virus-inoculation, which is after


38
virus infection induces increased expression of TGF-ft, in bronchiolar walls prior
to fibrosis and to determine whether TGF-p, gene expression induced by viral
bronchiolitis is greater in BN rats that are susceptible to virus-induced fibrosis
than in F344 rats that are resistant to this virus-induced effect.
Materials and Methods
Animals
Twenty-two day old weanling male BN and F344 rats were purchased from
Harlan Sprague Dawley Inc., Indianapolis, IN. They were negative for serum
antibodies to Sendai virus, pneumonia virus of mice, mycoplasma, Kilham rat
virus, and sialodacryoadenitis virus/rat corona virus, and for respiratory aerobic
bacteria. The control and experimental groups were separated and housed in
adjacent isolation cubicles.
Experimental Protocol
Three days after arrival, the rats in the experimental group were inoculated
with parainfluenza type 1 (Sendai) virus at a concentration of 1-3 plaque forming
units per ml of gas in an aerosol exposure apparatus (Tri-R Instruments,
Rockville Center, NY) for 15 minutes. Viral assays to calibrate exposure were
performed as previously described.33'32 Sendai virus strain P3193 produced in


APPENDIX
ATTEMPTED DIGOXIGENIN NUCLEAR RUN ON ASSAYS
Protocol
This protocol was extensively modified from one using 32P outlined by M E.
Greenberg and T.P. Bender in Short Protocols in Molecular Biology. 2nd
Ed. 1992. pp 4-25.
Isolate nuclei and cytoplasmic RNA
1) Pellet the cells from one to five 175-cm2 tissue culture flasks (approx 5 x
107 cells), 5 min at 500xg (1500rpm), 4C. Remove the supernatant
completely, and loosen pellet by vortexing at half maximal speed for 5 sec.
Gently resuspend cells in 5 ml PBS, add 45 ml PBS, and collect again by
centrifugation. Wash twice more; remove sample to count cells from the
last suspension.
2) Add 4 ml NP-40 lysis buffer, and continue vortexing as buffer is added.
When lysis buffer is completely added, vortex cells at half maximal speed
for 10 sec.
129